{
  "file_name": "CUAD_v1/full_contract_pdf\\Part_I\\Manufacturing\\KitovPharmaLtd_20190326_20-F_EX-4.15_11584449_EX-4.15_Manufacturing Agreement.pdf",
  "annotations": [
    {
      "id": "KitovPharmaLtd_20190326_20-F_EX-4.15_11584449_EX-4.15_Manufacturing Agreement__Document Name_0",
      "question": "Highlight the parts (if any) of this contract related to \"Document Name\" that should be reviewed by a lawyer. Details: The name of the contract",
      "answer_text": "PRODUCT MANUFACTURING AGREEMENT",
      "page_number": 0,
      "words": [
        {
          "text": "PRODUCT MANUFACTURING AGREEMENT",
          "bbox": [
            1216.0,
            510.0,
            2093.0,
            546.0
          ],
          "confidence": 0.994750440120697
        }
      ],
      "nearby_headers": [
        {
          "text": "THE SYMBOL <****\" DENOTES PLACES WHERE PORTIONS OF THIS DOCUMENT HAVE BEEN OMITTED PURSUANT TO A REQUEST",
          "page": 0,
          "bbox": [
            304.0,
            338.0,
            3009.0,
            380.0
          ]
        },
        {
          "text": "FOR CONFIDENTIAL TREATMENT. SUCH MATERIAL WILL BE FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE",
          "page": 0,
          "bbox": [
            399.0,
            398.0,
            2907.0,
            435.0
          ]
        },
        {
          "text": "COMIMISSION.",
          "page": 0,
          "bbox": [
            1503.0,
            455.0,
            1805.0,
            492.0
          ]
        },
        {
          "text": "PRODUCT MANUFACTURING AGREEMENT",
          "page": 0,
          "bbox": [
            1216.0,
            510.0,
            2093.0,
            546.0
          ]
        },
        {
          "text": "WHEREAS:",
          "page": 0,
          "bbox": [
            281.0,
            848.0,
            515.0,
            884.0
          ]
        },
        {
          "text": "WHEREAS:",
          "page": 0,
          "bbox": [
            279.0,
            959.0,
            513.0,
            996.0
          ]
        },
        {
          "text": "WHEREAS:",
          "page": 0,
          "bbox": [
            281.0,
            1071.0,
            515.0,
            1107.0
          ]
        }
      ]
    },
    {
      "id": "KitovPharmaLtd_20190326_20-F_EX-4.15_11584449_EX-4.15_Manufacturing Agreement__Parties_0",
      "question": "Highlight the parts (if any) of this contract related to \"Parties\" that should be reviewed by a lawyer. Details: The two or more parties who signed the contract",
      "answer_text": "KITOV Pharma Ltd.",
      "page_number": 0,
      "words": [
        {
          "text": "at ****, Israel (\"Dexcel'') and KITOV Pharma Ltd., with its registered office at 132 Menachem Begin Road, Azrieli Center, Tel Aviv, 6701101, Israel.",
          "bbox": [
            274.0,
            618.0,
            3000.0,
            665.0
          ],
          "confidence": 0.9887864589691162
        }
      ],
      "nearby_headers": [
        {
          "text": "THE SYMBOL <****\" DENOTES PLACES WHERE PORTIONS OF THIS DOCUMENT HAVE BEEN OMITTED PURSUANT TO A REQUEST",
          "page": 0,
          "bbox": [
            304.0,
            338.0,
            3009.0,
            380.0
          ]
        },
        {
          "text": "FOR CONFIDENTIAL TREATMENT. SUCH MATERIAL WILL BE FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE",
          "page": 0,
          "bbox": [
            399.0,
            398.0,
            2907.0,
            435.0
          ]
        },
        {
          "text": "COMIMISSION.",
          "page": 0,
          "bbox": [
            1503.0,
            455.0,
            1805.0,
            492.0
          ]
        },
        {
          "text": "PRODUCT MANUFACTURING AGREEMENT",
          "page": 0,
          "bbox": [
            1216.0,
            510.0,
            2093.0,
            546.0
          ]
        },
        {
          "text": "WHEREAS:",
          "page": 0,
          "bbox": [
            281.0,
            848.0,
            515.0,
            884.0
          ]
        },
        {
          "text": "WHEREAS:",
          "page": 0,
          "bbox": [
            279.0,
            959.0,
            513.0,
            996.0
          ]
        },
        {
          "text": "WHEREAS:",
          "page": 0,
          "bbox": [
            281.0,
            1071.0,
            515.0,
            1107.0
          ]
        }
      ]
    },
    {
      "id": "KitovPharmaLtd_20190326_20-F_EX-4.15_11584449_EX-4.15_Manufacturing Agreement__Parties_0",
      "question": "Highlight the parts (if any) of this contract related to \"Parties\" that should be reviewed by a lawyer. Details: The two or more parties who signed the contract",
      "answer_text": "Dexcel and Kitov are hereinafter jointly the \"Parties\" and individually a \"Party.\"",
      "page_number": 0,
      "words": [
        {
          "text": "(\"Kitov'). Dexcel and Kitov are hereinafter jointly the \"Parties' and individually a \"Party.\".",
          "bbox": [
            279.0,
            678.0,
            1945.0,
            722.0
          ],
          "confidence": 0.98404461145401
        }
      ],
      "nearby_headers": [
        {
          "text": "THE SYMBOL <****\" DENOTES PLACES WHERE PORTIONS OF THIS DOCUMENT HAVE BEEN OMITTED PURSUANT TO A REQUEST",
          "page": 0,
          "bbox": [
            304.0,
            338.0,
            3009.0,
            380.0
          ]
        },
        {
          "text": "FOR CONFIDENTIAL TREATMENT. SUCH MATERIAL WILL BE FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE",
          "page": 0,
          "bbox": [
            399.0,
            398.0,
            2907.0,
            435.0
          ]
        },
        {
          "text": "COMIMISSION.",
          "page": 0,
          "bbox": [
            1503.0,
            455.0,
            1805.0,
            492.0
          ]
        },
        {
          "text": "PRODUCT MANUFACTURING AGREEMENT",
          "page": 0,
          "bbox": [
            1216.0,
            510.0,
            2093.0,
            546.0
          ]
        },
        {
          "text": "WHEREAS:",
          "page": 0,
          "bbox": [
            281.0,
            848.0,
            515.0,
            884.0
          ]
        },
        {
          "text": "WHEREAS:",
          "page": 0,
          "bbox": [
            279.0,
            959.0,
            513.0,
            996.0
          ]
        },
        {
          "text": "WHEREAS:",
          "page": 0,
          "bbox": [
            281.0,
            1071.0,
            515.0,
            1107.0
          ]
        }
      ]
    },
    {
      "id": "KitovPharmaLtd_20190326_20-F_EX-4.15_11584449_EX-4.15_Manufacturing Agreement__Parties_0",
      "question": "Highlight the parts (if any) of this contract related to \"Parties\" that should be reviewed by a lawyer. Details: The two or more parties who signed the contract",
      "answer_text": "Dexcel",
      "page_number": 0,
      "words": [
        {
          "text": "This Product Manufacturing Agreement (\"Agreement') is made as of the Effective Date by and between DEXCEL LTD., with its registered address.",
          "bbox": [
            275.0,
            563.0,
            3023.0,
            609.0
          ],
          "confidence": 0.989086925983429
        }
      ],
      "nearby_headers": [
        {
          "text": "THE SYMBOL <****\" DENOTES PLACES WHERE PORTIONS OF THIS DOCUMENT HAVE BEEN OMITTED PURSUANT TO A REQUEST",
          "page": 0,
          "bbox": [
            304.0,
            338.0,
            3009.0,
            380.0
          ]
        },
        {
          "text": "FOR CONFIDENTIAL TREATMENT. SUCH MATERIAL WILL BE FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE",
          "page": 0,
          "bbox": [
            399.0,
            398.0,
            2907.0,
            435.0
          ]
        },
        {
          "text": "COMIMISSION.",
          "page": 0,
          "bbox": [
            1503.0,
            455.0,
            1805.0,
            492.0
          ]
        },
        {
          "text": "PRODUCT MANUFACTURING AGREEMENT",
          "page": 0,
          "bbox": [
            1216.0,
            510.0,
            2093.0,
            546.0
          ]
        },
        {
          "text": "WHEREAS:",
          "page": 0,
          "bbox": [
            281.0,
            848.0,
            515.0,
            884.0
          ]
        },
        {
          "text": "WHEREAS:",
          "page": 0,
          "bbox": [
            279.0,
            959.0,
            513.0,
            996.0
          ]
        },
        {
          "text": "WHEREAS:",
          "page": 0,
          "bbox": [
            281.0,
            1071.0,
            515.0,
            1107.0
          ]
        }
      ]
    },
    {
      "id": "KitovPharmaLtd_20190326_20-F_EX-4.15_11584449_EX-4.15_Manufacturing Agreement__Parties_0",
      "question": "Highlight the parts (if any) of this contract related to \"Parties\" that should be reviewed by a lawyer. Details: The two or more parties who signed the contract",
      "answer_text": "DEXCEL LTD.",
      "page_number": 0,
      "words": [
        {
          "text": "This Product Manufacturing Agreement (\"Agreement') is made as of the Effective Date by and between DEXCEL LTD., with its registered address.",
          "bbox": [
            275.0,
            563.0,
            3023.0,
            609.0
          ],
          "confidence": 0.989086925983429
        }
      ],
      "nearby_headers": [
        {
          "text": "THE SYMBOL <****\" DENOTES PLACES WHERE PORTIONS OF THIS DOCUMENT HAVE BEEN OMITTED PURSUANT TO A REQUEST",
          "page": 0,
          "bbox": [
            304.0,
            338.0,
            3009.0,
            380.0
          ]
        },
        {
          "text": "FOR CONFIDENTIAL TREATMENT. SUCH MATERIAL WILL BE FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE",
          "page": 0,
          "bbox": [
            399.0,
            398.0,
            2907.0,
            435.0
          ]
        },
        {
          "text": "COMIMISSION.",
          "page": 0,
          "bbox": [
            1503.0,
            455.0,
            1805.0,
            492.0
          ]
        },
        {
          "text": "PRODUCT MANUFACTURING AGREEMENT",
          "page": 0,
          "bbox": [
            1216.0,
            510.0,
            2093.0,
            546.0
          ]
        },
        {
          "text": "WHEREAS:",
          "page": 0,
          "bbox": [
            281.0,
            848.0,
            515.0,
            884.0
          ]
        },
        {
          "text": "WHEREAS:",
          "page": 0,
          "bbox": [
            279.0,
            959.0,
            513.0,
            996.0
          ]
        },
        {
          "text": "WHEREAS:",
          "page": 0,
          "bbox": [
            281.0,
            1071.0,
            515.0,
            1107.0
          ]
        }
      ]
    },
    {
      "id": "KitovPharmaLtd_20190326_20-F_EX-4.15_11584449_EX-4.15_Manufacturing Agreement__Parties_0",
      "question": "Highlight the parts (if any) of this contract related to \"Parties\" that should be reviewed by a lawyer. Details: The two or more parties who signed the contract",
      "answer_text": "Kitov",
      "page_number": 0,
      "words": [
        {
          "text": "at ****, Israel (\"Dexcel'') and KITOV Pharma Ltd., with its registered office at 132 Menachem Begin Road, Azrieli Center, Tel Aviv, 6701101, Israel.",
          "bbox": [
            274.0,
            618.0,
            3000.0,
            665.0
          ],
          "confidence": 0.9887864589691162
        }
      ],
      "nearby_headers": [
        {
          "text": "THE SYMBOL <****\" DENOTES PLACES WHERE PORTIONS OF THIS DOCUMENT HAVE BEEN OMITTED PURSUANT TO A REQUEST",
          "page": 0,
          "bbox": [
            304.0,
            338.0,
            3009.0,
            380.0
          ]
        },
        {
          "text": "FOR CONFIDENTIAL TREATMENT. SUCH MATERIAL WILL BE FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE",
          "page": 0,
          "bbox": [
            399.0,
            398.0,
            2907.0,
            435.0
          ]
        },
        {
          "text": "COMIMISSION.",
          "page": 0,
          "bbox": [
            1503.0,
            455.0,
            1805.0,
            492.0
          ]
        },
        {
          "text": "PRODUCT MANUFACTURING AGREEMENT",
          "page": 0,
          "bbox": [
            1216.0,
            510.0,
            2093.0,
            546.0
          ]
        },
        {
          "text": "WHEREAS:",
          "page": 0,
          "bbox": [
            281.0,
            848.0,
            515.0,
            884.0
          ]
        },
        {
          "text": "WHEREAS:",
          "page": 0,
          "bbox": [
            279.0,
            959.0,
            513.0,
            996.0
          ]
        },
        {
          "text": "WHEREAS:",
          "page": 0,
          "bbox": [
            281.0,
            1071.0,
            515.0,
            1107.0
          ]
        }
      ]
    },
    {
      "id": "KitovPharmaLtd_20190326_20-F_EX-4.15_11584449_EX-4.15_Manufacturing Agreement__Effective Date_0",
      "question": "Highlight the parts (if any) of this contract related to \"Effective Date\" that should be reviewed by a lawyer. Details: The date when the contract is effective ",
      "answer_text": "\"Effective Date\" shall mean the date of signature of the last Party to execute this Agreement.",
      "page_number": 0,
      "words": [
        {
          "text": "Exhibit 4.15",
          "bbox": [
            2798.0,
            283.0,
            3029.0,
            325.0
          ],
          "confidence": 0.9998080730438232
        },
        {
          "text": "THE SYMBOL <****\" DENOTES PLACES WHERE PORTIONS OF THIS DOCUMENT HAVE BEEN OMITTED PURSUANT TO A REQUEST",
          "bbox": [
            304.0,
            338.0,
            3009.0,
            380.0
          ],
          "confidence": 0.983539879322052
        },
        {
          "text": "FOR CONFIDENTIAL TREATMENT. SUCH MATERIAL WILL BE FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE",
          "bbox": [
            399.0,
            398.0,
            2907.0,
            435.0
          ],
          "confidence": 0.9926196932792664
        },
        {
          "text": "COMIMISSION.",
          "bbox": [
            1503.0,
            455.0,
            1805.0,
            492.0
          ],
          "confidence": 0.9562864303588867
        },
        {
          "text": "PRODUCT MANUFACTURING AGREEMENT",
          "bbox": [
            1216.0,
            510.0,
            2093.0,
            546.0
          ],
          "confidence": 0.994750440120697
        },
        {
          "text": "This Product Manufacturing Agreement (\"Agreement') is made as of the Effective Date by and between DEXCEL LTD., with its registered address.",
          "bbox": [
            275.0,
            563.0,
            3023.0,
            609.0
          ],
          "confidence": 0.989086925983429
        },
        {
          "text": "at ****, Israel (\"Dexcel'') and KITOV Pharma Ltd., with its registered office at 132 Menachem Begin Road, Azrieli Center, Tel Aviv, 6701101, Israel.",
          "bbox": [
            274.0,
            618.0,
            3000.0,
            665.0
          ],
          "confidence": 0.9887864589691162
        },
        {
          "text": "(\"Kitov'). Dexcel and Kitov are hereinafter jointly the \"Parties' and individually a \"Party.\".",
          "bbox": [
            279.0,
            678.0,
            1945.0,
            722.0
          ],
          "confidence": 0.98404461145401
        },
        {
          "text": "WHEREAS: Dexcel is a pharmaceutical company engaged in various activities including, but not limited to, the research, development,",
          "bbox": [
            275.0,
            729.0,
            2817.0,
            780.0
          ],
          "confidence": 0.9837751388549805
        },
        {
          "text": "manufacture, and marketing of various drugs and pharmaceutical specialties in various dosage forms;",
          "bbox": [
            549.0,
            795.0,
            2438.0,
            831.0
          ],
          "confidence": 0.9977880120277405
        },
        {
          "text": "WHEREAS:",
          "bbox": [
            281.0,
            848.0,
            515.0,
            884.0
          ],
          "confidence": 0.9993464946746826
        },
        {
          "text": "Kitov is a pharmaceutical company engaged in various activities including, but not limited to, the development of pharmaceutical",
          "bbox": [
            546.0,
            844.0,
            2951.0,
            890.0
          ],
          "confidence": 0.9910856485366821
        },
        {
          "text": "products;",
          "bbox": [
            551.0,
            906.0,
            732.0,
            945.0
          ],
          "confidence": 0.9994080066680908
        },
        {
          "text": "WHEREAS:",
          "bbox": [
            279.0,
            959.0,
            513.0,
            996.0
          ],
          "confidence": 0.9993117451667786
        },
        {
          "text": "Kitov and Dexcel entered into a Development Services Agreement on April 1, 2014 (\"Development Agreement'), pursuant to which",
          "bbox": [
            549.0,
            958.0,
            2991.0,
            1000.0
          ],
          "confidence": 0.9946937561035156
        },
        {
          "text": "Dexcel performed certain development services for Kitov with respect to the Product;",
          "bbox": [
            551.0,
            1016.0,
            2139.0,
            1058.0
          ],
          "confidence": 0.9957237243652344
        },
        {
          "text": "WHEREAS:",
          "bbox": [
            281.0,
            1071.0,
            515.0,
            1107.0
          ],
          "confidence": 0.9993150234222412
        },
        {
          "text": "Kitov desires that Dexcel manufacture and package the Product for Kitov in accordance with the terms of this Agreement, and Dexcel",
          "bbox": [
            546.0,
            1069.0,
            3029.0,
            1115.0
          ],
          "confidence": 0.9908015131950378
        },
        {
          "text": "is willing to manufacture and package the Product for Kitov in accordance with the terms of this Agreement..",
          "bbox": [
            547.0,
            1126.0,
            2561.0,
            1171.0
          ],
          "confidence": 0.9924741387367249
        },
        {
          "text": "NOw, THEREFORE, in consideration of the mutual covenants herein contained, the Parties, intending to be legally bound, hereby agree as",
          "bbox": [
            275.0,
            1180.0,
            2876.0,
            1228.0
          ],
          "confidence": 0.9950727820396423
        },
        {
          "text": "follows:",
          "bbox": [
            275.0,
            1237.0,
            426.0,
            1279.0
          ],
          "confidence": 0.9998461008071899
        },
        {
          "text": "1",
          "bbox": [
            277.0,
            1299.0,
            303.0,
            1330.0
          ],
          "confidence": 0.9999181032180786
        },
        {
          "text": "Definitions",
          "bbox": [
            368.0,
            1296.0,
            589.0,
            1334.0
          ],
          "confidence": 0.999856173992157
        },
        {
          "text": "For the purpose of this Agreement, the terms set forth in this clause, whether used in singular or plural form, shall mean, unless otherwise expressly.",
          "bbox": [
            277.0,
            1352.0,
            3012.0,
            1394.0
          ],
          "confidence": 0.9917291402816772
        },
        {
          "text": "provided for in this Agreement or the context otherwise requires, the following:.",
          "bbox": [
            277.0,
            1405.0,
            1749.0,
            1453.0
          ],
          "confidence": 0.9938557744026184
        },
        {
          "text": "1.1",
          "bbox": [
            379.0,
            1460.0,
            439.0,
            1506.0
          ],
          "confidence": 0.9998831748962402
        },
        {
          "text": "\"Affiliate\"' of a Party shall mean any corporation or other business entity directly or indirectly Controlled by, under common Control.",
          "bbox": [
            546.0,
            1458.0,
            3012.0,
            1509.0
          ],
          "confidence": 0.9893513917922974
        },
        {
          "text": "with, or in the Control of such Party..",
          "bbox": [
            551.0,
            1518.0,
            1222.0,
            1564.0
          ],
          "confidence": 0.9819372296333313
        },
        {
          "text": "1.2",
          "bbox": [
            377.0,
            1573.0,
            440.0,
            1619.0
          ],
          "confidence": 0.9997513890266418
        },
        {
          "text": "\"Anti-Corruption and Anti-Bribery Laws\" shall mean the United States Foreign Corrupt Practices Act of 1977, as amended, the",
          "bbox": [
            549.0,
            1577.0,
            2925.0,
            1619.0
          ],
          "confidence": 0.9937560558319092
        },
        {
          "text": "Bribery Act 2010 (2010 Chapter 23) of the Parliament of the United Kingdom, any rules or regulations under such acts, and any other",
          "bbox": [
            551.0,
            1634.0,
            3011.0,
            1676.0
          ],
          "confidence": 0.9908789992332458
        },
        {
          "text": "anti-corruption or anti-bribery statutes, laws or regulations applicable to a Party..",
          "bbox": [
            547.0,
            1687.0,
            2039.0,
            1732.0
          ],
          "confidence": 0.9931536316871643
        },
        {
          "text": "1.3",
          "bbox": [
            379.0,
            1741.0,
            440.0,
            1787.0
          ],
          "confidence": 0.9998380541801453
        },
        {
          "text": "\"API\"' shall mean the active pharmaceutical ingredients Celecoxib and Amlodipine Besylate..",
          "bbox": [
            549.0,
            1741.0,
            2277.0,
            1787.0
          ],
          "confidence": 0.9627962112426758
        },
        {
          "text": "Source: KITOV PHARMA LTD., 20-F, 3/26/2019",
          "bbox": [
            332.0,
            4437.0,
            1256.0,
            4479.0
          ],
          "confidence": 0.988348126411438
        }
      ],
      "nearby_headers": [
        {
          "text": "THE SYMBOL <****\" DENOTES PLACES WHERE PORTIONS OF THIS DOCUMENT HAVE BEEN OMITTED PURSUANT TO A REQUEST",
          "page": 0,
          "bbox": [
            304.0,
            338.0,
            3009.0,
            380.0
          ]
        },
        {
          "text": "FOR CONFIDENTIAL TREATMENT. SUCH MATERIAL WILL BE FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE",
          "page": 0,
          "bbox": [
            399.0,
            398.0,
            2907.0,
            435.0
          ]
        },
        {
          "text": "COMIMISSION.",
          "page": 0,
          "bbox": [
            1503.0,
            455.0,
            1805.0,
            492.0
          ]
        },
        {
          "text": "PRODUCT MANUFACTURING AGREEMENT",
          "page": 0,
          "bbox": [
            1216.0,
            510.0,
            2093.0,
            546.0
          ]
        },
        {
          "text": "WHEREAS:",
          "page": 0,
          "bbox": [
            281.0,
            848.0,
            515.0,
            884.0
          ]
        },
        {
          "text": "WHEREAS:",
          "page": 0,
          "bbox": [
            279.0,
            959.0,
            513.0,
            996.0
          ]
        },
        {
          "text": "WHEREAS:",
          "page": 0,
          "bbox": [
            281.0,
            1071.0,
            515.0,
            1107.0
          ]
        }
      ]
    },
    {
      "id": "KitovPharmaLtd_20190326_20-F_EX-4.15_11584449_EX-4.15_Manufacturing Agreement__Expiration Date_0",
      "question": "Highlight the parts (if any) of this contract related to \"Expiration Date\" that should be reviewed by a lawyer. Details: On what date will the contract's initial term expire?",
      "answer_text": "The Agreement shall commence on the Effective Date and remain in full force and effect for an initial term of **** from the Supply Commencement Date of the Product (\"Initial Term\").",
      "page_number": 0,
      "words": [
        {
          "text": "Exhibit 4.15",
          "bbox": [
            2798.0,
            283.0,
            3029.0,
            325.0
          ],
          "confidence": 0.9998080730438232
        },
        {
          "text": "THE SYMBOL <****\" DENOTES PLACES WHERE PORTIONS OF THIS DOCUMENT HAVE BEEN OMITTED PURSUANT TO A REQUEST",
          "bbox": [
            304.0,
            338.0,
            3009.0,
            380.0
          ],
          "confidence": 0.983539879322052
        },
        {
          "text": "FOR CONFIDENTIAL TREATMENT. SUCH MATERIAL WILL BE FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE",
          "bbox": [
            399.0,
            398.0,
            2907.0,
            435.0
          ],
          "confidence": 0.9926196932792664
        },
        {
          "text": "COMIMISSION.",
          "bbox": [
            1503.0,
            455.0,
            1805.0,
            492.0
          ],
          "confidence": 0.9562864303588867
        },
        {
          "text": "PRODUCT MANUFACTURING AGREEMENT",
          "bbox": [
            1216.0,
            510.0,
            2093.0,
            546.0
          ],
          "confidence": 0.994750440120697
        },
        {
          "text": "This Product Manufacturing Agreement (\"Agreement') is made as of the Effective Date by and between DEXCEL LTD., with its registered address.",
          "bbox": [
            275.0,
            563.0,
            3023.0,
            609.0
          ],
          "confidence": 0.989086925983429
        },
        {
          "text": "at ****, Israel (\"Dexcel'') and KITOV Pharma Ltd., with its registered office at 132 Menachem Begin Road, Azrieli Center, Tel Aviv, 6701101, Israel.",
          "bbox": [
            274.0,
            618.0,
            3000.0,
            665.0
          ],
          "confidence": 0.9887864589691162
        },
        {
          "text": "(\"Kitov'). Dexcel and Kitov are hereinafter jointly the \"Parties' and individually a \"Party.\".",
          "bbox": [
            279.0,
            678.0,
            1945.0,
            722.0
          ],
          "confidence": 0.98404461145401
        },
        {
          "text": "WHEREAS: Dexcel is a pharmaceutical company engaged in various activities including, but not limited to, the research, development,",
          "bbox": [
            275.0,
            729.0,
            2817.0,
            780.0
          ],
          "confidence": 0.9837751388549805
        },
        {
          "text": "manufacture, and marketing of various drugs and pharmaceutical specialties in various dosage forms;",
          "bbox": [
            549.0,
            795.0,
            2438.0,
            831.0
          ],
          "confidence": 0.9977880120277405
        },
        {
          "text": "WHEREAS:",
          "bbox": [
            281.0,
            848.0,
            515.0,
            884.0
          ],
          "confidence": 0.9993464946746826
        },
        {
          "text": "Kitov is a pharmaceutical company engaged in various activities including, but not limited to, the development of pharmaceutical",
          "bbox": [
            546.0,
            844.0,
            2951.0,
            890.0
          ],
          "confidence": 0.9910856485366821
        },
        {
          "text": "products;",
          "bbox": [
            551.0,
            906.0,
            732.0,
            945.0
          ],
          "confidence": 0.9994080066680908
        },
        {
          "text": "WHEREAS:",
          "bbox": [
            279.0,
            959.0,
            513.0,
            996.0
          ],
          "confidence": 0.9993117451667786
        },
        {
          "text": "Kitov and Dexcel entered into a Development Services Agreement on April 1, 2014 (\"Development Agreement'), pursuant to which",
          "bbox": [
            549.0,
            958.0,
            2991.0,
            1000.0
          ],
          "confidence": 0.9946937561035156
        },
        {
          "text": "Dexcel performed certain development services for Kitov with respect to the Product;",
          "bbox": [
            551.0,
            1016.0,
            2139.0,
            1058.0
          ],
          "confidence": 0.9957237243652344
        },
        {
          "text": "WHEREAS:",
          "bbox": [
            281.0,
            1071.0,
            515.0,
            1107.0
          ],
          "confidence": 0.9993150234222412
        },
        {
          "text": "Kitov desires that Dexcel manufacture and package the Product for Kitov in accordance with the terms of this Agreement, and Dexcel",
          "bbox": [
            546.0,
            1069.0,
            3029.0,
            1115.0
          ],
          "confidence": 0.9908015131950378
        },
        {
          "text": "is willing to manufacture and package the Product for Kitov in accordance with the terms of this Agreement..",
          "bbox": [
            547.0,
            1126.0,
            2561.0,
            1171.0
          ],
          "confidence": 0.9924741387367249
        },
        {
          "text": "NOw, THEREFORE, in consideration of the mutual covenants herein contained, the Parties, intending to be legally bound, hereby agree as",
          "bbox": [
            275.0,
            1180.0,
            2876.0,
            1228.0
          ],
          "confidence": 0.9950727820396423
        },
        {
          "text": "follows:",
          "bbox": [
            275.0,
            1237.0,
            426.0,
            1279.0
          ],
          "confidence": 0.9998461008071899
        },
        {
          "text": "1",
          "bbox": [
            277.0,
            1299.0,
            303.0,
            1330.0
          ],
          "confidence": 0.9999181032180786
        },
        {
          "text": "Definitions",
          "bbox": [
            368.0,
            1296.0,
            589.0,
            1334.0
          ],
          "confidence": 0.999856173992157
        },
        {
          "text": "For the purpose of this Agreement, the terms set forth in this clause, whether used in singular or plural form, shall mean, unless otherwise expressly.",
          "bbox": [
            277.0,
            1352.0,
            3012.0,
            1394.0
          ],
          "confidence": 0.9917291402816772
        },
        {
          "text": "provided for in this Agreement or the context otherwise requires, the following:.",
          "bbox": [
            277.0,
            1405.0,
            1749.0,
            1453.0
          ],
          "confidence": 0.9938557744026184
        },
        {
          "text": "1.1",
          "bbox": [
            379.0,
            1460.0,
            439.0,
            1506.0
          ],
          "confidence": 0.9998831748962402
        },
        {
          "text": "\"Affiliate\"' of a Party shall mean any corporation or other business entity directly or indirectly Controlled by, under common Control.",
          "bbox": [
            546.0,
            1458.0,
            3012.0,
            1509.0
          ],
          "confidence": 0.9893513917922974
        },
        {
          "text": "with, or in the Control of such Party..",
          "bbox": [
            551.0,
            1518.0,
            1222.0,
            1564.0
          ],
          "confidence": 0.9819372296333313
        },
        {
          "text": "1.2",
          "bbox": [
            377.0,
            1573.0,
            440.0,
            1619.0
          ],
          "confidence": 0.9997513890266418
        },
        {
          "text": "\"Anti-Corruption and Anti-Bribery Laws\" shall mean the United States Foreign Corrupt Practices Act of 1977, as amended, the",
          "bbox": [
            549.0,
            1577.0,
            2925.0,
            1619.0
          ],
          "confidence": 0.9937560558319092
        },
        {
          "text": "Bribery Act 2010 (2010 Chapter 23) of the Parliament of the United Kingdom, any rules or regulations under such acts, and any other",
          "bbox": [
            551.0,
            1634.0,
            3011.0,
            1676.0
          ],
          "confidence": 0.9908789992332458
        },
        {
          "text": "anti-corruption or anti-bribery statutes, laws or regulations applicable to a Party..",
          "bbox": [
            547.0,
            1687.0,
            2039.0,
            1732.0
          ],
          "confidence": 0.9931536316871643
        },
        {
          "text": "1.3",
          "bbox": [
            379.0,
            1741.0,
            440.0,
            1787.0
          ],
          "confidence": 0.9998380541801453
        },
        {
          "text": "\"API\"' shall mean the active pharmaceutical ingredients Celecoxib and Amlodipine Besylate..",
          "bbox": [
            549.0,
            1741.0,
            2277.0,
            1787.0
          ],
          "confidence": 0.9627962112426758
        },
        {
          "text": "Source: KITOV PHARMA LTD., 20-F, 3/26/2019",
          "bbox": [
            332.0,
            4437.0,
            1256.0,
            4479.0
          ],
          "confidence": 0.988348126411438
        }
      ],
      "nearby_headers": [
        {
          "text": "THE SYMBOL <****\" DENOTES PLACES WHERE PORTIONS OF THIS DOCUMENT HAVE BEEN OMITTED PURSUANT TO A REQUEST",
          "page": 0,
          "bbox": [
            304.0,
            338.0,
            3009.0,
            380.0
          ]
        },
        {
          "text": "FOR CONFIDENTIAL TREATMENT. SUCH MATERIAL WILL BE FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE",
          "page": 0,
          "bbox": [
            399.0,
            398.0,
            2907.0,
            435.0
          ]
        },
        {
          "text": "COMIMISSION.",
          "page": 0,
          "bbox": [
            1503.0,
            455.0,
            1805.0,
            492.0
          ]
        },
        {
          "text": "PRODUCT MANUFACTURING AGREEMENT",
          "page": 0,
          "bbox": [
            1216.0,
            510.0,
            2093.0,
            546.0
          ]
        },
        {
          "text": "WHEREAS:",
          "page": 0,
          "bbox": [
            281.0,
            848.0,
            515.0,
            884.0
          ]
        },
        {
          "text": "WHEREAS:",
          "page": 0,
          "bbox": [
            279.0,
            959.0,
            513.0,
            996.0
          ]
        },
        {
          "text": "WHEREAS:",
          "page": 0,
          "bbox": [
            281.0,
            1071.0,
            515.0,
            1107.0
          ]
        }
      ]
    },
    {
      "id": "KitovPharmaLtd_20190326_20-F_EX-4.15_11584449_EX-4.15_Manufacturing Agreement__Renewal Term_0_multi",
      "question": "Highlight the parts (if any) of this contract related to \"Renewal Term\" that should be reviewed by a lawyer. Details: What is the renewal term after the initial term expires? This includes automatic extensions and unilateral extensions with prior notice.",
      "answer_text": "Following the Initial Term, the Agreement shall automatically be renewed for additional periods of **** (each, a \"Renewal Term,\" and, together with the Initial Term, the \"Term\")), unless a Party provides written notification of non-renewal to the other Party at least **** of the Initial Term or a Renewal Term.",
      "page_number": 0,
      "words": [
        {
          "text": "Exhibit 4.15",
          "bbox": [
            2798.0,
            283.0,
            3029.0,
            325.0
          ],
          "confidence": 0.9998080730438232
        },
        {
          "text": "THE SYMBOL <****\" DENOTES PLACES WHERE PORTIONS OF THIS DOCUMENT HAVE BEEN OMITTED PURSUANT TO A REQUEST",
          "bbox": [
            304.0,
            338.0,
            3009.0,
            380.0
          ],
          "confidence": 0.983539879322052
        },
        {
          "text": "FOR CONFIDENTIAL TREATMENT. SUCH MATERIAL WILL BE FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE",
          "bbox": [
            399.0,
            398.0,
            2907.0,
            435.0
          ],
          "confidence": 0.9926196932792664
        },
        {
          "text": "COMIMISSION.",
          "bbox": [
            1503.0,
            455.0,
            1805.0,
            492.0
          ],
          "confidence": 0.9562864303588867
        },
        {
          "text": "PRODUCT MANUFACTURING AGREEMENT",
          "bbox": [
            1216.0,
            510.0,
            2093.0,
            546.0
          ],
          "confidence": 0.994750440120697
        },
        {
          "text": "This Product Manufacturing Agreement (\"Agreement') is made as of the Effective Date by and between DEXCEL LTD., with its registered address.",
          "bbox": [
            275.0,
            563.0,
            3023.0,
            609.0
          ],
          "confidence": 0.989086925983429
        },
        {
          "text": "at ****, Israel (\"Dexcel'') and KITOV Pharma Ltd., with its registered office at 132 Menachem Begin Road, Azrieli Center, Tel Aviv, 6701101, Israel.",
          "bbox": [
            274.0,
            618.0,
            3000.0,
            665.0
          ],
          "confidence": 0.9887864589691162
        },
        {
          "text": "(\"Kitov'). Dexcel and Kitov are hereinafter jointly the \"Parties' and individually a \"Party.\".",
          "bbox": [
            279.0,
            678.0,
            1945.0,
            722.0
          ],
          "confidence": 0.98404461145401
        },
        {
          "text": "WHEREAS: Dexcel is a pharmaceutical company engaged in various activities including, but not limited to, the research, development,",
          "bbox": [
            275.0,
            729.0,
            2817.0,
            780.0
          ],
          "confidence": 0.9837751388549805
        },
        {
          "text": "manufacture, and marketing of various drugs and pharmaceutical specialties in various dosage forms;",
          "bbox": [
            549.0,
            795.0,
            2438.0,
            831.0
          ],
          "confidence": 0.9977880120277405
        },
        {
          "text": "WHEREAS:",
          "bbox": [
            281.0,
            848.0,
            515.0,
            884.0
          ],
          "confidence": 0.9993464946746826
        },
        {
          "text": "Kitov is a pharmaceutical company engaged in various activities including, but not limited to, the development of pharmaceutical",
          "bbox": [
            546.0,
            844.0,
            2951.0,
            890.0
          ],
          "confidence": 0.9910856485366821
        },
        {
          "text": "products;",
          "bbox": [
            551.0,
            906.0,
            732.0,
            945.0
          ],
          "confidence": 0.9994080066680908
        },
        {
          "text": "WHEREAS:",
          "bbox": [
            279.0,
            959.0,
            513.0,
            996.0
          ],
          "confidence": 0.9993117451667786
        },
        {
          "text": "Kitov and Dexcel entered into a Development Services Agreement on April 1, 2014 (\"Development Agreement'), pursuant to which",
          "bbox": [
            549.0,
            958.0,
            2991.0,
            1000.0
          ],
          "confidence": 0.9946937561035156
        },
        {
          "text": "Dexcel performed certain development services for Kitov with respect to the Product;",
          "bbox": [
            551.0,
            1016.0,
            2139.0,
            1058.0
          ],
          "confidence": 0.9957237243652344
        },
        {
          "text": "WHEREAS:",
          "bbox": [
            281.0,
            1071.0,
            515.0,
            1107.0
          ],
          "confidence": 0.9993150234222412
        },
        {
          "text": "Kitov desires that Dexcel manufacture and package the Product for Kitov in accordance with the terms of this Agreement, and Dexcel",
          "bbox": [
            546.0,
            1069.0,
            3029.0,
            1115.0
          ],
          "confidence": 0.9908015131950378
        },
        {
          "text": "is willing to manufacture and package the Product for Kitov in accordance with the terms of this Agreement..",
          "bbox": [
            547.0,
            1126.0,
            2561.0,
            1171.0
          ],
          "confidence": 0.9924741387367249
        },
        {
          "text": "NOw, THEREFORE, in consideration of the mutual covenants herein contained, the Parties, intending to be legally bound, hereby agree as",
          "bbox": [
            275.0,
            1180.0,
            2876.0,
            1228.0
          ],
          "confidence": 0.9950727820396423
        },
        {
          "text": "follows:",
          "bbox": [
            275.0,
            1237.0,
            426.0,
            1279.0
          ],
          "confidence": 0.9998461008071899
        },
        {
          "text": "1",
          "bbox": [
            277.0,
            1299.0,
            303.0,
            1330.0
          ],
          "confidence": 0.9999181032180786
        },
        {
          "text": "Definitions",
          "bbox": [
            368.0,
            1296.0,
            589.0,
            1334.0
          ],
          "confidence": 0.999856173992157
        },
        {
          "text": "For the purpose of this Agreement, the terms set forth in this clause, whether used in singular or plural form, shall mean, unless otherwise expressly.",
          "bbox": [
            277.0,
            1352.0,
            3012.0,
            1394.0
          ],
          "confidence": 0.9917291402816772
        },
        {
          "text": "provided for in this Agreement or the context otherwise requires, the following:.",
          "bbox": [
            277.0,
            1405.0,
            1749.0,
            1453.0
          ],
          "confidence": 0.9938557744026184
        },
        {
          "text": "1.1",
          "bbox": [
            379.0,
            1460.0,
            439.0,
            1506.0
          ],
          "confidence": 0.9998831748962402
        },
        {
          "text": "\"Affiliate\"' of a Party shall mean any corporation or other business entity directly or indirectly Controlled by, under common Control.",
          "bbox": [
            546.0,
            1458.0,
            3012.0,
            1509.0
          ],
          "confidence": 0.9893513917922974
        },
        {
          "text": "with, or in the Control of such Party..",
          "bbox": [
            551.0,
            1518.0,
            1222.0,
            1564.0
          ],
          "confidence": 0.9819372296333313
        },
        {
          "text": "1.2",
          "bbox": [
            377.0,
            1573.0,
            440.0,
            1619.0
          ],
          "confidence": 0.9997513890266418
        },
        {
          "text": "\"Anti-Corruption and Anti-Bribery Laws\" shall mean the United States Foreign Corrupt Practices Act of 1977, as amended, the",
          "bbox": [
            549.0,
            1577.0,
            2925.0,
            1619.0
          ],
          "confidence": 0.9937560558319092
        },
        {
          "text": "Bribery Act 2010 (2010 Chapter 23) of the Parliament of the United Kingdom, any rules or regulations under such acts, and any other",
          "bbox": [
            551.0,
            1634.0,
            3011.0,
            1676.0
          ],
          "confidence": 0.9908789992332458
        },
        {
          "text": "anti-corruption or anti-bribery statutes, laws or regulations applicable to a Party..",
          "bbox": [
            547.0,
            1687.0,
            2039.0,
            1732.0
          ],
          "confidence": 0.9931536316871643
        },
        {
          "text": "1.3",
          "bbox": [
            379.0,
            1741.0,
            440.0,
            1787.0
          ],
          "confidence": 0.9998380541801453
        },
        {
          "text": "\"API\"' shall mean the active pharmaceutical ingredients Celecoxib and Amlodipine Besylate..",
          "bbox": [
            549.0,
            1741.0,
            2277.0,
            1787.0
          ],
          "confidence": 0.9627962112426758
        },
        {
          "text": "Source: KITOV PHARMA LTD., 20-F, 3/26/2019",
          "bbox": [
            332.0,
            4437.0,
            1256.0,
            4479.0
          ],
          "confidence": 0.988348126411438
        }
      ],
      "multi_page": true,
      "part_of": 2,
      "nearby_headers": [
        {
          "text": "THE SYMBOL <****\" DENOTES PLACES WHERE PORTIONS OF THIS DOCUMENT HAVE BEEN OMITTED PURSUANT TO A REQUEST",
          "page": 0,
          "bbox": [
            304.0,
            338.0,
            3009.0,
            380.0
          ]
        },
        {
          "text": "FOR CONFIDENTIAL TREATMENT. SUCH MATERIAL WILL BE FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE",
          "page": 0,
          "bbox": [
            399.0,
            398.0,
            2907.0,
            435.0
          ]
        },
        {
          "text": "COMIMISSION.",
          "page": 0,
          "bbox": [
            1503.0,
            455.0,
            1805.0,
            492.0
          ]
        },
        {
          "text": "PRODUCT MANUFACTURING AGREEMENT",
          "page": 0,
          "bbox": [
            1216.0,
            510.0,
            2093.0,
            546.0
          ]
        },
        {
          "text": "WHEREAS:",
          "page": 0,
          "bbox": [
            281.0,
            848.0,
            515.0,
            884.0
          ]
        },
        {
          "text": "WHEREAS:",
          "page": 0,
          "bbox": [
            279.0,
            959.0,
            513.0,
            996.0
          ]
        },
        {
          "text": "WHEREAS:",
          "page": 0,
          "bbox": [
            281.0,
            1071.0,
            515.0,
            1107.0
          ]
        }
      ]
    },
    {
      "id": "KitovPharmaLtd_20190326_20-F_EX-4.15_11584449_EX-4.15_Manufacturing Agreement__Renewal Term_1_multi",
      "question": "Highlight the parts (if any) of this contract related to \"Renewal Term\" that should be reviewed by a lawyer. Details: What is the renewal term after the initial term expires? This includes automatic extensions and unilateral extensions with prior notice.",
      "answer_text": "Following the Initial Term, the Agreement shall automatically be renewed for additional periods of **** (each, a \"Renewal Term,\" and, together with the Initial Term, the \"Term\")), unless a Party provides written notification of non-renewal to the other Party at least **** of the Initial Term or a Renewal Term.",
      "page_number": 1,
      "words": [
        {
          "text": "1.4",
          "bbox": [
            379.0,
            281.0,
            442.0,
            327.0
          ],
          "confidence": 0.9997868537902832
        },
        {
          "text": "\"Batch' shall mean the defined quantity of the Product processed in a single process or series of processes in a manner designed to.",
          "bbox": [
            549.0,
            281.0,
            3011.0,
            329.0
          ],
          "confidence": 0.9841217398643494
        },
        {
          "text": "be homogeneous. The Batch size for the Product is **** tablets.",
          "bbox": [
            551.0,
            338.0,
            1756.0,
            382.0
          ],
          "confidence": 0.9994081258773804
        },
        {
          "text": "1.5",
          "bbox": [
            376.0,
            390.0,
            443.0,
            443.0
          ],
          "confidence": 0.9997324347496033
        },
        {
          "text": "\"cGMPs\" or \"Good Manufacturing Practice\"' shall mean the part of quality assurance which ensures that the Product is consistently.",
          "bbox": [
            549.0,
            395.0,
            3023.0,
            440.0
          ],
          "confidence": 0.985264241695404
        },
        {
          "text": "produced and controlled to the quality standards appropriate to their intended use, the principles and guidelines of which are",
          "bbox": [
            549.0,
            451.0,
            2884.0,
            499.0
          ],
          "confidence": 0.9912954568862915
        },
        {
          "text": "specified in European Commission Directive 2003/94/EC and the FDA's current Good Manufacturing Practices, particularly 21 CFR ",
          "bbox": [
            547.0,
            506.0,
            3003.0,
            557.0
          ],
          "confidence": 0.995246410369873
        },
        {
          "text": "210 et seq., and 21 CFR $$ 600-610, as both may be amended from time to time..",
          "bbox": [
            549.0,
            565.0,
            2006.0,
            607.0
          ],
          "confidence": 0.9747835993766785
        },
        {
          "text": "1.6",
          "bbox": [
            379.0,
            619.0,
            442.0,
            663.0
          ],
          "confidence": 0.9999213218688965
        },
        {
          "text": "\"Change of Control' shall mean (i) any change, sale, merger, reorganization, or any other event or action that results in a third party,",
          "bbox": [
            547.0,
            618.0,
            3005.0,
            669.0
          ],
          "confidence": 0.9930126070976257
        },
        {
          "text": "which is a material competitor to the other Party to this agreement, acquiring: (a) all or substantially all of the business or assets of a.",
          "bbox": [
            551.0,
            678.0,
            3002.0,
            722.0
          ],
          "confidence": 0.9852778911590576
        },
        {
          "text": "Party relating to this Agreement, (b) Control, directly or indirectly, of such Party (and/or any corporate entity that Controls, directly.",
          "bbox": [
            551.0,
            735.0,
            2985.0,
            778.0
          ],
          "confidence": 0.9932605624198914
        },
        {
          "text": "or indirectly, such Party), or (ii) any assignment or delegation of, sale or transfer of a Party's rights and obligations under this",
          "bbox": [
            549.0,
            789.0,
            2878.0,
            835.0
          ],
          "confidence": 0.9923490881919861
        },
        {
          "text": "Agreement (or any part hereof) to a third party.",
          "bbox": [
            555.0,
            848.0,
            1426.0,
            890.0
          ],
          "confidence": 0.9961597323417664
        },
        {
          "text": "Notwithstanding anything in the immediately preceding paragraph to the contrary, where the Party in question is Dexcel, any of the",
          "bbox": [
            549.0,
            903.0,
            2991.0,
            945.0
          ],
          "confidence": 0.9957303404808044
        },
        {
          "text": "foregoing events or actions shall not be considered a Change of Control where any one or more of the relevant third party or parties.",
          "bbox": [
            551.0,
            961.0,
            3007.0,
            1003.0
          ],
          "confidence": 0.9899225234985352
        },
        {
          "text": "referred to in clause (i) above is (A) a Family Member, or (B) any entity Controlled by Mr. **** and/or a Family Member.",
          "bbox": [
            544.0,
            1005.0,
            2788.0,
            1064.0
          ],
          "confidence": 0.9933032989501953
        },
        {
          "text": "1.7",
          "bbox": [
            379.0,
            1067.0,
            442.0,
            1113.0
          ],
          "confidence": 0.9998312592506409
        },
        {
          "text": "\"Claims' shall mean any demands, claims, actions, causes of action, assessments, losses, damages, injuries, liabilities, costs and.",
          "bbox": [
            549.0,
            1069.0,
            2953.0,
            1115.0
          ],
          "confidence": 0.9854910969734192
        },
        {
          "text": "expenses (including, without limitation, reasonable attorneys' fees and expenses) filed, raised, initiated or made by any governmental.",
          "bbox": [
            553.0,
            1129.0,
            3021.0,
            1171.0
          ],
          "confidence": 0.992518424987793
        },
        {
          "text": "authority and/or third party.",
          "bbox": [
            551.0,
            1184.0,
            1066.0,
            1226.0
          ],
          "confidence": 0.983346164226532
        },
        {
          "text": "1.8",
          "bbox": [
            379.0,
            1235.0,
            442.0,
            1281.0
          ],
          "confidence": 0.9999089241027832
        },
        {
          "text": "\"Confidential Information\"' shall have the meaning set forth in Section 7.1.",
          "bbox": [
            549.0,
            1235.0,
            1939.0,
            1281.0
          ],
          "confidence": 0.9719286561012268
        },
        {
          "text": "1.9",
          "bbox": [
            379.0,
            1292.0,
            440.0,
            1336.0
          ],
          "confidence": 0.9999080300331116
        },
        {
          "text": "\"Confirmed Order' shall have the meaning set forth in Section 3.3.2.",
          "bbox": [
            549.0,
            1292.0,
            1834.0,
            1338.0
          ],
          "confidence": 0.9867768883705139
        },
        {
          "text": "1.10",
          "bbox": [
            379.0,
            1347.0,
            462.0,
            1394.0
          ],
          "confidence": 0.9999012351036072
        },
        {
          "text": "\"Control' or \"Controlled' shall mean possession of more than fifty percent (50%) of the share capital of a corporation or other",
          "bbox": [
            547.0,
            1345.0,
            2915.0,
            1398.0
          ],
          "confidence": 0.981292724609375
        },
        {
          "text": "business entity, and/or the power to direct or cause the direction of the management and policies of a corporation or other entity",
          "bbox": [
            549.0,
            1405.0,
            2936.0,
            1451.0
          ],
          "confidence": 0.9941077828407288
        },
        {
          "text": "whether through the ownership of voting securities, by contract or otherwise..",
          "bbox": [
            553.0,
            1467.0,
            1996.0,
            1504.0
          ],
          "confidence": 0.9934757947921753
        },
        {
          "text": "1.11",
          "bbox": [
            379.0,
            1517.0,
            455.0,
            1561.0
          ],
          "confidence": 0.999779224395752
        },
        {
          "text": "\"Delivery' shall mean the time when the Product is placed at the disposal of Kitov at Dexcel's Facility based on an ****",
          "bbox": [
            546.0,
            1508.0,
            2799.0,
            1568.0
          ],
          "confidence": 0.992178738117218
        },
        {
          "text": "(Incoterms 2010).",
          "bbox": [
            555.0,
            1579.0,
            904.0,
            1617.0
          ],
          "confidence": 0.99842768907547
        },
        {
          "text": "1.12",
          "bbox": [
            377.0,
            1626.0,
            462.0,
            1674.0
          ],
          "confidence": 0.9999103546142578
        },
        {
          "text": "\"Distributors\" shall mean any Person under contract with Kitov or any of its Affiliates for the distribution of the Product in a certain",
          "bbox": [
            553.0,
            1634.0,
            3018.0,
            1670.0
          ],
          "confidence": 0.9918192625045776
        },
        {
          "text": "territory or territories..",
          "bbox": [
            551.0,
            1692.0,
            946.0,
            1729.0
          ],
          "confidence": 0.9840478301048279
        },
        {
          "text": "1.13",
          "bbox": [
            381.0,
            1741.0,
            459.0,
            1785.0
          ],
          "confidence": 0.8832098245620728
        },
        {
          "text": "\"Effective Date' shall mean the date of signature of the last Party to execute this Agreement..",
          "bbox": [
            549.0,
            1741.0,
            2267.0,
            1787.0
          ],
          "confidence": 0.9844200611114502
        },
        {
          "text": "1.14",
          "bbox": [
            379.0,
            1798.0,
            460.0,
            1840.0
          ],
          "confidence": 0.9994210004806519
        },
        {
          "text": "\"EMA\" means the European Medicines Agency or any successor entity.",
          "bbox": [
            549.0,
            1798.0,
            1898.0,
            1846.0
          ],
          "confidence": 0.9979910254478455
        },
        {
          "text": "1.15",
          "bbox": [
            379.0,
            1851.0,
            460.0,
            1900.0
          ],
          "confidence": 0.9995757341384888
        },
        {
          "text": "\"Family Member\" shall mean ****.",
          "bbox": [
            547.0,
            1847.0,
            1222.0,
            1902.0
          ],
          "confidence": 0.9885128736495972
        },
        {
          "text": "1.16",
          "bbox": [
            379.0,
            1908.0,
            462.0,
            1955.0
          ],
          "confidence": 0.9999197125434875
        },
        {
          "text": "\"FDA\" means the U.S. Food and Drug Administration or any successor entity..",
          "bbox": [
            549.0,
            1911.0,
            2005.0,
            1953.0
          ],
          "confidence": 0.986582338809967
        },
        {
          "text": "2",
          "bbox": [
            1638.0,
            2025.0,
            1669.0,
            2061.0
          ],
          "confidence": 0.999761164188385
        },
        {
          "text": "Source: KITOV PHARMA LTD., 20-F, 3/26/2019",
          "bbox": [
            332.0,
            4437.0,
            1256.0,
            4479.0
          ],
          "confidence": 0.989766538143158
        }
      ],
      "multi_page": true,
      "part_of": 2
    },
    {
      "id": "KitovPharmaLtd_20190326_20-F_EX-4.15_11584449_EX-4.15_Manufacturing Agreement__Notice Period To Terminate Renewal_0_multi",
      "question": "Highlight the parts (if any) of this contract related to \"Notice Period To Terminate Renewal\" that should be reviewed by a lawyer. Details: What is the notice period required to terminate renewal?",
      "answer_text": "Following the Initial Term, the Agreement shall automatically be renewed for additional periods of **** (each, a \"Renewal Term,\" and, together with the Initial Term, the \"Term\")), unless a Party provides written notification of non-renewal to the other Party at least **** of the Initial Term or a Renewal Term.",
      "page_number": 0,
      "words": [
        {
          "text": "Exhibit 4.15",
          "bbox": [
            2798.0,
            283.0,
            3029.0,
            325.0
          ],
          "confidence": 0.9998080730438232
        },
        {
          "text": "THE SYMBOL <****\" DENOTES PLACES WHERE PORTIONS OF THIS DOCUMENT HAVE BEEN OMITTED PURSUANT TO A REQUEST",
          "bbox": [
            304.0,
            338.0,
            3009.0,
            380.0
          ],
          "confidence": 0.983539879322052
        },
        {
          "text": "FOR CONFIDENTIAL TREATMENT. SUCH MATERIAL WILL BE FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE",
          "bbox": [
            399.0,
            398.0,
            2907.0,
            435.0
          ],
          "confidence": 0.9926196932792664
        },
        {
          "text": "COMIMISSION.",
          "bbox": [
            1503.0,
            455.0,
            1805.0,
            492.0
          ],
          "confidence": 0.9562864303588867
        },
        {
          "text": "PRODUCT MANUFACTURING AGREEMENT",
          "bbox": [
            1216.0,
            510.0,
            2093.0,
            546.0
          ],
          "confidence": 0.994750440120697
        },
        {
          "text": "This Product Manufacturing Agreement (\"Agreement') is made as of the Effective Date by and between DEXCEL LTD., with its registered address.",
          "bbox": [
            275.0,
            563.0,
            3023.0,
            609.0
          ],
          "confidence": 0.989086925983429
        },
        {
          "text": "at ****, Israel (\"Dexcel'') and KITOV Pharma Ltd., with its registered office at 132 Menachem Begin Road, Azrieli Center, Tel Aviv, 6701101, Israel.",
          "bbox": [
            274.0,
            618.0,
            3000.0,
            665.0
          ],
          "confidence": 0.9887864589691162
        },
        {
          "text": "(\"Kitov'). Dexcel and Kitov are hereinafter jointly the \"Parties' and individually a \"Party.\".",
          "bbox": [
            279.0,
            678.0,
            1945.0,
            722.0
          ],
          "confidence": 0.98404461145401
        },
        {
          "text": "WHEREAS: Dexcel is a pharmaceutical company engaged in various activities including, but not limited to, the research, development,",
          "bbox": [
            275.0,
            729.0,
            2817.0,
            780.0
          ],
          "confidence": 0.9837751388549805
        },
        {
          "text": "manufacture, and marketing of various drugs and pharmaceutical specialties in various dosage forms;",
          "bbox": [
            549.0,
            795.0,
            2438.0,
            831.0
          ],
          "confidence": 0.9977880120277405
        },
        {
          "text": "WHEREAS:",
          "bbox": [
            281.0,
            848.0,
            515.0,
            884.0
          ],
          "confidence": 0.9993464946746826
        },
        {
          "text": "Kitov is a pharmaceutical company engaged in various activities including, but not limited to, the development of pharmaceutical",
          "bbox": [
            546.0,
            844.0,
            2951.0,
            890.0
          ],
          "confidence": 0.9910856485366821
        },
        {
          "text": "products;",
          "bbox": [
            551.0,
            906.0,
            732.0,
            945.0
          ],
          "confidence": 0.9994080066680908
        },
        {
          "text": "WHEREAS:",
          "bbox": [
            279.0,
            959.0,
            513.0,
            996.0
          ],
          "confidence": 0.9993117451667786
        },
        {
          "text": "Kitov and Dexcel entered into a Development Services Agreement on April 1, 2014 (\"Development Agreement'), pursuant to which",
          "bbox": [
            549.0,
            958.0,
            2991.0,
            1000.0
          ],
          "confidence": 0.9946937561035156
        },
        {
          "text": "Dexcel performed certain development services for Kitov with respect to the Product;",
          "bbox": [
            551.0,
            1016.0,
            2139.0,
            1058.0
          ],
          "confidence": 0.9957237243652344
        },
        {
          "text": "WHEREAS:",
          "bbox": [
            281.0,
            1071.0,
            515.0,
            1107.0
          ],
          "confidence": 0.9993150234222412
        },
        {
          "text": "Kitov desires that Dexcel manufacture and package the Product for Kitov in accordance with the terms of this Agreement, and Dexcel",
          "bbox": [
            546.0,
            1069.0,
            3029.0,
            1115.0
          ],
          "confidence": 0.9908015131950378
        },
        {
          "text": "is willing to manufacture and package the Product for Kitov in accordance with the terms of this Agreement..",
          "bbox": [
            547.0,
            1126.0,
            2561.0,
            1171.0
          ],
          "confidence": 0.9924741387367249
        },
        {
          "text": "NOw, THEREFORE, in consideration of the mutual covenants herein contained, the Parties, intending to be legally bound, hereby agree as",
          "bbox": [
            275.0,
            1180.0,
            2876.0,
            1228.0
          ],
          "confidence": 0.9950727820396423
        },
        {
          "text": "follows:",
          "bbox": [
            275.0,
            1237.0,
            426.0,
            1279.0
          ],
          "confidence": 0.9998461008071899
        },
        {
          "text": "1",
          "bbox": [
            277.0,
            1299.0,
            303.0,
            1330.0
          ],
          "confidence": 0.9999181032180786
        },
        {
          "text": "Definitions",
          "bbox": [
            368.0,
            1296.0,
            589.0,
            1334.0
          ],
          "confidence": 0.999856173992157
        },
        {
          "text": "For the purpose of this Agreement, the terms set forth in this clause, whether used in singular or plural form, shall mean, unless otherwise expressly.",
          "bbox": [
            277.0,
            1352.0,
            3012.0,
            1394.0
          ],
          "confidence": 0.9917291402816772
        },
        {
          "text": "provided for in this Agreement or the context otherwise requires, the following:.",
          "bbox": [
            277.0,
            1405.0,
            1749.0,
            1453.0
          ],
          "confidence": 0.9938557744026184
        },
        {
          "text": "1.1",
          "bbox": [
            379.0,
            1460.0,
            439.0,
            1506.0
          ],
          "confidence": 0.9998831748962402
        },
        {
          "text": "\"Affiliate\"' of a Party shall mean any corporation or other business entity directly or indirectly Controlled by, under common Control.",
          "bbox": [
            546.0,
            1458.0,
            3012.0,
            1509.0
          ],
          "confidence": 0.9893513917922974
        },
        {
          "text": "with, or in the Control of such Party..",
          "bbox": [
            551.0,
            1518.0,
            1222.0,
            1564.0
          ],
          "confidence": 0.9819372296333313
        },
        {
          "text": "1.2",
          "bbox": [
            377.0,
            1573.0,
            440.0,
            1619.0
          ],
          "confidence": 0.9997513890266418
        },
        {
          "text": "\"Anti-Corruption and Anti-Bribery Laws\" shall mean the United States Foreign Corrupt Practices Act of 1977, as amended, the",
          "bbox": [
            549.0,
            1577.0,
            2925.0,
            1619.0
          ],
          "confidence": 0.9937560558319092
        },
        {
          "text": "Bribery Act 2010 (2010 Chapter 23) of the Parliament of the United Kingdom, any rules or regulations under such acts, and any other",
          "bbox": [
            551.0,
            1634.0,
            3011.0,
            1676.0
          ],
          "confidence": 0.9908789992332458
        },
        {
          "text": "anti-corruption or anti-bribery statutes, laws or regulations applicable to a Party..",
          "bbox": [
            547.0,
            1687.0,
            2039.0,
            1732.0
          ],
          "confidence": 0.9931536316871643
        },
        {
          "text": "1.3",
          "bbox": [
            379.0,
            1741.0,
            440.0,
            1787.0
          ],
          "confidence": 0.9998380541801453
        },
        {
          "text": "\"API\"' shall mean the active pharmaceutical ingredients Celecoxib and Amlodipine Besylate..",
          "bbox": [
            549.0,
            1741.0,
            2277.0,
            1787.0
          ],
          "confidence": 0.9627962112426758
        },
        {
          "text": "Source: KITOV PHARMA LTD., 20-F, 3/26/2019",
          "bbox": [
            332.0,
            4437.0,
            1256.0,
            4479.0
          ],
          "confidence": 0.988348126411438
        }
      ],
      "multi_page": true,
      "part_of": 2,
      "nearby_headers": [
        {
          "text": "THE SYMBOL <****\" DENOTES PLACES WHERE PORTIONS OF THIS DOCUMENT HAVE BEEN OMITTED PURSUANT TO A REQUEST",
          "page": 0,
          "bbox": [
            304.0,
            338.0,
            3009.0,
            380.0
          ]
        },
        {
          "text": "FOR CONFIDENTIAL TREATMENT. SUCH MATERIAL WILL BE FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE",
          "page": 0,
          "bbox": [
            399.0,
            398.0,
            2907.0,
            435.0
          ]
        },
        {
          "text": "COMIMISSION.",
          "page": 0,
          "bbox": [
            1503.0,
            455.0,
            1805.0,
            492.0
          ]
        },
        {
          "text": "PRODUCT MANUFACTURING AGREEMENT",
          "page": 0,
          "bbox": [
            1216.0,
            510.0,
            2093.0,
            546.0
          ]
        },
        {
          "text": "WHEREAS:",
          "page": 0,
          "bbox": [
            281.0,
            848.0,
            515.0,
            884.0
          ]
        },
        {
          "text": "WHEREAS:",
          "page": 0,
          "bbox": [
            279.0,
            959.0,
            513.0,
            996.0
          ]
        },
        {
          "text": "WHEREAS:",
          "page": 0,
          "bbox": [
            281.0,
            1071.0,
            515.0,
            1107.0
          ]
        }
      ]
    },
    {
      "id": "KitovPharmaLtd_20190326_20-F_EX-4.15_11584449_EX-4.15_Manufacturing Agreement__Notice Period To Terminate Renewal_1_multi",
      "question": "Highlight the parts (if any) of this contract related to \"Notice Period To Terminate Renewal\" that should be reviewed by a lawyer. Details: What is the notice period required to terminate renewal?",
      "answer_text": "Following the Initial Term, the Agreement shall automatically be renewed for additional periods of **** (each, a \"Renewal Term,\" and, together with the Initial Term, the \"Term\")), unless a Party provides written notification of non-renewal to the other Party at least **** of the Initial Term or a Renewal Term.",
      "page_number": 1,
      "words": [
        {
          "text": "1.4",
          "bbox": [
            379.0,
            281.0,
            442.0,
            327.0
          ],
          "confidence": 0.9997868537902832
        },
        {
          "text": "\"Batch' shall mean the defined quantity of the Product processed in a single process or series of processes in a manner designed to.",
          "bbox": [
            549.0,
            281.0,
            3011.0,
            329.0
          ],
          "confidence": 0.9841217398643494
        },
        {
          "text": "be homogeneous. The Batch size for the Product is **** tablets.",
          "bbox": [
            551.0,
            338.0,
            1756.0,
            382.0
          ],
          "confidence": 0.9994081258773804
        },
        {
          "text": "1.5",
          "bbox": [
            376.0,
            390.0,
            443.0,
            443.0
          ],
          "confidence": 0.9997324347496033
        },
        {
          "text": "\"cGMPs\" or \"Good Manufacturing Practice\"' shall mean the part of quality assurance which ensures that the Product is consistently.",
          "bbox": [
            549.0,
            395.0,
            3023.0,
            440.0
          ],
          "confidence": 0.985264241695404
        },
        {
          "text": "produced and controlled to the quality standards appropriate to their intended use, the principles and guidelines of which are",
          "bbox": [
            549.0,
            451.0,
            2884.0,
            499.0
          ],
          "confidence": 0.9912954568862915
        },
        {
          "text": "specified in European Commission Directive 2003/94/EC and the FDA's current Good Manufacturing Practices, particularly 21 CFR ",
          "bbox": [
            547.0,
            506.0,
            3003.0,
            557.0
          ],
          "confidence": 0.995246410369873
        },
        {
          "text": "210 et seq., and 21 CFR $$ 600-610, as both may be amended from time to time..",
          "bbox": [
            549.0,
            565.0,
            2006.0,
            607.0
          ],
          "confidence": 0.9747835993766785
        },
        {
          "text": "1.6",
          "bbox": [
            379.0,
            619.0,
            442.0,
            663.0
          ],
          "confidence": 0.9999213218688965
        },
        {
          "text": "\"Change of Control' shall mean (i) any change, sale, merger, reorganization, or any other event or action that results in a third party,",
          "bbox": [
            547.0,
            618.0,
            3005.0,
            669.0
          ],
          "confidence": 0.9930126070976257
        },
        {
          "text": "which is a material competitor to the other Party to this agreement, acquiring: (a) all or substantially all of the business or assets of a.",
          "bbox": [
            551.0,
            678.0,
            3002.0,
            722.0
          ],
          "confidence": 0.9852778911590576
        },
        {
          "text": "Party relating to this Agreement, (b) Control, directly or indirectly, of such Party (and/or any corporate entity that Controls, directly.",
          "bbox": [
            551.0,
            735.0,
            2985.0,
            778.0
          ],
          "confidence": 0.9932605624198914
        },
        {
          "text": "or indirectly, such Party), or (ii) any assignment or delegation of, sale or transfer of a Party's rights and obligations under this",
          "bbox": [
            549.0,
            789.0,
            2878.0,
            835.0
          ],
          "confidence": 0.9923490881919861
        },
        {
          "text": "Agreement (or any part hereof) to a third party.",
          "bbox": [
            555.0,
            848.0,
            1426.0,
            890.0
          ],
          "confidence": 0.9961597323417664
        },
        {
          "text": "Notwithstanding anything in the immediately preceding paragraph to the contrary, where the Party in question is Dexcel, any of the",
          "bbox": [
            549.0,
            903.0,
            2991.0,
            945.0
          ],
          "confidence": 0.9957303404808044
        },
        {
          "text": "foregoing events or actions shall not be considered a Change of Control where any one or more of the relevant third party or parties.",
          "bbox": [
            551.0,
            961.0,
            3007.0,
            1003.0
          ],
          "confidence": 0.9899225234985352
        },
        {
          "text": "referred to in clause (i) above is (A) a Family Member, or (B) any entity Controlled by Mr. **** and/or a Family Member.",
          "bbox": [
            544.0,
            1005.0,
            2788.0,
            1064.0
          ],
          "confidence": 0.9933032989501953
        },
        {
          "text": "1.7",
          "bbox": [
            379.0,
            1067.0,
            442.0,
            1113.0
          ],
          "confidence": 0.9998312592506409
        },
        {
          "text": "\"Claims' shall mean any demands, claims, actions, causes of action, assessments, losses, damages, injuries, liabilities, costs and.",
          "bbox": [
            549.0,
            1069.0,
            2953.0,
            1115.0
          ],
          "confidence": 0.9854910969734192
        },
        {
          "text": "expenses (including, without limitation, reasonable attorneys' fees and expenses) filed, raised, initiated or made by any governmental.",
          "bbox": [
            553.0,
            1129.0,
            3021.0,
            1171.0
          ],
          "confidence": 0.992518424987793
        },
        {
          "text": "authority and/or third party.",
          "bbox": [
            551.0,
            1184.0,
            1066.0,
            1226.0
          ],
          "confidence": 0.983346164226532
        },
        {
          "text": "1.8",
          "bbox": [
            379.0,
            1235.0,
            442.0,
            1281.0
          ],
          "confidence": 0.9999089241027832
        },
        {
          "text": "\"Confidential Information\"' shall have the meaning set forth in Section 7.1.",
          "bbox": [
            549.0,
            1235.0,
            1939.0,
            1281.0
          ],
          "confidence": 0.9719286561012268
        },
        {
          "text": "1.9",
          "bbox": [
            379.0,
            1292.0,
            440.0,
            1336.0
          ],
          "confidence": 0.9999080300331116
        },
        {
          "text": "\"Confirmed Order' shall have the meaning set forth in Section 3.3.2.",
          "bbox": [
            549.0,
            1292.0,
            1834.0,
            1338.0
          ],
          "confidence": 0.9867768883705139
        },
        {
          "text": "1.10",
          "bbox": [
            379.0,
            1347.0,
            462.0,
            1394.0
          ],
          "confidence": 0.9999012351036072
        },
        {
          "text": "\"Control' or \"Controlled' shall mean possession of more than fifty percent (50%) of the share capital of a corporation or other",
          "bbox": [
            547.0,
            1345.0,
            2915.0,
            1398.0
          ],
          "confidence": 0.981292724609375
        },
        {
          "text": "business entity, and/or the power to direct or cause the direction of the management and policies of a corporation or other entity",
          "bbox": [
            549.0,
            1405.0,
            2936.0,
            1451.0
          ],
          "confidence": 0.9941077828407288
        },
        {
          "text": "whether through the ownership of voting securities, by contract or otherwise..",
          "bbox": [
            553.0,
            1467.0,
            1996.0,
            1504.0
          ],
          "confidence": 0.9934757947921753
        },
        {
          "text": "1.11",
          "bbox": [
            379.0,
            1517.0,
            455.0,
            1561.0
          ],
          "confidence": 0.999779224395752
        },
        {
          "text": "\"Delivery' shall mean the time when the Product is placed at the disposal of Kitov at Dexcel's Facility based on an ****",
          "bbox": [
            546.0,
            1508.0,
            2799.0,
            1568.0
          ],
          "confidence": 0.992178738117218
        },
        {
          "text": "(Incoterms 2010).",
          "bbox": [
            555.0,
            1579.0,
            904.0,
            1617.0
          ],
          "confidence": 0.99842768907547
        },
        {
          "text": "1.12",
          "bbox": [
            377.0,
            1626.0,
            462.0,
            1674.0
          ],
          "confidence": 0.9999103546142578
        },
        {
          "text": "\"Distributors\" shall mean any Person under contract with Kitov or any of its Affiliates for the distribution of the Product in a certain",
          "bbox": [
            553.0,
            1634.0,
            3018.0,
            1670.0
          ],
          "confidence": 0.9918192625045776
        },
        {
          "text": "territory or territories..",
          "bbox": [
            551.0,
            1692.0,
            946.0,
            1729.0
          ],
          "confidence": 0.9840478301048279
        },
        {
          "text": "1.13",
          "bbox": [
            381.0,
            1741.0,
            459.0,
            1785.0
          ],
          "confidence": 0.8832098245620728
        },
        {
          "text": "\"Effective Date' shall mean the date of signature of the last Party to execute this Agreement..",
          "bbox": [
            549.0,
            1741.0,
            2267.0,
            1787.0
          ],
          "confidence": 0.9844200611114502
        },
        {
          "text": "1.14",
          "bbox": [
            379.0,
            1798.0,
            460.0,
            1840.0
          ],
          "confidence": 0.9994210004806519
        },
        {
          "text": "\"EMA\" means the European Medicines Agency or any successor entity.",
          "bbox": [
            549.0,
            1798.0,
            1898.0,
            1846.0
          ],
          "confidence": 0.9979910254478455
        },
        {
          "text": "1.15",
          "bbox": [
            379.0,
            1851.0,
            460.0,
            1900.0
          ],
          "confidence": 0.9995757341384888
        },
        {
          "text": "\"Family Member\" shall mean ****.",
          "bbox": [
            547.0,
            1847.0,
            1222.0,
            1902.0
          ],
          "confidence": 0.9885128736495972
        },
        {
          "text": "1.16",
          "bbox": [
            379.0,
            1908.0,
            462.0,
            1955.0
          ],
          "confidence": 0.9999197125434875
        },
        {
          "text": "\"FDA\" means the U.S. Food and Drug Administration or any successor entity..",
          "bbox": [
            549.0,
            1911.0,
            2005.0,
            1953.0
          ],
          "confidence": 0.986582338809967
        },
        {
          "text": "2",
          "bbox": [
            1638.0,
            2025.0,
            1669.0,
            2061.0
          ],
          "confidence": 0.999761164188385
        },
        {
          "text": "Source: KITOV PHARMA LTD., 20-F, 3/26/2019",
          "bbox": [
            332.0,
            4437.0,
            1256.0,
            4479.0
          ],
          "confidence": 0.989766538143158
        }
      ],
      "multi_page": true,
      "part_of": 2
    },
    {
      "id": "KitovPharmaLtd_20190326_20-F_EX-4.15_11584449_EX-4.15_Manufacturing Agreement__Governing Law_0",
      "question": "Highlight the parts (if any) of this contract related to \"Governing Law\" that should be reviewed by a lawyer. Details: Which state/country's law governs the interpretation of the contract?",
      "answer_text": "This Agreement shall be interpreted and enforced exclusively under the laws of the State of Israel, without regard to the conflict of laws provisions thereof.",
      "page_number": 0,
      "words": [
        {
          "text": "Exhibit 4.15",
          "bbox": [
            2798.0,
            283.0,
            3029.0,
            325.0
          ],
          "confidence": 0.9998080730438232
        },
        {
          "text": "THE SYMBOL <****\" DENOTES PLACES WHERE PORTIONS OF THIS DOCUMENT HAVE BEEN OMITTED PURSUANT TO A REQUEST",
          "bbox": [
            304.0,
            338.0,
            3009.0,
            380.0
          ],
          "confidence": 0.983539879322052
        },
        {
          "text": "FOR CONFIDENTIAL TREATMENT. SUCH MATERIAL WILL BE FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE",
          "bbox": [
            399.0,
            398.0,
            2907.0,
            435.0
          ],
          "confidence": 0.9926196932792664
        },
        {
          "text": "COMIMISSION.",
          "bbox": [
            1503.0,
            455.0,
            1805.0,
            492.0
          ],
          "confidence": 0.9562864303588867
        },
        {
          "text": "PRODUCT MANUFACTURING AGREEMENT",
          "bbox": [
            1216.0,
            510.0,
            2093.0,
            546.0
          ],
          "confidence": 0.994750440120697
        },
        {
          "text": "This Product Manufacturing Agreement (\"Agreement') is made as of the Effective Date by and between DEXCEL LTD., with its registered address.",
          "bbox": [
            275.0,
            563.0,
            3023.0,
            609.0
          ],
          "confidence": 0.989086925983429
        },
        {
          "text": "at ****, Israel (\"Dexcel'') and KITOV Pharma Ltd., with its registered office at 132 Menachem Begin Road, Azrieli Center, Tel Aviv, 6701101, Israel.",
          "bbox": [
            274.0,
            618.0,
            3000.0,
            665.0
          ],
          "confidence": 0.9887864589691162
        },
        {
          "text": "(\"Kitov'). Dexcel and Kitov are hereinafter jointly the \"Parties' and individually a \"Party.\".",
          "bbox": [
            279.0,
            678.0,
            1945.0,
            722.0
          ],
          "confidence": 0.98404461145401
        },
        {
          "text": "WHEREAS: Dexcel is a pharmaceutical company engaged in various activities including, but not limited to, the research, development,",
          "bbox": [
            275.0,
            729.0,
            2817.0,
            780.0
          ],
          "confidence": 0.9837751388549805
        },
        {
          "text": "manufacture, and marketing of various drugs and pharmaceutical specialties in various dosage forms;",
          "bbox": [
            549.0,
            795.0,
            2438.0,
            831.0
          ],
          "confidence": 0.9977880120277405
        },
        {
          "text": "WHEREAS:",
          "bbox": [
            281.0,
            848.0,
            515.0,
            884.0
          ],
          "confidence": 0.9993464946746826
        },
        {
          "text": "Kitov is a pharmaceutical company engaged in various activities including, but not limited to, the development of pharmaceutical",
          "bbox": [
            546.0,
            844.0,
            2951.0,
            890.0
          ],
          "confidence": 0.9910856485366821
        },
        {
          "text": "products;",
          "bbox": [
            551.0,
            906.0,
            732.0,
            945.0
          ],
          "confidence": 0.9994080066680908
        },
        {
          "text": "WHEREAS:",
          "bbox": [
            279.0,
            959.0,
            513.0,
            996.0
          ],
          "confidence": 0.9993117451667786
        },
        {
          "text": "Kitov and Dexcel entered into a Development Services Agreement on April 1, 2014 (\"Development Agreement'), pursuant to which",
          "bbox": [
            549.0,
            958.0,
            2991.0,
            1000.0
          ],
          "confidence": 0.9946937561035156
        },
        {
          "text": "Dexcel performed certain development services for Kitov with respect to the Product;",
          "bbox": [
            551.0,
            1016.0,
            2139.0,
            1058.0
          ],
          "confidence": 0.9957237243652344
        },
        {
          "text": "WHEREAS:",
          "bbox": [
            281.0,
            1071.0,
            515.0,
            1107.0
          ],
          "confidence": 0.9993150234222412
        },
        {
          "text": "Kitov desires that Dexcel manufacture and package the Product for Kitov in accordance with the terms of this Agreement, and Dexcel",
          "bbox": [
            546.0,
            1069.0,
            3029.0,
            1115.0
          ],
          "confidence": 0.9908015131950378
        },
        {
          "text": "is willing to manufacture and package the Product for Kitov in accordance with the terms of this Agreement..",
          "bbox": [
            547.0,
            1126.0,
            2561.0,
            1171.0
          ],
          "confidence": 0.9924741387367249
        },
        {
          "text": "NOw, THEREFORE, in consideration of the mutual covenants herein contained, the Parties, intending to be legally bound, hereby agree as",
          "bbox": [
            275.0,
            1180.0,
            2876.0,
            1228.0
          ],
          "confidence": 0.9950727820396423
        },
        {
          "text": "follows:",
          "bbox": [
            275.0,
            1237.0,
            426.0,
            1279.0
          ],
          "confidence": 0.9998461008071899
        },
        {
          "text": "1",
          "bbox": [
            277.0,
            1299.0,
            303.0,
            1330.0
          ],
          "confidence": 0.9999181032180786
        },
        {
          "text": "Definitions",
          "bbox": [
            368.0,
            1296.0,
            589.0,
            1334.0
          ],
          "confidence": 0.999856173992157
        },
        {
          "text": "For the purpose of this Agreement, the terms set forth in this clause, whether used in singular or plural form, shall mean, unless otherwise expressly.",
          "bbox": [
            277.0,
            1352.0,
            3012.0,
            1394.0
          ],
          "confidence": 0.9917291402816772
        },
        {
          "text": "provided for in this Agreement or the context otherwise requires, the following:.",
          "bbox": [
            277.0,
            1405.0,
            1749.0,
            1453.0
          ],
          "confidence": 0.9938557744026184
        },
        {
          "text": "1.1",
          "bbox": [
            379.0,
            1460.0,
            439.0,
            1506.0
          ],
          "confidence": 0.9998831748962402
        },
        {
          "text": "\"Affiliate\"' of a Party shall mean any corporation or other business entity directly or indirectly Controlled by, under common Control.",
          "bbox": [
            546.0,
            1458.0,
            3012.0,
            1509.0
          ],
          "confidence": 0.9893513917922974
        },
        {
          "text": "with, or in the Control of such Party..",
          "bbox": [
            551.0,
            1518.0,
            1222.0,
            1564.0
          ],
          "confidence": 0.9819372296333313
        },
        {
          "text": "1.2",
          "bbox": [
            377.0,
            1573.0,
            440.0,
            1619.0
          ],
          "confidence": 0.9997513890266418
        },
        {
          "text": "\"Anti-Corruption and Anti-Bribery Laws\" shall mean the United States Foreign Corrupt Practices Act of 1977, as amended, the",
          "bbox": [
            549.0,
            1577.0,
            2925.0,
            1619.0
          ],
          "confidence": 0.9937560558319092
        },
        {
          "text": "Bribery Act 2010 (2010 Chapter 23) of the Parliament of the United Kingdom, any rules or regulations under such acts, and any other",
          "bbox": [
            551.0,
            1634.0,
            3011.0,
            1676.0
          ],
          "confidence": 0.9908789992332458
        },
        {
          "text": "anti-corruption or anti-bribery statutes, laws or regulations applicable to a Party..",
          "bbox": [
            547.0,
            1687.0,
            2039.0,
            1732.0
          ],
          "confidence": 0.9931536316871643
        },
        {
          "text": "1.3",
          "bbox": [
            379.0,
            1741.0,
            440.0,
            1787.0
          ],
          "confidence": 0.9998380541801453
        },
        {
          "text": "\"API\"' shall mean the active pharmaceutical ingredients Celecoxib and Amlodipine Besylate..",
          "bbox": [
            549.0,
            1741.0,
            2277.0,
            1787.0
          ],
          "confidence": 0.9627962112426758
        },
        {
          "text": "Source: KITOV PHARMA LTD., 20-F, 3/26/2019",
          "bbox": [
            332.0,
            4437.0,
            1256.0,
            4479.0
          ],
          "confidence": 0.988348126411438
        }
      ],
      "nearby_headers": [
        {
          "text": "THE SYMBOL <****\" DENOTES PLACES WHERE PORTIONS OF THIS DOCUMENT HAVE BEEN OMITTED PURSUANT TO A REQUEST",
          "page": 0,
          "bbox": [
            304.0,
            338.0,
            3009.0,
            380.0
          ]
        },
        {
          "text": "FOR CONFIDENTIAL TREATMENT. SUCH MATERIAL WILL BE FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE",
          "page": 0,
          "bbox": [
            399.0,
            398.0,
            2907.0,
            435.0
          ]
        },
        {
          "text": "COMIMISSION.",
          "page": 0,
          "bbox": [
            1503.0,
            455.0,
            1805.0,
            492.0
          ]
        },
        {
          "text": "PRODUCT MANUFACTURING AGREEMENT",
          "page": 0,
          "bbox": [
            1216.0,
            510.0,
            2093.0,
            546.0
          ]
        },
        {
          "text": "WHEREAS:",
          "page": 0,
          "bbox": [
            281.0,
            848.0,
            515.0,
            884.0
          ]
        },
        {
          "text": "WHEREAS:",
          "page": 0,
          "bbox": [
            279.0,
            959.0,
            513.0,
            996.0
          ]
        },
        {
          "text": "WHEREAS:",
          "page": 0,
          "bbox": [
            281.0,
            1071.0,
            515.0,
            1107.0
          ]
        }
      ]
    },
    {
      "id": "KitovPharmaLtd_20190326_20-F_EX-4.15_11584449_EX-4.15_Manufacturing Agreement__Exclusivity_0_multi",
      "question": "Highlight the parts (if any) of this contract related to \"Exclusivity\" that should be reviewed by a lawyer. Details: Is there an exclusive dealing  commitment with the counterparty? This includes a commitment to procure all “requirements” from one party of certain technology, goods, or services or a prohibition on licensing or selling technology, goods or services to third parties, or a prohibition on  collaborating or working with other parties), whether during the contract or  after the contract ends (or both).",
      "answer_text": "Kitov hereby grants to Dexcel a fully paid, limited license right to use all of its Confidential Information and Intellectual Property Rights (including, inter alia, the Kitov Foreground IP, Kitov Data, Kitov's share of the Joint IP, and the Trademark (\"Kitov Product IP\")) necessary in order for Dexcel to manufacture, Label, package with the Livery, test and release the Product for shipment, exclusively for Kitov, for and during the Term.",
      "page_number": 0,
      "words": [
        {
          "text": "Exhibit 4.15",
          "bbox": [
            2798.0,
            283.0,
            3029.0,
            325.0
          ],
          "confidence": 0.9998080730438232
        },
        {
          "text": "THE SYMBOL <****\" DENOTES PLACES WHERE PORTIONS OF THIS DOCUMENT HAVE BEEN OMITTED PURSUANT TO A REQUEST",
          "bbox": [
            304.0,
            338.0,
            3009.0,
            380.0
          ],
          "confidence": 0.983539879322052
        },
        {
          "text": "FOR CONFIDENTIAL TREATMENT. SUCH MATERIAL WILL BE FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE",
          "bbox": [
            399.0,
            398.0,
            2907.0,
            435.0
          ],
          "confidence": 0.9926196932792664
        },
        {
          "text": "COMIMISSION.",
          "bbox": [
            1503.0,
            455.0,
            1805.0,
            492.0
          ],
          "confidence": 0.9562864303588867
        },
        {
          "text": "PRODUCT MANUFACTURING AGREEMENT",
          "bbox": [
            1216.0,
            510.0,
            2093.0,
            546.0
          ],
          "confidence": 0.994750440120697
        },
        {
          "text": "This Product Manufacturing Agreement (\"Agreement') is made as of the Effective Date by and between DEXCEL LTD., with its registered address.",
          "bbox": [
            275.0,
            563.0,
            3023.0,
            609.0
          ],
          "confidence": 0.989086925983429
        },
        {
          "text": "at ****, Israel (\"Dexcel'') and KITOV Pharma Ltd., with its registered office at 132 Menachem Begin Road, Azrieli Center, Tel Aviv, 6701101, Israel.",
          "bbox": [
            274.0,
            618.0,
            3000.0,
            665.0
          ],
          "confidence": 0.9887864589691162
        },
        {
          "text": "(\"Kitov'). Dexcel and Kitov are hereinafter jointly the \"Parties' and individually a \"Party.\".",
          "bbox": [
            279.0,
            678.0,
            1945.0,
            722.0
          ],
          "confidence": 0.98404461145401
        },
        {
          "text": "WHEREAS: Dexcel is a pharmaceutical company engaged in various activities including, but not limited to, the research, development,",
          "bbox": [
            275.0,
            729.0,
            2817.0,
            780.0
          ],
          "confidence": 0.9837751388549805
        },
        {
          "text": "manufacture, and marketing of various drugs and pharmaceutical specialties in various dosage forms;",
          "bbox": [
            549.0,
            795.0,
            2438.0,
            831.0
          ],
          "confidence": 0.9977880120277405
        },
        {
          "text": "WHEREAS:",
          "bbox": [
            281.0,
            848.0,
            515.0,
            884.0
          ],
          "confidence": 0.9993464946746826
        },
        {
          "text": "Kitov is a pharmaceutical company engaged in various activities including, but not limited to, the development of pharmaceutical",
          "bbox": [
            546.0,
            844.0,
            2951.0,
            890.0
          ],
          "confidence": 0.9910856485366821
        },
        {
          "text": "products;",
          "bbox": [
            551.0,
            906.0,
            732.0,
            945.0
          ],
          "confidence": 0.9994080066680908
        },
        {
          "text": "WHEREAS:",
          "bbox": [
            279.0,
            959.0,
            513.0,
            996.0
          ],
          "confidence": 0.9993117451667786
        },
        {
          "text": "Kitov and Dexcel entered into a Development Services Agreement on April 1, 2014 (\"Development Agreement'), pursuant to which",
          "bbox": [
            549.0,
            958.0,
            2991.0,
            1000.0
          ],
          "confidence": 0.9946937561035156
        },
        {
          "text": "Dexcel performed certain development services for Kitov with respect to the Product;",
          "bbox": [
            551.0,
            1016.0,
            2139.0,
            1058.0
          ],
          "confidence": 0.9957237243652344
        },
        {
          "text": "WHEREAS:",
          "bbox": [
            281.0,
            1071.0,
            515.0,
            1107.0
          ],
          "confidence": 0.9993150234222412
        },
        {
          "text": "Kitov desires that Dexcel manufacture and package the Product for Kitov in accordance with the terms of this Agreement, and Dexcel",
          "bbox": [
            546.0,
            1069.0,
            3029.0,
            1115.0
          ],
          "confidence": 0.9908015131950378
        },
        {
          "text": "is willing to manufacture and package the Product for Kitov in accordance with the terms of this Agreement..",
          "bbox": [
            547.0,
            1126.0,
            2561.0,
            1171.0
          ],
          "confidence": 0.9924741387367249
        },
        {
          "text": "NOw, THEREFORE, in consideration of the mutual covenants herein contained, the Parties, intending to be legally bound, hereby agree as",
          "bbox": [
            275.0,
            1180.0,
            2876.0,
            1228.0
          ],
          "confidence": 0.9950727820396423
        },
        {
          "text": "follows:",
          "bbox": [
            275.0,
            1237.0,
            426.0,
            1279.0
          ],
          "confidence": 0.9998461008071899
        },
        {
          "text": "1",
          "bbox": [
            277.0,
            1299.0,
            303.0,
            1330.0
          ],
          "confidence": 0.9999181032180786
        },
        {
          "text": "Definitions",
          "bbox": [
            368.0,
            1296.0,
            589.0,
            1334.0
          ],
          "confidence": 0.999856173992157
        },
        {
          "text": "For the purpose of this Agreement, the terms set forth in this clause, whether used in singular or plural form, shall mean, unless otherwise expressly.",
          "bbox": [
            277.0,
            1352.0,
            3012.0,
            1394.0
          ],
          "confidence": 0.9917291402816772
        },
        {
          "text": "provided for in this Agreement or the context otherwise requires, the following:.",
          "bbox": [
            277.0,
            1405.0,
            1749.0,
            1453.0
          ],
          "confidence": 0.9938557744026184
        },
        {
          "text": "1.1",
          "bbox": [
            379.0,
            1460.0,
            439.0,
            1506.0
          ],
          "confidence": 0.9998831748962402
        },
        {
          "text": "\"Affiliate\"' of a Party shall mean any corporation or other business entity directly or indirectly Controlled by, under common Control.",
          "bbox": [
            546.0,
            1458.0,
            3012.0,
            1509.0
          ],
          "confidence": 0.9893513917922974
        },
        {
          "text": "with, or in the Control of such Party..",
          "bbox": [
            551.0,
            1518.0,
            1222.0,
            1564.0
          ],
          "confidence": 0.9819372296333313
        },
        {
          "text": "1.2",
          "bbox": [
            377.0,
            1573.0,
            440.0,
            1619.0
          ],
          "confidence": 0.9997513890266418
        },
        {
          "text": "\"Anti-Corruption and Anti-Bribery Laws\" shall mean the United States Foreign Corrupt Practices Act of 1977, as amended, the",
          "bbox": [
            549.0,
            1577.0,
            2925.0,
            1619.0
          ],
          "confidence": 0.9937560558319092
        },
        {
          "text": "Bribery Act 2010 (2010 Chapter 23) of the Parliament of the United Kingdom, any rules or regulations under such acts, and any other",
          "bbox": [
            551.0,
            1634.0,
            3011.0,
            1676.0
          ],
          "confidence": 0.9908789992332458
        },
        {
          "text": "anti-corruption or anti-bribery statutes, laws or regulations applicable to a Party..",
          "bbox": [
            547.0,
            1687.0,
            2039.0,
            1732.0
          ],
          "confidence": 0.9931536316871643
        },
        {
          "text": "1.3",
          "bbox": [
            379.0,
            1741.0,
            440.0,
            1787.0
          ],
          "confidence": 0.9998380541801453
        },
        {
          "text": "\"API\"' shall mean the active pharmaceutical ingredients Celecoxib and Amlodipine Besylate..",
          "bbox": [
            549.0,
            1741.0,
            2277.0,
            1787.0
          ],
          "confidence": 0.9627962112426758
        },
        {
          "text": "Source: KITOV PHARMA LTD., 20-F, 3/26/2019",
          "bbox": [
            332.0,
            4437.0,
            1256.0,
            4479.0
          ],
          "confidence": 0.988348126411438
        }
      ],
      "multi_page": true,
      "part_of": 2,
      "nearby_headers": [
        {
          "text": "THE SYMBOL <****\" DENOTES PLACES WHERE PORTIONS OF THIS DOCUMENT HAVE BEEN OMITTED PURSUANT TO A REQUEST",
          "page": 0,
          "bbox": [
            304.0,
            338.0,
            3009.0,
            380.0
          ]
        },
        {
          "text": "FOR CONFIDENTIAL TREATMENT. SUCH MATERIAL WILL BE FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE",
          "page": 0,
          "bbox": [
            399.0,
            398.0,
            2907.0,
            435.0
          ]
        },
        {
          "text": "COMIMISSION.",
          "page": 0,
          "bbox": [
            1503.0,
            455.0,
            1805.0,
            492.0
          ]
        },
        {
          "text": "PRODUCT MANUFACTURING AGREEMENT",
          "page": 0,
          "bbox": [
            1216.0,
            510.0,
            2093.0,
            546.0
          ]
        },
        {
          "text": "WHEREAS:",
          "page": 0,
          "bbox": [
            281.0,
            848.0,
            515.0,
            884.0
          ]
        },
        {
          "text": "WHEREAS:",
          "page": 0,
          "bbox": [
            279.0,
            959.0,
            513.0,
            996.0
          ]
        },
        {
          "text": "WHEREAS:",
          "page": 0,
          "bbox": [
            281.0,
            1071.0,
            515.0,
            1107.0
          ]
        }
      ]
    },
    {
      "id": "KitovPharmaLtd_20190326_20-F_EX-4.15_11584449_EX-4.15_Manufacturing Agreement__Exclusivity_1_multi",
      "question": "Highlight the parts (if any) of this contract related to \"Exclusivity\" that should be reviewed by a lawyer. Details: Is there an exclusive dealing  commitment with the counterparty? This includes a commitment to procure all “requirements” from one party of certain technology, goods, or services or a prohibition on licensing or selling technology, goods or services to third parties, or a prohibition on  collaborating or working with other parties), whether during the contract or  after the contract ends (or both).",
      "answer_text": "Kitov hereby grants to Dexcel a fully paid, limited license right to use all of its Confidential Information and Intellectual Property Rights (including, inter alia, the Kitov Foreground IP, Kitov Data, Kitov's share of the Joint IP, and the Trademark (\"Kitov Product IP\")) necessary in order for Dexcel to manufacture, Label, package with the Livery, test and release the Product for shipment, exclusively for Kitov, for and during the Term.",
      "page_number": 1,
      "words": [
        {
          "text": "1.4",
          "bbox": [
            379.0,
            281.0,
            442.0,
            327.0
          ],
          "confidence": 0.9997868537902832
        },
        {
          "text": "\"Batch' shall mean the defined quantity of the Product processed in a single process or series of processes in a manner designed to.",
          "bbox": [
            549.0,
            281.0,
            3011.0,
            329.0
          ],
          "confidence": 0.9841217398643494
        },
        {
          "text": "be homogeneous. The Batch size for the Product is **** tablets.",
          "bbox": [
            551.0,
            338.0,
            1756.0,
            382.0
          ],
          "confidence": 0.9994081258773804
        },
        {
          "text": "1.5",
          "bbox": [
            376.0,
            390.0,
            443.0,
            443.0
          ],
          "confidence": 0.9997324347496033
        },
        {
          "text": "\"cGMPs\" or \"Good Manufacturing Practice\"' shall mean the part of quality assurance which ensures that the Product is consistently.",
          "bbox": [
            549.0,
            395.0,
            3023.0,
            440.0
          ],
          "confidence": 0.985264241695404
        },
        {
          "text": "produced and controlled to the quality standards appropriate to their intended use, the principles and guidelines of which are",
          "bbox": [
            549.0,
            451.0,
            2884.0,
            499.0
          ],
          "confidence": 0.9912954568862915
        },
        {
          "text": "specified in European Commission Directive 2003/94/EC and the FDA's current Good Manufacturing Practices, particularly 21 CFR ",
          "bbox": [
            547.0,
            506.0,
            3003.0,
            557.0
          ],
          "confidence": 0.995246410369873
        },
        {
          "text": "210 et seq., and 21 CFR $$ 600-610, as both may be amended from time to time..",
          "bbox": [
            549.0,
            565.0,
            2006.0,
            607.0
          ],
          "confidence": 0.9747835993766785
        },
        {
          "text": "1.6",
          "bbox": [
            379.0,
            619.0,
            442.0,
            663.0
          ],
          "confidence": 0.9999213218688965
        },
        {
          "text": "\"Change of Control' shall mean (i) any change, sale, merger, reorganization, or any other event or action that results in a third party,",
          "bbox": [
            547.0,
            618.0,
            3005.0,
            669.0
          ],
          "confidence": 0.9930126070976257
        },
        {
          "text": "which is a material competitor to the other Party to this agreement, acquiring: (a) all or substantially all of the business or assets of a.",
          "bbox": [
            551.0,
            678.0,
            3002.0,
            722.0
          ],
          "confidence": 0.9852778911590576
        },
        {
          "text": "Party relating to this Agreement, (b) Control, directly or indirectly, of such Party (and/or any corporate entity that Controls, directly.",
          "bbox": [
            551.0,
            735.0,
            2985.0,
            778.0
          ],
          "confidence": 0.9932605624198914
        },
        {
          "text": "or indirectly, such Party), or (ii) any assignment or delegation of, sale or transfer of a Party's rights and obligations under this",
          "bbox": [
            549.0,
            789.0,
            2878.0,
            835.0
          ],
          "confidence": 0.9923490881919861
        },
        {
          "text": "Agreement (or any part hereof) to a third party.",
          "bbox": [
            555.0,
            848.0,
            1426.0,
            890.0
          ],
          "confidence": 0.9961597323417664
        },
        {
          "text": "Notwithstanding anything in the immediately preceding paragraph to the contrary, where the Party in question is Dexcel, any of the",
          "bbox": [
            549.0,
            903.0,
            2991.0,
            945.0
          ],
          "confidence": 0.9957303404808044
        },
        {
          "text": "foregoing events or actions shall not be considered a Change of Control where any one or more of the relevant third party or parties.",
          "bbox": [
            551.0,
            961.0,
            3007.0,
            1003.0
          ],
          "confidence": 0.9899225234985352
        },
        {
          "text": "referred to in clause (i) above is (A) a Family Member, or (B) any entity Controlled by Mr. **** and/or a Family Member.",
          "bbox": [
            544.0,
            1005.0,
            2788.0,
            1064.0
          ],
          "confidence": 0.9933032989501953
        },
        {
          "text": "1.7",
          "bbox": [
            379.0,
            1067.0,
            442.0,
            1113.0
          ],
          "confidence": 0.9998312592506409
        },
        {
          "text": "\"Claims' shall mean any demands, claims, actions, causes of action, assessments, losses, damages, injuries, liabilities, costs and.",
          "bbox": [
            549.0,
            1069.0,
            2953.0,
            1115.0
          ],
          "confidence": 0.9854910969734192
        },
        {
          "text": "expenses (including, without limitation, reasonable attorneys' fees and expenses) filed, raised, initiated or made by any governmental.",
          "bbox": [
            553.0,
            1129.0,
            3021.0,
            1171.0
          ],
          "confidence": 0.992518424987793
        },
        {
          "text": "authority and/or third party.",
          "bbox": [
            551.0,
            1184.0,
            1066.0,
            1226.0
          ],
          "confidence": 0.983346164226532
        },
        {
          "text": "1.8",
          "bbox": [
            379.0,
            1235.0,
            442.0,
            1281.0
          ],
          "confidence": 0.9999089241027832
        },
        {
          "text": "\"Confidential Information\"' shall have the meaning set forth in Section 7.1.",
          "bbox": [
            549.0,
            1235.0,
            1939.0,
            1281.0
          ],
          "confidence": 0.9719286561012268
        },
        {
          "text": "1.9",
          "bbox": [
            379.0,
            1292.0,
            440.0,
            1336.0
          ],
          "confidence": 0.9999080300331116
        },
        {
          "text": "\"Confirmed Order' shall have the meaning set forth in Section 3.3.2.",
          "bbox": [
            549.0,
            1292.0,
            1834.0,
            1338.0
          ],
          "confidence": 0.9867768883705139
        },
        {
          "text": "1.10",
          "bbox": [
            379.0,
            1347.0,
            462.0,
            1394.0
          ],
          "confidence": 0.9999012351036072
        },
        {
          "text": "\"Control' or \"Controlled' shall mean possession of more than fifty percent (50%) of the share capital of a corporation or other",
          "bbox": [
            547.0,
            1345.0,
            2915.0,
            1398.0
          ],
          "confidence": 0.981292724609375
        },
        {
          "text": "business entity, and/or the power to direct or cause the direction of the management and policies of a corporation or other entity",
          "bbox": [
            549.0,
            1405.0,
            2936.0,
            1451.0
          ],
          "confidence": 0.9941077828407288
        },
        {
          "text": "whether through the ownership of voting securities, by contract or otherwise..",
          "bbox": [
            553.0,
            1467.0,
            1996.0,
            1504.0
          ],
          "confidence": 0.9934757947921753
        },
        {
          "text": "1.11",
          "bbox": [
            379.0,
            1517.0,
            455.0,
            1561.0
          ],
          "confidence": 0.999779224395752
        },
        {
          "text": "\"Delivery' shall mean the time when the Product is placed at the disposal of Kitov at Dexcel's Facility based on an ****",
          "bbox": [
            546.0,
            1508.0,
            2799.0,
            1568.0
          ],
          "confidence": 0.992178738117218
        },
        {
          "text": "(Incoterms 2010).",
          "bbox": [
            555.0,
            1579.0,
            904.0,
            1617.0
          ],
          "confidence": 0.99842768907547
        },
        {
          "text": "1.12",
          "bbox": [
            377.0,
            1626.0,
            462.0,
            1674.0
          ],
          "confidence": 0.9999103546142578
        },
        {
          "text": "\"Distributors\" shall mean any Person under contract with Kitov or any of its Affiliates for the distribution of the Product in a certain",
          "bbox": [
            553.0,
            1634.0,
            3018.0,
            1670.0
          ],
          "confidence": 0.9918192625045776
        },
        {
          "text": "territory or territories..",
          "bbox": [
            551.0,
            1692.0,
            946.0,
            1729.0
          ],
          "confidence": 0.9840478301048279
        },
        {
          "text": "1.13",
          "bbox": [
            381.0,
            1741.0,
            459.0,
            1785.0
          ],
          "confidence": 0.8832098245620728
        },
        {
          "text": "\"Effective Date' shall mean the date of signature of the last Party to execute this Agreement..",
          "bbox": [
            549.0,
            1741.0,
            2267.0,
            1787.0
          ],
          "confidence": 0.9844200611114502
        },
        {
          "text": "1.14",
          "bbox": [
            379.0,
            1798.0,
            460.0,
            1840.0
          ],
          "confidence": 0.9994210004806519
        },
        {
          "text": "\"EMA\" means the European Medicines Agency or any successor entity.",
          "bbox": [
            549.0,
            1798.0,
            1898.0,
            1846.0
          ],
          "confidence": 0.9979910254478455
        },
        {
          "text": "1.15",
          "bbox": [
            379.0,
            1851.0,
            460.0,
            1900.0
          ],
          "confidence": 0.9995757341384888
        },
        {
          "text": "\"Family Member\" shall mean ****.",
          "bbox": [
            547.0,
            1847.0,
            1222.0,
            1902.0
          ],
          "confidence": 0.9885128736495972
        },
        {
          "text": "1.16",
          "bbox": [
            379.0,
            1908.0,
            462.0,
            1955.0
          ],
          "confidence": 0.9999197125434875
        },
        {
          "text": "\"FDA\" means the U.S. Food and Drug Administration or any successor entity..",
          "bbox": [
            549.0,
            1911.0,
            2005.0,
            1953.0
          ],
          "confidence": 0.986582338809967
        },
        {
          "text": "2",
          "bbox": [
            1638.0,
            2025.0,
            1669.0,
            2061.0
          ],
          "confidence": 0.999761164188385
        },
        {
          "text": "Source: KITOV PHARMA LTD., 20-F, 3/26/2019",
          "bbox": [
            332.0,
            4437.0,
            1256.0,
            4479.0
          ],
          "confidence": 0.989766538143158
        }
      ],
      "multi_page": true,
      "part_of": 2
    },
    {
      "id": "KitovPharmaLtd_20190326_20-F_EX-4.15_11584449_EX-4.15_Manufacturing Agreement__Change Of Control_0",
      "question": "Highlight the parts (if any) of this contract related to \"Change Of Control\" that should be reviewed by a lawyer. Details: Does one party have the right to terminate or is consent or notice required of the counterparty if such party undergoes a change of control, such as a merger, stock sale, transfer of all or substantially all of its assets or business, or assignment by operation of law?",
      "answer_text": "The affected Party is obligated to notify the other Party of its decision to terminate within thirty (30) days following notice of the Change of Control.",
      "page_number": 0,
      "words": [
        {
          "text": "Exhibit 4.15",
          "bbox": [
            2798.0,
            283.0,
            3029.0,
            325.0
          ],
          "confidence": 0.9998080730438232
        },
        {
          "text": "THE SYMBOL <****\" DENOTES PLACES WHERE PORTIONS OF THIS DOCUMENT HAVE BEEN OMITTED PURSUANT TO A REQUEST",
          "bbox": [
            304.0,
            338.0,
            3009.0,
            380.0
          ],
          "confidence": 0.983539879322052
        },
        {
          "text": "FOR CONFIDENTIAL TREATMENT. SUCH MATERIAL WILL BE FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE",
          "bbox": [
            399.0,
            398.0,
            2907.0,
            435.0
          ],
          "confidence": 0.9926196932792664
        },
        {
          "text": "COMIMISSION.",
          "bbox": [
            1503.0,
            455.0,
            1805.0,
            492.0
          ],
          "confidence": 0.9562864303588867
        },
        {
          "text": "PRODUCT MANUFACTURING AGREEMENT",
          "bbox": [
            1216.0,
            510.0,
            2093.0,
            546.0
          ],
          "confidence": 0.994750440120697
        },
        {
          "text": "This Product Manufacturing Agreement (\"Agreement') is made as of the Effective Date by and between DEXCEL LTD., with its registered address.",
          "bbox": [
            275.0,
            563.0,
            3023.0,
            609.0
          ],
          "confidence": 0.989086925983429
        },
        {
          "text": "at ****, Israel (\"Dexcel'') and KITOV Pharma Ltd., with its registered office at 132 Menachem Begin Road, Azrieli Center, Tel Aviv, 6701101, Israel.",
          "bbox": [
            274.0,
            618.0,
            3000.0,
            665.0
          ],
          "confidence": 0.9887864589691162
        },
        {
          "text": "(\"Kitov'). Dexcel and Kitov are hereinafter jointly the \"Parties' and individually a \"Party.\".",
          "bbox": [
            279.0,
            678.0,
            1945.0,
            722.0
          ],
          "confidence": 0.98404461145401
        },
        {
          "text": "WHEREAS: Dexcel is a pharmaceutical company engaged in various activities including, but not limited to, the research, development,",
          "bbox": [
            275.0,
            729.0,
            2817.0,
            780.0
          ],
          "confidence": 0.9837751388549805
        },
        {
          "text": "manufacture, and marketing of various drugs and pharmaceutical specialties in various dosage forms;",
          "bbox": [
            549.0,
            795.0,
            2438.0,
            831.0
          ],
          "confidence": 0.9977880120277405
        },
        {
          "text": "WHEREAS:",
          "bbox": [
            281.0,
            848.0,
            515.0,
            884.0
          ],
          "confidence": 0.9993464946746826
        },
        {
          "text": "Kitov is a pharmaceutical company engaged in various activities including, but not limited to, the development of pharmaceutical",
          "bbox": [
            546.0,
            844.0,
            2951.0,
            890.0
          ],
          "confidence": 0.9910856485366821
        },
        {
          "text": "products;",
          "bbox": [
            551.0,
            906.0,
            732.0,
            945.0
          ],
          "confidence": 0.9994080066680908
        },
        {
          "text": "WHEREAS:",
          "bbox": [
            279.0,
            959.0,
            513.0,
            996.0
          ],
          "confidence": 0.9993117451667786
        },
        {
          "text": "Kitov and Dexcel entered into a Development Services Agreement on April 1, 2014 (\"Development Agreement'), pursuant to which",
          "bbox": [
            549.0,
            958.0,
            2991.0,
            1000.0
          ],
          "confidence": 0.9946937561035156
        },
        {
          "text": "Dexcel performed certain development services for Kitov with respect to the Product;",
          "bbox": [
            551.0,
            1016.0,
            2139.0,
            1058.0
          ],
          "confidence": 0.9957237243652344
        },
        {
          "text": "WHEREAS:",
          "bbox": [
            281.0,
            1071.0,
            515.0,
            1107.0
          ],
          "confidence": 0.9993150234222412
        },
        {
          "text": "Kitov desires that Dexcel manufacture and package the Product for Kitov in accordance with the terms of this Agreement, and Dexcel",
          "bbox": [
            546.0,
            1069.0,
            3029.0,
            1115.0
          ],
          "confidence": 0.9908015131950378
        },
        {
          "text": "is willing to manufacture and package the Product for Kitov in accordance with the terms of this Agreement..",
          "bbox": [
            547.0,
            1126.0,
            2561.0,
            1171.0
          ],
          "confidence": 0.9924741387367249
        },
        {
          "text": "NOw, THEREFORE, in consideration of the mutual covenants herein contained, the Parties, intending to be legally bound, hereby agree as",
          "bbox": [
            275.0,
            1180.0,
            2876.0,
            1228.0
          ],
          "confidence": 0.9950727820396423
        },
        {
          "text": "follows:",
          "bbox": [
            275.0,
            1237.0,
            426.0,
            1279.0
          ],
          "confidence": 0.9998461008071899
        },
        {
          "text": "1",
          "bbox": [
            277.0,
            1299.0,
            303.0,
            1330.0
          ],
          "confidence": 0.9999181032180786
        },
        {
          "text": "Definitions",
          "bbox": [
            368.0,
            1296.0,
            589.0,
            1334.0
          ],
          "confidence": 0.999856173992157
        },
        {
          "text": "For the purpose of this Agreement, the terms set forth in this clause, whether used in singular or plural form, shall mean, unless otherwise expressly.",
          "bbox": [
            277.0,
            1352.0,
            3012.0,
            1394.0
          ],
          "confidence": 0.9917291402816772
        },
        {
          "text": "provided for in this Agreement or the context otherwise requires, the following:.",
          "bbox": [
            277.0,
            1405.0,
            1749.0,
            1453.0
          ],
          "confidence": 0.9938557744026184
        },
        {
          "text": "1.1",
          "bbox": [
            379.0,
            1460.0,
            439.0,
            1506.0
          ],
          "confidence": 0.9998831748962402
        },
        {
          "text": "\"Affiliate\"' of a Party shall mean any corporation or other business entity directly or indirectly Controlled by, under common Control.",
          "bbox": [
            546.0,
            1458.0,
            3012.0,
            1509.0
          ],
          "confidence": 0.9893513917922974
        },
        {
          "text": "with, or in the Control of such Party..",
          "bbox": [
            551.0,
            1518.0,
            1222.0,
            1564.0
          ],
          "confidence": 0.9819372296333313
        },
        {
          "text": "1.2",
          "bbox": [
            377.0,
            1573.0,
            440.0,
            1619.0
          ],
          "confidence": 0.9997513890266418
        },
        {
          "text": "\"Anti-Corruption and Anti-Bribery Laws\" shall mean the United States Foreign Corrupt Practices Act of 1977, as amended, the",
          "bbox": [
            549.0,
            1577.0,
            2925.0,
            1619.0
          ],
          "confidence": 0.9937560558319092
        },
        {
          "text": "Bribery Act 2010 (2010 Chapter 23) of the Parliament of the United Kingdom, any rules or regulations under such acts, and any other",
          "bbox": [
            551.0,
            1634.0,
            3011.0,
            1676.0
          ],
          "confidence": 0.9908789992332458
        },
        {
          "text": "anti-corruption or anti-bribery statutes, laws or regulations applicable to a Party..",
          "bbox": [
            547.0,
            1687.0,
            2039.0,
            1732.0
          ],
          "confidence": 0.9931536316871643
        },
        {
          "text": "1.3",
          "bbox": [
            379.0,
            1741.0,
            440.0,
            1787.0
          ],
          "confidence": 0.9998380541801453
        },
        {
          "text": "\"API\"' shall mean the active pharmaceutical ingredients Celecoxib and Amlodipine Besylate..",
          "bbox": [
            549.0,
            1741.0,
            2277.0,
            1787.0
          ],
          "confidence": 0.9627962112426758
        },
        {
          "text": "Source: KITOV PHARMA LTD., 20-F, 3/26/2019",
          "bbox": [
            332.0,
            4437.0,
            1256.0,
            4479.0
          ],
          "confidence": 0.988348126411438
        }
      ],
      "nearby_headers": [
        {
          "text": "THE SYMBOL <****\" DENOTES PLACES WHERE PORTIONS OF THIS DOCUMENT HAVE BEEN OMITTED PURSUANT TO A REQUEST",
          "page": 0,
          "bbox": [
            304.0,
            338.0,
            3009.0,
            380.0
          ]
        },
        {
          "text": "FOR CONFIDENTIAL TREATMENT. SUCH MATERIAL WILL BE FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE",
          "page": 0,
          "bbox": [
            399.0,
            398.0,
            2907.0,
            435.0
          ]
        },
        {
          "text": "COMIMISSION.",
          "page": 0,
          "bbox": [
            1503.0,
            455.0,
            1805.0,
            492.0
          ]
        },
        {
          "text": "PRODUCT MANUFACTURING AGREEMENT",
          "page": 0,
          "bbox": [
            1216.0,
            510.0,
            2093.0,
            546.0
          ]
        },
        {
          "text": "WHEREAS:",
          "page": 0,
          "bbox": [
            281.0,
            848.0,
            515.0,
            884.0
          ]
        },
        {
          "text": "WHEREAS:",
          "page": 0,
          "bbox": [
            279.0,
            959.0,
            513.0,
            996.0
          ]
        },
        {
          "text": "WHEREAS:",
          "page": 0,
          "bbox": [
            281.0,
            1071.0,
            515.0,
            1107.0
          ]
        }
      ]
    },
    {
      "id": "KitovPharmaLtd_20190326_20-F_EX-4.15_11584449_EX-4.15_Manufacturing Agreement__Change Of Control_0",
      "question": "Highlight the parts (if any) of this contract related to \"Change Of Control\" that should be reviewed by a lawyer. Details: Does one party have the right to terminate or is consent or notice required of the counterparty if such party undergoes a change of control, such as a merger, stock sale, transfer of all or substantially all of its assets or business, or assignment by operation of law?",
      "answer_text": "in the event of a Change of Control, the Party which was not subject to the Change of Control may terminate this Agreement upon six (6) months advance written notification.",
      "page_number": 0,
      "words": [
        {
          "text": "Exhibit 4.15",
          "bbox": [
            2798.0,
            283.0,
            3029.0,
            325.0
          ],
          "confidence": 0.9998080730438232
        },
        {
          "text": "THE SYMBOL <****\" DENOTES PLACES WHERE PORTIONS OF THIS DOCUMENT HAVE BEEN OMITTED PURSUANT TO A REQUEST",
          "bbox": [
            304.0,
            338.0,
            3009.0,
            380.0
          ],
          "confidence": 0.983539879322052
        },
        {
          "text": "FOR CONFIDENTIAL TREATMENT. SUCH MATERIAL WILL BE FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE",
          "bbox": [
            399.0,
            398.0,
            2907.0,
            435.0
          ],
          "confidence": 0.9926196932792664
        },
        {
          "text": "COMIMISSION.",
          "bbox": [
            1503.0,
            455.0,
            1805.0,
            492.0
          ],
          "confidence": 0.9562864303588867
        },
        {
          "text": "PRODUCT MANUFACTURING AGREEMENT",
          "bbox": [
            1216.0,
            510.0,
            2093.0,
            546.0
          ],
          "confidence": 0.994750440120697
        },
        {
          "text": "This Product Manufacturing Agreement (\"Agreement') is made as of the Effective Date by and between DEXCEL LTD., with its registered address.",
          "bbox": [
            275.0,
            563.0,
            3023.0,
            609.0
          ],
          "confidence": 0.989086925983429
        },
        {
          "text": "at ****, Israel (\"Dexcel'') and KITOV Pharma Ltd., with its registered office at 132 Menachem Begin Road, Azrieli Center, Tel Aviv, 6701101, Israel.",
          "bbox": [
            274.0,
            618.0,
            3000.0,
            665.0
          ],
          "confidence": 0.9887864589691162
        },
        {
          "text": "(\"Kitov'). Dexcel and Kitov are hereinafter jointly the \"Parties' and individually a \"Party.\".",
          "bbox": [
            279.0,
            678.0,
            1945.0,
            722.0
          ],
          "confidence": 0.98404461145401
        },
        {
          "text": "WHEREAS: Dexcel is a pharmaceutical company engaged in various activities including, but not limited to, the research, development,",
          "bbox": [
            275.0,
            729.0,
            2817.0,
            780.0
          ],
          "confidence": 0.9837751388549805
        },
        {
          "text": "manufacture, and marketing of various drugs and pharmaceutical specialties in various dosage forms;",
          "bbox": [
            549.0,
            795.0,
            2438.0,
            831.0
          ],
          "confidence": 0.9977880120277405
        },
        {
          "text": "WHEREAS:",
          "bbox": [
            281.0,
            848.0,
            515.0,
            884.0
          ],
          "confidence": 0.9993464946746826
        },
        {
          "text": "Kitov is a pharmaceutical company engaged in various activities including, but not limited to, the development of pharmaceutical",
          "bbox": [
            546.0,
            844.0,
            2951.0,
            890.0
          ],
          "confidence": 0.9910856485366821
        },
        {
          "text": "products;",
          "bbox": [
            551.0,
            906.0,
            732.0,
            945.0
          ],
          "confidence": 0.9994080066680908
        },
        {
          "text": "WHEREAS:",
          "bbox": [
            279.0,
            959.0,
            513.0,
            996.0
          ],
          "confidence": 0.9993117451667786
        },
        {
          "text": "Kitov and Dexcel entered into a Development Services Agreement on April 1, 2014 (\"Development Agreement'), pursuant to which",
          "bbox": [
            549.0,
            958.0,
            2991.0,
            1000.0
          ],
          "confidence": 0.9946937561035156
        },
        {
          "text": "Dexcel performed certain development services for Kitov with respect to the Product;",
          "bbox": [
            551.0,
            1016.0,
            2139.0,
            1058.0
          ],
          "confidence": 0.9957237243652344
        },
        {
          "text": "WHEREAS:",
          "bbox": [
            281.0,
            1071.0,
            515.0,
            1107.0
          ],
          "confidence": 0.9993150234222412
        },
        {
          "text": "Kitov desires that Dexcel manufacture and package the Product for Kitov in accordance with the terms of this Agreement, and Dexcel",
          "bbox": [
            546.0,
            1069.0,
            3029.0,
            1115.0
          ],
          "confidence": 0.9908015131950378
        },
        {
          "text": "is willing to manufacture and package the Product for Kitov in accordance with the terms of this Agreement..",
          "bbox": [
            547.0,
            1126.0,
            2561.0,
            1171.0
          ],
          "confidence": 0.9924741387367249
        },
        {
          "text": "NOw, THEREFORE, in consideration of the mutual covenants herein contained, the Parties, intending to be legally bound, hereby agree as",
          "bbox": [
            275.0,
            1180.0,
            2876.0,
            1228.0
          ],
          "confidence": 0.9950727820396423
        },
        {
          "text": "follows:",
          "bbox": [
            275.0,
            1237.0,
            426.0,
            1279.0
          ],
          "confidence": 0.9998461008071899
        },
        {
          "text": "1",
          "bbox": [
            277.0,
            1299.0,
            303.0,
            1330.0
          ],
          "confidence": 0.9999181032180786
        },
        {
          "text": "Definitions",
          "bbox": [
            368.0,
            1296.0,
            589.0,
            1334.0
          ],
          "confidence": 0.999856173992157
        },
        {
          "text": "For the purpose of this Agreement, the terms set forth in this clause, whether used in singular or plural form, shall mean, unless otherwise expressly.",
          "bbox": [
            277.0,
            1352.0,
            3012.0,
            1394.0
          ],
          "confidence": 0.9917291402816772
        },
        {
          "text": "provided for in this Agreement or the context otherwise requires, the following:.",
          "bbox": [
            277.0,
            1405.0,
            1749.0,
            1453.0
          ],
          "confidence": 0.9938557744026184
        },
        {
          "text": "1.1",
          "bbox": [
            379.0,
            1460.0,
            439.0,
            1506.0
          ],
          "confidence": 0.9998831748962402
        },
        {
          "text": "\"Affiliate\"' of a Party shall mean any corporation or other business entity directly or indirectly Controlled by, under common Control.",
          "bbox": [
            546.0,
            1458.0,
            3012.0,
            1509.0
          ],
          "confidence": 0.9893513917922974
        },
        {
          "text": "with, or in the Control of such Party..",
          "bbox": [
            551.0,
            1518.0,
            1222.0,
            1564.0
          ],
          "confidence": 0.9819372296333313
        },
        {
          "text": "1.2",
          "bbox": [
            377.0,
            1573.0,
            440.0,
            1619.0
          ],
          "confidence": 0.9997513890266418
        },
        {
          "text": "\"Anti-Corruption and Anti-Bribery Laws\" shall mean the United States Foreign Corrupt Practices Act of 1977, as amended, the",
          "bbox": [
            549.0,
            1577.0,
            2925.0,
            1619.0
          ],
          "confidence": 0.9937560558319092
        },
        {
          "text": "Bribery Act 2010 (2010 Chapter 23) of the Parliament of the United Kingdom, any rules or regulations under such acts, and any other",
          "bbox": [
            551.0,
            1634.0,
            3011.0,
            1676.0
          ],
          "confidence": 0.9908789992332458
        },
        {
          "text": "anti-corruption or anti-bribery statutes, laws or regulations applicable to a Party..",
          "bbox": [
            547.0,
            1687.0,
            2039.0,
            1732.0
          ],
          "confidence": 0.9931536316871643
        },
        {
          "text": "1.3",
          "bbox": [
            379.0,
            1741.0,
            440.0,
            1787.0
          ],
          "confidence": 0.9998380541801453
        },
        {
          "text": "\"API\"' shall mean the active pharmaceutical ingredients Celecoxib and Amlodipine Besylate..",
          "bbox": [
            549.0,
            1741.0,
            2277.0,
            1787.0
          ],
          "confidence": 0.9627962112426758
        },
        {
          "text": "Source: KITOV PHARMA LTD., 20-F, 3/26/2019",
          "bbox": [
            332.0,
            4437.0,
            1256.0,
            4479.0
          ],
          "confidence": 0.988348126411438
        }
      ],
      "nearby_headers": [
        {
          "text": "THE SYMBOL <****\" DENOTES PLACES WHERE PORTIONS OF THIS DOCUMENT HAVE BEEN OMITTED PURSUANT TO A REQUEST",
          "page": 0,
          "bbox": [
            304.0,
            338.0,
            3009.0,
            380.0
          ]
        },
        {
          "text": "FOR CONFIDENTIAL TREATMENT. SUCH MATERIAL WILL BE FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE",
          "page": 0,
          "bbox": [
            399.0,
            398.0,
            2907.0,
            435.0
          ]
        },
        {
          "text": "COMIMISSION.",
          "page": 0,
          "bbox": [
            1503.0,
            455.0,
            1805.0,
            492.0
          ]
        },
        {
          "text": "PRODUCT MANUFACTURING AGREEMENT",
          "page": 0,
          "bbox": [
            1216.0,
            510.0,
            2093.0,
            546.0
          ]
        },
        {
          "text": "WHEREAS:",
          "page": 0,
          "bbox": [
            281.0,
            848.0,
            515.0,
            884.0
          ]
        },
        {
          "text": "WHEREAS:",
          "page": 0,
          "bbox": [
            279.0,
            959.0,
            513.0,
            996.0
          ]
        },
        {
          "text": "WHEREAS:",
          "page": 0,
          "bbox": [
            281.0,
            1071.0,
            515.0,
            1107.0
          ]
        }
      ]
    },
    {
      "id": "KitovPharmaLtd_20190326_20-F_EX-4.15_11584449_EX-4.15_Manufacturing Agreement__Change Of Control_0",
      "question": "Highlight the parts (if any) of this contract related to \"Change Of Control\" that should be reviewed by a lawyer. Details: Does one party have the right to terminate or is consent or notice required of the counterparty if such party undergoes a change of control, such as a merger, stock sale, transfer of all or substantially all of its assets or business, or assignment by operation of law?",
      "answer_text": "This Agreement may be terminated:",
      "page_number": 0,
      "words": [
        {
          "text": "Exhibit 4.15",
          "bbox": [
            2798.0,
            283.0,
            3029.0,
            325.0
          ],
          "confidence": 0.9998080730438232
        },
        {
          "text": "THE SYMBOL <****\" DENOTES PLACES WHERE PORTIONS OF THIS DOCUMENT HAVE BEEN OMITTED PURSUANT TO A REQUEST",
          "bbox": [
            304.0,
            338.0,
            3009.0,
            380.0
          ],
          "confidence": 0.983539879322052
        },
        {
          "text": "FOR CONFIDENTIAL TREATMENT. SUCH MATERIAL WILL BE FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE",
          "bbox": [
            399.0,
            398.0,
            2907.0,
            435.0
          ],
          "confidence": 0.9926196932792664
        },
        {
          "text": "COMIMISSION.",
          "bbox": [
            1503.0,
            455.0,
            1805.0,
            492.0
          ],
          "confidence": 0.9562864303588867
        },
        {
          "text": "PRODUCT MANUFACTURING AGREEMENT",
          "bbox": [
            1216.0,
            510.0,
            2093.0,
            546.0
          ],
          "confidence": 0.994750440120697
        },
        {
          "text": "This Product Manufacturing Agreement (\"Agreement') is made as of the Effective Date by and between DEXCEL LTD., with its registered address.",
          "bbox": [
            275.0,
            563.0,
            3023.0,
            609.0
          ],
          "confidence": 0.989086925983429
        },
        {
          "text": "at ****, Israel (\"Dexcel'') and KITOV Pharma Ltd., with its registered office at 132 Menachem Begin Road, Azrieli Center, Tel Aviv, 6701101, Israel.",
          "bbox": [
            274.0,
            618.0,
            3000.0,
            665.0
          ],
          "confidence": 0.9887864589691162
        },
        {
          "text": "(\"Kitov'). Dexcel and Kitov are hereinafter jointly the \"Parties' and individually a \"Party.\".",
          "bbox": [
            279.0,
            678.0,
            1945.0,
            722.0
          ],
          "confidence": 0.98404461145401
        },
        {
          "text": "WHEREAS: Dexcel is a pharmaceutical company engaged in various activities including, but not limited to, the research, development,",
          "bbox": [
            275.0,
            729.0,
            2817.0,
            780.0
          ],
          "confidence": 0.9837751388549805
        },
        {
          "text": "manufacture, and marketing of various drugs and pharmaceutical specialties in various dosage forms;",
          "bbox": [
            549.0,
            795.0,
            2438.0,
            831.0
          ],
          "confidence": 0.9977880120277405
        },
        {
          "text": "WHEREAS:",
          "bbox": [
            281.0,
            848.0,
            515.0,
            884.0
          ],
          "confidence": 0.9993464946746826
        },
        {
          "text": "Kitov is a pharmaceutical company engaged in various activities including, but not limited to, the development of pharmaceutical",
          "bbox": [
            546.0,
            844.0,
            2951.0,
            890.0
          ],
          "confidence": 0.9910856485366821
        },
        {
          "text": "products;",
          "bbox": [
            551.0,
            906.0,
            732.0,
            945.0
          ],
          "confidence": 0.9994080066680908
        },
        {
          "text": "WHEREAS:",
          "bbox": [
            279.0,
            959.0,
            513.0,
            996.0
          ],
          "confidence": 0.9993117451667786
        },
        {
          "text": "Kitov and Dexcel entered into a Development Services Agreement on April 1, 2014 (\"Development Agreement'), pursuant to which",
          "bbox": [
            549.0,
            958.0,
            2991.0,
            1000.0
          ],
          "confidence": 0.9946937561035156
        },
        {
          "text": "Dexcel performed certain development services for Kitov with respect to the Product;",
          "bbox": [
            551.0,
            1016.0,
            2139.0,
            1058.0
          ],
          "confidence": 0.9957237243652344
        },
        {
          "text": "WHEREAS:",
          "bbox": [
            281.0,
            1071.0,
            515.0,
            1107.0
          ],
          "confidence": 0.9993150234222412
        },
        {
          "text": "Kitov desires that Dexcel manufacture and package the Product for Kitov in accordance with the terms of this Agreement, and Dexcel",
          "bbox": [
            546.0,
            1069.0,
            3029.0,
            1115.0
          ],
          "confidence": 0.9908015131950378
        },
        {
          "text": "is willing to manufacture and package the Product for Kitov in accordance with the terms of this Agreement..",
          "bbox": [
            547.0,
            1126.0,
            2561.0,
            1171.0
          ],
          "confidence": 0.9924741387367249
        },
        {
          "text": "NOw, THEREFORE, in consideration of the mutual covenants herein contained, the Parties, intending to be legally bound, hereby agree as",
          "bbox": [
            275.0,
            1180.0,
            2876.0,
            1228.0
          ],
          "confidence": 0.9950727820396423
        },
        {
          "text": "follows:",
          "bbox": [
            275.0,
            1237.0,
            426.0,
            1279.0
          ],
          "confidence": 0.9998461008071899
        },
        {
          "text": "1",
          "bbox": [
            277.0,
            1299.0,
            303.0,
            1330.0
          ],
          "confidence": 0.9999181032180786
        },
        {
          "text": "Definitions",
          "bbox": [
            368.0,
            1296.0,
            589.0,
            1334.0
          ],
          "confidence": 0.999856173992157
        },
        {
          "text": "For the purpose of this Agreement, the terms set forth in this clause, whether used in singular or plural form, shall mean, unless otherwise expressly.",
          "bbox": [
            277.0,
            1352.0,
            3012.0,
            1394.0
          ],
          "confidence": 0.9917291402816772
        },
        {
          "text": "provided for in this Agreement or the context otherwise requires, the following:.",
          "bbox": [
            277.0,
            1405.0,
            1749.0,
            1453.0
          ],
          "confidence": 0.9938557744026184
        },
        {
          "text": "1.1",
          "bbox": [
            379.0,
            1460.0,
            439.0,
            1506.0
          ],
          "confidence": 0.9998831748962402
        },
        {
          "text": "\"Affiliate\"' of a Party shall mean any corporation or other business entity directly or indirectly Controlled by, under common Control.",
          "bbox": [
            546.0,
            1458.0,
            3012.0,
            1509.0
          ],
          "confidence": 0.9893513917922974
        },
        {
          "text": "with, or in the Control of such Party..",
          "bbox": [
            551.0,
            1518.0,
            1222.0,
            1564.0
          ],
          "confidence": 0.9819372296333313
        },
        {
          "text": "1.2",
          "bbox": [
            377.0,
            1573.0,
            440.0,
            1619.0
          ],
          "confidence": 0.9997513890266418
        },
        {
          "text": "\"Anti-Corruption and Anti-Bribery Laws\" shall mean the United States Foreign Corrupt Practices Act of 1977, as amended, the",
          "bbox": [
            549.0,
            1577.0,
            2925.0,
            1619.0
          ],
          "confidence": 0.9937560558319092
        },
        {
          "text": "Bribery Act 2010 (2010 Chapter 23) of the Parliament of the United Kingdom, any rules or regulations under such acts, and any other",
          "bbox": [
            551.0,
            1634.0,
            3011.0,
            1676.0
          ],
          "confidence": 0.9908789992332458
        },
        {
          "text": "anti-corruption or anti-bribery statutes, laws or regulations applicable to a Party..",
          "bbox": [
            547.0,
            1687.0,
            2039.0,
            1732.0
          ],
          "confidence": 0.9931536316871643
        },
        {
          "text": "1.3",
          "bbox": [
            379.0,
            1741.0,
            440.0,
            1787.0
          ],
          "confidence": 0.9998380541801453
        },
        {
          "text": "\"API\"' shall mean the active pharmaceutical ingredients Celecoxib and Amlodipine Besylate..",
          "bbox": [
            549.0,
            1741.0,
            2277.0,
            1787.0
          ],
          "confidence": 0.9627962112426758
        },
        {
          "text": "Source: KITOV PHARMA LTD., 20-F, 3/26/2019",
          "bbox": [
            332.0,
            4437.0,
            1256.0,
            4479.0
          ],
          "confidence": 0.988348126411438
        }
      ],
      "nearby_headers": [
        {
          "text": "THE SYMBOL <****\" DENOTES PLACES WHERE PORTIONS OF THIS DOCUMENT HAVE BEEN OMITTED PURSUANT TO A REQUEST",
          "page": 0,
          "bbox": [
            304.0,
            338.0,
            3009.0,
            380.0
          ]
        },
        {
          "text": "FOR CONFIDENTIAL TREATMENT. SUCH MATERIAL WILL BE FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE",
          "page": 0,
          "bbox": [
            399.0,
            398.0,
            2907.0,
            435.0
          ]
        },
        {
          "text": "COMIMISSION.",
          "page": 0,
          "bbox": [
            1503.0,
            455.0,
            1805.0,
            492.0
          ]
        },
        {
          "text": "PRODUCT MANUFACTURING AGREEMENT",
          "page": 0,
          "bbox": [
            1216.0,
            510.0,
            2093.0,
            546.0
          ]
        },
        {
          "text": "WHEREAS:",
          "page": 0,
          "bbox": [
            281.0,
            848.0,
            515.0,
            884.0
          ]
        },
        {
          "text": "WHEREAS:",
          "page": 0,
          "bbox": [
            279.0,
            959.0,
            513.0,
            996.0
          ]
        },
        {
          "text": "WHEREAS:",
          "page": 0,
          "bbox": [
            281.0,
            1071.0,
            515.0,
            1107.0
          ]
        }
      ]
    },
    {
      "id": "KitovPharmaLtd_20190326_20-F_EX-4.15_11584449_EX-4.15_Manufacturing Agreement__Change Of Control_0_multi",
      "question": "Highlight the parts (if any) of this contract related to \"Change Of Control\" that should be reviewed by a lawyer. Details: Does one party have the right to terminate or is consent or notice required of the counterparty if such party undergoes a change of control, such as a merger, stock sale, transfer of all or substantially all of its assets or business, or assignment by operation of law?",
      "answer_text": "For purposes of this Agreement, any merger, consolidation, or change of corporate structure following which there is a Change of Control of Kitov shall be considered as an assignment by Kitov, allowing Dexcel to terminate the Agreement as heretofore provided.",
      "page_number": 0,
      "words": [
        {
          "text": "Exhibit 4.15",
          "bbox": [
            2798.0,
            283.0,
            3029.0,
            325.0
          ],
          "confidence": 0.9998080730438232
        },
        {
          "text": "THE SYMBOL <****\" DENOTES PLACES WHERE PORTIONS OF THIS DOCUMENT HAVE BEEN OMITTED PURSUANT TO A REQUEST",
          "bbox": [
            304.0,
            338.0,
            3009.0,
            380.0
          ],
          "confidence": 0.983539879322052
        },
        {
          "text": "FOR CONFIDENTIAL TREATMENT. SUCH MATERIAL WILL BE FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE",
          "bbox": [
            399.0,
            398.0,
            2907.0,
            435.0
          ],
          "confidence": 0.9926196932792664
        },
        {
          "text": "COMIMISSION.",
          "bbox": [
            1503.0,
            455.0,
            1805.0,
            492.0
          ],
          "confidence": 0.9562864303588867
        },
        {
          "text": "PRODUCT MANUFACTURING AGREEMENT",
          "bbox": [
            1216.0,
            510.0,
            2093.0,
            546.0
          ],
          "confidence": 0.994750440120697
        },
        {
          "text": "This Product Manufacturing Agreement (\"Agreement') is made as of the Effective Date by and between DEXCEL LTD., with its registered address.",
          "bbox": [
            275.0,
            563.0,
            3023.0,
            609.0
          ],
          "confidence": 0.989086925983429
        },
        {
          "text": "at ****, Israel (\"Dexcel'') and KITOV Pharma Ltd., with its registered office at 132 Menachem Begin Road, Azrieli Center, Tel Aviv, 6701101, Israel.",
          "bbox": [
            274.0,
            618.0,
            3000.0,
            665.0
          ],
          "confidence": 0.9887864589691162
        },
        {
          "text": "(\"Kitov'). Dexcel and Kitov are hereinafter jointly the \"Parties' and individually a \"Party.\".",
          "bbox": [
            279.0,
            678.0,
            1945.0,
            722.0
          ],
          "confidence": 0.98404461145401
        },
        {
          "text": "WHEREAS: Dexcel is a pharmaceutical company engaged in various activities including, but not limited to, the research, development,",
          "bbox": [
            275.0,
            729.0,
            2817.0,
            780.0
          ],
          "confidence": 0.9837751388549805
        },
        {
          "text": "manufacture, and marketing of various drugs and pharmaceutical specialties in various dosage forms;",
          "bbox": [
            549.0,
            795.0,
            2438.0,
            831.0
          ],
          "confidence": 0.9977880120277405
        },
        {
          "text": "WHEREAS:",
          "bbox": [
            281.0,
            848.0,
            515.0,
            884.0
          ],
          "confidence": 0.9993464946746826
        },
        {
          "text": "Kitov is a pharmaceutical company engaged in various activities including, but not limited to, the development of pharmaceutical",
          "bbox": [
            546.0,
            844.0,
            2951.0,
            890.0
          ],
          "confidence": 0.9910856485366821
        },
        {
          "text": "products;",
          "bbox": [
            551.0,
            906.0,
            732.0,
            945.0
          ],
          "confidence": 0.9994080066680908
        },
        {
          "text": "WHEREAS:",
          "bbox": [
            279.0,
            959.0,
            513.0,
            996.0
          ],
          "confidence": 0.9993117451667786
        },
        {
          "text": "Kitov and Dexcel entered into a Development Services Agreement on April 1, 2014 (\"Development Agreement'), pursuant to which",
          "bbox": [
            549.0,
            958.0,
            2991.0,
            1000.0
          ],
          "confidence": 0.9946937561035156
        },
        {
          "text": "Dexcel performed certain development services for Kitov with respect to the Product;",
          "bbox": [
            551.0,
            1016.0,
            2139.0,
            1058.0
          ],
          "confidence": 0.9957237243652344
        },
        {
          "text": "WHEREAS:",
          "bbox": [
            281.0,
            1071.0,
            515.0,
            1107.0
          ],
          "confidence": 0.9993150234222412
        },
        {
          "text": "Kitov desires that Dexcel manufacture and package the Product for Kitov in accordance with the terms of this Agreement, and Dexcel",
          "bbox": [
            546.0,
            1069.0,
            3029.0,
            1115.0
          ],
          "confidence": 0.9908015131950378
        },
        {
          "text": "is willing to manufacture and package the Product for Kitov in accordance with the terms of this Agreement..",
          "bbox": [
            547.0,
            1126.0,
            2561.0,
            1171.0
          ],
          "confidence": 0.9924741387367249
        },
        {
          "text": "NOw, THEREFORE, in consideration of the mutual covenants herein contained, the Parties, intending to be legally bound, hereby agree as",
          "bbox": [
            275.0,
            1180.0,
            2876.0,
            1228.0
          ],
          "confidence": 0.9950727820396423
        },
        {
          "text": "follows:",
          "bbox": [
            275.0,
            1237.0,
            426.0,
            1279.0
          ],
          "confidence": 0.9998461008071899
        },
        {
          "text": "1",
          "bbox": [
            277.0,
            1299.0,
            303.0,
            1330.0
          ],
          "confidence": 0.9999181032180786
        },
        {
          "text": "Definitions",
          "bbox": [
            368.0,
            1296.0,
            589.0,
            1334.0
          ],
          "confidence": 0.999856173992157
        },
        {
          "text": "For the purpose of this Agreement, the terms set forth in this clause, whether used in singular or plural form, shall mean, unless otherwise expressly.",
          "bbox": [
            277.0,
            1352.0,
            3012.0,
            1394.0
          ],
          "confidence": 0.9917291402816772
        },
        {
          "text": "provided for in this Agreement or the context otherwise requires, the following:.",
          "bbox": [
            277.0,
            1405.0,
            1749.0,
            1453.0
          ],
          "confidence": 0.9938557744026184
        },
        {
          "text": "1.1",
          "bbox": [
            379.0,
            1460.0,
            439.0,
            1506.0
          ],
          "confidence": 0.9998831748962402
        },
        {
          "text": "\"Affiliate\"' of a Party shall mean any corporation or other business entity directly or indirectly Controlled by, under common Control.",
          "bbox": [
            546.0,
            1458.0,
            3012.0,
            1509.0
          ],
          "confidence": 0.9893513917922974
        },
        {
          "text": "with, or in the Control of such Party..",
          "bbox": [
            551.0,
            1518.0,
            1222.0,
            1564.0
          ],
          "confidence": 0.9819372296333313
        },
        {
          "text": "1.2",
          "bbox": [
            377.0,
            1573.0,
            440.0,
            1619.0
          ],
          "confidence": 0.9997513890266418
        },
        {
          "text": "\"Anti-Corruption and Anti-Bribery Laws\" shall mean the United States Foreign Corrupt Practices Act of 1977, as amended, the",
          "bbox": [
            549.0,
            1577.0,
            2925.0,
            1619.0
          ],
          "confidence": 0.9937560558319092
        },
        {
          "text": "Bribery Act 2010 (2010 Chapter 23) of the Parliament of the United Kingdom, any rules or regulations under such acts, and any other",
          "bbox": [
            551.0,
            1634.0,
            3011.0,
            1676.0
          ],
          "confidence": 0.9908789992332458
        },
        {
          "text": "anti-corruption or anti-bribery statutes, laws or regulations applicable to a Party..",
          "bbox": [
            547.0,
            1687.0,
            2039.0,
            1732.0
          ],
          "confidence": 0.9931536316871643
        },
        {
          "text": "1.3",
          "bbox": [
            379.0,
            1741.0,
            440.0,
            1787.0
          ],
          "confidence": 0.9998380541801453
        },
        {
          "text": "\"API\"' shall mean the active pharmaceutical ingredients Celecoxib and Amlodipine Besylate..",
          "bbox": [
            549.0,
            1741.0,
            2277.0,
            1787.0
          ],
          "confidence": 0.9627962112426758
        },
        {
          "text": "Source: KITOV PHARMA LTD., 20-F, 3/26/2019",
          "bbox": [
            332.0,
            4437.0,
            1256.0,
            4479.0
          ],
          "confidence": 0.988348126411438
        }
      ],
      "multi_page": true,
      "part_of": 2,
      "nearby_headers": [
        {
          "text": "THE SYMBOL <****\" DENOTES PLACES WHERE PORTIONS OF THIS DOCUMENT HAVE BEEN OMITTED PURSUANT TO A REQUEST",
          "page": 0,
          "bbox": [
            304.0,
            338.0,
            3009.0,
            380.0
          ]
        },
        {
          "text": "FOR CONFIDENTIAL TREATMENT. SUCH MATERIAL WILL BE FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE",
          "page": 0,
          "bbox": [
            399.0,
            398.0,
            2907.0,
            435.0
          ]
        },
        {
          "text": "COMIMISSION.",
          "page": 0,
          "bbox": [
            1503.0,
            455.0,
            1805.0,
            492.0
          ]
        },
        {
          "text": "PRODUCT MANUFACTURING AGREEMENT",
          "page": 0,
          "bbox": [
            1216.0,
            510.0,
            2093.0,
            546.0
          ]
        },
        {
          "text": "WHEREAS:",
          "page": 0,
          "bbox": [
            281.0,
            848.0,
            515.0,
            884.0
          ]
        },
        {
          "text": "WHEREAS:",
          "page": 0,
          "bbox": [
            279.0,
            959.0,
            513.0,
            996.0
          ]
        },
        {
          "text": "WHEREAS:",
          "page": 0,
          "bbox": [
            281.0,
            1071.0,
            515.0,
            1107.0
          ]
        }
      ]
    },
    {
      "id": "KitovPharmaLtd_20190326_20-F_EX-4.15_11584449_EX-4.15_Manufacturing Agreement__Change Of Control_1_multi",
      "question": "Highlight the parts (if any) of this contract related to \"Change Of Control\" that should be reviewed by a lawyer. Details: Does one party have the right to terminate or is consent or notice required of the counterparty if such party undergoes a change of control, such as a merger, stock sale, transfer of all or substantially all of its assets or business, or assignment by operation of law?",
      "answer_text": "For purposes of this Agreement, any merger, consolidation, or change of corporate structure following which there is a Change of Control of Kitov shall be considered as an assignment by Kitov, allowing Dexcel to terminate the Agreement as heretofore provided.",
      "page_number": 1,
      "words": [
        {
          "text": "1.4",
          "bbox": [
            379.0,
            281.0,
            442.0,
            327.0
          ],
          "confidence": 0.9997868537902832
        },
        {
          "text": "\"Batch' shall mean the defined quantity of the Product processed in a single process or series of processes in a manner designed to.",
          "bbox": [
            549.0,
            281.0,
            3011.0,
            329.0
          ],
          "confidence": 0.9841217398643494
        },
        {
          "text": "be homogeneous. The Batch size for the Product is **** tablets.",
          "bbox": [
            551.0,
            338.0,
            1756.0,
            382.0
          ],
          "confidence": 0.9994081258773804
        },
        {
          "text": "1.5",
          "bbox": [
            376.0,
            390.0,
            443.0,
            443.0
          ],
          "confidence": 0.9997324347496033
        },
        {
          "text": "\"cGMPs\" or \"Good Manufacturing Practice\"' shall mean the part of quality assurance which ensures that the Product is consistently.",
          "bbox": [
            549.0,
            395.0,
            3023.0,
            440.0
          ],
          "confidence": 0.985264241695404
        },
        {
          "text": "produced and controlled to the quality standards appropriate to their intended use, the principles and guidelines of which are",
          "bbox": [
            549.0,
            451.0,
            2884.0,
            499.0
          ],
          "confidence": 0.9912954568862915
        },
        {
          "text": "specified in European Commission Directive 2003/94/EC and the FDA's current Good Manufacturing Practices, particularly 21 CFR ",
          "bbox": [
            547.0,
            506.0,
            3003.0,
            557.0
          ],
          "confidence": 0.995246410369873
        },
        {
          "text": "210 et seq., and 21 CFR $$ 600-610, as both may be amended from time to time..",
          "bbox": [
            549.0,
            565.0,
            2006.0,
            607.0
          ],
          "confidence": 0.9747835993766785
        },
        {
          "text": "1.6",
          "bbox": [
            379.0,
            619.0,
            442.0,
            663.0
          ],
          "confidence": 0.9999213218688965
        },
        {
          "text": "\"Change of Control' shall mean (i) any change, sale, merger, reorganization, or any other event or action that results in a third party,",
          "bbox": [
            547.0,
            618.0,
            3005.0,
            669.0
          ],
          "confidence": 0.9930126070976257
        },
        {
          "text": "which is a material competitor to the other Party to this agreement, acquiring: (a) all or substantially all of the business or assets of a.",
          "bbox": [
            551.0,
            678.0,
            3002.0,
            722.0
          ],
          "confidence": 0.9852778911590576
        },
        {
          "text": "Party relating to this Agreement, (b) Control, directly or indirectly, of such Party (and/or any corporate entity that Controls, directly.",
          "bbox": [
            551.0,
            735.0,
            2985.0,
            778.0
          ],
          "confidence": 0.9932605624198914
        },
        {
          "text": "or indirectly, such Party), or (ii) any assignment or delegation of, sale or transfer of a Party's rights and obligations under this",
          "bbox": [
            549.0,
            789.0,
            2878.0,
            835.0
          ],
          "confidence": 0.9923490881919861
        },
        {
          "text": "Agreement (or any part hereof) to a third party.",
          "bbox": [
            555.0,
            848.0,
            1426.0,
            890.0
          ],
          "confidence": 0.9961597323417664
        },
        {
          "text": "Notwithstanding anything in the immediately preceding paragraph to the contrary, where the Party in question is Dexcel, any of the",
          "bbox": [
            549.0,
            903.0,
            2991.0,
            945.0
          ],
          "confidence": 0.9957303404808044
        },
        {
          "text": "foregoing events or actions shall not be considered a Change of Control where any one or more of the relevant third party or parties.",
          "bbox": [
            551.0,
            961.0,
            3007.0,
            1003.0
          ],
          "confidence": 0.9899225234985352
        },
        {
          "text": "referred to in clause (i) above is (A) a Family Member, or (B) any entity Controlled by Mr. **** and/or a Family Member.",
          "bbox": [
            544.0,
            1005.0,
            2788.0,
            1064.0
          ],
          "confidence": 0.9933032989501953
        },
        {
          "text": "1.7",
          "bbox": [
            379.0,
            1067.0,
            442.0,
            1113.0
          ],
          "confidence": 0.9998312592506409
        },
        {
          "text": "\"Claims' shall mean any demands, claims, actions, causes of action, assessments, losses, damages, injuries, liabilities, costs and.",
          "bbox": [
            549.0,
            1069.0,
            2953.0,
            1115.0
          ],
          "confidence": 0.9854910969734192
        },
        {
          "text": "expenses (including, without limitation, reasonable attorneys' fees and expenses) filed, raised, initiated or made by any governmental.",
          "bbox": [
            553.0,
            1129.0,
            3021.0,
            1171.0
          ],
          "confidence": 0.992518424987793
        },
        {
          "text": "authority and/or third party.",
          "bbox": [
            551.0,
            1184.0,
            1066.0,
            1226.0
          ],
          "confidence": 0.983346164226532
        },
        {
          "text": "1.8",
          "bbox": [
            379.0,
            1235.0,
            442.0,
            1281.0
          ],
          "confidence": 0.9999089241027832
        },
        {
          "text": "\"Confidential Information\"' shall have the meaning set forth in Section 7.1.",
          "bbox": [
            549.0,
            1235.0,
            1939.0,
            1281.0
          ],
          "confidence": 0.9719286561012268
        },
        {
          "text": "1.9",
          "bbox": [
            379.0,
            1292.0,
            440.0,
            1336.0
          ],
          "confidence": 0.9999080300331116
        },
        {
          "text": "\"Confirmed Order' shall have the meaning set forth in Section 3.3.2.",
          "bbox": [
            549.0,
            1292.0,
            1834.0,
            1338.0
          ],
          "confidence": 0.9867768883705139
        },
        {
          "text": "1.10",
          "bbox": [
            379.0,
            1347.0,
            462.0,
            1394.0
          ],
          "confidence": 0.9999012351036072
        },
        {
          "text": "\"Control' or \"Controlled' shall mean possession of more than fifty percent (50%) of the share capital of a corporation or other",
          "bbox": [
            547.0,
            1345.0,
            2915.0,
            1398.0
          ],
          "confidence": 0.981292724609375
        },
        {
          "text": "business entity, and/or the power to direct or cause the direction of the management and policies of a corporation or other entity",
          "bbox": [
            549.0,
            1405.0,
            2936.0,
            1451.0
          ],
          "confidence": 0.9941077828407288
        },
        {
          "text": "whether through the ownership of voting securities, by contract or otherwise..",
          "bbox": [
            553.0,
            1467.0,
            1996.0,
            1504.0
          ],
          "confidence": 0.9934757947921753
        },
        {
          "text": "1.11",
          "bbox": [
            379.0,
            1517.0,
            455.0,
            1561.0
          ],
          "confidence": 0.999779224395752
        },
        {
          "text": "\"Delivery' shall mean the time when the Product is placed at the disposal of Kitov at Dexcel's Facility based on an ****",
          "bbox": [
            546.0,
            1508.0,
            2799.0,
            1568.0
          ],
          "confidence": 0.992178738117218
        },
        {
          "text": "(Incoterms 2010).",
          "bbox": [
            555.0,
            1579.0,
            904.0,
            1617.0
          ],
          "confidence": 0.99842768907547
        },
        {
          "text": "1.12",
          "bbox": [
            377.0,
            1626.0,
            462.0,
            1674.0
          ],
          "confidence": 0.9999103546142578
        },
        {
          "text": "\"Distributors\" shall mean any Person under contract with Kitov or any of its Affiliates for the distribution of the Product in a certain",
          "bbox": [
            553.0,
            1634.0,
            3018.0,
            1670.0
          ],
          "confidence": 0.9918192625045776
        },
        {
          "text": "territory or territories..",
          "bbox": [
            551.0,
            1692.0,
            946.0,
            1729.0
          ],
          "confidence": 0.9840478301048279
        },
        {
          "text": "1.13",
          "bbox": [
            381.0,
            1741.0,
            459.0,
            1785.0
          ],
          "confidence": 0.8832098245620728
        },
        {
          "text": "\"Effective Date' shall mean the date of signature of the last Party to execute this Agreement..",
          "bbox": [
            549.0,
            1741.0,
            2267.0,
            1787.0
          ],
          "confidence": 0.9844200611114502
        },
        {
          "text": "1.14",
          "bbox": [
            379.0,
            1798.0,
            460.0,
            1840.0
          ],
          "confidence": 0.9994210004806519
        },
        {
          "text": "\"EMA\" means the European Medicines Agency or any successor entity.",
          "bbox": [
            549.0,
            1798.0,
            1898.0,
            1846.0
          ],
          "confidence": 0.9979910254478455
        },
        {
          "text": "1.15",
          "bbox": [
            379.0,
            1851.0,
            460.0,
            1900.0
          ],
          "confidence": 0.9995757341384888
        },
        {
          "text": "\"Family Member\" shall mean ****.",
          "bbox": [
            547.0,
            1847.0,
            1222.0,
            1902.0
          ],
          "confidence": 0.9885128736495972
        },
        {
          "text": "1.16",
          "bbox": [
            379.0,
            1908.0,
            462.0,
            1955.0
          ],
          "confidence": 0.9999197125434875
        },
        {
          "text": "\"FDA\" means the U.S. Food and Drug Administration or any successor entity..",
          "bbox": [
            549.0,
            1911.0,
            2005.0,
            1953.0
          ],
          "confidence": 0.986582338809967
        },
        {
          "text": "2",
          "bbox": [
            1638.0,
            2025.0,
            1669.0,
            2061.0
          ],
          "confidence": 0.999761164188385
        },
        {
          "text": "Source: KITOV PHARMA LTD., 20-F, 3/26/2019",
          "bbox": [
            332.0,
            4437.0,
            1256.0,
            4479.0
          ],
          "confidence": 0.989766538143158
        }
      ],
      "multi_page": true,
      "part_of": 2
    },
    {
      "id": "KitovPharmaLtd_20190326_20-F_EX-4.15_11584449_EX-4.15_Manufacturing Agreement__Anti-Assignment_0_multi",
      "question": "Highlight the parts (if any) of this contract related to \"Anti-Assignment\" that should be reviewed by a lawyer. Details: Is consent or notice required of a party if the contract is assigned to a third party?",
      "answer_text": "Notwithstanding the aforesaid, either Party shall be entitled to assign, delegate, and/or subcontract its rights and obligation under this Agreement, in whole or in part, to one or more of its Affiliates on prior written notice to the other Party.",
      "page_number": 0,
      "words": [
        {
          "text": "Exhibit 4.15",
          "bbox": [
            2798.0,
            283.0,
            3029.0,
            325.0
          ],
          "confidence": 0.9998080730438232
        },
        {
          "text": "THE SYMBOL <****\" DENOTES PLACES WHERE PORTIONS OF THIS DOCUMENT HAVE BEEN OMITTED PURSUANT TO A REQUEST",
          "bbox": [
            304.0,
            338.0,
            3009.0,
            380.0
          ],
          "confidence": 0.983539879322052
        },
        {
          "text": "FOR CONFIDENTIAL TREATMENT. SUCH MATERIAL WILL BE FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE",
          "bbox": [
            399.0,
            398.0,
            2907.0,
            435.0
          ],
          "confidence": 0.9926196932792664
        },
        {
          "text": "COMIMISSION.",
          "bbox": [
            1503.0,
            455.0,
            1805.0,
            492.0
          ],
          "confidence": 0.9562864303588867
        },
        {
          "text": "PRODUCT MANUFACTURING AGREEMENT",
          "bbox": [
            1216.0,
            510.0,
            2093.0,
            546.0
          ],
          "confidence": 0.994750440120697
        },
        {
          "text": "This Product Manufacturing Agreement (\"Agreement') is made as of the Effective Date by and between DEXCEL LTD., with its registered address.",
          "bbox": [
            275.0,
            563.0,
            3023.0,
            609.0
          ],
          "confidence": 0.989086925983429
        },
        {
          "text": "at ****, Israel (\"Dexcel'') and KITOV Pharma Ltd., with its registered office at 132 Menachem Begin Road, Azrieli Center, Tel Aviv, 6701101, Israel.",
          "bbox": [
            274.0,
            618.0,
            3000.0,
            665.0
          ],
          "confidence": 0.9887864589691162
        },
        {
          "text": "(\"Kitov'). Dexcel and Kitov are hereinafter jointly the \"Parties' and individually a \"Party.\".",
          "bbox": [
            279.0,
            678.0,
            1945.0,
            722.0
          ],
          "confidence": 0.98404461145401
        },
        {
          "text": "WHEREAS: Dexcel is a pharmaceutical company engaged in various activities including, but not limited to, the research, development,",
          "bbox": [
            275.0,
            729.0,
            2817.0,
            780.0
          ],
          "confidence": 0.9837751388549805
        },
        {
          "text": "manufacture, and marketing of various drugs and pharmaceutical specialties in various dosage forms;",
          "bbox": [
            549.0,
            795.0,
            2438.0,
            831.0
          ],
          "confidence": 0.9977880120277405
        },
        {
          "text": "WHEREAS:",
          "bbox": [
            281.0,
            848.0,
            515.0,
            884.0
          ],
          "confidence": 0.9993464946746826
        },
        {
          "text": "Kitov is a pharmaceutical company engaged in various activities including, but not limited to, the development of pharmaceutical",
          "bbox": [
            546.0,
            844.0,
            2951.0,
            890.0
          ],
          "confidence": 0.9910856485366821
        },
        {
          "text": "products;",
          "bbox": [
            551.0,
            906.0,
            732.0,
            945.0
          ],
          "confidence": 0.9994080066680908
        },
        {
          "text": "WHEREAS:",
          "bbox": [
            279.0,
            959.0,
            513.0,
            996.0
          ],
          "confidence": 0.9993117451667786
        },
        {
          "text": "Kitov and Dexcel entered into a Development Services Agreement on April 1, 2014 (\"Development Agreement'), pursuant to which",
          "bbox": [
            549.0,
            958.0,
            2991.0,
            1000.0
          ],
          "confidence": 0.9946937561035156
        },
        {
          "text": "Dexcel performed certain development services for Kitov with respect to the Product;",
          "bbox": [
            551.0,
            1016.0,
            2139.0,
            1058.0
          ],
          "confidence": 0.9957237243652344
        },
        {
          "text": "WHEREAS:",
          "bbox": [
            281.0,
            1071.0,
            515.0,
            1107.0
          ],
          "confidence": 0.9993150234222412
        },
        {
          "text": "Kitov desires that Dexcel manufacture and package the Product for Kitov in accordance with the terms of this Agreement, and Dexcel",
          "bbox": [
            546.0,
            1069.0,
            3029.0,
            1115.0
          ],
          "confidence": 0.9908015131950378
        },
        {
          "text": "is willing to manufacture and package the Product for Kitov in accordance with the terms of this Agreement..",
          "bbox": [
            547.0,
            1126.0,
            2561.0,
            1171.0
          ],
          "confidence": 0.9924741387367249
        },
        {
          "text": "NOw, THEREFORE, in consideration of the mutual covenants herein contained, the Parties, intending to be legally bound, hereby agree as",
          "bbox": [
            275.0,
            1180.0,
            2876.0,
            1228.0
          ],
          "confidence": 0.9950727820396423
        },
        {
          "text": "follows:",
          "bbox": [
            275.0,
            1237.0,
            426.0,
            1279.0
          ],
          "confidence": 0.9998461008071899
        },
        {
          "text": "1",
          "bbox": [
            277.0,
            1299.0,
            303.0,
            1330.0
          ],
          "confidence": 0.9999181032180786
        },
        {
          "text": "Definitions",
          "bbox": [
            368.0,
            1296.0,
            589.0,
            1334.0
          ],
          "confidence": 0.999856173992157
        },
        {
          "text": "For the purpose of this Agreement, the terms set forth in this clause, whether used in singular or plural form, shall mean, unless otherwise expressly.",
          "bbox": [
            277.0,
            1352.0,
            3012.0,
            1394.0
          ],
          "confidence": 0.9917291402816772
        },
        {
          "text": "provided for in this Agreement or the context otherwise requires, the following:.",
          "bbox": [
            277.0,
            1405.0,
            1749.0,
            1453.0
          ],
          "confidence": 0.9938557744026184
        },
        {
          "text": "1.1",
          "bbox": [
            379.0,
            1460.0,
            439.0,
            1506.0
          ],
          "confidence": 0.9998831748962402
        },
        {
          "text": "\"Affiliate\"' of a Party shall mean any corporation or other business entity directly or indirectly Controlled by, under common Control.",
          "bbox": [
            546.0,
            1458.0,
            3012.0,
            1509.0
          ],
          "confidence": 0.9893513917922974
        },
        {
          "text": "with, or in the Control of such Party..",
          "bbox": [
            551.0,
            1518.0,
            1222.0,
            1564.0
          ],
          "confidence": 0.9819372296333313
        },
        {
          "text": "1.2",
          "bbox": [
            377.0,
            1573.0,
            440.0,
            1619.0
          ],
          "confidence": 0.9997513890266418
        },
        {
          "text": "\"Anti-Corruption and Anti-Bribery Laws\" shall mean the United States Foreign Corrupt Practices Act of 1977, as amended, the",
          "bbox": [
            549.0,
            1577.0,
            2925.0,
            1619.0
          ],
          "confidence": 0.9937560558319092
        },
        {
          "text": "Bribery Act 2010 (2010 Chapter 23) of the Parliament of the United Kingdom, any rules or regulations under such acts, and any other",
          "bbox": [
            551.0,
            1634.0,
            3011.0,
            1676.0
          ],
          "confidence": 0.9908789992332458
        },
        {
          "text": "anti-corruption or anti-bribery statutes, laws or regulations applicable to a Party..",
          "bbox": [
            547.0,
            1687.0,
            2039.0,
            1732.0
          ],
          "confidence": 0.9931536316871643
        },
        {
          "text": "1.3",
          "bbox": [
            379.0,
            1741.0,
            440.0,
            1787.0
          ],
          "confidence": 0.9998380541801453
        },
        {
          "text": "\"API\"' shall mean the active pharmaceutical ingredients Celecoxib and Amlodipine Besylate..",
          "bbox": [
            549.0,
            1741.0,
            2277.0,
            1787.0
          ],
          "confidence": 0.9627962112426758
        },
        {
          "text": "Source: KITOV PHARMA LTD., 20-F, 3/26/2019",
          "bbox": [
            332.0,
            4437.0,
            1256.0,
            4479.0
          ],
          "confidence": 0.988348126411438
        }
      ],
      "multi_page": true,
      "part_of": 2,
      "nearby_headers": [
        {
          "text": "THE SYMBOL <****\" DENOTES PLACES WHERE PORTIONS OF THIS DOCUMENT HAVE BEEN OMITTED PURSUANT TO A REQUEST",
          "page": 0,
          "bbox": [
            304.0,
            338.0,
            3009.0,
            380.0
          ]
        },
        {
          "text": "FOR CONFIDENTIAL TREATMENT. SUCH MATERIAL WILL BE FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE",
          "page": 0,
          "bbox": [
            399.0,
            398.0,
            2907.0,
            435.0
          ]
        },
        {
          "text": "COMIMISSION.",
          "page": 0,
          "bbox": [
            1503.0,
            455.0,
            1805.0,
            492.0
          ]
        },
        {
          "text": "PRODUCT MANUFACTURING AGREEMENT",
          "page": 0,
          "bbox": [
            1216.0,
            510.0,
            2093.0,
            546.0
          ]
        },
        {
          "text": "WHEREAS:",
          "page": 0,
          "bbox": [
            281.0,
            848.0,
            515.0,
            884.0
          ]
        },
        {
          "text": "WHEREAS:",
          "page": 0,
          "bbox": [
            279.0,
            959.0,
            513.0,
            996.0
          ]
        },
        {
          "text": "WHEREAS:",
          "page": 0,
          "bbox": [
            281.0,
            1071.0,
            515.0,
            1107.0
          ]
        }
      ]
    },
    {
      "id": "KitovPharmaLtd_20190326_20-F_EX-4.15_11584449_EX-4.15_Manufacturing Agreement__Anti-Assignment_1_multi",
      "question": "Highlight the parts (if any) of this contract related to \"Anti-Assignment\" that should be reviewed by a lawyer. Details: Is consent or notice required of a party if the contract is assigned to a third party?",
      "answer_text": "Notwithstanding the aforesaid, either Party shall be entitled to assign, delegate, and/or subcontract its rights and obligation under this Agreement, in whole or in part, to one or more of its Affiliates on prior written notice to the other Party.",
      "page_number": 1,
      "words": [
        {
          "text": "1.4",
          "bbox": [
            379.0,
            281.0,
            442.0,
            327.0
          ],
          "confidence": 0.9997868537902832
        },
        {
          "text": "\"Batch' shall mean the defined quantity of the Product processed in a single process or series of processes in a manner designed to.",
          "bbox": [
            549.0,
            281.0,
            3011.0,
            329.0
          ],
          "confidence": 0.9841217398643494
        },
        {
          "text": "be homogeneous. The Batch size for the Product is **** tablets.",
          "bbox": [
            551.0,
            338.0,
            1756.0,
            382.0
          ],
          "confidence": 0.9994081258773804
        },
        {
          "text": "1.5",
          "bbox": [
            376.0,
            390.0,
            443.0,
            443.0
          ],
          "confidence": 0.9997324347496033
        },
        {
          "text": "\"cGMPs\" or \"Good Manufacturing Practice\"' shall mean the part of quality assurance which ensures that the Product is consistently.",
          "bbox": [
            549.0,
            395.0,
            3023.0,
            440.0
          ],
          "confidence": 0.985264241695404
        },
        {
          "text": "produced and controlled to the quality standards appropriate to their intended use, the principles and guidelines of which are",
          "bbox": [
            549.0,
            451.0,
            2884.0,
            499.0
          ],
          "confidence": 0.9912954568862915
        },
        {
          "text": "specified in European Commission Directive 2003/94/EC and the FDA's current Good Manufacturing Practices, particularly 21 CFR ",
          "bbox": [
            547.0,
            506.0,
            3003.0,
            557.0
          ],
          "confidence": 0.995246410369873
        },
        {
          "text": "210 et seq., and 21 CFR $$ 600-610, as both may be amended from time to time..",
          "bbox": [
            549.0,
            565.0,
            2006.0,
            607.0
          ],
          "confidence": 0.9747835993766785
        },
        {
          "text": "1.6",
          "bbox": [
            379.0,
            619.0,
            442.0,
            663.0
          ],
          "confidence": 0.9999213218688965
        },
        {
          "text": "\"Change of Control' shall mean (i) any change, sale, merger, reorganization, or any other event or action that results in a third party,",
          "bbox": [
            547.0,
            618.0,
            3005.0,
            669.0
          ],
          "confidence": 0.9930126070976257
        },
        {
          "text": "which is a material competitor to the other Party to this agreement, acquiring: (a) all or substantially all of the business or assets of a.",
          "bbox": [
            551.0,
            678.0,
            3002.0,
            722.0
          ],
          "confidence": 0.9852778911590576
        },
        {
          "text": "Party relating to this Agreement, (b) Control, directly or indirectly, of such Party (and/or any corporate entity that Controls, directly.",
          "bbox": [
            551.0,
            735.0,
            2985.0,
            778.0
          ],
          "confidence": 0.9932605624198914
        },
        {
          "text": "or indirectly, such Party), or (ii) any assignment or delegation of, sale or transfer of a Party's rights and obligations under this",
          "bbox": [
            549.0,
            789.0,
            2878.0,
            835.0
          ],
          "confidence": 0.9923490881919861
        },
        {
          "text": "Agreement (or any part hereof) to a third party.",
          "bbox": [
            555.0,
            848.0,
            1426.0,
            890.0
          ],
          "confidence": 0.9961597323417664
        },
        {
          "text": "Notwithstanding anything in the immediately preceding paragraph to the contrary, where the Party in question is Dexcel, any of the",
          "bbox": [
            549.0,
            903.0,
            2991.0,
            945.0
          ],
          "confidence": 0.9957303404808044
        },
        {
          "text": "foregoing events or actions shall not be considered a Change of Control where any one or more of the relevant third party or parties.",
          "bbox": [
            551.0,
            961.0,
            3007.0,
            1003.0
          ],
          "confidence": 0.9899225234985352
        },
        {
          "text": "referred to in clause (i) above is (A) a Family Member, or (B) any entity Controlled by Mr. **** and/or a Family Member.",
          "bbox": [
            544.0,
            1005.0,
            2788.0,
            1064.0
          ],
          "confidence": 0.9933032989501953
        },
        {
          "text": "1.7",
          "bbox": [
            379.0,
            1067.0,
            442.0,
            1113.0
          ],
          "confidence": 0.9998312592506409
        },
        {
          "text": "\"Claims' shall mean any demands, claims, actions, causes of action, assessments, losses, damages, injuries, liabilities, costs and.",
          "bbox": [
            549.0,
            1069.0,
            2953.0,
            1115.0
          ],
          "confidence": 0.9854910969734192
        },
        {
          "text": "expenses (including, without limitation, reasonable attorneys' fees and expenses) filed, raised, initiated or made by any governmental.",
          "bbox": [
            553.0,
            1129.0,
            3021.0,
            1171.0
          ],
          "confidence": 0.992518424987793
        },
        {
          "text": "authority and/or third party.",
          "bbox": [
            551.0,
            1184.0,
            1066.0,
            1226.0
          ],
          "confidence": 0.983346164226532
        },
        {
          "text": "1.8",
          "bbox": [
            379.0,
            1235.0,
            442.0,
            1281.0
          ],
          "confidence": 0.9999089241027832
        },
        {
          "text": "\"Confidential Information\"' shall have the meaning set forth in Section 7.1.",
          "bbox": [
            549.0,
            1235.0,
            1939.0,
            1281.0
          ],
          "confidence": 0.9719286561012268
        },
        {
          "text": "1.9",
          "bbox": [
            379.0,
            1292.0,
            440.0,
            1336.0
          ],
          "confidence": 0.9999080300331116
        },
        {
          "text": "\"Confirmed Order' shall have the meaning set forth in Section 3.3.2.",
          "bbox": [
            549.0,
            1292.0,
            1834.0,
            1338.0
          ],
          "confidence": 0.9867768883705139
        },
        {
          "text": "1.10",
          "bbox": [
            379.0,
            1347.0,
            462.0,
            1394.0
          ],
          "confidence": 0.9999012351036072
        },
        {
          "text": "\"Control' or \"Controlled' shall mean possession of more than fifty percent (50%) of the share capital of a corporation or other",
          "bbox": [
            547.0,
            1345.0,
            2915.0,
            1398.0
          ],
          "confidence": 0.981292724609375
        },
        {
          "text": "business entity, and/or the power to direct or cause the direction of the management and policies of a corporation or other entity",
          "bbox": [
            549.0,
            1405.0,
            2936.0,
            1451.0
          ],
          "confidence": 0.9941077828407288
        },
        {
          "text": "whether through the ownership of voting securities, by contract or otherwise..",
          "bbox": [
            553.0,
            1467.0,
            1996.0,
            1504.0
          ],
          "confidence": 0.9934757947921753
        },
        {
          "text": "1.11",
          "bbox": [
            379.0,
            1517.0,
            455.0,
            1561.0
          ],
          "confidence": 0.999779224395752
        },
        {
          "text": "\"Delivery' shall mean the time when the Product is placed at the disposal of Kitov at Dexcel's Facility based on an ****",
          "bbox": [
            546.0,
            1508.0,
            2799.0,
            1568.0
          ],
          "confidence": 0.992178738117218
        },
        {
          "text": "(Incoterms 2010).",
          "bbox": [
            555.0,
            1579.0,
            904.0,
            1617.0
          ],
          "confidence": 0.99842768907547
        },
        {
          "text": "1.12",
          "bbox": [
            377.0,
            1626.0,
            462.0,
            1674.0
          ],
          "confidence": 0.9999103546142578
        },
        {
          "text": "\"Distributors\" shall mean any Person under contract with Kitov or any of its Affiliates for the distribution of the Product in a certain",
          "bbox": [
            553.0,
            1634.0,
            3018.0,
            1670.0
          ],
          "confidence": 0.9918192625045776
        },
        {
          "text": "territory or territories..",
          "bbox": [
            551.0,
            1692.0,
            946.0,
            1729.0
          ],
          "confidence": 0.9840478301048279
        },
        {
          "text": "1.13",
          "bbox": [
            381.0,
            1741.0,
            459.0,
            1785.0
          ],
          "confidence": 0.8832098245620728
        },
        {
          "text": "\"Effective Date' shall mean the date of signature of the last Party to execute this Agreement..",
          "bbox": [
            549.0,
            1741.0,
            2267.0,
            1787.0
          ],
          "confidence": 0.9844200611114502
        },
        {
          "text": "1.14",
          "bbox": [
            379.0,
            1798.0,
            460.0,
            1840.0
          ],
          "confidence": 0.9994210004806519
        },
        {
          "text": "\"EMA\" means the European Medicines Agency or any successor entity.",
          "bbox": [
            549.0,
            1798.0,
            1898.0,
            1846.0
          ],
          "confidence": 0.9979910254478455
        },
        {
          "text": "1.15",
          "bbox": [
            379.0,
            1851.0,
            460.0,
            1900.0
          ],
          "confidence": 0.9995757341384888
        },
        {
          "text": "\"Family Member\" shall mean ****.",
          "bbox": [
            547.0,
            1847.0,
            1222.0,
            1902.0
          ],
          "confidence": 0.9885128736495972
        },
        {
          "text": "1.16",
          "bbox": [
            379.0,
            1908.0,
            462.0,
            1955.0
          ],
          "confidence": 0.9999197125434875
        },
        {
          "text": "\"FDA\" means the U.S. Food and Drug Administration or any successor entity..",
          "bbox": [
            549.0,
            1911.0,
            2005.0,
            1953.0
          ],
          "confidence": 0.986582338809967
        },
        {
          "text": "2",
          "bbox": [
            1638.0,
            2025.0,
            1669.0,
            2061.0
          ],
          "confidence": 0.999761164188385
        },
        {
          "text": "Source: KITOV PHARMA LTD., 20-F, 3/26/2019",
          "bbox": [
            332.0,
            4437.0,
            1256.0,
            4479.0
          ],
          "confidence": 0.989766538143158
        }
      ],
      "multi_page": true,
      "part_of": 2
    },
    {
      "id": "KitovPharmaLtd_20190326_20-F_EX-4.15_11584449_EX-4.15_Manufacturing Agreement__Anti-Assignment_0_multi",
      "question": "Highlight the parts (if any) of this contract related to \"Anti-Assignment\" that should be reviewed by a lawyer. Details: Is consent or notice required of a party if the contract is assigned to a third party?",
      "answer_text": "For purposes of this Agreement, any merger, consolidation, or change of corporate structure following which there is a Change of Control of Kitov shall be considered as an assignment by Kitov, allowing Dexcel to terminate the Agreement as heretofore provided.",
      "page_number": 0,
      "words": [
        {
          "text": "Exhibit 4.15",
          "bbox": [
            2798.0,
            283.0,
            3029.0,
            325.0
          ],
          "confidence": 0.9998080730438232
        },
        {
          "text": "THE SYMBOL <****\" DENOTES PLACES WHERE PORTIONS OF THIS DOCUMENT HAVE BEEN OMITTED PURSUANT TO A REQUEST",
          "bbox": [
            304.0,
            338.0,
            3009.0,
            380.0
          ],
          "confidence": 0.983539879322052
        },
        {
          "text": "FOR CONFIDENTIAL TREATMENT. SUCH MATERIAL WILL BE FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE",
          "bbox": [
            399.0,
            398.0,
            2907.0,
            435.0
          ],
          "confidence": 0.9926196932792664
        },
        {
          "text": "COMIMISSION.",
          "bbox": [
            1503.0,
            455.0,
            1805.0,
            492.0
          ],
          "confidence": 0.9562864303588867
        },
        {
          "text": "PRODUCT MANUFACTURING AGREEMENT",
          "bbox": [
            1216.0,
            510.0,
            2093.0,
            546.0
          ],
          "confidence": 0.994750440120697
        },
        {
          "text": "This Product Manufacturing Agreement (\"Agreement') is made as of the Effective Date by and between DEXCEL LTD., with its registered address.",
          "bbox": [
            275.0,
            563.0,
            3023.0,
            609.0
          ],
          "confidence": 0.989086925983429
        },
        {
          "text": "at ****, Israel (\"Dexcel'') and KITOV Pharma Ltd., with its registered office at 132 Menachem Begin Road, Azrieli Center, Tel Aviv, 6701101, Israel.",
          "bbox": [
            274.0,
            618.0,
            3000.0,
            665.0
          ],
          "confidence": 0.9887864589691162
        },
        {
          "text": "(\"Kitov'). Dexcel and Kitov are hereinafter jointly the \"Parties' and individually a \"Party.\".",
          "bbox": [
            279.0,
            678.0,
            1945.0,
            722.0
          ],
          "confidence": 0.98404461145401
        },
        {
          "text": "WHEREAS: Dexcel is a pharmaceutical company engaged in various activities including, but not limited to, the research, development,",
          "bbox": [
            275.0,
            729.0,
            2817.0,
            780.0
          ],
          "confidence": 0.9837751388549805
        },
        {
          "text": "manufacture, and marketing of various drugs and pharmaceutical specialties in various dosage forms;",
          "bbox": [
            549.0,
            795.0,
            2438.0,
            831.0
          ],
          "confidence": 0.9977880120277405
        },
        {
          "text": "WHEREAS:",
          "bbox": [
            281.0,
            848.0,
            515.0,
            884.0
          ],
          "confidence": 0.9993464946746826
        },
        {
          "text": "Kitov is a pharmaceutical company engaged in various activities including, but not limited to, the development of pharmaceutical",
          "bbox": [
            546.0,
            844.0,
            2951.0,
            890.0
          ],
          "confidence": 0.9910856485366821
        },
        {
          "text": "products;",
          "bbox": [
            551.0,
            906.0,
            732.0,
            945.0
          ],
          "confidence": 0.9994080066680908
        },
        {
          "text": "WHEREAS:",
          "bbox": [
            279.0,
            959.0,
            513.0,
            996.0
          ],
          "confidence": 0.9993117451667786
        },
        {
          "text": "Kitov and Dexcel entered into a Development Services Agreement on April 1, 2014 (\"Development Agreement'), pursuant to which",
          "bbox": [
            549.0,
            958.0,
            2991.0,
            1000.0
          ],
          "confidence": 0.9946937561035156
        },
        {
          "text": "Dexcel performed certain development services for Kitov with respect to the Product;",
          "bbox": [
            551.0,
            1016.0,
            2139.0,
            1058.0
          ],
          "confidence": 0.9957237243652344
        },
        {
          "text": "WHEREAS:",
          "bbox": [
            281.0,
            1071.0,
            515.0,
            1107.0
          ],
          "confidence": 0.9993150234222412
        },
        {
          "text": "Kitov desires that Dexcel manufacture and package the Product for Kitov in accordance with the terms of this Agreement, and Dexcel",
          "bbox": [
            546.0,
            1069.0,
            3029.0,
            1115.0
          ],
          "confidence": 0.9908015131950378
        },
        {
          "text": "is willing to manufacture and package the Product for Kitov in accordance with the terms of this Agreement..",
          "bbox": [
            547.0,
            1126.0,
            2561.0,
            1171.0
          ],
          "confidence": 0.9924741387367249
        },
        {
          "text": "NOw, THEREFORE, in consideration of the mutual covenants herein contained, the Parties, intending to be legally bound, hereby agree as",
          "bbox": [
            275.0,
            1180.0,
            2876.0,
            1228.0
          ],
          "confidence": 0.9950727820396423
        },
        {
          "text": "follows:",
          "bbox": [
            275.0,
            1237.0,
            426.0,
            1279.0
          ],
          "confidence": 0.9998461008071899
        },
        {
          "text": "1",
          "bbox": [
            277.0,
            1299.0,
            303.0,
            1330.0
          ],
          "confidence": 0.9999181032180786
        },
        {
          "text": "Definitions",
          "bbox": [
            368.0,
            1296.0,
            589.0,
            1334.0
          ],
          "confidence": 0.999856173992157
        },
        {
          "text": "For the purpose of this Agreement, the terms set forth in this clause, whether used in singular or plural form, shall mean, unless otherwise expressly.",
          "bbox": [
            277.0,
            1352.0,
            3012.0,
            1394.0
          ],
          "confidence": 0.9917291402816772
        },
        {
          "text": "provided for in this Agreement or the context otherwise requires, the following:.",
          "bbox": [
            277.0,
            1405.0,
            1749.0,
            1453.0
          ],
          "confidence": 0.9938557744026184
        },
        {
          "text": "1.1",
          "bbox": [
            379.0,
            1460.0,
            439.0,
            1506.0
          ],
          "confidence": 0.9998831748962402
        },
        {
          "text": "\"Affiliate\"' of a Party shall mean any corporation or other business entity directly or indirectly Controlled by, under common Control.",
          "bbox": [
            546.0,
            1458.0,
            3012.0,
            1509.0
          ],
          "confidence": 0.9893513917922974
        },
        {
          "text": "with, or in the Control of such Party..",
          "bbox": [
            551.0,
            1518.0,
            1222.0,
            1564.0
          ],
          "confidence": 0.9819372296333313
        },
        {
          "text": "1.2",
          "bbox": [
            377.0,
            1573.0,
            440.0,
            1619.0
          ],
          "confidence": 0.9997513890266418
        },
        {
          "text": "\"Anti-Corruption and Anti-Bribery Laws\" shall mean the United States Foreign Corrupt Practices Act of 1977, as amended, the",
          "bbox": [
            549.0,
            1577.0,
            2925.0,
            1619.0
          ],
          "confidence": 0.9937560558319092
        },
        {
          "text": "Bribery Act 2010 (2010 Chapter 23) of the Parliament of the United Kingdom, any rules or regulations under such acts, and any other",
          "bbox": [
            551.0,
            1634.0,
            3011.0,
            1676.0
          ],
          "confidence": 0.9908789992332458
        },
        {
          "text": "anti-corruption or anti-bribery statutes, laws or regulations applicable to a Party..",
          "bbox": [
            547.0,
            1687.0,
            2039.0,
            1732.0
          ],
          "confidence": 0.9931536316871643
        },
        {
          "text": "1.3",
          "bbox": [
            379.0,
            1741.0,
            440.0,
            1787.0
          ],
          "confidence": 0.9998380541801453
        },
        {
          "text": "\"API\"' shall mean the active pharmaceutical ingredients Celecoxib and Amlodipine Besylate..",
          "bbox": [
            549.0,
            1741.0,
            2277.0,
            1787.0
          ],
          "confidence": 0.9627962112426758
        },
        {
          "text": "Source: KITOV PHARMA LTD., 20-F, 3/26/2019",
          "bbox": [
            332.0,
            4437.0,
            1256.0,
            4479.0
          ],
          "confidence": 0.988348126411438
        }
      ],
      "multi_page": true,
      "part_of": 2,
      "nearby_headers": [
        {
          "text": "THE SYMBOL <****\" DENOTES PLACES WHERE PORTIONS OF THIS DOCUMENT HAVE BEEN OMITTED PURSUANT TO A REQUEST",
          "page": 0,
          "bbox": [
            304.0,
            338.0,
            3009.0,
            380.0
          ]
        },
        {
          "text": "FOR CONFIDENTIAL TREATMENT. SUCH MATERIAL WILL BE FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE",
          "page": 0,
          "bbox": [
            399.0,
            398.0,
            2907.0,
            435.0
          ]
        },
        {
          "text": "COMIMISSION.",
          "page": 0,
          "bbox": [
            1503.0,
            455.0,
            1805.0,
            492.0
          ]
        },
        {
          "text": "PRODUCT MANUFACTURING AGREEMENT",
          "page": 0,
          "bbox": [
            1216.0,
            510.0,
            2093.0,
            546.0
          ]
        },
        {
          "text": "WHEREAS:",
          "page": 0,
          "bbox": [
            281.0,
            848.0,
            515.0,
            884.0
          ]
        },
        {
          "text": "WHEREAS:",
          "page": 0,
          "bbox": [
            279.0,
            959.0,
            513.0,
            996.0
          ]
        },
        {
          "text": "WHEREAS:",
          "page": 0,
          "bbox": [
            281.0,
            1071.0,
            515.0,
            1107.0
          ]
        }
      ]
    },
    {
      "id": "KitovPharmaLtd_20190326_20-F_EX-4.15_11584449_EX-4.15_Manufacturing Agreement__Anti-Assignment_1_multi",
      "question": "Highlight the parts (if any) of this contract related to \"Anti-Assignment\" that should be reviewed by a lawyer. Details: Is consent or notice required of a party if the contract is assigned to a third party?",
      "answer_text": "For purposes of this Agreement, any merger, consolidation, or change of corporate structure following which there is a Change of Control of Kitov shall be considered as an assignment by Kitov, allowing Dexcel to terminate the Agreement as heretofore provided.",
      "page_number": 1,
      "words": [
        {
          "text": "1.4",
          "bbox": [
            379.0,
            281.0,
            442.0,
            327.0
          ],
          "confidence": 0.9997868537902832
        },
        {
          "text": "\"Batch' shall mean the defined quantity of the Product processed in a single process or series of processes in a manner designed to.",
          "bbox": [
            549.0,
            281.0,
            3011.0,
            329.0
          ],
          "confidence": 0.9841217398643494
        },
        {
          "text": "be homogeneous. The Batch size for the Product is **** tablets.",
          "bbox": [
            551.0,
            338.0,
            1756.0,
            382.0
          ],
          "confidence": 0.9994081258773804
        },
        {
          "text": "1.5",
          "bbox": [
            376.0,
            390.0,
            443.0,
            443.0
          ],
          "confidence": 0.9997324347496033
        },
        {
          "text": "\"cGMPs\" or \"Good Manufacturing Practice\"' shall mean the part of quality assurance which ensures that the Product is consistently.",
          "bbox": [
            549.0,
            395.0,
            3023.0,
            440.0
          ],
          "confidence": 0.985264241695404
        },
        {
          "text": "produced and controlled to the quality standards appropriate to their intended use, the principles and guidelines of which are",
          "bbox": [
            549.0,
            451.0,
            2884.0,
            499.0
          ],
          "confidence": 0.9912954568862915
        },
        {
          "text": "specified in European Commission Directive 2003/94/EC and the FDA's current Good Manufacturing Practices, particularly 21 CFR ",
          "bbox": [
            547.0,
            506.0,
            3003.0,
            557.0
          ],
          "confidence": 0.995246410369873
        },
        {
          "text": "210 et seq., and 21 CFR $$ 600-610, as both may be amended from time to time..",
          "bbox": [
            549.0,
            565.0,
            2006.0,
            607.0
          ],
          "confidence": 0.9747835993766785
        },
        {
          "text": "1.6",
          "bbox": [
            379.0,
            619.0,
            442.0,
            663.0
          ],
          "confidence": 0.9999213218688965
        },
        {
          "text": "\"Change of Control' shall mean (i) any change, sale, merger, reorganization, or any other event or action that results in a third party,",
          "bbox": [
            547.0,
            618.0,
            3005.0,
            669.0
          ],
          "confidence": 0.9930126070976257
        },
        {
          "text": "which is a material competitor to the other Party to this agreement, acquiring: (a) all or substantially all of the business or assets of a.",
          "bbox": [
            551.0,
            678.0,
            3002.0,
            722.0
          ],
          "confidence": 0.9852778911590576
        },
        {
          "text": "Party relating to this Agreement, (b) Control, directly or indirectly, of such Party (and/or any corporate entity that Controls, directly.",
          "bbox": [
            551.0,
            735.0,
            2985.0,
            778.0
          ],
          "confidence": 0.9932605624198914
        },
        {
          "text": "or indirectly, such Party), or (ii) any assignment or delegation of, sale or transfer of a Party's rights and obligations under this",
          "bbox": [
            549.0,
            789.0,
            2878.0,
            835.0
          ],
          "confidence": 0.9923490881919861
        },
        {
          "text": "Agreement (or any part hereof) to a third party.",
          "bbox": [
            555.0,
            848.0,
            1426.0,
            890.0
          ],
          "confidence": 0.9961597323417664
        },
        {
          "text": "Notwithstanding anything in the immediately preceding paragraph to the contrary, where the Party in question is Dexcel, any of the",
          "bbox": [
            549.0,
            903.0,
            2991.0,
            945.0
          ],
          "confidence": 0.9957303404808044
        },
        {
          "text": "foregoing events or actions shall not be considered a Change of Control where any one or more of the relevant third party or parties.",
          "bbox": [
            551.0,
            961.0,
            3007.0,
            1003.0
          ],
          "confidence": 0.9899225234985352
        },
        {
          "text": "referred to in clause (i) above is (A) a Family Member, or (B) any entity Controlled by Mr. **** and/or a Family Member.",
          "bbox": [
            544.0,
            1005.0,
            2788.0,
            1064.0
          ],
          "confidence": 0.9933032989501953
        },
        {
          "text": "1.7",
          "bbox": [
            379.0,
            1067.0,
            442.0,
            1113.0
          ],
          "confidence": 0.9998312592506409
        },
        {
          "text": "\"Claims' shall mean any demands, claims, actions, causes of action, assessments, losses, damages, injuries, liabilities, costs and.",
          "bbox": [
            549.0,
            1069.0,
            2953.0,
            1115.0
          ],
          "confidence": 0.9854910969734192
        },
        {
          "text": "expenses (including, without limitation, reasonable attorneys' fees and expenses) filed, raised, initiated or made by any governmental.",
          "bbox": [
            553.0,
            1129.0,
            3021.0,
            1171.0
          ],
          "confidence": 0.992518424987793
        },
        {
          "text": "authority and/or third party.",
          "bbox": [
            551.0,
            1184.0,
            1066.0,
            1226.0
          ],
          "confidence": 0.983346164226532
        },
        {
          "text": "1.8",
          "bbox": [
            379.0,
            1235.0,
            442.0,
            1281.0
          ],
          "confidence": 0.9999089241027832
        },
        {
          "text": "\"Confidential Information\"' shall have the meaning set forth in Section 7.1.",
          "bbox": [
            549.0,
            1235.0,
            1939.0,
            1281.0
          ],
          "confidence": 0.9719286561012268
        },
        {
          "text": "1.9",
          "bbox": [
            379.0,
            1292.0,
            440.0,
            1336.0
          ],
          "confidence": 0.9999080300331116
        },
        {
          "text": "\"Confirmed Order' shall have the meaning set forth in Section 3.3.2.",
          "bbox": [
            549.0,
            1292.0,
            1834.0,
            1338.0
          ],
          "confidence": 0.9867768883705139
        },
        {
          "text": "1.10",
          "bbox": [
            379.0,
            1347.0,
            462.0,
            1394.0
          ],
          "confidence": 0.9999012351036072
        },
        {
          "text": "\"Control' or \"Controlled' shall mean possession of more than fifty percent (50%) of the share capital of a corporation or other",
          "bbox": [
            547.0,
            1345.0,
            2915.0,
            1398.0
          ],
          "confidence": 0.981292724609375
        },
        {
          "text": "business entity, and/or the power to direct or cause the direction of the management and policies of a corporation or other entity",
          "bbox": [
            549.0,
            1405.0,
            2936.0,
            1451.0
          ],
          "confidence": 0.9941077828407288
        },
        {
          "text": "whether through the ownership of voting securities, by contract or otherwise..",
          "bbox": [
            553.0,
            1467.0,
            1996.0,
            1504.0
          ],
          "confidence": 0.9934757947921753
        },
        {
          "text": "1.11",
          "bbox": [
            379.0,
            1517.0,
            455.0,
            1561.0
          ],
          "confidence": 0.999779224395752
        },
        {
          "text": "\"Delivery' shall mean the time when the Product is placed at the disposal of Kitov at Dexcel's Facility based on an ****",
          "bbox": [
            546.0,
            1508.0,
            2799.0,
            1568.0
          ],
          "confidence": 0.992178738117218
        },
        {
          "text": "(Incoterms 2010).",
          "bbox": [
            555.0,
            1579.0,
            904.0,
            1617.0
          ],
          "confidence": 0.99842768907547
        },
        {
          "text": "1.12",
          "bbox": [
            377.0,
            1626.0,
            462.0,
            1674.0
          ],
          "confidence": 0.9999103546142578
        },
        {
          "text": "\"Distributors\" shall mean any Person under contract with Kitov or any of its Affiliates for the distribution of the Product in a certain",
          "bbox": [
            553.0,
            1634.0,
            3018.0,
            1670.0
          ],
          "confidence": 0.9918192625045776
        },
        {
          "text": "territory or territories..",
          "bbox": [
            551.0,
            1692.0,
            946.0,
            1729.0
          ],
          "confidence": 0.9840478301048279
        },
        {
          "text": "1.13",
          "bbox": [
            381.0,
            1741.0,
            459.0,
            1785.0
          ],
          "confidence": 0.8832098245620728
        },
        {
          "text": "\"Effective Date' shall mean the date of signature of the last Party to execute this Agreement..",
          "bbox": [
            549.0,
            1741.0,
            2267.0,
            1787.0
          ],
          "confidence": 0.9844200611114502
        },
        {
          "text": "1.14",
          "bbox": [
            379.0,
            1798.0,
            460.0,
            1840.0
          ],
          "confidence": 0.9994210004806519
        },
        {
          "text": "\"EMA\" means the European Medicines Agency or any successor entity.",
          "bbox": [
            549.0,
            1798.0,
            1898.0,
            1846.0
          ],
          "confidence": 0.9979910254478455
        },
        {
          "text": "1.15",
          "bbox": [
            379.0,
            1851.0,
            460.0,
            1900.0
          ],
          "confidence": 0.9995757341384888
        },
        {
          "text": "\"Family Member\" shall mean ****.",
          "bbox": [
            547.0,
            1847.0,
            1222.0,
            1902.0
          ],
          "confidence": 0.9885128736495972
        },
        {
          "text": "1.16",
          "bbox": [
            379.0,
            1908.0,
            462.0,
            1955.0
          ],
          "confidence": 0.9999197125434875
        },
        {
          "text": "\"FDA\" means the U.S. Food and Drug Administration or any successor entity..",
          "bbox": [
            549.0,
            1911.0,
            2005.0,
            1953.0
          ],
          "confidence": 0.986582338809967
        },
        {
          "text": "2",
          "bbox": [
            1638.0,
            2025.0,
            1669.0,
            2061.0
          ],
          "confidence": 0.999761164188385
        },
        {
          "text": "Source: KITOV PHARMA LTD., 20-F, 3/26/2019",
          "bbox": [
            332.0,
            4437.0,
            1256.0,
            4479.0
          ],
          "confidence": 0.989766538143158
        }
      ],
      "multi_page": true,
      "part_of": 2
    },
    {
      "id": "KitovPharmaLtd_20190326_20-F_EX-4.15_11584449_EX-4.15_Manufacturing Agreement__Price Restrictions_5",
      "question": "Highlight the parts (if any) of this contract related to \"Price Restrictions\" that should be reviewed by a lawyer. Details: Is there a restriction on the  ability of a party to raise or reduce prices of technology, goods, or  services provided?",
      "answer_text": "Commencing with ****, Dexcel may adjust the Supply Price for the next following Year not more often than ****.",
      "page_number": 5,
      "words": [
        {
          "text": "3.3.2",
          "bbox": [
            546.0,
            281.0,
            642.0,
            329.0
          ],
          "confidence": 0.9434774518013
        },
        {
          "text": "All Kitov purchase orders are subject to confirmation in writing by Dexcel, which confirmation shall be delivered by e-mail",
          "bbox": [
            723.0,
            285.0,
            2985.0,
            327.0
          ],
          "confidence": 0.9894149899482727
        },
        {
          "text": "within ten (10) Working Days of Dexcel's receipt of each purchase order (each, a \"Confirmed Order'). If Kitov does not",
          "bbox": [
            721.0,
            342.0,
            2951.0,
            382.0
          ],
          "confidence": 0.9911361932754517
        },
        {
          "text": "receive a response from Dexcel within such ten (10) Working Days, Kitov shall contact Dexcel to confirm that Dexcel has.",
          "bbox": [
            718.0,
            398.0,
            2958.0,
            440.0
          ],
          "confidence": 0.9875890612602234
        },
        {
          "text": "received the purchase order. Except as provided in Section 3.3.3, Dexcel shall use its best endeavors to accept all purchase",
          "bbox": [
            718.0,
            455.0,
            2992.0,
            497.0
          ],
          "confidence": 0.9911577701568604
        },
        {
          "text": "orders placed by Kitov, which meet the Minimum Order Requirements and the remaining terms and conditions of this",
          "bbox": [
            721.0,
            510.0,
            2891.0,
            552.0
          ],
          "confidence": 0.9922667741775513
        },
        {
          "text": "Agreement.",
          "bbox": [
            721.0,
            570.0,
            935.0,
            609.0
          ],
          "confidence": 0.9962464570999146
        },
        {
          "text": "3.3.3",
          "bbox": [
            546.0,
            618.0,
            640.0,
            665.0
          ],
          "confidence": 0.9999570846557617
        },
        {
          "text": "In the event that a Kitov purchase order is greater than Kitov's Forecast by more than **** percent (****%), Dexcel shall.",
          "bbox": [
            712.0,
            610.0,
            3000.0,
            669.0
          ],
          "confidence": 0.9875805974006653
        },
        {
          "text": "make a good faith determination of its ability to accept such purchase order, consistent with its manufacturing schedule, the",
          "bbox": [
            720.0,
            680.0,
            3023.0,
            722.0
          ],
          "confidence": 0.9916281700134277
        },
        {
          "text": "availability of the Product API and other materials, and its other planning requirements, in Dexcel's sole discretion.",
          "bbox": [
            721.0,
            735.0,
            2849.0,
            777.0
          ],
          "confidence": 0.9932313561439514
        },
        {
          "text": "3.3.4",
          "bbox": [
            546.0,
            786.0,
            642.0,
            833.0
          ],
          "confidence": 0.9999475479125977
        },
        {
          "text": "Dexcel will supply the Product only on the terms of this Agreement or any additional terms specifically agreed upon in",
          "bbox": [
            716.0,
            789.0,
            2918.0,
            835.0
          ],
          "confidence": 0.9973685145378113
        },
        {
          "text": "writing by both parties; in the event of any conflict, the provisions of this Agreement shall prevail..",
          "bbox": [
            718.0,
            844.0,
            2554.0,
            890.0
          ],
          "confidence": 0.9870245456695557
        },
        {
          "text": "3.3.5",
          "bbox": [
            547.0,
            901.0,
            640.0,
            943.0
          ],
          "confidence": 0.9999610185623169
        },
        {
          "text": "Dexcel shall use reasonable commercial efforts to deliver the Confirmed Orders to Kitov in full on the required delivery date.",
          "bbox": [
            716.0,
            901.0,
            3014.0,
            945.0
          ],
          "confidence": 0.9913590550422668
        },
        {
          "text": "Each shipment shall be accompanied by certificates of analysis and such other documents required to be included pursuant",
          "bbox": [
            720.0,
            958.0,
            3021.0,
            1001.0
          ],
          "confidence": 0.9921665191650391
        },
        {
          "text": "to the Quality Agreement.",
          "bbox": [
            720.0,
            1016.0,
            1204.0,
            1058.0
          ],
          "confidence": 0.9912893772125244
        },
        {
          "text": "3.3.6",
          "bbox": [
            547.0,
            1069.0,
            642.0,
            1111.0
          ],
          "confidence": 0.9999575614929199
        },
        {
          "text": "Dexcel shall supply the Product with at least **** percent (****%) of the shelf life upon Delivery unless otherwise agreed.",
          "bbox": [
            714.0,
            1062.0,
            3012.0,
            1118.0
          ],
          "confidence": 0.9902474284172058
        },
        {
          "text": "by the Parties.",
          "bbox": [
            720.0,
            1129.0,
            984.0,
            1168.0
          ],
          "confidence": 0.9999343752861023
        },
        {
          "text": "3.3.7",
          "bbox": [
            546.0,
            1179.0,
            642.0,
            1226.0
          ],
          "confidence": 0.9999601244926453
        },
        {
          "text": "The Parties shall store and transport the Product in compliance with applicable laws and regulations for pharmaceutical",
          "bbox": [
            718.0,
            1180.0,
            2933.0,
            1226.0
          ],
          "confidence": 0.995474100112915
        },
        {
          "text": "products, the Quality Agreement and the relevant Marketing Authorization. Dexcel will be responsible for packaging the",
          "bbox": [
            720.0,
            1239.0,
            2956.0,
            1285.0
          ],
          "confidence": 0.9956637620925903
        },
        {
          "text": "Product in a manner appropriate for shipment and for including data loggers with each such shipment in accordance with",
          "bbox": [
            718.0,
            1294.0,
            2967.0,
            1339.0
          ],
          "confidence": 0.9952689409255981
        },
        {
          "text": "the provisions of the Quality Agreement.",
          "bbox": [
            720.0,
            1352.0,
            1486.0,
            1394.0
          ],
          "confidence": 0.9980079531669617
        },
        {
          "text": "3.3.8",
          "bbox": [
            547.0,
            1405.0,
            640.0,
            1447.0
          ],
          "confidence": 0.9999614953994751
        },
        {
          "text": "Kitov shall be solely responsible, at its own cost and expense, for all activities related to the sale, marketing, shipping",
          "bbox": [
            718.0,
            1405.0,
            2902.0,
            1453.0
          ],
          "confidence": 0.9957238435745239
        },
        {
          "text": "distribution, storage following the delivery of the Products, order fulfilment, invoicing, collection, and any other activities",
          "bbox": [
            720.0,
            1462.0,
            2978.0,
            1506.0
          ],
          "confidence": 0.9958134293556213
        },
        {
          "text": "directly or indirectly related to the promotion, marketing, distribution, or sale of the Product in any country..",
          "bbox": [
            720.0,
            1519.0,
            2704.0,
            1564.0
          ],
          "confidence": 0.9921367764472961
        },
        {
          "text": "3.4",
          "bbox": [
            379.0,
            1573.0,
            442.0,
            1617.0
          ],
          "confidence": 0.9998099207878113
        },
        {
          "text": "The Supply Prices for the Product shall be:",
          "bbox": [
            549.0,
            1573.0,
            1349.0,
            1619.0
          ],
          "confidence": 0.9797550439834595
        },
        {
          "text": "Supply Price/Pack",
          "bbox": [
            2226.0,
            1635.0,
            2581.0,
            1674.0
          ],
          "confidence": 0.999737024307251
        },
        {
          "text": "Strength",
          "bbox": [
            815.0,
            1684.0,
            995.0,
            1736.0
          ],
          "confidence": 0.9999426603317261
        },
        {
          "text": "Pack Size",
          "bbox": [
            1558.0,
            1685.0,
            1755.0,
            1729.0
          ],
          "confidence": 0.9999058842658997
        },
        {
          "text": "(in US Dollars)",
          "bbox": [
            2258.0,
            1685.0,
            2549.0,
            1733.0
          ],
          "confidence": 0.9927319884300232
        },
        {
          "text": "200/10mg",
          "bbox": [
            550.0,
            1744.0,
            733.0,
            1799.0
          ],
          "confidence": 0.999897301197052
        },
        {
          "text": "Bottle **** tablets",
          "bbox": [
            1479.0,
            1741.0,
            1842.0,
            1795.0
          ],
          "confidence": 0.9947194457054138
        },
        {
          "text": "****",
          "bbox": [
            2351.0,
            1749.0,
            2456.0,
            1780.0
          ],
          "confidence": 0.9974921941757202
        },
        {
          "text": "200/10mg",
          "bbox": [
            551.0,
            1803.0,
            733.0,
            1853.0
          ],
          "confidence": 0.9997483491897583
        },
        {
          "text": "Bottle **** tablets",
          "bbox": [
            1479.0,
            1800.0,
            1842.0,
            1849.0
          ],
          "confidence": 0.9994450807571411
        },
        {
          "text": "****",
          "bbox": [
            2349.0,
            1801.0,
            2456.0,
            1837.0
          ],
          "confidence": 0.9985682964324951
        },
        {
          "text": "200/5mg",
          "bbox": [
            550.0,
            1858.0,
            713.0,
            1910.0
          ],
          "confidence": 0.9999508857727051
        },
        {
          "text": "Bottle **** tablets",
          "bbox": [
            1477.0,
            1855.0,
            1842.0,
            1908.0
          ],
          "confidence": 0.999535083770752
        },
        {
          "text": "****",
          "bbox": [
            2351.0,
            1860.0,
            2454.0,
            1891.0
          ],
          "confidence": 0.9990599155426025
        },
        {
          "text": "200/5mg",
          "bbox": [
            550.0,
            1914.0,
            713.0,
            1969.0
          ],
          "confidence": 0.999963641166687
        },
        {
          "text": "Bottle **** tablets",
          "bbox": [
            1477.0,
            1911.0,
            1843.0,
            1965.0
          ],
          "confidence": 0.9998353719711304
        },
        {
          "text": "****",
          "bbox": [
            2352.0,
            1915.0,
            2454.0,
            1946.0
          ],
          "confidence": 0.9958478808403015
        },
        {
          "text": "200/2.5mg",
          "bbox": [
            550.0,
            1969.0,
            746.0,
            2023.0
          ],
          "confidence": 0.9999762773513794
        },
        {
          "text": "Bottle **** tablets",
          "bbox": [
            1477.0,
            1966.0,
            1843.0,
            2021.0
          ],
          "confidence": 0.9926854968070984
        },
        {
          "text": "****",
          "bbox": [
            2354.0,
            1975.0,
            2452.0,
            2001.0
          ],
          "confidence": 0.9938992261886597
        },
        {
          "text": "200/2.5mg",
          "bbox": [
            549.0,
            2026.0,
            744.0,
            2080.0
          ],
          "confidence": 0.9999659061431885
        },
        {
          "text": "Bottle **** tablets",
          "bbox": [
            1475.0,
            2023.0,
            1843.0,
            2076.0
          ],
          "confidence": 0.999362051486969
        },
        {
          "text": "****",
          "bbox": [
            2354.0,
            2032.0,
            2454.0,
            2058.0
          ],
          "confidence": 0.9877436757087708
        },
        {
          "text": "6",
          "bbox": [
            1638.0,
            2143.0,
            1669.0,
            2184.0
          ],
          "confidence": 0.9990893602371216
        },
        {
          "text": "Source: KITOV PHARMA LTD., 20-F, 3/26/2019",
          "bbox": [
            332.0,
            4435.0,
            1254.0,
            4477.0
          ],
          "confidence": 0.9868283271789551
        }
      ]
    },
    {
      "id": "KitovPharmaLtd_20190326_20-F_EX-4.15_11584449_EX-4.15_Manufacturing Agreement__Minimum Commitment_0",
      "question": "Highlight the parts (if any) of this contract related to \"Minimum Commitment\" that should be reviewed by a lawyer. Details: Is there a minimum order size or minimum amount or units per-time period that one party must buy from the counterparty under the contract?",
      "answer_text": "Dexcel shall supply the Product with at least **** percent (****%) of the shelf life upon Delivery unless otherwise agreed by the Parties.",
      "page_number": 0,
      "words": [
        {
          "text": "Exhibit 4.15",
          "bbox": [
            2798.0,
            283.0,
            3029.0,
            325.0
          ],
          "confidence": 0.9998080730438232
        },
        {
          "text": "THE SYMBOL <****\" DENOTES PLACES WHERE PORTIONS OF THIS DOCUMENT HAVE BEEN OMITTED PURSUANT TO A REQUEST",
          "bbox": [
            304.0,
            338.0,
            3009.0,
            380.0
          ],
          "confidence": 0.983539879322052
        },
        {
          "text": "FOR CONFIDENTIAL TREATMENT. SUCH MATERIAL WILL BE FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE",
          "bbox": [
            399.0,
            398.0,
            2907.0,
            435.0
          ],
          "confidence": 0.9926196932792664
        },
        {
          "text": "COMIMISSION.",
          "bbox": [
            1503.0,
            455.0,
            1805.0,
            492.0
          ],
          "confidence": 0.9562864303588867
        },
        {
          "text": "PRODUCT MANUFACTURING AGREEMENT",
          "bbox": [
            1216.0,
            510.0,
            2093.0,
            546.0
          ],
          "confidence": 0.994750440120697
        },
        {
          "text": "This Product Manufacturing Agreement (\"Agreement') is made as of the Effective Date by and between DEXCEL LTD., with its registered address.",
          "bbox": [
            275.0,
            563.0,
            3023.0,
            609.0
          ],
          "confidence": 0.989086925983429
        },
        {
          "text": "at ****, Israel (\"Dexcel'') and KITOV Pharma Ltd., with its registered office at 132 Menachem Begin Road, Azrieli Center, Tel Aviv, 6701101, Israel.",
          "bbox": [
            274.0,
            618.0,
            3000.0,
            665.0
          ],
          "confidence": 0.9887864589691162
        },
        {
          "text": "(\"Kitov'). Dexcel and Kitov are hereinafter jointly the \"Parties' and individually a \"Party.\".",
          "bbox": [
            279.0,
            678.0,
            1945.0,
            722.0
          ],
          "confidence": 0.98404461145401
        },
        {
          "text": "WHEREAS: Dexcel is a pharmaceutical company engaged in various activities including, but not limited to, the research, development,",
          "bbox": [
            275.0,
            729.0,
            2817.0,
            780.0
          ],
          "confidence": 0.9837751388549805
        },
        {
          "text": "manufacture, and marketing of various drugs and pharmaceutical specialties in various dosage forms;",
          "bbox": [
            549.0,
            795.0,
            2438.0,
            831.0
          ],
          "confidence": 0.9977880120277405
        },
        {
          "text": "WHEREAS:",
          "bbox": [
            281.0,
            848.0,
            515.0,
            884.0
          ],
          "confidence": 0.9993464946746826
        },
        {
          "text": "Kitov is a pharmaceutical company engaged in various activities including, but not limited to, the development of pharmaceutical",
          "bbox": [
            546.0,
            844.0,
            2951.0,
            890.0
          ],
          "confidence": 0.9910856485366821
        },
        {
          "text": "products;",
          "bbox": [
            551.0,
            906.0,
            732.0,
            945.0
          ],
          "confidence": 0.9994080066680908
        },
        {
          "text": "WHEREAS:",
          "bbox": [
            279.0,
            959.0,
            513.0,
            996.0
          ],
          "confidence": 0.9993117451667786
        },
        {
          "text": "Kitov and Dexcel entered into a Development Services Agreement on April 1, 2014 (\"Development Agreement'), pursuant to which",
          "bbox": [
            549.0,
            958.0,
            2991.0,
            1000.0
          ],
          "confidence": 0.9946937561035156
        },
        {
          "text": "Dexcel performed certain development services for Kitov with respect to the Product;",
          "bbox": [
            551.0,
            1016.0,
            2139.0,
            1058.0
          ],
          "confidence": 0.9957237243652344
        },
        {
          "text": "WHEREAS:",
          "bbox": [
            281.0,
            1071.0,
            515.0,
            1107.0
          ],
          "confidence": 0.9993150234222412
        },
        {
          "text": "Kitov desires that Dexcel manufacture and package the Product for Kitov in accordance with the terms of this Agreement, and Dexcel",
          "bbox": [
            546.0,
            1069.0,
            3029.0,
            1115.0
          ],
          "confidence": 0.9908015131950378
        },
        {
          "text": "is willing to manufacture and package the Product for Kitov in accordance with the terms of this Agreement..",
          "bbox": [
            547.0,
            1126.0,
            2561.0,
            1171.0
          ],
          "confidence": 0.9924741387367249
        },
        {
          "text": "NOw, THEREFORE, in consideration of the mutual covenants herein contained, the Parties, intending to be legally bound, hereby agree as",
          "bbox": [
            275.0,
            1180.0,
            2876.0,
            1228.0
          ],
          "confidence": 0.9950727820396423
        },
        {
          "text": "follows:",
          "bbox": [
            275.0,
            1237.0,
            426.0,
            1279.0
          ],
          "confidence": 0.9998461008071899
        },
        {
          "text": "1",
          "bbox": [
            277.0,
            1299.0,
            303.0,
            1330.0
          ],
          "confidence": 0.9999181032180786
        },
        {
          "text": "Definitions",
          "bbox": [
            368.0,
            1296.0,
            589.0,
            1334.0
          ],
          "confidence": 0.999856173992157
        },
        {
          "text": "For the purpose of this Agreement, the terms set forth in this clause, whether used in singular or plural form, shall mean, unless otherwise expressly.",
          "bbox": [
            277.0,
            1352.0,
            3012.0,
            1394.0
          ],
          "confidence": 0.9917291402816772
        },
        {
          "text": "provided for in this Agreement or the context otherwise requires, the following:.",
          "bbox": [
            277.0,
            1405.0,
            1749.0,
            1453.0
          ],
          "confidence": 0.9938557744026184
        },
        {
          "text": "1.1",
          "bbox": [
            379.0,
            1460.0,
            439.0,
            1506.0
          ],
          "confidence": 0.9998831748962402
        },
        {
          "text": "\"Affiliate\"' of a Party shall mean any corporation or other business entity directly or indirectly Controlled by, under common Control.",
          "bbox": [
            546.0,
            1458.0,
            3012.0,
            1509.0
          ],
          "confidence": 0.9893513917922974
        },
        {
          "text": "with, or in the Control of such Party..",
          "bbox": [
            551.0,
            1518.0,
            1222.0,
            1564.0
          ],
          "confidence": 0.9819372296333313
        },
        {
          "text": "1.2",
          "bbox": [
            377.0,
            1573.0,
            440.0,
            1619.0
          ],
          "confidence": 0.9997513890266418
        },
        {
          "text": "\"Anti-Corruption and Anti-Bribery Laws\" shall mean the United States Foreign Corrupt Practices Act of 1977, as amended, the",
          "bbox": [
            549.0,
            1577.0,
            2925.0,
            1619.0
          ],
          "confidence": 0.9937560558319092
        },
        {
          "text": "Bribery Act 2010 (2010 Chapter 23) of the Parliament of the United Kingdom, any rules or regulations under such acts, and any other",
          "bbox": [
            551.0,
            1634.0,
            3011.0,
            1676.0
          ],
          "confidence": 0.9908789992332458
        },
        {
          "text": "anti-corruption or anti-bribery statutes, laws or regulations applicable to a Party..",
          "bbox": [
            547.0,
            1687.0,
            2039.0,
            1732.0
          ],
          "confidence": 0.9931536316871643
        },
        {
          "text": "1.3",
          "bbox": [
            379.0,
            1741.0,
            440.0,
            1787.0
          ],
          "confidence": 0.9998380541801453
        },
        {
          "text": "\"API\"' shall mean the active pharmaceutical ingredients Celecoxib and Amlodipine Besylate..",
          "bbox": [
            549.0,
            1741.0,
            2277.0,
            1787.0
          ],
          "confidence": 0.9627962112426758
        },
        {
          "text": "Source: KITOV PHARMA LTD., 20-F, 3/26/2019",
          "bbox": [
            332.0,
            4437.0,
            1256.0,
            4479.0
          ],
          "confidence": 0.988348126411438
        }
      ],
      "nearby_headers": [
        {
          "text": "THE SYMBOL <****\" DENOTES PLACES WHERE PORTIONS OF THIS DOCUMENT HAVE BEEN OMITTED PURSUANT TO A REQUEST",
          "page": 0,
          "bbox": [
            304.0,
            338.0,
            3009.0,
            380.0
          ]
        },
        {
          "text": "FOR CONFIDENTIAL TREATMENT. SUCH MATERIAL WILL BE FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE",
          "page": 0,
          "bbox": [
            399.0,
            398.0,
            2907.0,
            435.0
          ]
        },
        {
          "text": "COMIMISSION.",
          "page": 0,
          "bbox": [
            1503.0,
            455.0,
            1805.0,
            492.0
          ]
        },
        {
          "text": "PRODUCT MANUFACTURING AGREEMENT",
          "page": 0,
          "bbox": [
            1216.0,
            510.0,
            2093.0,
            546.0
          ]
        },
        {
          "text": "WHEREAS:",
          "page": 0,
          "bbox": [
            281.0,
            848.0,
            515.0,
            884.0
          ]
        },
        {
          "text": "WHEREAS:",
          "page": 0,
          "bbox": [
            279.0,
            959.0,
            513.0,
            996.0
          ]
        },
        {
          "text": "WHEREAS:",
          "page": 0,
          "bbox": [
            281.0,
            1071.0,
            515.0,
            1107.0
          ]
        }
      ]
    },
    {
      "id": "KitovPharmaLtd_20190326_20-F_EX-4.15_11584449_EX-4.15_Manufacturing Agreement__Minimum Commitment_0_multi",
      "question": "Highlight the parts (if any) of this contract related to \"Minimum Commitment\" that should be reviewed by a lawyer. Details: Is there a minimum order size or minimum amount or units per-time period that one party must buy from the counterparty under the contract?",
      "answer_text": "Kitov shall provide Dexcel with written purchase orders meeting the Minimum Order Requirements and in a form reasonably acceptable to Dexcel, and which shall specify at least the following: a description of the Product ordered, the quantity ordered, the current Supply Price, and the required delivery date thereof, such required delivery date to be not less than one hundred and twenty (120) days from the purchase order placement date (one hundred and eighty (180) days before the anticipated Supply Commencement Date and/or the launch of a new SKU).",
      "page_number": 0,
      "words": [
        {
          "text": "Exhibit 4.15",
          "bbox": [
            2798.0,
            283.0,
            3029.0,
            325.0
          ],
          "confidence": 0.9998080730438232
        },
        {
          "text": "THE SYMBOL <****\" DENOTES PLACES WHERE PORTIONS OF THIS DOCUMENT HAVE BEEN OMITTED PURSUANT TO A REQUEST",
          "bbox": [
            304.0,
            338.0,
            3009.0,
            380.0
          ],
          "confidence": 0.983539879322052
        },
        {
          "text": "FOR CONFIDENTIAL TREATMENT. SUCH MATERIAL WILL BE FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE",
          "bbox": [
            399.0,
            398.0,
            2907.0,
            435.0
          ],
          "confidence": 0.9926196932792664
        },
        {
          "text": "COMIMISSION.",
          "bbox": [
            1503.0,
            455.0,
            1805.0,
            492.0
          ],
          "confidence": 0.9562864303588867
        },
        {
          "text": "PRODUCT MANUFACTURING AGREEMENT",
          "bbox": [
            1216.0,
            510.0,
            2093.0,
            546.0
          ],
          "confidence": 0.994750440120697
        },
        {
          "text": "This Product Manufacturing Agreement (\"Agreement') is made as of the Effective Date by and between DEXCEL LTD., with its registered address.",
          "bbox": [
            275.0,
            563.0,
            3023.0,
            609.0
          ],
          "confidence": 0.989086925983429
        },
        {
          "text": "at ****, Israel (\"Dexcel'') and KITOV Pharma Ltd., with its registered office at 132 Menachem Begin Road, Azrieli Center, Tel Aviv, 6701101, Israel.",
          "bbox": [
            274.0,
            618.0,
            3000.0,
            665.0
          ],
          "confidence": 0.9887864589691162
        },
        {
          "text": "(\"Kitov'). Dexcel and Kitov are hereinafter jointly the \"Parties' and individually a \"Party.\".",
          "bbox": [
            279.0,
            678.0,
            1945.0,
            722.0
          ],
          "confidence": 0.98404461145401
        },
        {
          "text": "WHEREAS: Dexcel is a pharmaceutical company engaged in various activities including, but not limited to, the research, development,",
          "bbox": [
            275.0,
            729.0,
            2817.0,
            780.0
          ],
          "confidence": 0.9837751388549805
        },
        {
          "text": "manufacture, and marketing of various drugs and pharmaceutical specialties in various dosage forms;",
          "bbox": [
            549.0,
            795.0,
            2438.0,
            831.0
          ],
          "confidence": 0.9977880120277405
        },
        {
          "text": "WHEREAS:",
          "bbox": [
            281.0,
            848.0,
            515.0,
            884.0
          ],
          "confidence": 0.9993464946746826
        },
        {
          "text": "Kitov is a pharmaceutical company engaged in various activities including, but not limited to, the development of pharmaceutical",
          "bbox": [
            546.0,
            844.0,
            2951.0,
            890.0
          ],
          "confidence": 0.9910856485366821
        },
        {
          "text": "products;",
          "bbox": [
            551.0,
            906.0,
            732.0,
            945.0
          ],
          "confidence": 0.9994080066680908
        },
        {
          "text": "WHEREAS:",
          "bbox": [
            279.0,
            959.0,
            513.0,
            996.0
          ],
          "confidence": 0.9993117451667786
        },
        {
          "text": "Kitov and Dexcel entered into a Development Services Agreement on April 1, 2014 (\"Development Agreement'), pursuant to which",
          "bbox": [
            549.0,
            958.0,
            2991.0,
            1000.0
          ],
          "confidence": 0.9946937561035156
        },
        {
          "text": "Dexcel performed certain development services for Kitov with respect to the Product;",
          "bbox": [
            551.0,
            1016.0,
            2139.0,
            1058.0
          ],
          "confidence": 0.9957237243652344
        },
        {
          "text": "WHEREAS:",
          "bbox": [
            281.0,
            1071.0,
            515.0,
            1107.0
          ],
          "confidence": 0.9993150234222412
        },
        {
          "text": "Kitov desires that Dexcel manufacture and package the Product for Kitov in accordance with the terms of this Agreement, and Dexcel",
          "bbox": [
            546.0,
            1069.0,
            3029.0,
            1115.0
          ],
          "confidence": 0.9908015131950378
        },
        {
          "text": "is willing to manufacture and package the Product for Kitov in accordance with the terms of this Agreement..",
          "bbox": [
            547.0,
            1126.0,
            2561.0,
            1171.0
          ],
          "confidence": 0.9924741387367249
        },
        {
          "text": "NOw, THEREFORE, in consideration of the mutual covenants herein contained, the Parties, intending to be legally bound, hereby agree as",
          "bbox": [
            275.0,
            1180.0,
            2876.0,
            1228.0
          ],
          "confidence": 0.9950727820396423
        },
        {
          "text": "follows:",
          "bbox": [
            275.0,
            1237.0,
            426.0,
            1279.0
          ],
          "confidence": 0.9998461008071899
        },
        {
          "text": "1",
          "bbox": [
            277.0,
            1299.0,
            303.0,
            1330.0
          ],
          "confidence": 0.9999181032180786
        },
        {
          "text": "Definitions",
          "bbox": [
            368.0,
            1296.0,
            589.0,
            1334.0
          ],
          "confidence": 0.999856173992157
        },
        {
          "text": "For the purpose of this Agreement, the terms set forth in this clause, whether used in singular or plural form, shall mean, unless otherwise expressly.",
          "bbox": [
            277.0,
            1352.0,
            3012.0,
            1394.0
          ],
          "confidence": 0.9917291402816772
        },
        {
          "text": "provided for in this Agreement or the context otherwise requires, the following:.",
          "bbox": [
            277.0,
            1405.0,
            1749.0,
            1453.0
          ],
          "confidence": 0.9938557744026184
        },
        {
          "text": "1.1",
          "bbox": [
            379.0,
            1460.0,
            439.0,
            1506.0
          ],
          "confidence": 0.9998831748962402
        },
        {
          "text": "\"Affiliate\"' of a Party shall mean any corporation or other business entity directly or indirectly Controlled by, under common Control.",
          "bbox": [
            546.0,
            1458.0,
            3012.0,
            1509.0
          ],
          "confidence": 0.9893513917922974
        },
        {
          "text": "with, or in the Control of such Party..",
          "bbox": [
            551.0,
            1518.0,
            1222.0,
            1564.0
          ],
          "confidence": 0.9819372296333313
        },
        {
          "text": "1.2",
          "bbox": [
            377.0,
            1573.0,
            440.0,
            1619.0
          ],
          "confidence": 0.9997513890266418
        },
        {
          "text": "\"Anti-Corruption and Anti-Bribery Laws\" shall mean the United States Foreign Corrupt Practices Act of 1977, as amended, the",
          "bbox": [
            549.0,
            1577.0,
            2925.0,
            1619.0
          ],
          "confidence": 0.9937560558319092
        },
        {
          "text": "Bribery Act 2010 (2010 Chapter 23) of the Parliament of the United Kingdom, any rules or regulations under such acts, and any other",
          "bbox": [
            551.0,
            1634.0,
            3011.0,
            1676.0
          ],
          "confidence": 0.9908789992332458
        },
        {
          "text": "anti-corruption or anti-bribery statutes, laws or regulations applicable to a Party..",
          "bbox": [
            547.0,
            1687.0,
            2039.0,
            1732.0
          ],
          "confidence": 0.9931536316871643
        },
        {
          "text": "1.3",
          "bbox": [
            379.0,
            1741.0,
            440.0,
            1787.0
          ],
          "confidence": 0.9998380541801453
        },
        {
          "text": "\"API\"' shall mean the active pharmaceutical ingredients Celecoxib and Amlodipine Besylate..",
          "bbox": [
            549.0,
            1741.0,
            2277.0,
            1787.0
          ],
          "confidence": 0.9627962112426758
        },
        {
          "text": "Source: KITOV PHARMA LTD., 20-F, 3/26/2019",
          "bbox": [
            332.0,
            4437.0,
            1256.0,
            4479.0
          ],
          "confidence": 0.988348126411438
        }
      ],
      "multi_page": true,
      "part_of": 2,
      "nearby_headers": [
        {
          "text": "THE SYMBOL <****\" DENOTES PLACES WHERE PORTIONS OF THIS DOCUMENT HAVE BEEN OMITTED PURSUANT TO A REQUEST",
          "page": 0,
          "bbox": [
            304.0,
            338.0,
            3009.0,
            380.0
          ]
        },
        {
          "text": "FOR CONFIDENTIAL TREATMENT. SUCH MATERIAL WILL BE FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE",
          "page": 0,
          "bbox": [
            399.0,
            398.0,
            2907.0,
            435.0
          ]
        },
        {
          "text": "COMIMISSION.",
          "page": 0,
          "bbox": [
            1503.0,
            455.0,
            1805.0,
            492.0
          ]
        },
        {
          "text": "PRODUCT MANUFACTURING AGREEMENT",
          "page": 0,
          "bbox": [
            1216.0,
            510.0,
            2093.0,
            546.0
          ]
        },
        {
          "text": "WHEREAS:",
          "page": 0,
          "bbox": [
            281.0,
            848.0,
            515.0,
            884.0
          ]
        },
        {
          "text": "WHEREAS:",
          "page": 0,
          "bbox": [
            279.0,
            959.0,
            513.0,
            996.0
          ]
        },
        {
          "text": "WHEREAS:",
          "page": 0,
          "bbox": [
            281.0,
            1071.0,
            515.0,
            1107.0
          ]
        }
      ]
    },
    {
      "id": "KitovPharmaLtd_20190326_20-F_EX-4.15_11584449_EX-4.15_Manufacturing Agreement__Minimum Commitment_1_multi",
      "question": "Highlight the parts (if any) of this contract related to \"Minimum Commitment\" that should be reviewed by a lawyer. Details: Is there a minimum order size or minimum amount or units per-time period that one party must buy from the counterparty under the contract?",
      "answer_text": "Kitov shall provide Dexcel with written purchase orders meeting the Minimum Order Requirements and in a form reasonably acceptable to Dexcel, and which shall specify at least the following: a description of the Product ordered, the quantity ordered, the current Supply Price, and the required delivery date thereof, such required delivery date to be not less than one hundred and twenty (120) days from the purchase order placement date (one hundred and eighty (180) days before the anticipated Supply Commencement Date and/or the launch of a new SKU).",
      "page_number": 1,
      "words": [
        {
          "text": "1.4",
          "bbox": [
            379.0,
            281.0,
            442.0,
            327.0
          ],
          "confidence": 0.9997868537902832
        },
        {
          "text": "\"Batch' shall mean the defined quantity of the Product processed in a single process or series of processes in a manner designed to.",
          "bbox": [
            549.0,
            281.0,
            3011.0,
            329.0
          ],
          "confidence": 0.9841217398643494
        },
        {
          "text": "be homogeneous. The Batch size for the Product is **** tablets.",
          "bbox": [
            551.0,
            338.0,
            1756.0,
            382.0
          ],
          "confidence": 0.9994081258773804
        },
        {
          "text": "1.5",
          "bbox": [
            376.0,
            390.0,
            443.0,
            443.0
          ],
          "confidence": 0.9997324347496033
        },
        {
          "text": "\"cGMPs\" or \"Good Manufacturing Practice\"' shall mean the part of quality assurance which ensures that the Product is consistently.",
          "bbox": [
            549.0,
            395.0,
            3023.0,
            440.0
          ],
          "confidence": 0.985264241695404
        },
        {
          "text": "produced and controlled to the quality standards appropriate to their intended use, the principles and guidelines of which are",
          "bbox": [
            549.0,
            451.0,
            2884.0,
            499.0
          ],
          "confidence": 0.9912954568862915
        },
        {
          "text": "specified in European Commission Directive 2003/94/EC and the FDA's current Good Manufacturing Practices, particularly 21 CFR ",
          "bbox": [
            547.0,
            506.0,
            3003.0,
            557.0
          ],
          "confidence": 0.995246410369873
        },
        {
          "text": "210 et seq., and 21 CFR $$ 600-610, as both may be amended from time to time..",
          "bbox": [
            549.0,
            565.0,
            2006.0,
            607.0
          ],
          "confidence": 0.9747835993766785
        },
        {
          "text": "1.6",
          "bbox": [
            379.0,
            619.0,
            442.0,
            663.0
          ],
          "confidence": 0.9999213218688965
        },
        {
          "text": "\"Change of Control' shall mean (i) any change, sale, merger, reorganization, or any other event or action that results in a third party,",
          "bbox": [
            547.0,
            618.0,
            3005.0,
            669.0
          ],
          "confidence": 0.9930126070976257
        },
        {
          "text": "which is a material competitor to the other Party to this agreement, acquiring: (a) all or substantially all of the business or assets of a.",
          "bbox": [
            551.0,
            678.0,
            3002.0,
            722.0
          ],
          "confidence": 0.9852778911590576
        },
        {
          "text": "Party relating to this Agreement, (b) Control, directly or indirectly, of such Party (and/or any corporate entity that Controls, directly.",
          "bbox": [
            551.0,
            735.0,
            2985.0,
            778.0
          ],
          "confidence": 0.9932605624198914
        },
        {
          "text": "or indirectly, such Party), or (ii) any assignment or delegation of, sale or transfer of a Party's rights and obligations under this",
          "bbox": [
            549.0,
            789.0,
            2878.0,
            835.0
          ],
          "confidence": 0.9923490881919861
        },
        {
          "text": "Agreement (or any part hereof) to a third party.",
          "bbox": [
            555.0,
            848.0,
            1426.0,
            890.0
          ],
          "confidence": 0.9961597323417664
        },
        {
          "text": "Notwithstanding anything in the immediately preceding paragraph to the contrary, where the Party in question is Dexcel, any of the",
          "bbox": [
            549.0,
            903.0,
            2991.0,
            945.0
          ],
          "confidence": 0.9957303404808044
        },
        {
          "text": "foregoing events or actions shall not be considered a Change of Control where any one or more of the relevant third party or parties.",
          "bbox": [
            551.0,
            961.0,
            3007.0,
            1003.0
          ],
          "confidence": 0.9899225234985352
        },
        {
          "text": "referred to in clause (i) above is (A) a Family Member, or (B) any entity Controlled by Mr. **** and/or a Family Member.",
          "bbox": [
            544.0,
            1005.0,
            2788.0,
            1064.0
          ],
          "confidence": 0.9933032989501953
        },
        {
          "text": "1.7",
          "bbox": [
            379.0,
            1067.0,
            442.0,
            1113.0
          ],
          "confidence": 0.9998312592506409
        },
        {
          "text": "\"Claims' shall mean any demands, claims, actions, causes of action, assessments, losses, damages, injuries, liabilities, costs and.",
          "bbox": [
            549.0,
            1069.0,
            2953.0,
            1115.0
          ],
          "confidence": 0.9854910969734192
        },
        {
          "text": "expenses (including, without limitation, reasonable attorneys' fees and expenses) filed, raised, initiated or made by any governmental.",
          "bbox": [
            553.0,
            1129.0,
            3021.0,
            1171.0
          ],
          "confidence": 0.992518424987793
        },
        {
          "text": "authority and/or third party.",
          "bbox": [
            551.0,
            1184.0,
            1066.0,
            1226.0
          ],
          "confidence": 0.983346164226532
        },
        {
          "text": "1.8",
          "bbox": [
            379.0,
            1235.0,
            442.0,
            1281.0
          ],
          "confidence": 0.9999089241027832
        },
        {
          "text": "\"Confidential Information\"' shall have the meaning set forth in Section 7.1.",
          "bbox": [
            549.0,
            1235.0,
            1939.0,
            1281.0
          ],
          "confidence": 0.9719286561012268
        },
        {
          "text": "1.9",
          "bbox": [
            379.0,
            1292.0,
            440.0,
            1336.0
          ],
          "confidence": 0.9999080300331116
        },
        {
          "text": "\"Confirmed Order' shall have the meaning set forth in Section 3.3.2.",
          "bbox": [
            549.0,
            1292.0,
            1834.0,
            1338.0
          ],
          "confidence": 0.9867768883705139
        },
        {
          "text": "1.10",
          "bbox": [
            379.0,
            1347.0,
            462.0,
            1394.0
          ],
          "confidence": 0.9999012351036072
        },
        {
          "text": "\"Control' or \"Controlled' shall mean possession of more than fifty percent (50%) of the share capital of a corporation or other",
          "bbox": [
            547.0,
            1345.0,
            2915.0,
            1398.0
          ],
          "confidence": 0.981292724609375
        },
        {
          "text": "business entity, and/or the power to direct or cause the direction of the management and policies of a corporation or other entity",
          "bbox": [
            549.0,
            1405.0,
            2936.0,
            1451.0
          ],
          "confidence": 0.9941077828407288
        },
        {
          "text": "whether through the ownership of voting securities, by contract or otherwise..",
          "bbox": [
            553.0,
            1467.0,
            1996.0,
            1504.0
          ],
          "confidence": 0.9934757947921753
        },
        {
          "text": "1.11",
          "bbox": [
            379.0,
            1517.0,
            455.0,
            1561.0
          ],
          "confidence": 0.999779224395752
        },
        {
          "text": "\"Delivery' shall mean the time when the Product is placed at the disposal of Kitov at Dexcel's Facility based on an ****",
          "bbox": [
            546.0,
            1508.0,
            2799.0,
            1568.0
          ],
          "confidence": 0.992178738117218
        },
        {
          "text": "(Incoterms 2010).",
          "bbox": [
            555.0,
            1579.0,
            904.0,
            1617.0
          ],
          "confidence": 0.99842768907547
        },
        {
          "text": "1.12",
          "bbox": [
            377.0,
            1626.0,
            462.0,
            1674.0
          ],
          "confidence": 0.9999103546142578
        },
        {
          "text": "\"Distributors\" shall mean any Person under contract with Kitov or any of its Affiliates for the distribution of the Product in a certain",
          "bbox": [
            553.0,
            1634.0,
            3018.0,
            1670.0
          ],
          "confidence": 0.9918192625045776
        },
        {
          "text": "territory or territories..",
          "bbox": [
            551.0,
            1692.0,
            946.0,
            1729.0
          ],
          "confidence": 0.9840478301048279
        },
        {
          "text": "1.13",
          "bbox": [
            381.0,
            1741.0,
            459.0,
            1785.0
          ],
          "confidence": 0.8832098245620728
        },
        {
          "text": "\"Effective Date' shall mean the date of signature of the last Party to execute this Agreement..",
          "bbox": [
            549.0,
            1741.0,
            2267.0,
            1787.0
          ],
          "confidence": 0.9844200611114502
        },
        {
          "text": "1.14",
          "bbox": [
            379.0,
            1798.0,
            460.0,
            1840.0
          ],
          "confidence": 0.9994210004806519
        },
        {
          "text": "\"EMA\" means the European Medicines Agency or any successor entity.",
          "bbox": [
            549.0,
            1798.0,
            1898.0,
            1846.0
          ],
          "confidence": 0.9979910254478455
        },
        {
          "text": "1.15",
          "bbox": [
            379.0,
            1851.0,
            460.0,
            1900.0
          ],
          "confidence": 0.9995757341384888
        },
        {
          "text": "\"Family Member\" shall mean ****.",
          "bbox": [
            547.0,
            1847.0,
            1222.0,
            1902.0
          ],
          "confidence": 0.9885128736495972
        },
        {
          "text": "1.16",
          "bbox": [
            379.0,
            1908.0,
            462.0,
            1955.0
          ],
          "confidence": 0.9999197125434875
        },
        {
          "text": "\"FDA\" means the U.S. Food and Drug Administration or any successor entity..",
          "bbox": [
            549.0,
            1911.0,
            2005.0,
            1953.0
          ],
          "confidence": 0.986582338809967
        },
        {
          "text": "2",
          "bbox": [
            1638.0,
            2025.0,
            1669.0,
            2061.0
          ],
          "confidence": 0.999761164188385
        },
        {
          "text": "Source: KITOV PHARMA LTD., 20-F, 3/26/2019",
          "bbox": [
            332.0,
            4437.0,
            1256.0,
            4479.0
          ],
          "confidence": 0.989766538143158
        }
      ],
      "multi_page": true,
      "part_of": 2
    },
    {
      "id": "KitovPharmaLtd_20190326_20-F_EX-4.15_11584449_EX-4.15_Manufacturing Agreement__Volume Restriction_0_multi",
      "question": "Highlight the parts (if any) of this contract related to \"Volume Restriction\" that should be reviewed by a lawyer. Details: Is there a fee increase or consent requirement, etc. if one party’s use of the product/services exceeds certain threshold?",
      "answer_text": "Dexcel shall order the Packaging materials required for the Product Packaging (including, but not limited to, all Labeling); provided that such orders shall not exceed the forecasted demand of such materials for the next following twelve (12) months",
      "page_number": 0,
      "words": [
        {
          "text": "Exhibit 4.15",
          "bbox": [
            2798.0,
            283.0,
            3029.0,
            325.0
          ],
          "confidence": 0.9998080730438232
        },
        {
          "text": "THE SYMBOL <****\" DENOTES PLACES WHERE PORTIONS OF THIS DOCUMENT HAVE BEEN OMITTED PURSUANT TO A REQUEST",
          "bbox": [
            304.0,
            338.0,
            3009.0,
            380.0
          ],
          "confidence": 0.983539879322052
        },
        {
          "text": "FOR CONFIDENTIAL TREATMENT. SUCH MATERIAL WILL BE FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE",
          "bbox": [
            399.0,
            398.0,
            2907.0,
            435.0
          ],
          "confidence": 0.9926196932792664
        },
        {
          "text": "COMIMISSION.",
          "bbox": [
            1503.0,
            455.0,
            1805.0,
            492.0
          ],
          "confidence": 0.9562864303588867
        },
        {
          "text": "PRODUCT MANUFACTURING AGREEMENT",
          "bbox": [
            1216.0,
            510.0,
            2093.0,
            546.0
          ],
          "confidence": 0.994750440120697
        },
        {
          "text": "This Product Manufacturing Agreement (\"Agreement') is made as of the Effective Date by and between DEXCEL LTD., with its registered address.",
          "bbox": [
            275.0,
            563.0,
            3023.0,
            609.0
          ],
          "confidence": 0.989086925983429
        },
        {
          "text": "at ****, Israel (\"Dexcel'') and KITOV Pharma Ltd., with its registered office at 132 Menachem Begin Road, Azrieli Center, Tel Aviv, 6701101, Israel.",
          "bbox": [
            274.0,
            618.0,
            3000.0,
            665.0
          ],
          "confidence": 0.9887864589691162
        },
        {
          "text": "(\"Kitov'). Dexcel and Kitov are hereinafter jointly the \"Parties' and individually a \"Party.\".",
          "bbox": [
            279.0,
            678.0,
            1945.0,
            722.0
          ],
          "confidence": 0.98404461145401
        },
        {
          "text": "WHEREAS: Dexcel is a pharmaceutical company engaged in various activities including, but not limited to, the research, development,",
          "bbox": [
            275.0,
            729.0,
            2817.0,
            780.0
          ],
          "confidence": 0.9837751388549805
        },
        {
          "text": "manufacture, and marketing of various drugs and pharmaceutical specialties in various dosage forms;",
          "bbox": [
            549.0,
            795.0,
            2438.0,
            831.0
          ],
          "confidence": 0.9977880120277405
        },
        {
          "text": "WHEREAS:",
          "bbox": [
            281.0,
            848.0,
            515.0,
            884.0
          ],
          "confidence": 0.9993464946746826
        },
        {
          "text": "Kitov is a pharmaceutical company engaged in various activities including, but not limited to, the development of pharmaceutical",
          "bbox": [
            546.0,
            844.0,
            2951.0,
            890.0
          ],
          "confidence": 0.9910856485366821
        },
        {
          "text": "products;",
          "bbox": [
            551.0,
            906.0,
            732.0,
            945.0
          ],
          "confidence": 0.9994080066680908
        },
        {
          "text": "WHEREAS:",
          "bbox": [
            279.0,
            959.0,
            513.0,
            996.0
          ],
          "confidence": 0.9993117451667786
        },
        {
          "text": "Kitov and Dexcel entered into a Development Services Agreement on April 1, 2014 (\"Development Agreement'), pursuant to which",
          "bbox": [
            549.0,
            958.0,
            2991.0,
            1000.0
          ],
          "confidence": 0.9946937561035156
        },
        {
          "text": "Dexcel performed certain development services for Kitov with respect to the Product;",
          "bbox": [
            551.0,
            1016.0,
            2139.0,
            1058.0
          ],
          "confidence": 0.9957237243652344
        },
        {
          "text": "WHEREAS:",
          "bbox": [
            281.0,
            1071.0,
            515.0,
            1107.0
          ],
          "confidence": 0.9993150234222412
        },
        {
          "text": "Kitov desires that Dexcel manufacture and package the Product for Kitov in accordance with the terms of this Agreement, and Dexcel",
          "bbox": [
            546.0,
            1069.0,
            3029.0,
            1115.0
          ],
          "confidence": 0.9908015131950378
        },
        {
          "text": "is willing to manufacture and package the Product for Kitov in accordance with the terms of this Agreement..",
          "bbox": [
            547.0,
            1126.0,
            2561.0,
            1171.0
          ],
          "confidence": 0.9924741387367249
        },
        {
          "text": "NOw, THEREFORE, in consideration of the mutual covenants herein contained, the Parties, intending to be legally bound, hereby agree as",
          "bbox": [
            275.0,
            1180.0,
            2876.0,
            1228.0
          ],
          "confidence": 0.9950727820396423
        },
        {
          "text": "follows:",
          "bbox": [
            275.0,
            1237.0,
            426.0,
            1279.0
          ],
          "confidence": 0.9998461008071899
        },
        {
          "text": "1",
          "bbox": [
            277.0,
            1299.0,
            303.0,
            1330.0
          ],
          "confidence": 0.9999181032180786
        },
        {
          "text": "Definitions",
          "bbox": [
            368.0,
            1296.0,
            589.0,
            1334.0
          ],
          "confidence": 0.999856173992157
        },
        {
          "text": "For the purpose of this Agreement, the terms set forth in this clause, whether used in singular or plural form, shall mean, unless otherwise expressly.",
          "bbox": [
            277.0,
            1352.0,
            3012.0,
            1394.0
          ],
          "confidence": 0.9917291402816772
        },
        {
          "text": "provided for in this Agreement or the context otherwise requires, the following:.",
          "bbox": [
            277.0,
            1405.0,
            1749.0,
            1453.0
          ],
          "confidence": 0.9938557744026184
        },
        {
          "text": "1.1",
          "bbox": [
            379.0,
            1460.0,
            439.0,
            1506.0
          ],
          "confidence": 0.9998831748962402
        },
        {
          "text": "\"Affiliate\"' of a Party shall mean any corporation or other business entity directly or indirectly Controlled by, under common Control.",
          "bbox": [
            546.0,
            1458.0,
            3012.0,
            1509.0
          ],
          "confidence": 0.9893513917922974
        },
        {
          "text": "with, or in the Control of such Party..",
          "bbox": [
            551.0,
            1518.0,
            1222.0,
            1564.0
          ],
          "confidence": 0.9819372296333313
        },
        {
          "text": "1.2",
          "bbox": [
            377.0,
            1573.0,
            440.0,
            1619.0
          ],
          "confidence": 0.9997513890266418
        },
        {
          "text": "\"Anti-Corruption and Anti-Bribery Laws\" shall mean the United States Foreign Corrupt Practices Act of 1977, as amended, the",
          "bbox": [
            549.0,
            1577.0,
            2925.0,
            1619.0
          ],
          "confidence": 0.9937560558319092
        },
        {
          "text": "Bribery Act 2010 (2010 Chapter 23) of the Parliament of the United Kingdom, any rules or regulations under such acts, and any other",
          "bbox": [
            551.0,
            1634.0,
            3011.0,
            1676.0
          ],
          "confidence": 0.9908789992332458
        },
        {
          "text": "anti-corruption or anti-bribery statutes, laws or regulations applicable to a Party..",
          "bbox": [
            547.0,
            1687.0,
            2039.0,
            1732.0
          ],
          "confidence": 0.9931536316871643
        },
        {
          "text": "1.3",
          "bbox": [
            379.0,
            1741.0,
            440.0,
            1787.0
          ],
          "confidence": 0.9998380541801453
        },
        {
          "text": "\"API\"' shall mean the active pharmaceutical ingredients Celecoxib and Amlodipine Besylate..",
          "bbox": [
            549.0,
            1741.0,
            2277.0,
            1787.0
          ],
          "confidence": 0.9627962112426758
        },
        {
          "text": "Source: KITOV PHARMA LTD., 20-F, 3/26/2019",
          "bbox": [
            332.0,
            4437.0,
            1256.0,
            4479.0
          ],
          "confidence": 0.988348126411438
        }
      ],
      "multi_page": true,
      "part_of": 2,
      "nearby_headers": [
        {
          "text": "THE SYMBOL <****\" DENOTES PLACES WHERE PORTIONS OF THIS DOCUMENT HAVE BEEN OMITTED PURSUANT TO A REQUEST",
          "page": 0,
          "bbox": [
            304.0,
            338.0,
            3009.0,
            380.0
          ]
        },
        {
          "text": "FOR CONFIDENTIAL TREATMENT. SUCH MATERIAL WILL BE FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE",
          "page": 0,
          "bbox": [
            399.0,
            398.0,
            2907.0,
            435.0
          ]
        },
        {
          "text": "COMIMISSION.",
          "page": 0,
          "bbox": [
            1503.0,
            455.0,
            1805.0,
            492.0
          ]
        },
        {
          "text": "PRODUCT MANUFACTURING AGREEMENT",
          "page": 0,
          "bbox": [
            1216.0,
            510.0,
            2093.0,
            546.0
          ]
        },
        {
          "text": "WHEREAS:",
          "page": 0,
          "bbox": [
            281.0,
            848.0,
            515.0,
            884.0
          ]
        },
        {
          "text": "WHEREAS:",
          "page": 0,
          "bbox": [
            279.0,
            959.0,
            513.0,
            996.0
          ]
        },
        {
          "text": "WHEREAS:",
          "page": 0,
          "bbox": [
            281.0,
            1071.0,
            515.0,
            1107.0
          ]
        }
      ]
    },
    {
      "id": "KitovPharmaLtd_20190326_20-F_EX-4.15_11584449_EX-4.15_Manufacturing Agreement__Volume Restriction_1_multi",
      "question": "Highlight the parts (if any) of this contract related to \"Volume Restriction\" that should be reviewed by a lawyer. Details: Is there a fee increase or consent requirement, etc. if one party’s use of the product/services exceeds certain threshold?",
      "answer_text": "Dexcel shall order the Packaging materials required for the Product Packaging (including, but not limited to, all Labeling); provided that such orders shall not exceed the forecasted demand of such materials for the next following twelve (12) months",
      "page_number": 1,
      "words": [
        {
          "text": "1.4",
          "bbox": [
            379.0,
            281.0,
            442.0,
            327.0
          ],
          "confidence": 0.9997868537902832
        },
        {
          "text": "\"Batch' shall mean the defined quantity of the Product processed in a single process or series of processes in a manner designed to.",
          "bbox": [
            549.0,
            281.0,
            3011.0,
            329.0
          ],
          "confidence": 0.9841217398643494
        },
        {
          "text": "be homogeneous. The Batch size for the Product is **** tablets.",
          "bbox": [
            551.0,
            338.0,
            1756.0,
            382.0
          ],
          "confidence": 0.9994081258773804
        },
        {
          "text": "1.5",
          "bbox": [
            376.0,
            390.0,
            443.0,
            443.0
          ],
          "confidence": 0.9997324347496033
        },
        {
          "text": "\"cGMPs\" or \"Good Manufacturing Practice\"' shall mean the part of quality assurance which ensures that the Product is consistently.",
          "bbox": [
            549.0,
            395.0,
            3023.0,
            440.0
          ],
          "confidence": 0.985264241695404
        },
        {
          "text": "produced and controlled to the quality standards appropriate to their intended use, the principles and guidelines of which are",
          "bbox": [
            549.0,
            451.0,
            2884.0,
            499.0
          ],
          "confidence": 0.9912954568862915
        },
        {
          "text": "specified in European Commission Directive 2003/94/EC and the FDA's current Good Manufacturing Practices, particularly 21 CFR ",
          "bbox": [
            547.0,
            506.0,
            3003.0,
            557.0
          ],
          "confidence": 0.995246410369873
        },
        {
          "text": "210 et seq., and 21 CFR $$ 600-610, as both may be amended from time to time..",
          "bbox": [
            549.0,
            565.0,
            2006.0,
            607.0
          ],
          "confidence": 0.9747835993766785
        },
        {
          "text": "1.6",
          "bbox": [
            379.0,
            619.0,
            442.0,
            663.0
          ],
          "confidence": 0.9999213218688965
        },
        {
          "text": "\"Change of Control' shall mean (i) any change, sale, merger, reorganization, or any other event or action that results in a third party,",
          "bbox": [
            547.0,
            618.0,
            3005.0,
            669.0
          ],
          "confidence": 0.9930126070976257
        },
        {
          "text": "which is a material competitor to the other Party to this agreement, acquiring: (a) all or substantially all of the business or assets of a.",
          "bbox": [
            551.0,
            678.0,
            3002.0,
            722.0
          ],
          "confidence": 0.9852778911590576
        },
        {
          "text": "Party relating to this Agreement, (b) Control, directly or indirectly, of such Party (and/or any corporate entity that Controls, directly.",
          "bbox": [
            551.0,
            735.0,
            2985.0,
            778.0
          ],
          "confidence": 0.9932605624198914
        },
        {
          "text": "or indirectly, such Party), or (ii) any assignment or delegation of, sale or transfer of a Party's rights and obligations under this",
          "bbox": [
            549.0,
            789.0,
            2878.0,
            835.0
          ],
          "confidence": 0.9923490881919861
        },
        {
          "text": "Agreement (or any part hereof) to a third party.",
          "bbox": [
            555.0,
            848.0,
            1426.0,
            890.0
          ],
          "confidence": 0.9961597323417664
        },
        {
          "text": "Notwithstanding anything in the immediately preceding paragraph to the contrary, where the Party in question is Dexcel, any of the",
          "bbox": [
            549.0,
            903.0,
            2991.0,
            945.0
          ],
          "confidence": 0.9957303404808044
        },
        {
          "text": "foregoing events or actions shall not be considered a Change of Control where any one or more of the relevant third party or parties.",
          "bbox": [
            551.0,
            961.0,
            3007.0,
            1003.0
          ],
          "confidence": 0.9899225234985352
        },
        {
          "text": "referred to in clause (i) above is (A) a Family Member, or (B) any entity Controlled by Mr. **** and/or a Family Member.",
          "bbox": [
            544.0,
            1005.0,
            2788.0,
            1064.0
          ],
          "confidence": 0.9933032989501953
        },
        {
          "text": "1.7",
          "bbox": [
            379.0,
            1067.0,
            442.0,
            1113.0
          ],
          "confidence": 0.9998312592506409
        },
        {
          "text": "\"Claims' shall mean any demands, claims, actions, causes of action, assessments, losses, damages, injuries, liabilities, costs and.",
          "bbox": [
            549.0,
            1069.0,
            2953.0,
            1115.0
          ],
          "confidence": 0.9854910969734192
        },
        {
          "text": "expenses (including, without limitation, reasonable attorneys' fees and expenses) filed, raised, initiated or made by any governmental.",
          "bbox": [
            553.0,
            1129.0,
            3021.0,
            1171.0
          ],
          "confidence": 0.992518424987793
        },
        {
          "text": "authority and/or third party.",
          "bbox": [
            551.0,
            1184.0,
            1066.0,
            1226.0
          ],
          "confidence": 0.983346164226532
        },
        {
          "text": "1.8",
          "bbox": [
            379.0,
            1235.0,
            442.0,
            1281.0
          ],
          "confidence": 0.9999089241027832
        },
        {
          "text": "\"Confidential Information\"' shall have the meaning set forth in Section 7.1.",
          "bbox": [
            549.0,
            1235.0,
            1939.0,
            1281.0
          ],
          "confidence": 0.9719286561012268
        },
        {
          "text": "1.9",
          "bbox": [
            379.0,
            1292.0,
            440.0,
            1336.0
          ],
          "confidence": 0.9999080300331116
        },
        {
          "text": "\"Confirmed Order' shall have the meaning set forth in Section 3.3.2.",
          "bbox": [
            549.0,
            1292.0,
            1834.0,
            1338.0
          ],
          "confidence": 0.9867768883705139
        },
        {
          "text": "1.10",
          "bbox": [
            379.0,
            1347.0,
            462.0,
            1394.0
          ],
          "confidence": 0.9999012351036072
        },
        {
          "text": "\"Control' or \"Controlled' shall mean possession of more than fifty percent (50%) of the share capital of a corporation or other",
          "bbox": [
            547.0,
            1345.0,
            2915.0,
            1398.0
          ],
          "confidence": 0.981292724609375
        },
        {
          "text": "business entity, and/or the power to direct or cause the direction of the management and policies of a corporation or other entity",
          "bbox": [
            549.0,
            1405.0,
            2936.0,
            1451.0
          ],
          "confidence": 0.9941077828407288
        },
        {
          "text": "whether through the ownership of voting securities, by contract or otherwise..",
          "bbox": [
            553.0,
            1467.0,
            1996.0,
            1504.0
          ],
          "confidence": 0.9934757947921753
        },
        {
          "text": "1.11",
          "bbox": [
            379.0,
            1517.0,
            455.0,
            1561.0
          ],
          "confidence": 0.999779224395752
        },
        {
          "text": "\"Delivery' shall mean the time when the Product is placed at the disposal of Kitov at Dexcel's Facility based on an ****",
          "bbox": [
            546.0,
            1508.0,
            2799.0,
            1568.0
          ],
          "confidence": 0.992178738117218
        },
        {
          "text": "(Incoterms 2010).",
          "bbox": [
            555.0,
            1579.0,
            904.0,
            1617.0
          ],
          "confidence": 0.99842768907547
        },
        {
          "text": "1.12",
          "bbox": [
            377.0,
            1626.0,
            462.0,
            1674.0
          ],
          "confidence": 0.9999103546142578
        },
        {
          "text": "\"Distributors\" shall mean any Person under contract with Kitov or any of its Affiliates for the distribution of the Product in a certain",
          "bbox": [
            553.0,
            1634.0,
            3018.0,
            1670.0
          ],
          "confidence": 0.9918192625045776
        },
        {
          "text": "territory or territories..",
          "bbox": [
            551.0,
            1692.0,
            946.0,
            1729.0
          ],
          "confidence": 0.9840478301048279
        },
        {
          "text": "1.13",
          "bbox": [
            381.0,
            1741.0,
            459.0,
            1785.0
          ],
          "confidence": 0.8832098245620728
        },
        {
          "text": "\"Effective Date' shall mean the date of signature of the last Party to execute this Agreement..",
          "bbox": [
            549.0,
            1741.0,
            2267.0,
            1787.0
          ],
          "confidence": 0.9844200611114502
        },
        {
          "text": "1.14",
          "bbox": [
            379.0,
            1798.0,
            460.0,
            1840.0
          ],
          "confidence": 0.9994210004806519
        },
        {
          "text": "\"EMA\" means the European Medicines Agency or any successor entity.",
          "bbox": [
            549.0,
            1798.0,
            1898.0,
            1846.0
          ],
          "confidence": 0.9979910254478455
        },
        {
          "text": "1.15",
          "bbox": [
            379.0,
            1851.0,
            460.0,
            1900.0
          ],
          "confidence": 0.9995757341384888
        },
        {
          "text": "\"Family Member\" shall mean ****.",
          "bbox": [
            547.0,
            1847.0,
            1222.0,
            1902.0
          ],
          "confidence": 0.9885128736495972
        },
        {
          "text": "1.16",
          "bbox": [
            379.0,
            1908.0,
            462.0,
            1955.0
          ],
          "confidence": 0.9999197125434875
        },
        {
          "text": "\"FDA\" means the U.S. Food and Drug Administration or any successor entity..",
          "bbox": [
            549.0,
            1911.0,
            2005.0,
            1953.0
          ],
          "confidence": 0.986582338809967
        },
        {
          "text": "2",
          "bbox": [
            1638.0,
            2025.0,
            1669.0,
            2061.0
          ],
          "confidence": 0.999761164188385
        },
        {
          "text": "Source: KITOV PHARMA LTD., 20-F, 3/26/2019",
          "bbox": [
            332.0,
            4437.0,
            1256.0,
            4479.0
          ],
          "confidence": 0.989766538143158
        }
      ],
      "multi_page": true,
      "part_of": 2
    },
    {
      "id": "KitovPharmaLtd_20190326_20-F_EX-4.15_11584449_EX-4.15_Manufacturing Agreement__Joint Ip Ownership_0_multi",
      "question": "Highlight the parts (if any) of this contract related to \"Joint Ip Ownership\" that should be reviewed by a lawyer. Details: Is there any clause providing for joint or shared ownership of intellectual property between the parties to the contract?",
      "answer_text": "Subject to the provisions of sections 8.1 and 8.2 above and without derogating therefrom, any and all rights, title and interest in any Intellectual Property Rights resulting from any development made by Dexcel which is related to the Product and embodied in the Deliverables or conceived in connection with the services provided hereunder by Dexcel to Kitov, which is only applicable for the manufacture, research, development, making of, use, sale, production, commercialisation and distribution of the Product, shall be jointly and equally (50%/50%) owned by Dexcel and Kitov (the \"Joint. IP\").",
      "page_number": 0,
      "words": [
        {
          "text": "Exhibit 4.15",
          "bbox": [
            2798.0,
            283.0,
            3029.0,
            325.0
          ],
          "confidence": 0.9998080730438232
        },
        {
          "text": "THE SYMBOL <****\" DENOTES PLACES WHERE PORTIONS OF THIS DOCUMENT HAVE BEEN OMITTED PURSUANT TO A REQUEST",
          "bbox": [
            304.0,
            338.0,
            3009.0,
            380.0
          ],
          "confidence": 0.983539879322052
        },
        {
          "text": "FOR CONFIDENTIAL TREATMENT. SUCH MATERIAL WILL BE FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE",
          "bbox": [
            399.0,
            398.0,
            2907.0,
            435.0
          ],
          "confidence": 0.9926196932792664
        },
        {
          "text": "COMIMISSION.",
          "bbox": [
            1503.0,
            455.0,
            1805.0,
            492.0
          ],
          "confidence": 0.9562864303588867
        },
        {
          "text": "PRODUCT MANUFACTURING AGREEMENT",
          "bbox": [
            1216.0,
            510.0,
            2093.0,
            546.0
          ],
          "confidence": 0.994750440120697
        },
        {
          "text": "This Product Manufacturing Agreement (\"Agreement') is made as of the Effective Date by and between DEXCEL LTD., with its registered address.",
          "bbox": [
            275.0,
            563.0,
            3023.0,
            609.0
          ],
          "confidence": 0.989086925983429
        },
        {
          "text": "at ****, Israel (\"Dexcel'') and KITOV Pharma Ltd., with its registered office at 132 Menachem Begin Road, Azrieli Center, Tel Aviv, 6701101, Israel.",
          "bbox": [
            274.0,
            618.0,
            3000.0,
            665.0
          ],
          "confidence": 0.9887864589691162
        },
        {
          "text": "(\"Kitov'). Dexcel and Kitov are hereinafter jointly the \"Parties' and individually a \"Party.\".",
          "bbox": [
            279.0,
            678.0,
            1945.0,
            722.0
          ],
          "confidence": 0.98404461145401
        },
        {
          "text": "WHEREAS: Dexcel is a pharmaceutical company engaged in various activities including, but not limited to, the research, development,",
          "bbox": [
            275.0,
            729.0,
            2817.0,
            780.0
          ],
          "confidence": 0.9837751388549805
        },
        {
          "text": "manufacture, and marketing of various drugs and pharmaceutical specialties in various dosage forms;",
          "bbox": [
            549.0,
            795.0,
            2438.0,
            831.0
          ],
          "confidence": 0.9977880120277405
        },
        {
          "text": "WHEREAS:",
          "bbox": [
            281.0,
            848.0,
            515.0,
            884.0
          ],
          "confidence": 0.9993464946746826
        },
        {
          "text": "Kitov is a pharmaceutical company engaged in various activities including, but not limited to, the development of pharmaceutical",
          "bbox": [
            546.0,
            844.0,
            2951.0,
            890.0
          ],
          "confidence": 0.9910856485366821
        },
        {
          "text": "products;",
          "bbox": [
            551.0,
            906.0,
            732.0,
            945.0
          ],
          "confidence": 0.9994080066680908
        },
        {
          "text": "WHEREAS:",
          "bbox": [
            279.0,
            959.0,
            513.0,
            996.0
          ],
          "confidence": 0.9993117451667786
        },
        {
          "text": "Kitov and Dexcel entered into a Development Services Agreement on April 1, 2014 (\"Development Agreement'), pursuant to which",
          "bbox": [
            549.0,
            958.0,
            2991.0,
            1000.0
          ],
          "confidence": 0.9946937561035156
        },
        {
          "text": "Dexcel performed certain development services for Kitov with respect to the Product;",
          "bbox": [
            551.0,
            1016.0,
            2139.0,
            1058.0
          ],
          "confidence": 0.9957237243652344
        },
        {
          "text": "WHEREAS:",
          "bbox": [
            281.0,
            1071.0,
            515.0,
            1107.0
          ],
          "confidence": 0.9993150234222412
        },
        {
          "text": "Kitov desires that Dexcel manufacture and package the Product for Kitov in accordance with the terms of this Agreement, and Dexcel",
          "bbox": [
            546.0,
            1069.0,
            3029.0,
            1115.0
          ],
          "confidence": 0.9908015131950378
        },
        {
          "text": "is willing to manufacture and package the Product for Kitov in accordance with the terms of this Agreement..",
          "bbox": [
            547.0,
            1126.0,
            2561.0,
            1171.0
          ],
          "confidence": 0.9924741387367249
        },
        {
          "text": "NOw, THEREFORE, in consideration of the mutual covenants herein contained, the Parties, intending to be legally bound, hereby agree as",
          "bbox": [
            275.0,
            1180.0,
            2876.0,
            1228.0
          ],
          "confidence": 0.9950727820396423
        },
        {
          "text": "follows:",
          "bbox": [
            275.0,
            1237.0,
            426.0,
            1279.0
          ],
          "confidence": 0.9998461008071899
        },
        {
          "text": "1",
          "bbox": [
            277.0,
            1299.0,
            303.0,
            1330.0
          ],
          "confidence": 0.9999181032180786
        },
        {
          "text": "Definitions",
          "bbox": [
            368.0,
            1296.0,
            589.0,
            1334.0
          ],
          "confidence": 0.999856173992157
        },
        {
          "text": "For the purpose of this Agreement, the terms set forth in this clause, whether used in singular or plural form, shall mean, unless otherwise expressly.",
          "bbox": [
            277.0,
            1352.0,
            3012.0,
            1394.0
          ],
          "confidence": 0.9917291402816772
        },
        {
          "text": "provided for in this Agreement or the context otherwise requires, the following:.",
          "bbox": [
            277.0,
            1405.0,
            1749.0,
            1453.0
          ],
          "confidence": 0.9938557744026184
        },
        {
          "text": "1.1",
          "bbox": [
            379.0,
            1460.0,
            439.0,
            1506.0
          ],
          "confidence": 0.9998831748962402
        },
        {
          "text": "\"Affiliate\"' of a Party shall mean any corporation or other business entity directly or indirectly Controlled by, under common Control.",
          "bbox": [
            546.0,
            1458.0,
            3012.0,
            1509.0
          ],
          "confidence": 0.9893513917922974
        },
        {
          "text": "with, or in the Control of such Party..",
          "bbox": [
            551.0,
            1518.0,
            1222.0,
            1564.0
          ],
          "confidence": 0.9819372296333313
        },
        {
          "text": "1.2",
          "bbox": [
            377.0,
            1573.0,
            440.0,
            1619.0
          ],
          "confidence": 0.9997513890266418
        },
        {
          "text": "\"Anti-Corruption and Anti-Bribery Laws\" shall mean the United States Foreign Corrupt Practices Act of 1977, as amended, the",
          "bbox": [
            549.0,
            1577.0,
            2925.0,
            1619.0
          ],
          "confidence": 0.9937560558319092
        },
        {
          "text": "Bribery Act 2010 (2010 Chapter 23) of the Parliament of the United Kingdom, any rules or regulations under such acts, and any other",
          "bbox": [
            551.0,
            1634.0,
            3011.0,
            1676.0
          ],
          "confidence": 0.9908789992332458
        },
        {
          "text": "anti-corruption or anti-bribery statutes, laws or regulations applicable to a Party..",
          "bbox": [
            547.0,
            1687.0,
            2039.0,
            1732.0
          ],
          "confidence": 0.9931536316871643
        },
        {
          "text": "1.3",
          "bbox": [
            379.0,
            1741.0,
            440.0,
            1787.0
          ],
          "confidence": 0.9998380541801453
        },
        {
          "text": "\"API\"' shall mean the active pharmaceutical ingredients Celecoxib and Amlodipine Besylate..",
          "bbox": [
            549.0,
            1741.0,
            2277.0,
            1787.0
          ],
          "confidence": 0.9627962112426758
        },
        {
          "text": "Source: KITOV PHARMA LTD., 20-F, 3/26/2019",
          "bbox": [
            332.0,
            4437.0,
            1256.0,
            4479.0
          ],
          "confidence": 0.988348126411438
        }
      ],
      "multi_page": true,
      "part_of": 2,
      "nearby_headers": [
        {
          "text": "THE SYMBOL <****\" DENOTES PLACES WHERE PORTIONS OF THIS DOCUMENT HAVE BEEN OMITTED PURSUANT TO A REQUEST",
          "page": 0,
          "bbox": [
            304.0,
            338.0,
            3009.0,
            380.0
          ]
        },
        {
          "text": "FOR CONFIDENTIAL TREATMENT. SUCH MATERIAL WILL BE FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE",
          "page": 0,
          "bbox": [
            399.0,
            398.0,
            2907.0,
            435.0
          ]
        },
        {
          "text": "COMIMISSION.",
          "page": 0,
          "bbox": [
            1503.0,
            455.0,
            1805.0,
            492.0
          ]
        },
        {
          "text": "PRODUCT MANUFACTURING AGREEMENT",
          "page": 0,
          "bbox": [
            1216.0,
            510.0,
            2093.0,
            546.0
          ]
        },
        {
          "text": "WHEREAS:",
          "page": 0,
          "bbox": [
            281.0,
            848.0,
            515.0,
            884.0
          ]
        },
        {
          "text": "WHEREAS:",
          "page": 0,
          "bbox": [
            279.0,
            959.0,
            513.0,
            996.0
          ]
        },
        {
          "text": "WHEREAS:",
          "page": 0,
          "bbox": [
            281.0,
            1071.0,
            515.0,
            1107.0
          ]
        }
      ]
    },
    {
      "id": "KitovPharmaLtd_20190326_20-F_EX-4.15_11584449_EX-4.15_Manufacturing Agreement__Joint Ip Ownership_1_multi",
      "question": "Highlight the parts (if any) of this contract related to \"Joint Ip Ownership\" that should be reviewed by a lawyer. Details: Is there any clause providing for joint or shared ownership of intellectual property between the parties to the contract?",
      "answer_text": "Subject to the provisions of sections 8.1 and 8.2 above and without derogating therefrom, any and all rights, title and interest in any Intellectual Property Rights resulting from any development made by Dexcel which is related to the Product and embodied in the Deliverables or conceived in connection with the services provided hereunder by Dexcel to Kitov, which is only applicable for the manufacture, research, development, making of, use, sale, production, commercialisation and distribution of the Product, shall be jointly and equally (50%/50%) owned by Dexcel and Kitov (the \"Joint. IP\").",
      "page_number": 1,
      "words": [
        {
          "text": "1.4",
          "bbox": [
            379.0,
            281.0,
            442.0,
            327.0
          ],
          "confidence": 0.9997868537902832
        },
        {
          "text": "\"Batch' shall mean the defined quantity of the Product processed in a single process or series of processes in a manner designed to.",
          "bbox": [
            549.0,
            281.0,
            3011.0,
            329.0
          ],
          "confidence": 0.9841217398643494
        },
        {
          "text": "be homogeneous. The Batch size for the Product is **** tablets.",
          "bbox": [
            551.0,
            338.0,
            1756.0,
            382.0
          ],
          "confidence": 0.9994081258773804
        },
        {
          "text": "1.5",
          "bbox": [
            376.0,
            390.0,
            443.0,
            443.0
          ],
          "confidence": 0.9997324347496033
        },
        {
          "text": "\"cGMPs\" or \"Good Manufacturing Practice\"' shall mean the part of quality assurance which ensures that the Product is consistently.",
          "bbox": [
            549.0,
            395.0,
            3023.0,
            440.0
          ],
          "confidence": 0.985264241695404
        },
        {
          "text": "produced and controlled to the quality standards appropriate to their intended use, the principles and guidelines of which are",
          "bbox": [
            549.0,
            451.0,
            2884.0,
            499.0
          ],
          "confidence": 0.9912954568862915
        },
        {
          "text": "specified in European Commission Directive 2003/94/EC and the FDA's current Good Manufacturing Practices, particularly 21 CFR ",
          "bbox": [
            547.0,
            506.0,
            3003.0,
            557.0
          ],
          "confidence": 0.995246410369873
        },
        {
          "text": "210 et seq., and 21 CFR $$ 600-610, as both may be amended from time to time..",
          "bbox": [
            549.0,
            565.0,
            2006.0,
            607.0
          ],
          "confidence": 0.9747835993766785
        },
        {
          "text": "1.6",
          "bbox": [
            379.0,
            619.0,
            442.0,
            663.0
          ],
          "confidence": 0.9999213218688965
        },
        {
          "text": "\"Change of Control' shall mean (i) any change, sale, merger, reorganization, or any other event or action that results in a third party,",
          "bbox": [
            547.0,
            618.0,
            3005.0,
            669.0
          ],
          "confidence": 0.9930126070976257
        },
        {
          "text": "which is a material competitor to the other Party to this agreement, acquiring: (a) all or substantially all of the business or assets of a.",
          "bbox": [
            551.0,
            678.0,
            3002.0,
            722.0
          ],
          "confidence": 0.9852778911590576
        },
        {
          "text": "Party relating to this Agreement, (b) Control, directly or indirectly, of such Party (and/or any corporate entity that Controls, directly.",
          "bbox": [
            551.0,
            735.0,
            2985.0,
            778.0
          ],
          "confidence": 0.9932605624198914
        },
        {
          "text": "or indirectly, such Party), or (ii) any assignment or delegation of, sale or transfer of a Party's rights and obligations under this",
          "bbox": [
            549.0,
            789.0,
            2878.0,
            835.0
          ],
          "confidence": 0.9923490881919861
        },
        {
          "text": "Agreement (or any part hereof) to a third party.",
          "bbox": [
            555.0,
            848.0,
            1426.0,
            890.0
          ],
          "confidence": 0.9961597323417664
        },
        {
          "text": "Notwithstanding anything in the immediately preceding paragraph to the contrary, where the Party in question is Dexcel, any of the",
          "bbox": [
            549.0,
            903.0,
            2991.0,
            945.0
          ],
          "confidence": 0.9957303404808044
        },
        {
          "text": "foregoing events or actions shall not be considered a Change of Control where any one or more of the relevant third party or parties.",
          "bbox": [
            551.0,
            961.0,
            3007.0,
            1003.0
          ],
          "confidence": 0.9899225234985352
        },
        {
          "text": "referred to in clause (i) above is (A) a Family Member, or (B) any entity Controlled by Mr. **** and/or a Family Member.",
          "bbox": [
            544.0,
            1005.0,
            2788.0,
            1064.0
          ],
          "confidence": 0.9933032989501953
        },
        {
          "text": "1.7",
          "bbox": [
            379.0,
            1067.0,
            442.0,
            1113.0
          ],
          "confidence": 0.9998312592506409
        },
        {
          "text": "\"Claims' shall mean any demands, claims, actions, causes of action, assessments, losses, damages, injuries, liabilities, costs and.",
          "bbox": [
            549.0,
            1069.0,
            2953.0,
            1115.0
          ],
          "confidence": 0.9854910969734192
        },
        {
          "text": "expenses (including, without limitation, reasonable attorneys' fees and expenses) filed, raised, initiated or made by any governmental.",
          "bbox": [
            553.0,
            1129.0,
            3021.0,
            1171.0
          ],
          "confidence": 0.992518424987793
        },
        {
          "text": "authority and/or third party.",
          "bbox": [
            551.0,
            1184.0,
            1066.0,
            1226.0
          ],
          "confidence": 0.983346164226532
        },
        {
          "text": "1.8",
          "bbox": [
            379.0,
            1235.0,
            442.0,
            1281.0
          ],
          "confidence": 0.9999089241027832
        },
        {
          "text": "\"Confidential Information\"' shall have the meaning set forth in Section 7.1.",
          "bbox": [
            549.0,
            1235.0,
            1939.0,
            1281.0
          ],
          "confidence": 0.9719286561012268
        },
        {
          "text": "1.9",
          "bbox": [
            379.0,
            1292.0,
            440.0,
            1336.0
          ],
          "confidence": 0.9999080300331116
        },
        {
          "text": "\"Confirmed Order' shall have the meaning set forth in Section 3.3.2.",
          "bbox": [
            549.0,
            1292.0,
            1834.0,
            1338.0
          ],
          "confidence": 0.9867768883705139
        },
        {
          "text": "1.10",
          "bbox": [
            379.0,
            1347.0,
            462.0,
            1394.0
          ],
          "confidence": 0.9999012351036072
        },
        {
          "text": "\"Control' or \"Controlled' shall mean possession of more than fifty percent (50%) of the share capital of a corporation or other",
          "bbox": [
            547.0,
            1345.0,
            2915.0,
            1398.0
          ],
          "confidence": 0.981292724609375
        },
        {
          "text": "business entity, and/or the power to direct or cause the direction of the management and policies of a corporation or other entity",
          "bbox": [
            549.0,
            1405.0,
            2936.0,
            1451.0
          ],
          "confidence": 0.9941077828407288
        },
        {
          "text": "whether through the ownership of voting securities, by contract or otherwise..",
          "bbox": [
            553.0,
            1467.0,
            1996.0,
            1504.0
          ],
          "confidence": 0.9934757947921753
        },
        {
          "text": "1.11",
          "bbox": [
            379.0,
            1517.0,
            455.0,
            1561.0
          ],
          "confidence": 0.999779224395752
        },
        {
          "text": "\"Delivery' shall mean the time when the Product is placed at the disposal of Kitov at Dexcel's Facility based on an ****",
          "bbox": [
            546.0,
            1508.0,
            2799.0,
            1568.0
          ],
          "confidence": 0.992178738117218
        },
        {
          "text": "(Incoterms 2010).",
          "bbox": [
            555.0,
            1579.0,
            904.0,
            1617.0
          ],
          "confidence": 0.99842768907547
        },
        {
          "text": "1.12",
          "bbox": [
            377.0,
            1626.0,
            462.0,
            1674.0
          ],
          "confidence": 0.9999103546142578
        },
        {
          "text": "\"Distributors\" shall mean any Person under contract with Kitov or any of its Affiliates for the distribution of the Product in a certain",
          "bbox": [
            553.0,
            1634.0,
            3018.0,
            1670.0
          ],
          "confidence": 0.9918192625045776
        },
        {
          "text": "territory or territories..",
          "bbox": [
            551.0,
            1692.0,
            946.0,
            1729.0
          ],
          "confidence": 0.9840478301048279
        },
        {
          "text": "1.13",
          "bbox": [
            381.0,
            1741.0,
            459.0,
            1785.0
          ],
          "confidence": 0.8832098245620728
        },
        {
          "text": "\"Effective Date' shall mean the date of signature of the last Party to execute this Agreement..",
          "bbox": [
            549.0,
            1741.0,
            2267.0,
            1787.0
          ],
          "confidence": 0.9844200611114502
        },
        {
          "text": "1.14",
          "bbox": [
            379.0,
            1798.0,
            460.0,
            1840.0
          ],
          "confidence": 0.9994210004806519
        },
        {
          "text": "\"EMA\" means the European Medicines Agency or any successor entity.",
          "bbox": [
            549.0,
            1798.0,
            1898.0,
            1846.0
          ],
          "confidence": 0.9979910254478455
        },
        {
          "text": "1.15",
          "bbox": [
            379.0,
            1851.0,
            460.0,
            1900.0
          ],
          "confidence": 0.9995757341384888
        },
        {
          "text": "\"Family Member\" shall mean ****.",
          "bbox": [
            547.0,
            1847.0,
            1222.0,
            1902.0
          ],
          "confidence": 0.9885128736495972
        },
        {
          "text": "1.16",
          "bbox": [
            379.0,
            1908.0,
            462.0,
            1955.0
          ],
          "confidence": 0.9999197125434875
        },
        {
          "text": "\"FDA\" means the U.S. Food and Drug Administration or any successor entity..",
          "bbox": [
            549.0,
            1911.0,
            2005.0,
            1953.0
          ],
          "confidence": 0.986582338809967
        },
        {
          "text": "2",
          "bbox": [
            1638.0,
            2025.0,
            1669.0,
            2061.0
          ],
          "confidence": 0.999761164188385
        },
        {
          "text": "Source: KITOV PHARMA LTD., 20-F, 3/26/2019",
          "bbox": [
            332.0,
            4437.0,
            1256.0,
            4479.0
          ],
          "confidence": 0.989766538143158
        }
      ],
      "multi_page": true,
      "part_of": 2
    },
    {
      "id": "KitovPharmaLtd_20190326_20-F_EX-4.15_11584449_EX-4.15_Manufacturing Agreement__License Grant_0",
      "question": "Highlight the parts (if any) of this contract related to \"License Grant\" that should be reviewed by a lawyer. Details: Does the contract contain a license granted by one party to its counterparty?",
      "answer_text": "Kitov hereby grants to Dexcel a fully paid, limited, non exclusive, license to use Kitov Data in as much as required for the provision of the Services by Dexcel.",
      "page_number": 0,
      "words": [
        {
          "text": "Exhibit 4.15",
          "bbox": [
            2798.0,
            283.0,
            3029.0,
            325.0
          ],
          "confidence": 0.9998080730438232
        },
        {
          "text": "THE SYMBOL <****\" DENOTES PLACES WHERE PORTIONS OF THIS DOCUMENT HAVE BEEN OMITTED PURSUANT TO A REQUEST",
          "bbox": [
            304.0,
            338.0,
            3009.0,
            380.0
          ],
          "confidence": 0.983539879322052
        },
        {
          "text": "FOR CONFIDENTIAL TREATMENT. SUCH MATERIAL WILL BE FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE",
          "bbox": [
            399.0,
            398.0,
            2907.0,
            435.0
          ],
          "confidence": 0.9926196932792664
        },
        {
          "text": "COMIMISSION.",
          "bbox": [
            1503.0,
            455.0,
            1805.0,
            492.0
          ],
          "confidence": 0.9562864303588867
        },
        {
          "text": "PRODUCT MANUFACTURING AGREEMENT",
          "bbox": [
            1216.0,
            510.0,
            2093.0,
            546.0
          ],
          "confidence": 0.994750440120697
        },
        {
          "text": "This Product Manufacturing Agreement (\"Agreement') is made as of the Effective Date by and between DEXCEL LTD., with its registered address.",
          "bbox": [
            275.0,
            563.0,
            3023.0,
            609.0
          ],
          "confidence": 0.989086925983429
        },
        {
          "text": "at ****, Israel (\"Dexcel'') and KITOV Pharma Ltd., with its registered office at 132 Menachem Begin Road, Azrieli Center, Tel Aviv, 6701101, Israel.",
          "bbox": [
            274.0,
            618.0,
            3000.0,
            665.0
          ],
          "confidence": 0.9887864589691162
        },
        {
          "text": "(\"Kitov'). Dexcel and Kitov are hereinafter jointly the \"Parties' and individually a \"Party.\".",
          "bbox": [
            279.0,
            678.0,
            1945.0,
            722.0
          ],
          "confidence": 0.98404461145401
        },
        {
          "text": "WHEREAS: Dexcel is a pharmaceutical company engaged in various activities including, but not limited to, the research, development,",
          "bbox": [
            275.0,
            729.0,
            2817.0,
            780.0
          ],
          "confidence": 0.9837751388549805
        },
        {
          "text": "manufacture, and marketing of various drugs and pharmaceutical specialties in various dosage forms;",
          "bbox": [
            549.0,
            795.0,
            2438.0,
            831.0
          ],
          "confidence": 0.9977880120277405
        },
        {
          "text": "WHEREAS:",
          "bbox": [
            281.0,
            848.0,
            515.0,
            884.0
          ],
          "confidence": 0.9993464946746826
        },
        {
          "text": "Kitov is a pharmaceutical company engaged in various activities including, but not limited to, the development of pharmaceutical",
          "bbox": [
            546.0,
            844.0,
            2951.0,
            890.0
          ],
          "confidence": 0.9910856485366821
        },
        {
          "text": "products;",
          "bbox": [
            551.0,
            906.0,
            732.0,
            945.0
          ],
          "confidence": 0.9994080066680908
        },
        {
          "text": "WHEREAS:",
          "bbox": [
            279.0,
            959.0,
            513.0,
            996.0
          ],
          "confidence": 0.9993117451667786
        },
        {
          "text": "Kitov and Dexcel entered into a Development Services Agreement on April 1, 2014 (\"Development Agreement'), pursuant to which",
          "bbox": [
            549.0,
            958.0,
            2991.0,
            1000.0
          ],
          "confidence": 0.9946937561035156
        },
        {
          "text": "Dexcel performed certain development services for Kitov with respect to the Product;",
          "bbox": [
            551.0,
            1016.0,
            2139.0,
            1058.0
          ],
          "confidence": 0.9957237243652344
        },
        {
          "text": "WHEREAS:",
          "bbox": [
            281.0,
            1071.0,
            515.0,
            1107.0
          ],
          "confidence": 0.9993150234222412
        },
        {
          "text": "Kitov desires that Dexcel manufacture and package the Product for Kitov in accordance with the terms of this Agreement, and Dexcel",
          "bbox": [
            546.0,
            1069.0,
            3029.0,
            1115.0
          ],
          "confidence": 0.9908015131950378
        },
        {
          "text": "is willing to manufacture and package the Product for Kitov in accordance with the terms of this Agreement..",
          "bbox": [
            547.0,
            1126.0,
            2561.0,
            1171.0
          ],
          "confidence": 0.9924741387367249
        },
        {
          "text": "NOw, THEREFORE, in consideration of the mutual covenants herein contained, the Parties, intending to be legally bound, hereby agree as",
          "bbox": [
            275.0,
            1180.0,
            2876.0,
            1228.0
          ],
          "confidence": 0.9950727820396423
        },
        {
          "text": "follows:",
          "bbox": [
            275.0,
            1237.0,
            426.0,
            1279.0
          ],
          "confidence": 0.9998461008071899
        },
        {
          "text": "1",
          "bbox": [
            277.0,
            1299.0,
            303.0,
            1330.0
          ],
          "confidence": 0.9999181032180786
        },
        {
          "text": "Definitions",
          "bbox": [
            368.0,
            1296.0,
            589.0,
            1334.0
          ],
          "confidence": 0.999856173992157
        },
        {
          "text": "For the purpose of this Agreement, the terms set forth in this clause, whether used in singular or plural form, shall mean, unless otherwise expressly.",
          "bbox": [
            277.0,
            1352.0,
            3012.0,
            1394.0
          ],
          "confidence": 0.9917291402816772
        },
        {
          "text": "provided for in this Agreement or the context otherwise requires, the following:.",
          "bbox": [
            277.0,
            1405.0,
            1749.0,
            1453.0
          ],
          "confidence": 0.9938557744026184
        },
        {
          "text": "1.1",
          "bbox": [
            379.0,
            1460.0,
            439.0,
            1506.0
          ],
          "confidence": 0.9998831748962402
        },
        {
          "text": "\"Affiliate\"' of a Party shall mean any corporation or other business entity directly or indirectly Controlled by, under common Control.",
          "bbox": [
            546.0,
            1458.0,
            3012.0,
            1509.0
          ],
          "confidence": 0.9893513917922974
        },
        {
          "text": "with, or in the Control of such Party..",
          "bbox": [
            551.0,
            1518.0,
            1222.0,
            1564.0
          ],
          "confidence": 0.9819372296333313
        },
        {
          "text": "1.2",
          "bbox": [
            377.0,
            1573.0,
            440.0,
            1619.0
          ],
          "confidence": 0.9997513890266418
        },
        {
          "text": "\"Anti-Corruption and Anti-Bribery Laws\" shall mean the United States Foreign Corrupt Practices Act of 1977, as amended, the",
          "bbox": [
            549.0,
            1577.0,
            2925.0,
            1619.0
          ],
          "confidence": 0.9937560558319092
        },
        {
          "text": "Bribery Act 2010 (2010 Chapter 23) of the Parliament of the United Kingdom, any rules or regulations under such acts, and any other",
          "bbox": [
            551.0,
            1634.0,
            3011.0,
            1676.0
          ],
          "confidence": 0.9908789992332458
        },
        {
          "text": "anti-corruption or anti-bribery statutes, laws or regulations applicable to a Party..",
          "bbox": [
            547.0,
            1687.0,
            2039.0,
            1732.0
          ],
          "confidence": 0.9931536316871643
        },
        {
          "text": "1.3",
          "bbox": [
            379.0,
            1741.0,
            440.0,
            1787.0
          ],
          "confidence": 0.9998380541801453
        },
        {
          "text": "\"API\"' shall mean the active pharmaceutical ingredients Celecoxib and Amlodipine Besylate..",
          "bbox": [
            549.0,
            1741.0,
            2277.0,
            1787.0
          ],
          "confidence": 0.9627962112426758
        },
        {
          "text": "Source: KITOV PHARMA LTD., 20-F, 3/26/2019",
          "bbox": [
            332.0,
            4437.0,
            1256.0,
            4479.0
          ],
          "confidence": 0.988348126411438
        }
      ],
      "nearby_headers": [
        {
          "text": "THE SYMBOL <****\" DENOTES PLACES WHERE PORTIONS OF THIS DOCUMENT HAVE BEEN OMITTED PURSUANT TO A REQUEST",
          "page": 0,
          "bbox": [
            304.0,
            338.0,
            3009.0,
            380.0
          ]
        },
        {
          "text": "FOR CONFIDENTIAL TREATMENT. SUCH MATERIAL WILL BE FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE",
          "page": 0,
          "bbox": [
            399.0,
            398.0,
            2907.0,
            435.0
          ]
        },
        {
          "text": "COMIMISSION.",
          "page": 0,
          "bbox": [
            1503.0,
            455.0,
            1805.0,
            492.0
          ]
        },
        {
          "text": "PRODUCT MANUFACTURING AGREEMENT",
          "page": 0,
          "bbox": [
            1216.0,
            510.0,
            2093.0,
            546.0
          ]
        },
        {
          "text": "WHEREAS:",
          "page": 0,
          "bbox": [
            281.0,
            848.0,
            515.0,
            884.0
          ]
        },
        {
          "text": "WHEREAS:",
          "page": 0,
          "bbox": [
            279.0,
            959.0,
            513.0,
            996.0
          ]
        },
        {
          "text": "WHEREAS:",
          "page": 0,
          "bbox": [
            281.0,
            1071.0,
            515.0,
            1107.0
          ]
        }
      ]
    },
    {
      "id": "KitovPharmaLtd_20190326_20-F_EX-4.15_11584449_EX-4.15_Manufacturing Agreement__License Grant_0_multi",
      "question": "Highlight the parts (if any) of this contract related to \"License Grant\" that should be reviewed by a lawyer. Details: Does the contract contain a license granted by one party to its counterparty?",
      "answer_text": "Kitov hereby grants to Dexcel a fully paid, limited license right to use all of its Confidential Information and Intellectual Property Rights (including, inter alia, the Kitov Foreground IP, Kitov Data, Kitov's share of the Joint IP, and the Trademark (\"Kitov Product IP\")) necessary in order for Dexcel to manufacture, Label, package with the Livery, test and release the Product for shipment, exclusively for Kitov, for and during the Term.",
      "page_number": 0,
      "words": [
        {
          "text": "Exhibit 4.15",
          "bbox": [
            2798.0,
            283.0,
            3029.0,
            325.0
          ],
          "confidence": 0.9998080730438232
        },
        {
          "text": "THE SYMBOL <****\" DENOTES PLACES WHERE PORTIONS OF THIS DOCUMENT HAVE BEEN OMITTED PURSUANT TO A REQUEST",
          "bbox": [
            304.0,
            338.0,
            3009.0,
            380.0
          ],
          "confidence": 0.983539879322052
        },
        {
          "text": "FOR CONFIDENTIAL TREATMENT. SUCH MATERIAL WILL BE FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE",
          "bbox": [
            399.0,
            398.0,
            2907.0,
            435.0
          ],
          "confidence": 0.9926196932792664
        },
        {
          "text": "COMIMISSION.",
          "bbox": [
            1503.0,
            455.0,
            1805.0,
            492.0
          ],
          "confidence": 0.9562864303588867
        },
        {
          "text": "PRODUCT MANUFACTURING AGREEMENT",
          "bbox": [
            1216.0,
            510.0,
            2093.0,
            546.0
          ],
          "confidence": 0.994750440120697
        },
        {
          "text": "This Product Manufacturing Agreement (\"Agreement') is made as of the Effective Date by and between DEXCEL LTD., with its registered address.",
          "bbox": [
            275.0,
            563.0,
            3023.0,
            609.0
          ],
          "confidence": 0.989086925983429
        },
        {
          "text": "at ****, Israel (\"Dexcel'') and KITOV Pharma Ltd., with its registered office at 132 Menachem Begin Road, Azrieli Center, Tel Aviv, 6701101, Israel.",
          "bbox": [
            274.0,
            618.0,
            3000.0,
            665.0
          ],
          "confidence": 0.9887864589691162
        },
        {
          "text": "(\"Kitov'). Dexcel and Kitov are hereinafter jointly the \"Parties' and individually a \"Party.\".",
          "bbox": [
            279.0,
            678.0,
            1945.0,
            722.0
          ],
          "confidence": 0.98404461145401
        },
        {
          "text": "WHEREAS: Dexcel is a pharmaceutical company engaged in various activities including, but not limited to, the research, development,",
          "bbox": [
            275.0,
            729.0,
            2817.0,
            780.0
          ],
          "confidence": 0.9837751388549805
        },
        {
          "text": "manufacture, and marketing of various drugs and pharmaceutical specialties in various dosage forms;",
          "bbox": [
            549.0,
            795.0,
            2438.0,
            831.0
          ],
          "confidence": 0.9977880120277405
        },
        {
          "text": "WHEREAS:",
          "bbox": [
            281.0,
            848.0,
            515.0,
            884.0
          ],
          "confidence": 0.9993464946746826
        },
        {
          "text": "Kitov is a pharmaceutical company engaged in various activities including, but not limited to, the development of pharmaceutical",
          "bbox": [
            546.0,
            844.0,
            2951.0,
            890.0
          ],
          "confidence": 0.9910856485366821
        },
        {
          "text": "products;",
          "bbox": [
            551.0,
            906.0,
            732.0,
            945.0
          ],
          "confidence": 0.9994080066680908
        },
        {
          "text": "WHEREAS:",
          "bbox": [
            279.0,
            959.0,
            513.0,
            996.0
          ],
          "confidence": 0.9993117451667786
        },
        {
          "text": "Kitov and Dexcel entered into a Development Services Agreement on April 1, 2014 (\"Development Agreement'), pursuant to which",
          "bbox": [
            549.0,
            958.0,
            2991.0,
            1000.0
          ],
          "confidence": 0.9946937561035156
        },
        {
          "text": "Dexcel performed certain development services for Kitov with respect to the Product;",
          "bbox": [
            551.0,
            1016.0,
            2139.0,
            1058.0
          ],
          "confidence": 0.9957237243652344
        },
        {
          "text": "WHEREAS:",
          "bbox": [
            281.0,
            1071.0,
            515.0,
            1107.0
          ],
          "confidence": 0.9993150234222412
        },
        {
          "text": "Kitov desires that Dexcel manufacture and package the Product for Kitov in accordance with the terms of this Agreement, and Dexcel",
          "bbox": [
            546.0,
            1069.0,
            3029.0,
            1115.0
          ],
          "confidence": 0.9908015131950378
        },
        {
          "text": "is willing to manufacture and package the Product for Kitov in accordance with the terms of this Agreement..",
          "bbox": [
            547.0,
            1126.0,
            2561.0,
            1171.0
          ],
          "confidence": 0.9924741387367249
        },
        {
          "text": "NOw, THEREFORE, in consideration of the mutual covenants herein contained, the Parties, intending to be legally bound, hereby agree as",
          "bbox": [
            275.0,
            1180.0,
            2876.0,
            1228.0
          ],
          "confidence": 0.9950727820396423
        },
        {
          "text": "follows:",
          "bbox": [
            275.0,
            1237.0,
            426.0,
            1279.0
          ],
          "confidence": 0.9998461008071899
        },
        {
          "text": "1",
          "bbox": [
            277.0,
            1299.0,
            303.0,
            1330.0
          ],
          "confidence": 0.9999181032180786
        },
        {
          "text": "Definitions",
          "bbox": [
            368.0,
            1296.0,
            589.0,
            1334.0
          ],
          "confidence": 0.999856173992157
        },
        {
          "text": "For the purpose of this Agreement, the terms set forth in this clause, whether used in singular or plural form, shall mean, unless otherwise expressly.",
          "bbox": [
            277.0,
            1352.0,
            3012.0,
            1394.0
          ],
          "confidence": 0.9917291402816772
        },
        {
          "text": "provided for in this Agreement or the context otherwise requires, the following:.",
          "bbox": [
            277.0,
            1405.0,
            1749.0,
            1453.0
          ],
          "confidence": 0.9938557744026184
        },
        {
          "text": "1.1",
          "bbox": [
            379.0,
            1460.0,
            439.0,
            1506.0
          ],
          "confidence": 0.9998831748962402
        },
        {
          "text": "\"Affiliate\"' of a Party shall mean any corporation or other business entity directly or indirectly Controlled by, under common Control.",
          "bbox": [
            546.0,
            1458.0,
            3012.0,
            1509.0
          ],
          "confidence": 0.9893513917922974
        },
        {
          "text": "with, or in the Control of such Party..",
          "bbox": [
            551.0,
            1518.0,
            1222.0,
            1564.0
          ],
          "confidence": 0.9819372296333313
        },
        {
          "text": "1.2",
          "bbox": [
            377.0,
            1573.0,
            440.0,
            1619.0
          ],
          "confidence": 0.9997513890266418
        },
        {
          "text": "\"Anti-Corruption and Anti-Bribery Laws\" shall mean the United States Foreign Corrupt Practices Act of 1977, as amended, the",
          "bbox": [
            549.0,
            1577.0,
            2925.0,
            1619.0
          ],
          "confidence": 0.9937560558319092
        },
        {
          "text": "Bribery Act 2010 (2010 Chapter 23) of the Parliament of the United Kingdom, any rules or regulations under such acts, and any other",
          "bbox": [
            551.0,
            1634.0,
            3011.0,
            1676.0
          ],
          "confidence": 0.9908789992332458
        },
        {
          "text": "anti-corruption or anti-bribery statutes, laws or regulations applicable to a Party..",
          "bbox": [
            547.0,
            1687.0,
            2039.0,
            1732.0
          ],
          "confidence": 0.9931536316871643
        },
        {
          "text": "1.3",
          "bbox": [
            379.0,
            1741.0,
            440.0,
            1787.0
          ],
          "confidence": 0.9998380541801453
        },
        {
          "text": "\"API\"' shall mean the active pharmaceutical ingredients Celecoxib and Amlodipine Besylate..",
          "bbox": [
            549.0,
            1741.0,
            2277.0,
            1787.0
          ],
          "confidence": 0.9627962112426758
        },
        {
          "text": "Source: KITOV PHARMA LTD., 20-F, 3/26/2019",
          "bbox": [
            332.0,
            4437.0,
            1256.0,
            4479.0
          ],
          "confidence": 0.988348126411438
        }
      ],
      "multi_page": true,
      "part_of": 2,
      "nearby_headers": [
        {
          "text": "THE SYMBOL <****\" DENOTES PLACES WHERE PORTIONS OF THIS DOCUMENT HAVE BEEN OMITTED PURSUANT TO A REQUEST",
          "page": 0,
          "bbox": [
            304.0,
            338.0,
            3009.0,
            380.0
          ]
        },
        {
          "text": "FOR CONFIDENTIAL TREATMENT. SUCH MATERIAL WILL BE FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE",
          "page": 0,
          "bbox": [
            399.0,
            398.0,
            2907.0,
            435.0
          ]
        },
        {
          "text": "COMIMISSION.",
          "page": 0,
          "bbox": [
            1503.0,
            455.0,
            1805.0,
            492.0
          ]
        },
        {
          "text": "PRODUCT MANUFACTURING AGREEMENT",
          "page": 0,
          "bbox": [
            1216.0,
            510.0,
            2093.0,
            546.0
          ]
        },
        {
          "text": "WHEREAS:",
          "page": 0,
          "bbox": [
            281.0,
            848.0,
            515.0,
            884.0
          ]
        },
        {
          "text": "WHEREAS:",
          "page": 0,
          "bbox": [
            279.0,
            959.0,
            513.0,
            996.0
          ]
        },
        {
          "text": "WHEREAS:",
          "page": 0,
          "bbox": [
            281.0,
            1071.0,
            515.0,
            1107.0
          ]
        }
      ]
    },
    {
      "id": "KitovPharmaLtd_20190326_20-F_EX-4.15_11584449_EX-4.15_Manufacturing Agreement__License Grant_1_multi",
      "question": "Highlight the parts (if any) of this contract related to \"License Grant\" that should be reviewed by a lawyer. Details: Does the contract contain a license granted by one party to its counterparty?",
      "answer_text": "Kitov hereby grants to Dexcel a fully paid, limited license right to use all of its Confidential Information and Intellectual Property Rights (including, inter alia, the Kitov Foreground IP, Kitov Data, Kitov's share of the Joint IP, and the Trademark (\"Kitov Product IP\")) necessary in order for Dexcel to manufacture, Label, package with the Livery, test and release the Product for shipment, exclusively for Kitov, for and during the Term.",
      "page_number": 1,
      "words": [
        {
          "text": "1.4",
          "bbox": [
            379.0,
            281.0,
            442.0,
            327.0
          ],
          "confidence": 0.9997868537902832
        },
        {
          "text": "\"Batch' shall mean the defined quantity of the Product processed in a single process or series of processes in a manner designed to.",
          "bbox": [
            549.0,
            281.0,
            3011.0,
            329.0
          ],
          "confidence": 0.9841217398643494
        },
        {
          "text": "be homogeneous. The Batch size for the Product is **** tablets.",
          "bbox": [
            551.0,
            338.0,
            1756.0,
            382.0
          ],
          "confidence": 0.9994081258773804
        },
        {
          "text": "1.5",
          "bbox": [
            376.0,
            390.0,
            443.0,
            443.0
          ],
          "confidence": 0.9997324347496033
        },
        {
          "text": "\"cGMPs\" or \"Good Manufacturing Practice\"' shall mean the part of quality assurance which ensures that the Product is consistently.",
          "bbox": [
            549.0,
            395.0,
            3023.0,
            440.0
          ],
          "confidence": 0.985264241695404
        },
        {
          "text": "produced and controlled to the quality standards appropriate to their intended use, the principles and guidelines of which are",
          "bbox": [
            549.0,
            451.0,
            2884.0,
            499.0
          ],
          "confidence": 0.9912954568862915
        },
        {
          "text": "specified in European Commission Directive 2003/94/EC and the FDA's current Good Manufacturing Practices, particularly 21 CFR ",
          "bbox": [
            547.0,
            506.0,
            3003.0,
            557.0
          ],
          "confidence": 0.995246410369873
        },
        {
          "text": "210 et seq., and 21 CFR $$ 600-610, as both may be amended from time to time..",
          "bbox": [
            549.0,
            565.0,
            2006.0,
            607.0
          ],
          "confidence": 0.9747835993766785
        },
        {
          "text": "1.6",
          "bbox": [
            379.0,
            619.0,
            442.0,
            663.0
          ],
          "confidence": 0.9999213218688965
        },
        {
          "text": "\"Change of Control' shall mean (i) any change, sale, merger, reorganization, or any other event or action that results in a third party,",
          "bbox": [
            547.0,
            618.0,
            3005.0,
            669.0
          ],
          "confidence": 0.9930126070976257
        },
        {
          "text": "which is a material competitor to the other Party to this agreement, acquiring: (a) all or substantially all of the business or assets of a.",
          "bbox": [
            551.0,
            678.0,
            3002.0,
            722.0
          ],
          "confidence": 0.9852778911590576
        },
        {
          "text": "Party relating to this Agreement, (b) Control, directly or indirectly, of such Party (and/or any corporate entity that Controls, directly.",
          "bbox": [
            551.0,
            735.0,
            2985.0,
            778.0
          ],
          "confidence": 0.9932605624198914
        },
        {
          "text": "or indirectly, such Party), or (ii) any assignment or delegation of, sale or transfer of a Party's rights and obligations under this",
          "bbox": [
            549.0,
            789.0,
            2878.0,
            835.0
          ],
          "confidence": 0.9923490881919861
        },
        {
          "text": "Agreement (or any part hereof) to a third party.",
          "bbox": [
            555.0,
            848.0,
            1426.0,
            890.0
          ],
          "confidence": 0.9961597323417664
        },
        {
          "text": "Notwithstanding anything in the immediately preceding paragraph to the contrary, where the Party in question is Dexcel, any of the",
          "bbox": [
            549.0,
            903.0,
            2991.0,
            945.0
          ],
          "confidence": 0.9957303404808044
        },
        {
          "text": "foregoing events or actions shall not be considered a Change of Control where any one or more of the relevant third party or parties.",
          "bbox": [
            551.0,
            961.0,
            3007.0,
            1003.0
          ],
          "confidence": 0.9899225234985352
        },
        {
          "text": "referred to in clause (i) above is (A) a Family Member, or (B) any entity Controlled by Mr. **** and/or a Family Member.",
          "bbox": [
            544.0,
            1005.0,
            2788.0,
            1064.0
          ],
          "confidence": 0.9933032989501953
        },
        {
          "text": "1.7",
          "bbox": [
            379.0,
            1067.0,
            442.0,
            1113.0
          ],
          "confidence": 0.9998312592506409
        },
        {
          "text": "\"Claims' shall mean any demands, claims, actions, causes of action, assessments, losses, damages, injuries, liabilities, costs and.",
          "bbox": [
            549.0,
            1069.0,
            2953.0,
            1115.0
          ],
          "confidence": 0.9854910969734192
        },
        {
          "text": "expenses (including, without limitation, reasonable attorneys' fees and expenses) filed, raised, initiated or made by any governmental.",
          "bbox": [
            553.0,
            1129.0,
            3021.0,
            1171.0
          ],
          "confidence": 0.992518424987793
        },
        {
          "text": "authority and/or third party.",
          "bbox": [
            551.0,
            1184.0,
            1066.0,
            1226.0
          ],
          "confidence": 0.983346164226532
        },
        {
          "text": "1.8",
          "bbox": [
            379.0,
            1235.0,
            442.0,
            1281.0
          ],
          "confidence": 0.9999089241027832
        },
        {
          "text": "\"Confidential Information\"' shall have the meaning set forth in Section 7.1.",
          "bbox": [
            549.0,
            1235.0,
            1939.0,
            1281.0
          ],
          "confidence": 0.9719286561012268
        },
        {
          "text": "1.9",
          "bbox": [
            379.0,
            1292.0,
            440.0,
            1336.0
          ],
          "confidence": 0.9999080300331116
        },
        {
          "text": "\"Confirmed Order' shall have the meaning set forth in Section 3.3.2.",
          "bbox": [
            549.0,
            1292.0,
            1834.0,
            1338.0
          ],
          "confidence": 0.9867768883705139
        },
        {
          "text": "1.10",
          "bbox": [
            379.0,
            1347.0,
            462.0,
            1394.0
          ],
          "confidence": 0.9999012351036072
        },
        {
          "text": "\"Control' or \"Controlled' shall mean possession of more than fifty percent (50%) of the share capital of a corporation or other",
          "bbox": [
            547.0,
            1345.0,
            2915.0,
            1398.0
          ],
          "confidence": 0.981292724609375
        },
        {
          "text": "business entity, and/or the power to direct or cause the direction of the management and policies of a corporation or other entity",
          "bbox": [
            549.0,
            1405.0,
            2936.0,
            1451.0
          ],
          "confidence": 0.9941077828407288
        },
        {
          "text": "whether through the ownership of voting securities, by contract or otherwise..",
          "bbox": [
            553.0,
            1467.0,
            1996.0,
            1504.0
          ],
          "confidence": 0.9934757947921753
        },
        {
          "text": "1.11",
          "bbox": [
            379.0,
            1517.0,
            455.0,
            1561.0
          ],
          "confidence": 0.999779224395752
        },
        {
          "text": "\"Delivery' shall mean the time when the Product is placed at the disposal of Kitov at Dexcel's Facility based on an ****",
          "bbox": [
            546.0,
            1508.0,
            2799.0,
            1568.0
          ],
          "confidence": 0.992178738117218
        },
        {
          "text": "(Incoterms 2010).",
          "bbox": [
            555.0,
            1579.0,
            904.0,
            1617.0
          ],
          "confidence": 0.99842768907547
        },
        {
          "text": "1.12",
          "bbox": [
            377.0,
            1626.0,
            462.0,
            1674.0
          ],
          "confidence": 0.9999103546142578
        },
        {
          "text": "\"Distributors\" shall mean any Person under contract with Kitov or any of its Affiliates for the distribution of the Product in a certain",
          "bbox": [
            553.0,
            1634.0,
            3018.0,
            1670.0
          ],
          "confidence": 0.9918192625045776
        },
        {
          "text": "territory or territories..",
          "bbox": [
            551.0,
            1692.0,
            946.0,
            1729.0
          ],
          "confidence": 0.9840478301048279
        },
        {
          "text": "1.13",
          "bbox": [
            381.0,
            1741.0,
            459.0,
            1785.0
          ],
          "confidence": 0.8832098245620728
        },
        {
          "text": "\"Effective Date' shall mean the date of signature of the last Party to execute this Agreement..",
          "bbox": [
            549.0,
            1741.0,
            2267.0,
            1787.0
          ],
          "confidence": 0.9844200611114502
        },
        {
          "text": "1.14",
          "bbox": [
            379.0,
            1798.0,
            460.0,
            1840.0
          ],
          "confidence": 0.9994210004806519
        },
        {
          "text": "\"EMA\" means the European Medicines Agency or any successor entity.",
          "bbox": [
            549.0,
            1798.0,
            1898.0,
            1846.0
          ],
          "confidence": 0.9979910254478455
        },
        {
          "text": "1.15",
          "bbox": [
            379.0,
            1851.0,
            460.0,
            1900.0
          ],
          "confidence": 0.9995757341384888
        },
        {
          "text": "\"Family Member\" shall mean ****.",
          "bbox": [
            547.0,
            1847.0,
            1222.0,
            1902.0
          ],
          "confidence": 0.9885128736495972
        },
        {
          "text": "1.16",
          "bbox": [
            379.0,
            1908.0,
            462.0,
            1955.0
          ],
          "confidence": 0.9999197125434875
        },
        {
          "text": "\"FDA\" means the U.S. Food and Drug Administration or any successor entity..",
          "bbox": [
            549.0,
            1911.0,
            2005.0,
            1953.0
          ],
          "confidence": 0.986582338809967
        },
        {
          "text": "2",
          "bbox": [
            1638.0,
            2025.0,
            1669.0,
            2061.0
          ],
          "confidence": 0.999761164188385
        },
        {
          "text": "Source: KITOV PHARMA LTD., 20-F, 3/26/2019",
          "bbox": [
            332.0,
            4437.0,
            1256.0,
            4479.0
          ],
          "confidence": 0.989766538143158
        }
      ],
      "multi_page": true,
      "part_of": 2
    },
    {
      "id": "KitovPharmaLtd_20190326_20-F_EX-4.15_11584449_EX-4.15_Manufacturing Agreement__Post-Termination Services_0_multi",
      "question": "Highlight the parts (if any) of this contract related to \"Post-Termination Services\" that should be reviewed by a lawyer. Details: Is a party subject to obligations after the termination or expiration of a contract, including any post-termination transition, payment, transfer of IP, wind-down, last-buy, or similar commitments?",
      "answer_text": "In the event of Product which Kitov claims have Apparent Defects or Hidden Defects, Dexcel shall have up to thirty (30) Working Days after receipt of the samples to show that the Product in question meets the Specifications (\"Period\").",
      "page_number": 0,
      "words": [
        {
          "text": "Exhibit 4.15",
          "bbox": [
            2798.0,
            283.0,
            3029.0,
            325.0
          ],
          "confidence": 0.9998080730438232
        },
        {
          "text": "THE SYMBOL <****\" DENOTES PLACES WHERE PORTIONS OF THIS DOCUMENT HAVE BEEN OMITTED PURSUANT TO A REQUEST",
          "bbox": [
            304.0,
            338.0,
            3009.0,
            380.0
          ],
          "confidence": 0.983539879322052
        },
        {
          "text": "FOR CONFIDENTIAL TREATMENT. SUCH MATERIAL WILL BE FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE",
          "bbox": [
            399.0,
            398.0,
            2907.0,
            435.0
          ],
          "confidence": 0.9926196932792664
        },
        {
          "text": "COMIMISSION.",
          "bbox": [
            1503.0,
            455.0,
            1805.0,
            492.0
          ],
          "confidence": 0.9562864303588867
        },
        {
          "text": "PRODUCT MANUFACTURING AGREEMENT",
          "bbox": [
            1216.0,
            510.0,
            2093.0,
            546.0
          ],
          "confidence": 0.994750440120697
        },
        {
          "text": "This Product Manufacturing Agreement (\"Agreement') is made as of the Effective Date by and between DEXCEL LTD., with its registered address.",
          "bbox": [
            275.0,
            563.0,
            3023.0,
            609.0
          ],
          "confidence": 0.989086925983429
        },
        {
          "text": "at ****, Israel (\"Dexcel'') and KITOV Pharma Ltd., with its registered office at 132 Menachem Begin Road, Azrieli Center, Tel Aviv, 6701101, Israel.",
          "bbox": [
            274.0,
            618.0,
            3000.0,
            665.0
          ],
          "confidence": 0.9887864589691162
        },
        {
          "text": "(\"Kitov'). Dexcel and Kitov are hereinafter jointly the \"Parties' and individually a \"Party.\".",
          "bbox": [
            279.0,
            678.0,
            1945.0,
            722.0
          ],
          "confidence": 0.98404461145401
        },
        {
          "text": "WHEREAS: Dexcel is a pharmaceutical company engaged in various activities including, but not limited to, the research, development,",
          "bbox": [
            275.0,
            729.0,
            2817.0,
            780.0
          ],
          "confidence": 0.9837751388549805
        },
        {
          "text": "manufacture, and marketing of various drugs and pharmaceutical specialties in various dosage forms;",
          "bbox": [
            549.0,
            795.0,
            2438.0,
            831.0
          ],
          "confidence": 0.9977880120277405
        },
        {
          "text": "WHEREAS:",
          "bbox": [
            281.0,
            848.0,
            515.0,
            884.0
          ],
          "confidence": 0.9993464946746826
        },
        {
          "text": "Kitov is a pharmaceutical company engaged in various activities including, but not limited to, the development of pharmaceutical",
          "bbox": [
            546.0,
            844.0,
            2951.0,
            890.0
          ],
          "confidence": 0.9910856485366821
        },
        {
          "text": "products;",
          "bbox": [
            551.0,
            906.0,
            732.0,
            945.0
          ],
          "confidence": 0.9994080066680908
        },
        {
          "text": "WHEREAS:",
          "bbox": [
            279.0,
            959.0,
            513.0,
            996.0
          ],
          "confidence": 0.9993117451667786
        },
        {
          "text": "Kitov and Dexcel entered into a Development Services Agreement on April 1, 2014 (\"Development Agreement'), pursuant to which",
          "bbox": [
            549.0,
            958.0,
            2991.0,
            1000.0
          ],
          "confidence": 0.9946937561035156
        },
        {
          "text": "Dexcel performed certain development services for Kitov with respect to the Product;",
          "bbox": [
            551.0,
            1016.0,
            2139.0,
            1058.0
          ],
          "confidence": 0.9957237243652344
        },
        {
          "text": "WHEREAS:",
          "bbox": [
            281.0,
            1071.0,
            515.0,
            1107.0
          ],
          "confidence": 0.9993150234222412
        },
        {
          "text": "Kitov desires that Dexcel manufacture and package the Product for Kitov in accordance with the terms of this Agreement, and Dexcel",
          "bbox": [
            546.0,
            1069.0,
            3029.0,
            1115.0
          ],
          "confidence": 0.9908015131950378
        },
        {
          "text": "is willing to manufacture and package the Product for Kitov in accordance with the terms of this Agreement..",
          "bbox": [
            547.0,
            1126.0,
            2561.0,
            1171.0
          ],
          "confidence": 0.9924741387367249
        },
        {
          "text": "NOw, THEREFORE, in consideration of the mutual covenants herein contained, the Parties, intending to be legally bound, hereby agree as",
          "bbox": [
            275.0,
            1180.0,
            2876.0,
            1228.0
          ],
          "confidence": 0.9950727820396423
        },
        {
          "text": "follows:",
          "bbox": [
            275.0,
            1237.0,
            426.0,
            1279.0
          ],
          "confidence": 0.9998461008071899
        },
        {
          "text": "1",
          "bbox": [
            277.0,
            1299.0,
            303.0,
            1330.0
          ],
          "confidence": 0.9999181032180786
        },
        {
          "text": "Definitions",
          "bbox": [
            368.0,
            1296.0,
            589.0,
            1334.0
          ],
          "confidence": 0.999856173992157
        },
        {
          "text": "For the purpose of this Agreement, the terms set forth in this clause, whether used in singular or plural form, shall mean, unless otherwise expressly.",
          "bbox": [
            277.0,
            1352.0,
            3012.0,
            1394.0
          ],
          "confidence": 0.9917291402816772
        },
        {
          "text": "provided for in this Agreement or the context otherwise requires, the following:.",
          "bbox": [
            277.0,
            1405.0,
            1749.0,
            1453.0
          ],
          "confidence": 0.9938557744026184
        },
        {
          "text": "1.1",
          "bbox": [
            379.0,
            1460.0,
            439.0,
            1506.0
          ],
          "confidence": 0.9998831748962402
        },
        {
          "text": "\"Affiliate\"' of a Party shall mean any corporation or other business entity directly or indirectly Controlled by, under common Control.",
          "bbox": [
            546.0,
            1458.0,
            3012.0,
            1509.0
          ],
          "confidence": 0.9893513917922974
        },
        {
          "text": "with, or in the Control of such Party..",
          "bbox": [
            551.0,
            1518.0,
            1222.0,
            1564.0
          ],
          "confidence": 0.9819372296333313
        },
        {
          "text": "1.2",
          "bbox": [
            377.0,
            1573.0,
            440.0,
            1619.0
          ],
          "confidence": 0.9997513890266418
        },
        {
          "text": "\"Anti-Corruption and Anti-Bribery Laws\" shall mean the United States Foreign Corrupt Practices Act of 1977, as amended, the",
          "bbox": [
            549.0,
            1577.0,
            2925.0,
            1619.0
          ],
          "confidence": 0.9937560558319092
        },
        {
          "text": "Bribery Act 2010 (2010 Chapter 23) of the Parliament of the United Kingdom, any rules or regulations under such acts, and any other",
          "bbox": [
            551.0,
            1634.0,
            3011.0,
            1676.0
          ],
          "confidence": 0.9908789992332458
        },
        {
          "text": "anti-corruption or anti-bribery statutes, laws or regulations applicable to a Party..",
          "bbox": [
            547.0,
            1687.0,
            2039.0,
            1732.0
          ],
          "confidence": 0.9931536316871643
        },
        {
          "text": "1.3",
          "bbox": [
            379.0,
            1741.0,
            440.0,
            1787.0
          ],
          "confidence": 0.9998380541801453
        },
        {
          "text": "\"API\"' shall mean the active pharmaceutical ingredients Celecoxib and Amlodipine Besylate..",
          "bbox": [
            549.0,
            1741.0,
            2277.0,
            1787.0
          ],
          "confidence": 0.9627962112426758
        },
        {
          "text": "Source: KITOV PHARMA LTD., 20-F, 3/26/2019",
          "bbox": [
            332.0,
            4437.0,
            1256.0,
            4479.0
          ],
          "confidence": 0.988348126411438
        }
      ],
      "multi_page": true,
      "part_of": 2,
      "nearby_headers": [
        {
          "text": "THE SYMBOL <****\" DENOTES PLACES WHERE PORTIONS OF THIS DOCUMENT HAVE BEEN OMITTED PURSUANT TO A REQUEST",
          "page": 0,
          "bbox": [
            304.0,
            338.0,
            3009.0,
            380.0
          ]
        },
        {
          "text": "FOR CONFIDENTIAL TREATMENT. SUCH MATERIAL WILL BE FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE",
          "page": 0,
          "bbox": [
            399.0,
            398.0,
            2907.0,
            435.0
          ]
        },
        {
          "text": "COMIMISSION.",
          "page": 0,
          "bbox": [
            1503.0,
            455.0,
            1805.0,
            492.0
          ]
        },
        {
          "text": "PRODUCT MANUFACTURING AGREEMENT",
          "page": 0,
          "bbox": [
            1216.0,
            510.0,
            2093.0,
            546.0
          ]
        },
        {
          "text": "WHEREAS:",
          "page": 0,
          "bbox": [
            281.0,
            848.0,
            515.0,
            884.0
          ]
        },
        {
          "text": "WHEREAS:",
          "page": 0,
          "bbox": [
            279.0,
            959.0,
            513.0,
            996.0
          ]
        },
        {
          "text": "WHEREAS:",
          "page": 0,
          "bbox": [
            281.0,
            1071.0,
            515.0,
            1107.0
          ]
        }
      ]
    },
    {
      "id": "KitovPharmaLtd_20190326_20-F_EX-4.15_11584449_EX-4.15_Manufacturing Agreement__Post-Termination Services_1_multi",
      "question": "Highlight the parts (if any) of this contract related to \"Post-Termination Services\" that should be reviewed by a lawyer. Details: Is a party subject to obligations after the termination or expiration of a contract, including any post-termination transition, payment, transfer of IP, wind-down, last-buy, or similar commitments?",
      "answer_text": "In the event of Product which Kitov claims have Apparent Defects or Hidden Defects, Dexcel shall have up to thirty (30) Working Days after receipt of the samples to show that the Product in question meets the Specifications (\"Period\").",
      "page_number": 1,
      "words": [
        {
          "text": "1.4",
          "bbox": [
            379.0,
            281.0,
            442.0,
            327.0
          ],
          "confidence": 0.9997868537902832
        },
        {
          "text": "\"Batch' shall mean the defined quantity of the Product processed in a single process or series of processes in a manner designed to.",
          "bbox": [
            549.0,
            281.0,
            3011.0,
            329.0
          ],
          "confidence": 0.9841217398643494
        },
        {
          "text": "be homogeneous. The Batch size for the Product is **** tablets.",
          "bbox": [
            551.0,
            338.0,
            1756.0,
            382.0
          ],
          "confidence": 0.9994081258773804
        },
        {
          "text": "1.5",
          "bbox": [
            376.0,
            390.0,
            443.0,
            443.0
          ],
          "confidence": 0.9997324347496033
        },
        {
          "text": "\"cGMPs\" or \"Good Manufacturing Practice\"' shall mean the part of quality assurance which ensures that the Product is consistently.",
          "bbox": [
            549.0,
            395.0,
            3023.0,
            440.0
          ],
          "confidence": 0.985264241695404
        },
        {
          "text": "produced and controlled to the quality standards appropriate to their intended use, the principles and guidelines of which are",
          "bbox": [
            549.0,
            451.0,
            2884.0,
            499.0
          ],
          "confidence": 0.9912954568862915
        },
        {
          "text": "specified in European Commission Directive 2003/94/EC and the FDA's current Good Manufacturing Practices, particularly 21 CFR ",
          "bbox": [
            547.0,
            506.0,
            3003.0,
            557.0
          ],
          "confidence": 0.995246410369873
        },
        {
          "text": "210 et seq., and 21 CFR $$ 600-610, as both may be amended from time to time..",
          "bbox": [
            549.0,
            565.0,
            2006.0,
            607.0
          ],
          "confidence": 0.9747835993766785
        },
        {
          "text": "1.6",
          "bbox": [
            379.0,
            619.0,
            442.0,
            663.0
          ],
          "confidence": 0.9999213218688965
        },
        {
          "text": "\"Change of Control' shall mean (i) any change, sale, merger, reorganization, or any other event or action that results in a third party,",
          "bbox": [
            547.0,
            618.0,
            3005.0,
            669.0
          ],
          "confidence": 0.9930126070976257
        },
        {
          "text": "which is a material competitor to the other Party to this agreement, acquiring: (a) all or substantially all of the business or assets of a.",
          "bbox": [
            551.0,
            678.0,
            3002.0,
            722.0
          ],
          "confidence": 0.9852778911590576
        },
        {
          "text": "Party relating to this Agreement, (b) Control, directly or indirectly, of such Party (and/or any corporate entity that Controls, directly.",
          "bbox": [
            551.0,
            735.0,
            2985.0,
            778.0
          ],
          "confidence": 0.9932605624198914
        },
        {
          "text": "or indirectly, such Party), or (ii) any assignment or delegation of, sale or transfer of a Party's rights and obligations under this",
          "bbox": [
            549.0,
            789.0,
            2878.0,
            835.0
          ],
          "confidence": 0.9923490881919861
        },
        {
          "text": "Agreement (or any part hereof) to a third party.",
          "bbox": [
            555.0,
            848.0,
            1426.0,
            890.0
          ],
          "confidence": 0.9961597323417664
        },
        {
          "text": "Notwithstanding anything in the immediately preceding paragraph to the contrary, where the Party in question is Dexcel, any of the",
          "bbox": [
            549.0,
            903.0,
            2991.0,
            945.0
          ],
          "confidence": 0.9957303404808044
        },
        {
          "text": "foregoing events or actions shall not be considered a Change of Control where any one or more of the relevant third party or parties.",
          "bbox": [
            551.0,
            961.0,
            3007.0,
            1003.0
          ],
          "confidence": 0.9899225234985352
        },
        {
          "text": "referred to in clause (i) above is (A) a Family Member, or (B) any entity Controlled by Mr. **** and/or a Family Member.",
          "bbox": [
            544.0,
            1005.0,
            2788.0,
            1064.0
          ],
          "confidence": 0.9933032989501953
        },
        {
          "text": "1.7",
          "bbox": [
            379.0,
            1067.0,
            442.0,
            1113.0
          ],
          "confidence": 0.9998312592506409
        },
        {
          "text": "\"Claims' shall mean any demands, claims, actions, causes of action, assessments, losses, damages, injuries, liabilities, costs and.",
          "bbox": [
            549.0,
            1069.0,
            2953.0,
            1115.0
          ],
          "confidence": 0.9854910969734192
        },
        {
          "text": "expenses (including, without limitation, reasonable attorneys' fees and expenses) filed, raised, initiated or made by any governmental.",
          "bbox": [
            553.0,
            1129.0,
            3021.0,
            1171.0
          ],
          "confidence": 0.992518424987793
        },
        {
          "text": "authority and/or third party.",
          "bbox": [
            551.0,
            1184.0,
            1066.0,
            1226.0
          ],
          "confidence": 0.983346164226532
        },
        {
          "text": "1.8",
          "bbox": [
            379.0,
            1235.0,
            442.0,
            1281.0
          ],
          "confidence": 0.9999089241027832
        },
        {
          "text": "\"Confidential Information\"' shall have the meaning set forth in Section 7.1.",
          "bbox": [
            549.0,
            1235.0,
            1939.0,
            1281.0
          ],
          "confidence": 0.9719286561012268
        },
        {
          "text": "1.9",
          "bbox": [
            379.0,
            1292.0,
            440.0,
            1336.0
          ],
          "confidence": 0.9999080300331116
        },
        {
          "text": "\"Confirmed Order' shall have the meaning set forth in Section 3.3.2.",
          "bbox": [
            549.0,
            1292.0,
            1834.0,
            1338.0
          ],
          "confidence": 0.9867768883705139
        },
        {
          "text": "1.10",
          "bbox": [
            379.0,
            1347.0,
            462.0,
            1394.0
          ],
          "confidence": 0.9999012351036072
        },
        {
          "text": "\"Control' or \"Controlled' shall mean possession of more than fifty percent (50%) of the share capital of a corporation or other",
          "bbox": [
            547.0,
            1345.0,
            2915.0,
            1398.0
          ],
          "confidence": 0.981292724609375
        },
        {
          "text": "business entity, and/or the power to direct or cause the direction of the management and policies of a corporation or other entity",
          "bbox": [
            549.0,
            1405.0,
            2936.0,
            1451.0
          ],
          "confidence": 0.9941077828407288
        },
        {
          "text": "whether through the ownership of voting securities, by contract or otherwise..",
          "bbox": [
            553.0,
            1467.0,
            1996.0,
            1504.0
          ],
          "confidence": 0.9934757947921753
        },
        {
          "text": "1.11",
          "bbox": [
            379.0,
            1517.0,
            455.0,
            1561.0
          ],
          "confidence": 0.999779224395752
        },
        {
          "text": "\"Delivery' shall mean the time when the Product is placed at the disposal of Kitov at Dexcel's Facility based on an ****",
          "bbox": [
            546.0,
            1508.0,
            2799.0,
            1568.0
          ],
          "confidence": 0.992178738117218
        },
        {
          "text": "(Incoterms 2010).",
          "bbox": [
            555.0,
            1579.0,
            904.0,
            1617.0
          ],
          "confidence": 0.99842768907547
        },
        {
          "text": "1.12",
          "bbox": [
            377.0,
            1626.0,
            462.0,
            1674.0
          ],
          "confidence": 0.9999103546142578
        },
        {
          "text": "\"Distributors\" shall mean any Person under contract with Kitov or any of its Affiliates for the distribution of the Product in a certain",
          "bbox": [
            553.0,
            1634.0,
            3018.0,
            1670.0
          ],
          "confidence": 0.9918192625045776
        },
        {
          "text": "territory or territories..",
          "bbox": [
            551.0,
            1692.0,
            946.0,
            1729.0
          ],
          "confidence": 0.9840478301048279
        },
        {
          "text": "1.13",
          "bbox": [
            381.0,
            1741.0,
            459.0,
            1785.0
          ],
          "confidence": 0.8832098245620728
        },
        {
          "text": "\"Effective Date' shall mean the date of signature of the last Party to execute this Agreement..",
          "bbox": [
            549.0,
            1741.0,
            2267.0,
            1787.0
          ],
          "confidence": 0.9844200611114502
        },
        {
          "text": "1.14",
          "bbox": [
            379.0,
            1798.0,
            460.0,
            1840.0
          ],
          "confidence": 0.9994210004806519
        },
        {
          "text": "\"EMA\" means the European Medicines Agency or any successor entity.",
          "bbox": [
            549.0,
            1798.0,
            1898.0,
            1846.0
          ],
          "confidence": 0.9979910254478455
        },
        {
          "text": "1.15",
          "bbox": [
            379.0,
            1851.0,
            460.0,
            1900.0
          ],
          "confidence": 0.9995757341384888
        },
        {
          "text": "\"Family Member\" shall mean ****.",
          "bbox": [
            547.0,
            1847.0,
            1222.0,
            1902.0
          ],
          "confidence": 0.9885128736495972
        },
        {
          "text": "1.16",
          "bbox": [
            379.0,
            1908.0,
            462.0,
            1955.0
          ],
          "confidence": 0.9999197125434875
        },
        {
          "text": "\"FDA\" means the U.S. Food and Drug Administration or any successor entity..",
          "bbox": [
            549.0,
            1911.0,
            2005.0,
            1953.0
          ],
          "confidence": 0.986582338809967
        },
        {
          "text": "2",
          "bbox": [
            1638.0,
            2025.0,
            1669.0,
            2061.0
          ],
          "confidence": 0.999761164188385
        },
        {
          "text": "Source: KITOV PHARMA LTD., 20-F, 3/26/2019",
          "bbox": [
            332.0,
            4437.0,
            1256.0,
            4479.0
          ],
          "confidence": 0.989766538143158
        }
      ],
      "multi_page": true,
      "part_of": 2
    },
    {
      "id": "KitovPharmaLtd_20190326_20-F_EX-4.15_11584449_EX-4.15_Manufacturing Agreement__Post-Termination Services_0",
      "question": "Highlight the parts (if any) of this contract related to \"Post-Termination Services\" that should be reviewed by a lawyer. Details: Is a party subject to obligations after the termination or expiration of a contract, including any post-termination transition, payment, transfer of IP, wind-down, last-buy, or similar commitments?",
      "answer_text": "Kitov shall be entitled to sell or otherwise dispose of its remaining stock of the Product until the end of the inventory's shelf life.",
      "page_number": 0,
      "words": [
        {
          "text": "Exhibit 4.15",
          "bbox": [
            2798.0,
            283.0,
            3029.0,
            325.0
          ],
          "confidence": 0.9998080730438232
        },
        {
          "text": "THE SYMBOL <****\" DENOTES PLACES WHERE PORTIONS OF THIS DOCUMENT HAVE BEEN OMITTED PURSUANT TO A REQUEST",
          "bbox": [
            304.0,
            338.0,
            3009.0,
            380.0
          ],
          "confidence": 0.983539879322052
        },
        {
          "text": "FOR CONFIDENTIAL TREATMENT. SUCH MATERIAL WILL BE FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE",
          "bbox": [
            399.0,
            398.0,
            2907.0,
            435.0
          ],
          "confidence": 0.9926196932792664
        },
        {
          "text": "COMIMISSION.",
          "bbox": [
            1503.0,
            455.0,
            1805.0,
            492.0
          ],
          "confidence": 0.9562864303588867
        },
        {
          "text": "PRODUCT MANUFACTURING AGREEMENT",
          "bbox": [
            1216.0,
            510.0,
            2093.0,
            546.0
          ],
          "confidence": 0.994750440120697
        },
        {
          "text": "This Product Manufacturing Agreement (\"Agreement') is made as of the Effective Date by and between DEXCEL LTD., with its registered address.",
          "bbox": [
            275.0,
            563.0,
            3023.0,
            609.0
          ],
          "confidence": 0.989086925983429
        },
        {
          "text": "at ****, Israel (\"Dexcel'') and KITOV Pharma Ltd., with its registered office at 132 Menachem Begin Road, Azrieli Center, Tel Aviv, 6701101, Israel.",
          "bbox": [
            274.0,
            618.0,
            3000.0,
            665.0
          ],
          "confidence": 0.9887864589691162
        },
        {
          "text": "(\"Kitov'). Dexcel and Kitov are hereinafter jointly the \"Parties' and individually a \"Party.\".",
          "bbox": [
            279.0,
            678.0,
            1945.0,
            722.0
          ],
          "confidence": 0.98404461145401
        },
        {
          "text": "WHEREAS: Dexcel is a pharmaceutical company engaged in various activities including, but not limited to, the research, development,",
          "bbox": [
            275.0,
            729.0,
            2817.0,
            780.0
          ],
          "confidence": 0.9837751388549805
        },
        {
          "text": "manufacture, and marketing of various drugs and pharmaceutical specialties in various dosage forms;",
          "bbox": [
            549.0,
            795.0,
            2438.0,
            831.0
          ],
          "confidence": 0.9977880120277405
        },
        {
          "text": "WHEREAS:",
          "bbox": [
            281.0,
            848.0,
            515.0,
            884.0
          ],
          "confidence": 0.9993464946746826
        },
        {
          "text": "Kitov is a pharmaceutical company engaged in various activities including, but not limited to, the development of pharmaceutical",
          "bbox": [
            546.0,
            844.0,
            2951.0,
            890.0
          ],
          "confidence": 0.9910856485366821
        },
        {
          "text": "products;",
          "bbox": [
            551.0,
            906.0,
            732.0,
            945.0
          ],
          "confidence": 0.9994080066680908
        },
        {
          "text": "WHEREAS:",
          "bbox": [
            279.0,
            959.0,
            513.0,
            996.0
          ],
          "confidence": 0.9993117451667786
        },
        {
          "text": "Kitov and Dexcel entered into a Development Services Agreement on April 1, 2014 (\"Development Agreement'), pursuant to which",
          "bbox": [
            549.0,
            958.0,
            2991.0,
            1000.0
          ],
          "confidence": 0.9946937561035156
        },
        {
          "text": "Dexcel performed certain development services for Kitov with respect to the Product;",
          "bbox": [
            551.0,
            1016.0,
            2139.0,
            1058.0
          ],
          "confidence": 0.9957237243652344
        },
        {
          "text": "WHEREAS:",
          "bbox": [
            281.0,
            1071.0,
            515.0,
            1107.0
          ],
          "confidence": 0.9993150234222412
        },
        {
          "text": "Kitov desires that Dexcel manufacture and package the Product for Kitov in accordance with the terms of this Agreement, and Dexcel",
          "bbox": [
            546.0,
            1069.0,
            3029.0,
            1115.0
          ],
          "confidence": 0.9908015131950378
        },
        {
          "text": "is willing to manufacture and package the Product for Kitov in accordance with the terms of this Agreement..",
          "bbox": [
            547.0,
            1126.0,
            2561.0,
            1171.0
          ],
          "confidence": 0.9924741387367249
        },
        {
          "text": "NOw, THEREFORE, in consideration of the mutual covenants herein contained, the Parties, intending to be legally bound, hereby agree as",
          "bbox": [
            275.0,
            1180.0,
            2876.0,
            1228.0
          ],
          "confidence": 0.9950727820396423
        },
        {
          "text": "follows:",
          "bbox": [
            275.0,
            1237.0,
            426.0,
            1279.0
          ],
          "confidence": 0.9998461008071899
        },
        {
          "text": "1",
          "bbox": [
            277.0,
            1299.0,
            303.0,
            1330.0
          ],
          "confidence": 0.9999181032180786
        },
        {
          "text": "Definitions",
          "bbox": [
            368.0,
            1296.0,
            589.0,
            1334.0
          ],
          "confidence": 0.999856173992157
        },
        {
          "text": "For the purpose of this Agreement, the terms set forth in this clause, whether used in singular or plural form, shall mean, unless otherwise expressly.",
          "bbox": [
            277.0,
            1352.0,
            3012.0,
            1394.0
          ],
          "confidence": 0.9917291402816772
        },
        {
          "text": "provided for in this Agreement or the context otherwise requires, the following:.",
          "bbox": [
            277.0,
            1405.0,
            1749.0,
            1453.0
          ],
          "confidence": 0.9938557744026184
        },
        {
          "text": "1.1",
          "bbox": [
            379.0,
            1460.0,
            439.0,
            1506.0
          ],
          "confidence": 0.9998831748962402
        },
        {
          "text": "\"Affiliate\"' of a Party shall mean any corporation or other business entity directly or indirectly Controlled by, under common Control.",
          "bbox": [
            546.0,
            1458.0,
            3012.0,
            1509.0
          ],
          "confidence": 0.9893513917922974
        },
        {
          "text": "with, or in the Control of such Party..",
          "bbox": [
            551.0,
            1518.0,
            1222.0,
            1564.0
          ],
          "confidence": 0.9819372296333313
        },
        {
          "text": "1.2",
          "bbox": [
            377.0,
            1573.0,
            440.0,
            1619.0
          ],
          "confidence": 0.9997513890266418
        },
        {
          "text": "\"Anti-Corruption and Anti-Bribery Laws\" shall mean the United States Foreign Corrupt Practices Act of 1977, as amended, the",
          "bbox": [
            549.0,
            1577.0,
            2925.0,
            1619.0
          ],
          "confidence": 0.9937560558319092
        },
        {
          "text": "Bribery Act 2010 (2010 Chapter 23) of the Parliament of the United Kingdom, any rules or regulations under such acts, and any other",
          "bbox": [
            551.0,
            1634.0,
            3011.0,
            1676.0
          ],
          "confidence": 0.9908789992332458
        },
        {
          "text": "anti-corruption or anti-bribery statutes, laws or regulations applicable to a Party..",
          "bbox": [
            547.0,
            1687.0,
            2039.0,
            1732.0
          ],
          "confidence": 0.9931536316871643
        },
        {
          "text": "1.3",
          "bbox": [
            379.0,
            1741.0,
            440.0,
            1787.0
          ],
          "confidence": 0.9998380541801453
        },
        {
          "text": "\"API\"' shall mean the active pharmaceutical ingredients Celecoxib and Amlodipine Besylate..",
          "bbox": [
            549.0,
            1741.0,
            2277.0,
            1787.0
          ],
          "confidence": 0.9627962112426758
        },
        {
          "text": "Source: KITOV PHARMA LTD., 20-F, 3/26/2019",
          "bbox": [
            332.0,
            4437.0,
            1256.0,
            4479.0
          ],
          "confidence": 0.988348126411438
        }
      ],
      "nearby_headers": [
        {
          "text": "THE SYMBOL <****\" DENOTES PLACES WHERE PORTIONS OF THIS DOCUMENT HAVE BEEN OMITTED PURSUANT TO A REQUEST",
          "page": 0,
          "bbox": [
            304.0,
            338.0,
            3009.0,
            380.0
          ]
        },
        {
          "text": "FOR CONFIDENTIAL TREATMENT. SUCH MATERIAL WILL BE FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE",
          "page": 0,
          "bbox": [
            399.0,
            398.0,
            2907.0,
            435.0
          ]
        },
        {
          "text": "COMIMISSION.",
          "page": 0,
          "bbox": [
            1503.0,
            455.0,
            1805.0,
            492.0
          ]
        },
        {
          "text": "PRODUCT MANUFACTURING AGREEMENT",
          "page": 0,
          "bbox": [
            1216.0,
            510.0,
            2093.0,
            546.0
          ]
        },
        {
          "text": "WHEREAS:",
          "page": 0,
          "bbox": [
            281.0,
            848.0,
            515.0,
            884.0
          ]
        },
        {
          "text": "WHEREAS:",
          "page": 0,
          "bbox": [
            279.0,
            959.0,
            513.0,
            996.0
          ]
        },
        {
          "text": "WHEREAS:",
          "page": 0,
          "bbox": [
            281.0,
            1071.0,
            515.0,
            1107.0
          ]
        }
      ]
    },
    {
      "id": "KitovPharmaLtd_20190326_20-F_EX-4.15_11584449_EX-4.15_Manufacturing Agreement__Audit Rights_0_multi",
      "question": "Highlight the parts (if any) of this contract related to \"Audit Rights\" that should be reviewed by a lawyer. Details: Does a party have the right to  audit the books, records, or physical locations of the counterparty to ensure compliance with the contract?",
      "answer_text": "Kitov shall have the right (at reasonable intervals, with reasonable prior written notice and during normal business hours, and not more often than annually) to inspect Dexcel's manufacturing facilities used in the manufacture, storage, testing, and/or release for shipment of the Product.",
      "page_number": 0,
      "words": [
        {
          "text": "Exhibit 4.15",
          "bbox": [
            2798.0,
            283.0,
            3029.0,
            325.0
          ],
          "confidence": 0.9998080730438232
        },
        {
          "text": "THE SYMBOL <****\" DENOTES PLACES WHERE PORTIONS OF THIS DOCUMENT HAVE BEEN OMITTED PURSUANT TO A REQUEST",
          "bbox": [
            304.0,
            338.0,
            3009.0,
            380.0
          ],
          "confidence": 0.983539879322052
        },
        {
          "text": "FOR CONFIDENTIAL TREATMENT. SUCH MATERIAL WILL BE FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE",
          "bbox": [
            399.0,
            398.0,
            2907.0,
            435.0
          ],
          "confidence": 0.9926196932792664
        },
        {
          "text": "COMIMISSION.",
          "bbox": [
            1503.0,
            455.0,
            1805.0,
            492.0
          ],
          "confidence": 0.9562864303588867
        },
        {
          "text": "PRODUCT MANUFACTURING AGREEMENT",
          "bbox": [
            1216.0,
            510.0,
            2093.0,
            546.0
          ],
          "confidence": 0.994750440120697
        },
        {
          "text": "This Product Manufacturing Agreement (\"Agreement') is made as of the Effective Date by and between DEXCEL LTD., with its registered address.",
          "bbox": [
            275.0,
            563.0,
            3023.0,
            609.0
          ],
          "confidence": 0.989086925983429
        },
        {
          "text": "at ****, Israel (\"Dexcel'') and KITOV Pharma Ltd., with its registered office at 132 Menachem Begin Road, Azrieli Center, Tel Aviv, 6701101, Israel.",
          "bbox": [
            274.0,
            618.0,
            3000.0,
            665.0
          ],
          "confidence": 0.9887864589691162
        },
        {
          "text": "(\"Kitov'). Dexcel and Kitov are hereinafter jointly the \"Parties' and individually a \"Party.\".",
          "bbox": [
            279.0,
            678.0,
            1945.0,
            722.0
          ],
          "confidence": 0.98404461145401
        },
        {
          "text": "WHEREAS: Dexcel is a pharmaceutical company engaged in various activities including, but not limited to, the research, development,",
          "bbox": [
            275.0,
            729.0,
            2817.0,
            780.0
          ],
          "confidence": 0.9837751388549805
        },
        {
          "text": "manufacture, and marketing of various drugs and pharmaceutical specialties in various dosage forms;",
          "bbox": [
            549.0,
            795.0,
            2438.0,
            831.0
          ],
          "confidence": 0.9977880120277405
        },
        {
          "text": "WHEREAS:",
          "bbox": [
            281.0,
            848.0,
            515.0,
            884.0
          ],
          "confidence": 0.9993464946746826
        },
        {
          "text": "Kitov is a pharmaceutical company engaged in various activities including, but not limited to, the development of pharmaceutical",
          "bbox": [
            546.0,
            844.0,
            2951.0,
            890.0
          ],
          "confidence": 0.9910856485366821
        },
        {
          "text": "products;",
          "bbox": [
            551.0,
            906.0,
            732.0,
            945.0
          ],
          "confidence": 0.9994080066680908
        },
        {
          "text": "WHEREAS:",
          "bbox": [
            279.0,
            959.0,
            513.0,
            996.0
          ],
          "confidence": 0.9993117451667786
        },
        {
          "text": "Kitov and Dexcel entered into a Development Services Agreement on April 1, 2014 (\"Development Agreement'), pursuant to which",
          "bbox": [
            549.0,
            958.0,
            2991.0,
            1000.0
          ],
          "confidence": 0.9946937561035156
        },
        {
          "text": "Dexcel performed certain development services for Kitov with respect to the Product;",
          "bbox": [
            551.0,
            1016.0,
            2139.0,
            1058.0
          ],
          "confidence": 0.9957237243652344
        },
        {
          "text": "WHEREAS:",
          "bbox": [
            281.0,
            1071.0,
            515.0,
            1107.0
          ],
          "confidence": 0.9993150234222412
        },
        {
          "text": "Kitov desires that Dexcel manufacture and package the Product for Kitov in accordance with the terms of this Agreement, and Dexcel",
          "bbox": [
            546.0,
            1069.0,
            3029.0,
            1115.0
          ],
          "confidence": 0.9908015131950378
        },
        {
          "text": "is willing to manufacture and package the Product for Kitov in accordance with the terms of this Agreement..",
          "bbox": [
            547.0,
            1126.0,
            2561.0,
            1171.0
          ],
          "confidence": 0.9924741387367249
        },
        {
          "text": "NOw, THEREFORE, in consideration of the mutual covenants herein contained, the Parties, intending to be legally bound, hereby agree as",
          "bbox": [
            275.0,
            1180.0,
            2876.0,
            1228.0
          ],
          "confidence": 0.9950727820396423
        },
        {
          "text": "follows:",
          "bbox": [
            275.0,
            1237.0,
            426.0,
            1279.0
          ],
          "confidence": 0.9998461008071899
        },
        {
          "text": "1",
          "bbox": [
            277.0,
            1299.0,
            303.0,
            1330.0
          ],
          "confidence": 0.9999181032180786
        },
        {
          "text": "Definitions",
          "bbox": [
            368.0,
            1296.0,
            589.0,
            1334.0
          ],
          "confidence": 0.999856173992157
        },
        {
          "text": "For the purpose of this Agreement, the terms set forth in this clause, whether used in singular or plural form, shall mean, unless otherwise expressly.",
          "bbox": [
            277.0,
            1352.0,
            3012.0,
            1394.0
          ],
          "confidence": 0.9917291402816772
        },
        {
          "text": "provided for in this Agreement or the context otherwise requires, the following:.",
          "bbox": [
            277.0,
            1405.0,
            1749.0,
            1453.0
          ],
          "confidence": 0.9938557744026184
        },
        {
          "text": "1.1",
          "bbox": [
            379.0,
            1460.0,
            439.0,
            1506.0
          ],
          "confidence": 0.9998831748962402
        },
        {
          "text": "\"Affiliate\"' of a Party shall mean any corporation or other business entity directly or indirectly Controlled by, under common Control.",
          "bbox": [
            546.0,
            1458.0,
            3012.0,
            1509.0
          ],
          "confidence": 0.9893513917922974
        },
        {
          "text": "with, or in the Control of such Party..",
          "bbox": [
            551.0,
            1518.0,
            1222.0,
            1564.0
          ],
          "confidence": 0.9819372296333313
        },
        {
          "text": "1.2",
          "bbox": [
            377.0,
            1573.0,
            440.0,
            1619.0
          ],
          "confidence": 0.9997513890266418
        },
        {
          "text": "\"Anti-Corruption and Anti-Bribery Laws\" shall mean the United States Foreign Corrupt Practices Act of 1977, as amended, the",
          "bbox": [
            549.0,
            1577.0,
            2925.0,
            1619.0
          ],
          "confidence": 0.9937560558319092
        },
        {
          "text": "Bribery Act 2010 (2010 Chapter 23) of the Parliament of the United Kingdom, any rules or regulations under such acts, and any other",
          "bbox": [
            551.0,
            1634.0,
            3011.0,
            1676.0
          ],
          "confidence": 0.9908789992332458
        },
        {
          "text": "anti-corruption or anti-bribery statutes, laws or regulations applicable to a Party..",
          "bbox": [
            547.0,
            1687.0,
            2039.0,
            1732.0
          ],
          "confidence": 0.9931536316871643
        },
        {
          "text": "1.3",
          "bbox": [
            379.0,
            1741.0,
            440.0,
            1787.0
          ],
          "confidence": 0.9998380541801453
        },
        {
          "text": "\"API\"' shall mean the active pharmaceutical ingredients Celecoxib and Amlodipine Besylate..",
          "bbox": [
            549.0,
            1741.0,
            2277.0,
            1787.0
          ],
          "confidence": 0.9627962112426758
        },
        {
          "text": "Source: KITOV PHARMA LTD., 20-F, 3/26/2019",
          "bbox": [
            332.0,
            4437.0,
            1256.0,
            4479.0
          ],
          "confidence": 0.988348126411438
        }
      ],
      "multi_page": true,
      "part_of": 2,
      "nearby_headers": [
        {
          "text": "THE SYMBOL <****\" DENOTES PLACES WHERE PORTIONS OF THIS DOCUMENT HAVE BEEN OMITTED PURSUANT TO A REQUEST",
          "page": 0,
          "bbox": [
            304.0,
            338.0,
            3009.0,
            380.0
          ]
        },
        {
          "text": "FOR CONFIDENTIAL TREATMENT. SUCH MATERIAL WILL BE FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE",
          "page": 0,
          "bbox": [
            399.0,
            398.0,
            2907.0,
            435.0
          ]
        },
        {
          "text": "COMIMISSION.",
          "page": 0,
          "bbox": [
            1503.0,
            455.0,
            1805.0,
            492.0
          ]
        },
        {
          "text": "PRODUCT MANUFACTURING AGREEMENT",
          "page": 0,
          "bbox": [
            1216.0,
            510.0,
            2093.0,
            546.0
          ]
        },
        {
          "text": "WHEREAS:",
          "page": 0,
          "bbox": [
            281.0,
            848.0,
            515.0,
            884.0
          ]
        },
        {
          "text": "WHEREAS:",
          "page": 0,
          "bbox": [
            279.0,
            959.0,
            513.0,
            996.0
          ]
        },
        {
          "text": "WHEREAS:",
          "page": 0,
          "bbox": [
            281.0,
            1071.0,
            515.0,
            1107.0
          ]
        }
      ]
    },
    {
      "id": "KitovPharmaLtd_20190326_20-F_EX-4.15_11584449_EX-4.15_Manufacturing Agreement__Audit Rights_1_multi",
      "question": "Highlight the parts (if any) of this contract related to \"Audit Rights\" that should be reviewed by a lawyer. Details: Does a party have the right to  audit the books, records, or physical locations of the counterparty to ensure compliance with the contract?",
      "answer_text": "Kitov shall have the right (at reasonable intervals, with reasonable prior written notice and during normal business hours, and not more often than annually) to inspect Dexcel's manufacturing facilities used in the manufacture, storage, testing, and/or release for shipment of the Product.",
      "page_number": 1,
      "words": [
        {
          "text": "1.4",
          "bbox": [
            379.0,
            281.0,
            442.0,
            327.0
          ],
          "confidence": 0.9997868537902832
        },
        {
          "text": "\"Batch' shall mean the defined quantity of the Product processed in a single process or series of processes in a manner designed to.",
          "bbox": [
            549.0,
            281.0,
            3011.0,
            329.0
          ],
          "confidence": 0.9841217398643494
        },
        {
          "text": "be homogeneous. The Batch size for the Product is **** tablets.",
          "bbox": [
            551.0,
            338.0,
            1756.0,
            382.0
          ],
          "confidence": 0.9994081258773804
        },
        {
          "text": "1.5",
          "bbox": [
            376.0,
            390.0,
            443.0,
            443.0
          ],
          "confidence": 0.9997324347496033
        },
        {
          "text": "\"cGMPs\" or \"Good Manufacturing Practice\"' shall mean the part of quality assurance which ensures that the Product is consistently.",
          "bbox": [
            549.0,
            395.0,
            3023.0,
            440.0
          ],
          "confidence": 0.985264241695404
        },
        {
          "text": "produced and controlled to the quality standards appropriate to their intended use, the principles and guidelines of which are",
          "bbox": [
            549.0,
            451.0,
            2884.0,
            499.0
          ],
          "confidence": 0.9912954568862915
        },
        {
          "text": "specified in European Commission Directive 2003/94/EC and the FDA's current Good Manufacturing Practices, particularly 21 CFR ",
          "bbox": [
            547.0,
            506.0,
            3003.0,
            557.0
          ],
          "confidence": 0.995246410369873
        },
        {
          "text": "210 et seq., and 21 CFR $$ 600-610, as both may be amended from time to time..",
          "bbox": [
            549.0,
            565.0,
            2006.0,
            607.0
          ],
          "confidence": 0.9747835993766785
        },
        {
          "text": "1.6",
          "bbox": [
            379.0,
            619.0,
            442.0,
            663.0
          ],
          "confidence": 0.9999213218688965
        },
        {
          "text": "\"Change of Control' shall mean (i) any change, sale, merger, reorganization, or any other event or action that results in a third party,",
          "bbox": [
            547.0,
            618.0,
            3005.0,
            669.0
          ],
          "confidence": 0.9930126070976257
        },
        {
          "text": "which is a material competitor to the other Party to this agreement, acquiring: (a) all or substantially all of the business or assets of a.",
          "bbox": [
            551.0,
            678.0,
            3002.0,
            722.0
          ],
          "confidence": 0.9852778911590576
        },
        {
          "text": "Party relating to this Agreement, (b) Control, directly or indirectly, of such Party (and/or any corporate entity that Controls, directly.",
          "bbox": [
            551.0,
            735.0,
            2985.0,
            778.0
          ],
          "confidence": 0.9932605624198914
        },
        {
          "text": "or indirectly, such Party), or (ii) any assignment or delegation of, sale or transfer of a Party's rights and obligations under this",
          "bbox": [
            549.0,
            789.0,
            2878.0,
            835.0
          ],
          "confidence": 0.9923490881919861
        },
        {
          "text": "Agreement (or any part hereof) to a third party.",
          "bbox": [
            555.0,
            848.0,
            1426.0,
            890.0
          ],
          "confidence": 0.9961597323417664
        },
        {
          "text": "Notwithstanding anything in the immediately preceding paragraph to the contrary, where the Party in question is Dexcel, any of the",
          "bbox": [
            549.0,
            903.0,
            2991.0,
            945.0
          ],
          "confidence": 0.9957303404808044
        },
        {
          "text": "foregoing events or actions shall not be considered a Change of Control where any one or more of the relevant third party or parties.",
          "bbox": [
            551.0,
            961.0,
            3007.0,
            1003.0
          ],
          "confidence": 0.9899225234985352
        },
        {
          "text": "referred to in clause (i) above is (A) a Family Member, or (B) any entity Controlled by Mr. **** and/or a Family Member.",
          "bbox": [
            544.0,
            1005.0,
            2788.0,
            1064.0
          ],
          "confidence": 0.9933032989501953
        },
        {
          "text": "1.7",
          "bbox": [
            379.0,
            1067.0,
            442.0,
            1113.0
          ],
          "confidence": 0.9998312592506409
        },
        {
          "text": "\"Claims' shall mean any demands, claims, actions, causes of action, assessments, losses, damages, injuries, liabilities, costs and.",
          "bbox": [
            549.0,
            1069.0,
            2953.0,
            1115.0
          ],
          "confidence": 0.9854910969734192
        },
        {
          "text": "expenses (including, without limitation, reasonable attorneys' fees and expenses) filed, raised, initiated or made by any governmental.",
          "bbox": [
            553.0,
            1129.0,
            3021.0,
            1171.0
          ],
          "confidence": 0.992518424987793
        },
        {
          "text": "authority and/or third party.",
          "bbox": [
            551.0,
            1184.0,
            1066.0,
            1226.0
          ],
          "confidence": 0.983346164226532
        },
        {
          "text": "1.8",
          "bbox": [
            379.0,
            1235.0,
            442.0,
            1281.0
          ],
          "confidence": 0.9999089241027832
        },
        {
          "text": "\"Confidential Information\"' shall have the meaning set forth in Section 7.1.",
          "bbox": [
            549.0,
            1235.0,
            1939.0,
            1281.0
          ],
          "confidence": 0.9719286561012268
        },
        {
          "text": "1.9",
          "bbox": [
            379.0,
            1292.0,
            440.0,
            1336.0
          ],
          "confidence": 0.9999080300331116
        },
        {
          "text": "\"Confirmed Order' shall have the meaning set forth in Section 3.3.2.",
          "bbox": [
            549.0,
            1292.0,
            1834.0,
            1338.0
          ],
          "confidence": 0.9867768883705139
        },
        {
          "text": "1.10",
          "bbox": [
            379.0,
            1347.0,
            462.0,
            1394.0
          ],
          "confidence": 0.9999012351036072
        },
        {
          "text": "\"Control' or \"Controlled' shall mean possession of more than fifty percent (50%) of the share capital of a corporation or other",
          "bbox": [
            547.0,
            1345.0,
            2915.0,
            1398.0
          ],
          "confidence": 0.981292724609375
        },
        {
          "text": "business entity, and/or the power to direct or cause the direction of the management and policies of a corporation or other entity",
          "bbox": [
            549.0,
            1405.0,
            2936.0,
            1451.0
          ],
          "confidence": 0.9941077828407288
        },
        {
          "text": "whether through the ownership of voting securities, by contract or otherwise..",
          "bbox": [
            553.0,
            1467.0,
            1996.0,
            1504.0
          ],
          "confidence": 0.9934757947921753
        },
        {
          "text": "1.11",
          "bbox": [
            379.0,
            1517.0,
            455.0,
            1561.0
          ],
          "confidence": 0.999779224395752
        },
        {
          "text": "\"Delivery' shall mean the time when the Product is placed at the disposal of Kitov at Dexcel's Facility based on an ****",
          "bbox": [
            546.0,
            1508.0,
            2799.0,
            1568.0
          ],
          "confidence": 0.992178738117218
        },
        {
          "text": "(Incoterms 2010).",
          "bbox": [
            555.0,
            1579.0,
            904.0,
            1617.0
          ],
          "confidence": 0.99842768907547
        },
        {
          "text": "1.12",
          "bbox": [
            377.0,
            1626.0,
            462.0,
            1674.0
          ],
          "confidence": 0.9999103546142578
        },
        {
          "text": "\"Distributors\" shall mean any Person under contract with Kitov or any of its Affiliates for the distribution of the Product in a certain",
          "bbox": [
            553.0,
            1634.0,
            3018.0,
            1670.0
          ],
          "confidence": 0.9918192625045776
        },
        {
          "text": "territory or territories..",
          "bbox": [
            551.0,
            1692.0,
            946.0,
            1729.0
          ],
          "confidence": 0.9840478301048279
        },
        {
          "text": "1.13",
          "bbox": [
            381.0,
            1741.0,
            459.0,
            1785.0
          ],
          "confidence": 0.8832098245620728
        },
        {
          "text": "\"Effective Date' shall mean the date of signature of the last Party to execute this Agreement..",
          "bbox": [
            549.0,
            1741.0,
            2267.0,
            1787.0
          ],
          "confidence": 0.9844200611114502
        },
        {
          "text": "1.14",
          "bbox": [
            379.0,
            1798.0,
            460.0,
            1840.0
          ],
          "confidence": 0.9994210004806519
        },
        {
          "text": "\"EMA\" means the European Medicines Agency or any successor entity.",
          "bbox": [
            549.0,
            1798.0,
            1898.0,
            1846.0
          ],
          "confidence": 0.9979910254478455
        },
        {
          "text": "1.15",
          "bbox": [
            379.0,
            1851.0,
            460.0,
            1900.0
          ],
          "confidence": 0.9995757341384888
        },
        {
          "text": "\"Family Member\" shall mean ****.",
          "bbox": [
            547.0,
            1847.0,
            1222.0,
            1902.0
          ],
          "confidence": 0.9885128736495972
        },
        {
          "text": "1.16",
          "bbox": [
            379.0,
            1908.0,
            462.0,
            1955.0
          ],
          "confidence": 0.9999197125434875
        },
        {
          "text": "\"FDA\" means the U.S. Food and Drug Administration or any successor entity..",
          "bbox": [
            549.0,
            1911.0,
            2005.0,
            1953.0
          ],
          "confidence": 0.986582338809967
        },
        {
          "text": "2",
          "bbox": [
            1638.0,
            2025.0,
            1669.0,
            2061.0
          ],
          "confidence": 0.999761164188385
        },
        {
          "text": "Source: KITOV PHARMA LTD., 20-F, 3/26/2019",
          "bbox": [
            332.0,
            4437.0,
            1256.0,
            4479.0
          ],
          "confidence": 0.989766538143158
        }
      ],
      "multi_page": true,
      "part_of": 2
    },
    {
      "id": "KitovPharmaLtd_20190326_20-F_EX-4.15_11584449_EX-4.15_Manufacturing Agreement__Uncapped Liability_0",
      "question": "Highlight the parts (if any) of this contract related to \"Uncapped Liability\" that should be reviewed by a lawyer. Details: Is a party’s liability uncapped upon the breach of its obligation in the contract? This also includes uncap liability for a particular type of breach such as IP infringement or breach of confidentiality obligation.",
      "answer_text": "Nothing in this Section ​8.7 shall operate to limit or exclude any liability under Section ​8.5 with respect to a Claim, or for fraud, or for breach by a Party of the provisions of Article ​7.",
      "page_number": 0,
      "words": [
        {
          "text": "Exhibit 4.15",
          "bbox": [
            2798.0,
            283.0,
            3029.0,
            325.0
          ],
          "confidence": 0.9998080730438232
        },
        {
          "text": "THE SYMBOL <****\" DENOTES PLACES WHERE PORTIONS OF THIS DOCUMENT HAVE BEEN OMITTED PURSUANT TO A REQUEST",
          "bbox": [
            304.0,
            338.0,
            3009.0,
            380.0
          ],
          "confidence": 0.983539879322052
        },
        {
          "text": "FOR CONFIDENTIAL TREATMENT. SUCH MATERIAL WILL BE FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE",
          "bbox": [
            399.0,
            398.0,
            2907.0,
            435.0
          ],
          "confidence": 0.9926196932792664
        },
        {
          "text": "COMIMISSION.",
          "bbox": [
            1503.0,
            455.0,
            1805.0,
            492.0
          ],
          "confidence": 0.9562864303588867
        },
        {
          "text": "PRODUCT MANUFACTURING AGREEMENT",
          "bbox": [
            1216.0,
            510.0,
            2093.0,
            546.0
          ],
          "confidence": 0.994750440120697
        },
        {
          "text": "This Product Manufacturing Agreement (\"Agreement') is made as of the Effective Date by and between DEXCEL LTD., with its registered address.",
          "bbox": [
            275.0,
            563.0,
            3023.0,
            609.0
          ],
          "confidence": 0.989086925983429
        },
        {
          "text": "at ****, Israel (\"Dexcel'') and KITOV Pharma Ltd., with its registered office at 132 Menachem Begin Road, Azrieli Center, Tel Aviv, 6701101, Israel.",
          "bbox": [
            274.0,
            618.0,
            3000.0,
            665.0
          ],
          "confidence": 0.9887864589691162
        },
        {
          "text": "(\"Kitov'). Dexcel and Kitov are hereinafter jointly the \"Parties' and individually a \"Party.\".",
          "bbox": [
            279.0,
            678.0,
            1945.0,
            722.0
          ],
          "confidence": 0.98404461145401
        },
        {
          "text": "WHEREAS: Dexcel is a pharmaceutical company engaged in various activities including, but not limited to, the research, development,",
          "bbox": [
            275.0,
            729.0,
            2817.0,
            780.0
          ],
          "confidence": 0.9837751388549805
        },
        {
          "text": "manufacture, and marketing of various drugs and pharmaceutical specialties in various dosage forms;",
          "bbox": [
            549.0,
            795.0,
            2438.0,
            831.0
          ],
          "confidence": 0.9977880120277405
        },
        {
          "text": "WHEREAS:",
          "bbox": [
            281.0,
            848.0,
            515.0,
            884.0
          ],
          "confidence": 0.9993464946746826
        },
        {
          "text": "Kitov is a pharmaceutical company engaged in various activities including, but not limited to, the development of pharmaceutical",
          "bbox": [
            546.0,
            844.0,
            2951.0,
            890.0
          ],
          "confidence": 0.9910856485366821
        },
        {
          "text": "products;",
          "bbox": [
            551.0,
            906.0,
            732.0,
            945.0
          ],
          "confidence": 0.9994080066680908
        },
        {
          "text": "WHEREAS:",
          "bbox": [
            279.0,
            959.0,
            513.0,
            996.0
          ],
          "confidence": 0.9993117451667786
        },
        {
          "text": "Kitov and Dexcel entered into a Development Services Agreement on April 1, 2014 (\"Development Agreement'), pursuant to which",
          "bbox": [
            549.0,
            958.0,
            2991.0,
            1000.0
          ],
          "confidence": 0.9946937561035156
        },
        {
          "text": "Dexcel performed certain development services for Kitov with respect to the Product;",
          "bbox": [
            551.0,
            1016.0,
            2139.0,
            1058.0
          ],
          "confidence": 0.9957237243652344
        },
        {
          "text": "WHEREAS:",
          "bbox": [
            281.0,
            1071.0,
            515.0,
            1107.0
          ],
          "confidence": 0.9993150234222412
        },
        {
          "text": "Kitov desires that Dexcel manufacture and package the Product for Kitov in accordance with the terms of this Agreement, and Dexcel",
          "bbox": [
            546.0,
            1069.0,
            3029.0,
            1115.0
          ],
          "confidence": 0.9908015131950378
        },
        {
          "text": "is willing to manufacture and package the Product for Kitov in accordance with the terms of this Agreement..",
          "bbox": [
            547.0,
            1126.0,
            2561.0,
            1171.0
          ],
          "confidence": 0.9924741387367249
        },
        {
          "text": "NOw, THEREFORE, in consideration of the mutual covenants herein contained, the Parties, intending to be legally bound, hereby agree as",
          "bbox": [
            275.0,
            1180.0,
            2876.0,
            1228.0
          ],
          "confidence": 0.9950727820396423
        },
        {
          "text": "follows:",
          "bbox": [
            275.0,
            1237.0,
            426.0,
            1279.0
          ],
          "confidence": 0.9998461008071899
        },
        {
          "text": "1",
          "bbox": [
            277.0,
            1299.0,
            303.0,
            1330.0
          ],
          "confidence": 0.9999181032180786
        },
        {
          "text": "Definitions",
          "bbox": [
            368.0,
            1296.0,
            589.0,
            1334.0
          ],
          "confidence": 0.999856173992157
        },
        {
          "text": "For the purpose of this Agreement, the terms set forth in this clause, whether used in singular or plural form, shall mean, unless otherwise expressly.",
          "bbox": [
            277.0,
            1352.0,
            3012.0,
            1394.0
          ],
          "confidence": 0.9917291402816772
        },
        {
          "text": "provided for in this Agreement or the context otherwise requires, the following:.",
          "bbox": [
            277.0,
            1405.0,
            1749.0,
            1453.0
          ],
          "confidence": 0.9938557744026184
        },
        {
          "text": "1.1",
          "bbox": [
            379.0,
            1460.0,
            439.0,
            1506.0
          ],
          "confidence": 0.9998831748962402
        },
        {
          "text": "\"Affiliate\"' of a Party shall mean any corporation or other business entity directly or indirectly Controlled by, under common Control.",
          "bbox": [
            546.0,
            1458.0,
            3012.0,
            1509.0
          ],
          "confidence": 0.9893513917922974
        },
        {
          "text": "with, or in the Control of such Party..",
          "bbox": [
            551.0,
            1518.0,
            1222.0,
            1564.0
          ],
          "confidence": 0.9819372296333313
        },
        {
          "text": "1.2",
          "bbox": [
            377.0,
            1573.0,
            440.0,
            1619.0
          ],
          "confidence": 0.9997513890266418
        },
        {
          "text": "\"Anti-Corruption and Anti-Bribery Laws\" shall mean the United States Foreign Corrupt Practices Act of 1977, as amended, the",
          "bbox": [
            549.0,
            1577.0,
            2925.0,
            1619.0
          ],
          "confidence": 0.9937560558319092
        },
        {
          "text": "Bribery Act 2010 (2010 Chapter 23) of the Parliament of the United Kingdom, any rules or regulations under such acts, and any other",
          "bbox": [
            551.0,
            1634.0,
            3011.0,
            1676.0
          ],
          "confidence": 0.9908789992332458
        },
        {
          "text": "anti-corruption or anti-bribery statutes, laws or regulations applicable to a Party..",
          "bbox": [
            547.0,
            1687.0,
            2039.0,
            1732.0
          ],
          "confidence": 0.9931536316871643
        },
        {
          "text": "1.3",
          "bbox": [
            379.0,
            1741.0,
            440.0,
            1787.0
          ],
          "confidence": 0.9998380541801453
        },
        {
          "text": "\"API\"' shall mean the active pharmaceutical ingredients Celecoxib and Amlodipine Besylate..",
          "bbox": [
            549.0,
            1741.0,
            2277.0,
            1787.0
          ],
          "confidence": 0.9627962112426758
        },
        {
          "text": "Source: KITOV PHARMA LTD., 20-F, 3/26/2019",
          "bbox": [
            332.0,
            4437.0,
            1256.0,
            4479.0
          ],
          "confidence": 0.988348126411438
        }
      ],
      "nearby_headers": [
        {
          "text": "THE SYMBOL <****\" DENOTES PLACES WHERE PORTIONS OF THIS DOCUMENT HAVE BEEN OMITTED PURSUANT TO A REQUEST",
          "page": 0,
          "bbox": [
            304.0,
            338.0,
            3009.0,
            380.0
          ]
        },
        {
          "text": "FOR CONFIDENTIAL TREATMENT. SUCH MATERIAL WILL BE FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE",
          "page": 0,
          "bbox": [
            399.0,
            398.0,
            2907.0,
            435.0
          ]
        },
        {
          "text": "COMIMISSION.",
          "page": 0,
          "bbox": [
            1503.0,
            455.0,
            1805.0,
            492.0
          ]
        },
        {
          "text": "PRODUCT MANUFACTURING AGREEMENT",
          "page": 0,
          "bbox": [
            1216.0,
            510.0,
            2093.0,
            546.0
          ]
        },
        {
          "text": "WHEREAS:",
          "page": 0,
          "bbox": [
            281.0,
            848.0,
            515.0,
            884.0
          ]
        },
        {
          "text": "WHEREAS:",
          "page": 0,
          "bbox": [
            279.0,
            959.0,
            513.0,
            996.0
          ]
        },
        {
          "text": "WHEREAS:",
          "page": 0,
          "bbox": [
            281.0,
            1071.0,
            515.0,
            1107.0
          ]
        }
      ]
    },
    {
      "id": "KitovPharmaLtd_20190326_20-F_EX-4.15_11584449_EX-4.15_Manufacturing Agreement__Cap On Liability_0_multi",
      "question": "Highlight the parts (if any) of this contract related to \"Cap On Liability\" that should be reviewed by a lawyer. Details: Does the contract include a cap on liability upon the breach of a party’s obligation? This includes time limitation for the counterparty to bring claims or maximum amount for recovery.",
      "answer_text": "Dexcel's responsibility for Product supplied by it to Kitov failing to meet the Specifications shall be limited to the replacement of the Product or the refund of the Supply Price paid by Kitov for such order, as agreed by the parties, except as otherwise provided under this Agreement.",
      "page_number": 0,
      "words": [
        {
          "text": "Exhibit 4.15",
          "bbox": [
            2798.0,
            283.0,
            3029.0,
            325.0
          ],
          "confidence": 0.9998080730438232
        },
        {
          "text": "THE SYMBOL <****\" DENOTES PLACES WHERE PORTIONS OF THIS DOCUMENT HAVE BEEN OMITTED PURSUANT TO A REQUEST",
          "bbox": [
            304.0,
            338.0,
            3009.0,
            380.0
          ],
          "confidence": 0.983539879322052
        },
        {
          "text": "FOR CONFIDENTIAL TREATMENT. SUCH MATERIAL WILL BE FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE",
          "bbox": [
            399.0,
            398.0,
            2907.0,
            435.0
          ],
          "confidence": 0.9926196932792664
        },
        {
          "text": "COMIMISSION.",
          "bbox": [
            1503.0,
            455.0,
            1805.0,
            492.0
          ],
          "confidence": 0.9562864303588867
        },
        {
          "text": "PRODUCT MANUFACTURING AGREEMENT",
          "bbox": [
            1216.0,
            510.0,
            2093.0,
            546.0
          ],
          "confidence": 0.994750440120697
        },
        {
          "text": "This Product Manufacturing Agreement (\"Agreement') is made as of the Effective Date by and between DEXCEL LTD., with its registered address.",
          "bbox": [
            275.0,
            563.0,
            3023.0,
            609.0
          ],
          "confidence": 0.989086925983429
        },
        {
          "text": "at ****, Israel (\"Dexcel'') and KITOV Pharma Ltd., with its registered office at 132 Menachem Begin Road, Azrieli Center, Tel Aviv, 6701101, Israel.",
          "bbox": [
            274.0,
            618.0,
            3000.0,
            665.0
          ],
          "confidence": 0.9887864589691162
        },
        {
          "text": "(\"Kitov'). Dexcel and Kitov are hereinafter jointly the \"Parties' and individually a \"Party.\".",
          "bbox": [
            279.0,
            678.0,
            1945.0,
            722.0
          ],
          "confidence": 0.98404461145401
        },
        {
          "text": "WHEREAS: Dexcel is a pharmaceutical company engaged in various activities including, but not limited to, the research, development,",
          "bbox": [
            275.0,
            729.0,
            2817.0,
            780.0
          ],
          "confidence": 0.9837751388549805
        },
        {
          "text": "manufacture, and marketing of various drugs and pharmaceutical specialties in various dosage forms;",
          "bbox": [
            549.0,
            795.0,
            2438.0,
            831.0
          ],
          "confidence": 0.9977880120277405
        },
        {
          "text": "WHEREAS:",
          "bbox": [
            281.0,
            848.0,
            515.0,
            884.0
          ],
          "confidence": 0.9993464946746826
        },
        {
          "text": "Kitov is a pharmaceutical company engaged in various activities including, but not limited to, the development of pharmaceutical",
          "bbox": [
            546.0,
            844.0,
            2951.0,
            890.0
          ],
          "confidence": 0.9910856485366821
        },
        {
          "text": "products;",
          "bbox": [
            551.0,
            906.0,
            732.0,
            945.0
          ],
          "confidence": 0.9994080066680908
        },
        {
          "text": "WHEREAS:",
          "bbox": [
            279.0,
            959.0,
            513.0,
            996.0
          ],
          "confidence": 0.9993117451667786
        },
        {
          "text": "Kitov and Dexcel entered into a Development Services Agreement on April 1, 2014 (\"Development Agreement'), pursuant to which",
          "bbox": [
            549.0,
            958.0,
            2991.0,
            1000.0
          ],
          "confidence": 0.9946937561035156
        },
        {
          "text": "Dexcel performed certain development services for Kitov with respect to the Product;",
          "bbox": [
            551.0,
            1016.0,
            2139.0,
            1058.0
          ],
          "confidence": 0.9957237243652344
        },
        {
          "text": "WHEREAS:",
          "bbox": [
            281.0,
            1071.0,
            515.0,
            1107.0
          ],
          "confidence": 0.9993150234222412
        },
        {
          "text": "Kitov desires that Dexcel manufacture and package the Product for Kitov in accordance with the terms of this Agreement, and Dexcel",
          "bbox": [
            546.0,
            1069.0,
            3029.0,
            1115.0
          ],
          "confidence": 0.9908015131950378
        },
        {
          "text": "is willing to manufacture and package the Product for Kitov in accordance with the terms of this Agreement..",
          "bbox": [
            547.0,
            1126.0,
            2561.0,
            1171.0
          ],
          "confidence": 0.9924741387367249
        },
        {
          "text": "NOw, THEREFORE, in consideration of the mutual covenants herein contained, the Parties, intending to be legally bound, hereby agree as",
          "bbox": [
            275.0,
            1180.0,
            2876.0,
            1228.0
          ],
          "confidence": 0.9950727820396423
        },
        {
          "text": "follows:",
          "bbox": [
            275.0,
            1237.0,
            426.0,
            1279.0
          ],
          "confidence": 0.9998461008071899
        },
        {
          "text": "1",
          "bbox": [
            277.0,
            1299.0,
            303.0,
            1330.0
          ],
          "confidence": 0.9999181032180786
        },
        {
          "text": "Definitions",
          "bbox": [
            368.0,
            1296.0,
            589.0,
            1334.0
          ],
          "confidence": 0.999856173992157
        },
        {
          "text": "For the purpose of this Agreement, the terms set forth in this clause, whether used in singular or plural form, shall mean, unless otherwise expressly.",
          "bbox": [
            277.0,
            1352.0,
            3012.0,
            1394.0
          ],
          "confidence": 0.9917291402816772
        },
        {
          "text": "provided for in this Agreement or the context otherwise requires, the following:.",
          "bbox": [
            277.0,
            1405.0,
            1749.0,
            1453.0
          ],
          "confidence": 0.9938557744026184
        },
        {
          "text": "1.1",
          "bbox": [
            379.0,
            1460.0,
            439.0,
            1506.0
          ],
          "confidence": 0.9998831748962402
        },
        {
          "text": "\"Affiliate\"' of a Party shall mean any corporation or other business entity directly or indirectly Controlled by, under common Control.",
          "bbox": [
            546.0,
            1458.0,
            3012.0,
            1509.0
          ],
          "confidence": 0.9893513917922974
        },
        {
          "text": "with, or in the Control of such Party..",
          "bbox": [
            551.0,
            1518.0,
            1222.0,
            1564.0
          ],
          "confidence": 0.9819372296333313
        },
        {
          "text": "1.2",
          "bbox": [
            377.0,
            1573.0,
            440.0,
            1619.0
          ],
          "confidence": 0.9997513890266418
        },
        {
          "text": "\"Anti-Corruption and Anti-Bribery Laws\" shall mean the United States Foreign Corrupt Practices Act of 1977, as amended, the",
          "bbox": [
            549.0,
            1577.0,
            2925.0,
            1619.0
          ],
          "confidence": 0.9937560558319092
        },
        {
          "text": "Bribery Act 2010 (2010 Chapter 23) of the Parliament of the United Kingdom, any rules or regulations under such acts, and any other",
          "bbox": [
            551.0,
            1634.0,
            3011.0,
            1676.0
          ],
          "confidence": 0.9908789992332458
        },
        {
          "text": "anti-corruption or anti-bribery statutes, laws or regulations applicable to a Party..",
          "bbox": [
            547.0,
            1687.0,
            2039.0,
            1732.0
          ],
          "confidence": 0.9931536316871643
        },
        {
          "text": "1.3",
          "bbox": [
            379.0,
            1741.0,
            440.0,
            1787.0
          ],
          "confidence": 0.9998380541801453
        },
        {
          "text": "\"API\"' shall mean the active pharmaceutical ingredients Celecoxib and Amlodipine Besylate..",
          "bbox": [
            549.0,
            1741.0,
            2277.0,
            1787.0
          ],
          "confidence": 0.9627962112426758
        },
        {
          "text": "Source: KITOV PHARMA LTD., 20-F, 3/26/2019",
          "bbox": [
            332.0,
            4437.0,
            1256.0,
            4479.0
          ],
          "confidence": 0.988348126411438
        }
      ],
      "multi_page": true,
      "part_of": 2,
      "nearby_headers": [
        {
          "text": "THE SYMBOL <****\" DENOTES PLACES WHERE PORTIONS OF THIS DOCUMENT HAVE BEEN OMITTED PURSUANT TO A REQUEST",
          "page": 0,
          "bbox": [
            304.0,
            338.0,
            3009.0,
            380.0
          ]
        },
        {
          "text": "FOR CONFIDENTIAL TREATMENT. SUCH MATERIAL WILL BE FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE",
          "page": 0,
          "bbox": [
            399.0,
            398.0,
            2907.0,
            435.0
          ]
        },
        {
          "text": "COMIMISSION.",
          "page": 0,
          "bbox": [
            1503.0,
            455.0,
            1805.0,
            492.0
          ]
        },
        {
          "text": "PRODUCT MANUFACTURING AGREEMENT",
          "page": 0,
          "bbox": [
            1216.0,
            510.0,
            2093.0,
            546.0
          ]
        },
        {
          "text": "WHEREAS:",
          "page": 0,
          "bbox": [
            281.0,
            848.0,
            515.0,
            884.0
          ]
        },
        {
          "text": "WHEREAS:",
          "page": 0,
          "bbox": [
            279.0,
            959.0,
            513.0,
            996.0
          ]
        },
        {
          "text": "WHEREAS:",
          "page": 0,
          "bbox": [
            281.0,
            1071.0,
            515.0,
            1107.0
          ]
        }
      ]
    },
    {
      "id": "KitovPharmaLtd_20190326_20-F_EX-4.15_11584449_EX-4.15_Manufacturing Agreement__Cap On Liability_1_multi",
      "question": "Highlight the parts (if any) of this contract related to \"Cap On Liability\" that should be reviewed by a lawyer. Details: Does the contract include a cap on liability upon the breach of a party’s obligation? This includes time limitation for the counterparty to bring claims or maximum amount for recovery.",
      "answer_text": "Dexcel's responsibility for Product supplied by it to Kitov failing to meet the Specifications shall be limited to the replacement of the Product or the refund of the Supply Price paid by Kitov for such order, as agreed by the parties, except as otherwise provided under this Agreement.",
      "page_number": 1,
      "words": [
        {
          "text": "1.4",
          "bbox": [
            379.0,
            281.0,
            442.0,
            327.0
          ],
          "confidence": 0.9997868537902832
        },
        {
          "text": "\"Batch' shall mean the defined quantity of the Product processed in a single process or series of processes in a manner designed to.",
          "bbox": [
            549.0,
            281.0,
            3011.0,
            329.0
          ],
          "confidence": 0.9841217398643494
        },
        {
          "text": "be homogeneous. The Batch size for the Product is **** tablets.",
          "bbox": [
            551.0,
            338.0,
            1756.0,
            382.0
          ],
          "confidence": 0.9994081258773804
        },
        {
          "text": "1.5",
          "bbox": [
            376.0,
            390.0,
            443.0,
            443.0
          ],
          "confidence": 0.9997324347496033
        },
        {
          "text": "\"cGMPs\" or \"Good Manufacturing Practice\"' shall mean the part of quality assurance which ensures that the Product is consistently.",
          "bbox": [
            549.0,
            395.0,
            3023.0,
            440.0
          ],
          "confidence": 0.985264241695404
        },
        {
          "text": "produced and controlled to the quality standards appropriate to their intended use, the principles and guidelines of which are",
          "bbox": [
            549.0,
            451.0,
            2884.0,
            499.0
          ],
          "confidence": 0.9912954568862915
        },
        {
          "text": "specified in European Commission Directive 2003/94/EC and the FDA's current Good Manufacturing Practices, particularly 21 CFR ",
          "bbox": [
            547.0,
            506.0,
            3003.0,
            557.0
          ],
          "confidence": 0.995246410369873
        },
        {
          "text": "210 et seq., and 21 CFR $$ 600-610, as both may be amended from time to time..",
          "bbox": [
            549.0,
            565.0,
            2006.0,
            607.0
          ],
          "confidence": 0.9747835993766785
        },
        {
          "text": "1.6",
          "bbox": [
            379.0,
            619.0,
            442.0,
            663.0
          ],
          "confidence": 0.9999213218688965
        },
        {
          "text": "\"Change of Control' shall mean (i) any change, sale, merger, reorganization, or any other event or action that results in a third party,",
          "bbox": [
            547.0,
            618.0,
            3005.0,
            669.0
          ],
          "confidence": 0.9930126070976257
        },
        {
          "text": "which is a material competitor to the other Party to this agreement, acquiring: (a) all or substantially all of the business or assets of a.",
          "bbox": [
            551.0,
            678.0,
            3002.0,
            722.0
          ],
          "confidence": 0.9852778911590576
        },
        {
          "text": "Party relating to this Agreement, (b) Control, directly or indirectly, of such Party (and/or any corporate entity that Controls, directly.",
          "bbox": [
            551.0,
            735.0,
            2985.0,
            778.0
          ],
          "confidence": 0.9932605624198914
        },
        {
          "text": "or indirectly, such Party), or (ii) any assignment or delegation of, sale or transfer of a Party's rights and obligations under this",
          "bbox": [
            549.0,
            789.0,
            2878.0,
            835.0
          ],
          "confidence": 0.9923490881919861
        },
        {
          "text": "Agreement (or any part hereof) to a third party.",
          "bbox": [
            555.0,
            848.0,
            1426.0,
            890.0
          ],
          "confidence": 0.9961597323417664
        },
        {
          "text": "Notwithstanding anything in the immediately preceding paragraph to the contrary, where the Party in question is Dexcel, any of the",
          "bbox": [
            549.0,
            903.0,
            2991.0,
            945.0
          ],
          "confidence": 0.9957303404808044
        },
        {
          "text": "foregoing events or actions shall not be considered a Change of Control where any one or more of the relevant third party or parties.",
          "bbox": [
            551.0,
            961.0,
            3007.0,
            1003.0
          ],
          "confidence": 0.9899225234985352
        },
        {
          "text": "referred to in clause (i) above is (A) a Family Member, or (B) any entity Controlled by Mr. **** and/or a Family Member.",
          "bbox": [
            544.0,
            1005.0,
            2788.0,
            1064.0
          ],
          "confidence": 0.9933032989501953
        },
        {
          "text": "1.7",
          "bbox": [
            379.0,
            1067.0,
            442.0,
            1113.0
          ],
          "confidence": 0.9998312592506409
        },
        {
          "text": "\"Claims' shall mean any demands, claims, actions, causes of action, assessments, losses, damages, injuries, liabilities, costs and.",
          "bbox": [
            549.0,
            1069.0,
            2953.0,
            1115.0
          ],
          "confidence": 0.9854910969734192
        },
        {
          "text": "expenses (including, without limitation, reasonable attorneys' fees and expenses) filed, raised, initiated or made by any governmental.",
          "bbox": [
            553.0,
            1129.0,
            3021.0,
            1171.0
          ],
          "confidence": 0.992518424987793
        },
        {
          "text": "authority and/or third party.",
          "bbox": [
            551.0,
            1184.0,
            1066.0,
            1226.0
          ],
          "confidence": 0.983346164226532
        },
        {
          "text": "1.8",
          "bbox": [
            379.0,
            1235.0,
            442.0,
            1281.0
          ],
          "confidence": 0.9999089241027832
        },
        {
          "text": "\"Confidential Information\"' shall have the meaning set forth in Section 7.1.",
          "bbox": [
            549.0,
            1235.0,
            1939.0,
            1281.0
          ],
          "confidence": 0.9719286561012268
        },
        {
          "text": "1.9",
          "bbox": [
            379.0,
            1292.0,
            440.0,
            1336.0
          ],
          "confidence": 0.9999080300331116
        },
        {
          "text": "\"Confirmed Order' shall have the meaning set forth in Section 3.3.2.",
          "bbox": [
            549.0,
            1292.0,
            1834.0,
            1338.0
          ],
          "confidence": 0.9867768883705139
        },
        {
          "text": "1.10",
          "bbox": [
            379.0,
            1347.0,
            462.0,
            1394.0
          ],
          "confidence": 0.9999012351036072
        },
        {
          "text": "\"Control' or \"Controlled' shall mean possession of more than fifty percent (50%) of the share capital of a corporation or other",
          "bbox": [
            547.0,
            1345.0,
            2915.0,
            1398.0
          ],
          "confidence": 0.981292724609375
        },
        {
          "text": "business entity, and/or the power to direct or cause the direction of the management and policies of a corporation or other entity",
          "bbox": [
            549.0,
            1405.0,
            2936.0,
            1451.0
          ],
          "confidence": 0.9941077828407288
        },
        {
          "text": "whether through the ownership of voting securities, by contract or otherwise..",
          "bbox": [
            553.0,
            1467.0,
            1996.0,
            1504.0
          ],
          "confidence": 0.9934757947921753
        },
        {
          "text": "1.11",
          "bbox": [
            379.0,
            1517.0,
            455.0,
            1561.0
          ],
          "confidence": 0.999779224395752
        },
        {
          "text": "\"Delivery' shall mean the time when the Product is placed at the disposal of Kitov at Dexcel's Facility based on an ****",
          "bbox": [
            546.0,
            1508.0,
            2799.0,
            1568.0
          ],
          "confidence": 0.992178738117218
        },
        {
          "text": "(Incoterms 2010).",
          "bbox": [
            555.0,
            1579.0,
            904.0,
            1617.0
          ],
          "confidence": 0.99842768907547
        },
        {
          "text": "1.12",
          "bbox": [
            377.0,
            1626.0,
            462.0,
            1674.0
          ],
          "confidence": 0.9999103546142578
        },
        {
          "text": "\"Distributors\" shall mean any Person under contract with Kitov or any of its Affiliates for the distribution of the Product in a certain",
          "bbox": [
            553.0,
            1634.0,
            3018.0,
            1670.0
          ],
          "confidence": 0.9918192625045776
        },
        {
          "text": "territory or territories..",
          "bbox": [
            551.0,
            1692.0,
            946.0,
            1729.0
          ],
          "confidence": 0.9840478301048279
        },
        {
          "text": "1.13",
          "bbox": [
            381.0,
            1741.0,
            459.0,
            1785.0
          ],
          "confidence": 0.8832098245620728
        },
        {
          "text": "\"Effective Date' shall mean the date of signature of the last Party to execute this Agreement..",
          "bbox": [
            549.0,
            1741.0,
            2267.0,
            1787.0
          ],
          "confidence": 0.9844200611114502
        },
        {
          "text": "1.14",
          "bbox": [
            379.0,
            1798.0,
            460.0,
            1840.0
          ],
          "confidence": 0.9994210004806519
        },
        {
          "text": "\"EMA\" means the European Medicines Agency or any successor entity.",
          "bbox": [
            549.0,
            1798.0,
            1898.0,
            1846.0
          ],
          "confidence": 0.9979910254478455
        },
        {
          "text": "1.15",
          "bbox": [
            379.0,
            1851.0,
            460.0,
            1900.0
          ],
          "confidence": 0.9995757341384888
        },
        {
          "text": "\"Family Member\" shall mean ****.",
          "bbox": [
            547.0,
            1847.0,
            1222.0,
            1902.0
          ],
          "confidence": 0.9885128736495972
        },
        {
          "text": "1.16",
          "bbox": [
            379.0,
            1908.0,
            462.0,
            1955.0
          ],
          "confidence": 0.9999197125434875
        },
        {
          "text": "\"FDA\" means the U.S. Food and Drug Administration or any successor entity..",
          "bbox": [
            549.0,
            1911.0,
            2005.0,
            1953.0
          ],
          "confidence": 0.986582338809967
        },
        {
          "text": "2",
          "bbox": [
            1638.0,
            2025.0,
            1669.0,
            2061.0
          ],
          "confidence": 0.999761164188385
        },
        {
          "text": "Source: KITOV PHARMA LTD., 20-F, 3/26/2019",
          "bbox": [
            332.0,
            4437.0,
            1256.0,
            4479.0
          ],
          "confidence": 0.989766538143158
        }
      ],
      "multi_page": true,
      "part_of": 2
    },
    {
      "id": "KitovPharmaLtd_20190326_20-F_EX-4.15_11584449_EX-4.15_Manufacturing Agreement__Cap On Liability_0_multi",
      "question": "Highlight the parts (if any) of this contract related to \"Cap On Liability\" that should be reviewed by a lawyer. Details: Does the contract include a cap on liability upon the breach of a party’s obligation? This includes time limitation for the counterparty to bring claims or maximum amount for recovery.",
      "answer_text": "Without prejudice to any other limitation (whether effective or not) of either Party's liability, neither Party shall be liable to the other Party (whether in contract, tort (including negligence) or for breach of statutory duty or otherwise) for any loss of profits, use, opportunity, goodwill, business or anticipated savings, for any indirect, incidental, special, indirect, punitive or consequential losses (in each case, irrespective of any negligence or other act, default or omission of a Party (or its employees or agents) and regardless of whether such loss or claim was foreseeable or not and whether the other Party has been informed of the possibility of such loss).",
      "page_number": 0,
      "words": [
        {
          "text": "Exhibit 4.15",
          "bbox": [
            2798.0,
            283.0,
            3029.0,
            325.0
          ],
          "confidence": 0.9998080730438232
        },
        {
          "text": "THE SYMBOL <****\" DENOTES PLACES WHERE PORTIONS OF THIS DOCUMENT HAVE BEEN OMITTED PURSUANT TO A REQUEST",
          "bbox": [
            304.0,
            338.0,
            3009.0,
            380.0
          ],
          "confidence": 0.983539879322052
        },
        {
          "text": "FOR CONFIDENTIAL TREATMENT. SUCH MATERIAL WILL BE FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE",
          "bbox": [
            399.0,
            398.0,
            2907.0,
            435.0
          ],
          "confidence": 0.9926196932792664
        },
        {
          "text": "COMIMISSION.",
          "bbox": [
            1503.0,
            455.0,
            1805.0,
            492.0
          ],
          "confidence": 0.9562864303588867
        },
        {
          "text": "PRODUCT MANUFACTURING AGREEMENT",
          "bbox": [
            1216.0,
            510.0,
            2093.0,
            546.0
          ],
          "confidence": 0.994750440120697
        },
        {
          "text": "This Product Manufacturing Agreement (\"Agreement') is made as of the Effective Date by and between DEXCEL LTD., with its registered address.",
          "bbox": [
            275.0,
            563.0,
            3023.0,
            609.0
          ],
          "confidence": 0.989086925983429
        },
        {
          "text": "at ****, Israel (\"Dexcel'') and KITOV Pharma Ltd., with its registered office at 132 Menachem Begin Road, Azrieli Center, Tel Aviv, 6701101, Israel.",
          "bbox": [
            274.0,
            618.0,
            3000.0,
            665.0
          ],
          "confidence": 0.9887864589691162
        },
        {
          "text": "(\"Kitov'). Dexcel and Kitov are hereinafter jointly the \"Parties' and individually a \"Party.\".",
          "bbox": [
            279.0,
            678.0,
            1945.0,
            722.0
          ],
          "confidence": 0.98404461145401
        },
        {
          "text": "WHEREAS: Dexcel is a pharmaceutical company engaged in various activities including, but not limited to, the research, development,",
          "bbox": [
            275.0,
            729.0,
            2817.0,
            780.0
          ],
          "confidence": 0.9837751388549805
        },
        {
          "text": "manufacture, and marketing of various drugs and pharmaceutical specialties in various dosage forms;",
          "bbox": [
            549.0,
            795.0,
            2438.0,
            831.0
          ],
          "confidence": 0.9977880120277405
        },
        {
          "text": "WHEREAS:",
          "bbox": [
            281.0,
            848.0,
            515.0,
            884.0
          ],
          "confidence": 0.9993464946746826
        },
        {
          "text": "Kitov is a pharmaceutical company engaged in various activities including, but not limited to, the development of pharmaceutical",
          "bbox": [
            546.0,
            844.0,
            2951.0,
            890.0
          ],
          "confidence": 0.9910856485366821
        },
        {
          "text": "products;",
          "bbox": [
            551.0,
            906.0,
            732.0,
            945.0
          ],
          "confidence": 0.9994080066680908
        },
        {
          "text": "WHEREAS:",
          "bbox": [
            279.0,
            959.0,
            513.0,
            996.0
          ],
          "confidence": 0.9993117451667786
        },
        {
          "text": "Kitov and Dexcel entered into a Development Services Agreement on April 1, 2014 (\"Development Agreement'), pursuant to which",
          "bbox": [
            549.0,
            958.0,
            2991.0,
            1000.0
          ],
          "confidence": 0.9946937561035156
        },
        {
          "text": "Dexcel performed certain development services for Kitov with respect to the Product;",
          "bbox": [
            551.0,
            1016.0,
            2139.0,
            1058.0
          ],
          "confidence": 0.9957237243652344
        },
        {
          "text": "WHEREAS:",
          "bbox": [
            281.0,
            1071.0,
            515.0,
            1107.0
          ],
          "confidence": 0.9993150234222412
        },
        {
          "text": "Kitov desires that Dexcel manufacture and package the Product for Kitov in accordance with the terms of this Agreement, and Dexcel",
          "bbox": [
            546.0,
            1069.0,
            3029.0,
            1115.0
          ],
          "confidence": 0.9908015131950378
        },
        {
          "text": "is willing to manufacture and package the Product for Kitov in accordance with the terms of this Agreement..",
          "bbox": [
            547.0,
            1126.0,
            2561.0,
            1171.0
          ],
          "confidence": 0.9924741387367249
        },
        {
          "text": "NOw, THEREFORE, in consideration of the mutual covenants herein contained, the Parties, intending to be legally bound, hereby agree as",
          "bbox": [
            275.0,
            1180.0,
            2876.0,
            1228.0
          ],
          "confidence": 0.9950727820396423
        },
        {
          "text": "follows:",
          "bbox": [
            275.0,
            1237.0,
            426.0,
            1279.0
          ],
          "confidence": 0.9998461008071899
        },
        {
          "text": "1",
          "bbox": [
            277.0,
            1299.0,
            303.0,
            1330.0
          ],
          "confidence": 0.9999181032180786
        },
        {
          "text": "Definitions",
          "bbox": [
            368.0,
            1296.0,
            589.0,
            1334.0
          ],
          "confidence": 0.999856173992157
        },
        {
          "text": "For the purpose of this Agreement, the terms set forth in this clause, whether used in singular or plural form, shall mean, unless otherwise expressly.",
          "bbox": [
            277.0,
            1352.0,
            3012.0,
            1394.0
          ],
          "confidence": 0.9917291402816772
        },
        {
          "text": "provided for in this Agreement or the context otherwise requires, the following:.",
          "bbox": [
            277.0,
            1405.0,
            1749.0,
            1453.0
          ],
          "confidence": 0.9938557744026184
        },
        {
          "text": "1.1",
          "bbox": [
            379.0,
            1460.0,
            439.0,
            1506.0
          ],
          "confidence": 0.9998831748962402
        },
        {
          "text": "\"Affiliate\"' of a Party shall mean any corporation or other business entity directly or indirectly Controlled by, under common Control.",
          "bbox": [
            546.0,
            1458.0,
            3012.0,
            1509.0
          ],
          "confidence": 0.9893513917922974
        },
        {
          "text": "with, or in the Control of such Party..",
          "bbox": [
            551.0,
            1518.0,
            1222.0,
            1564.0
          ],
          "confidence": 0.9819372296333313
        },
        {
          "text": "1.2",
          "bbox": [
            377.0,
            1573.0,
            440.0,
            1619.0
          ],
          "confidence": 0.9997513890266418
        },
        {
          "text": "\"Anti-Corruption and Anti-Bribery Laws\" shall mean the United States Foreign Corrupt Practices Act of 1977, as amended, the",
          "bbox": [
            549.0,
            1577.0,
            2925.0,
            1619.0
          ],
          "confidence": 0.9937560558319092
        },
        {
          "text": "Bribery Act 2010 (2010 Chapter 23) of the Parliament of the United Kingdom, any rules or regulations under such acts, and any other",
          "bbox": [
            551.0,
            1634.0,
            3011.0,
            1676.0
          ],
          "confidence": 0.9908789992332458
        },
        {
          "text": "anti-corruption or anti-bribery statutes, laws or regulations applicable to a Party..",
          "bbox": [
            547.0,
            1687.0,
            2039.0,
            1732.0
          ],
          "confidence": 0.9931536316871643
        },
        {
          "text": "1.3",
          "bbox": [
            379.0,
            1741.0,
            440.0,
            1787.0
          ],
          "confidence": 0.9998380541801453
        },
        {
          "text": "\"API\"' shall mean the active pharmaceutical ingredients Celecoxib and Amlodipine Besylate..",
          "bbox": [
            549.0,
            1741.0,
            2277.0,
            1787.0
          ],
          "confidence": 0.9627962112426758
        },
        {
          "text": "Source: KITOV PHARMA LTD., 20-F, 3/26/2019",
          "bbox": [
            332.0,
            4437.0,
            1256.0,
            4479.0
          ],
          "confidence": 0.988348126411438
        }
      ],
      "multi_page": true,
      "part_of": 2,
      "nearby_headers": [
        {
          "text": "THE SYMBOL <****\" DENOTES PLACES WHERE PORTIONS OF THIS DOCUMENT HAVE BEEN OMITTED PURSUANT TO A REQUEST",
          "page": 0,
          "bbox": [
            304.0,
            338.0,
            3009.0,
            380.0
          ]
        },
        {
          "text": "FOR CONFIDENTIAL TREATMENT. SUCH MATERIAL WILL BE FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE",
          "page": 0,
          "bbox": [
            399.0,
            398.0,
            2907.0,
            435.0
          ]
        },
        {
          "text": "COMIMISSION.",
          "page": 0,
          "bbox": [
            1503.0,
            455.0,
            1805.0,
            492.0
          ]
        },
        {
          "text": "PRODUCT MANUFACTURING AGREEMENT",
          "page": 0,
          "bbox": [
            1216.0,
            510.0,
            2093.0,
            546.0
          ]
        },
        {
          "text": "WHEREAS:",
          "page": 0,
          "bbox": [
            281.0,
            848.0,
            515.0,
            884.0
          ]
        },
        {
          "text": "WHEREAS:",
          "page": 0,
          "bbox": [
            279.0,
            959.0,
            513.0,
            996.0
          ]
        },
        {
          "text": "WHEREAS:",
          "page": 0,
          "bbox": [
            281.0,
            1071.0,
            515.0,
            1107.0
          ]
        }
      ]
    },
    {
      "id": "KitovPharmaLtd_20190326_20-F_EX-4.15_11584449_EX-4.15_Manufacturing Agreement__Cap On Liability_1_multi",
      "question": "Highlight the parts (if any) of this contract related to \"Cap On Liability\" that should be reviewed by a lawyer. Details: Does the contract include a cap on liability upon the breach of a party’s obligation? This includes time limitation for the counterparty to bring claims or maximum amount for recovery.",
      "answer_text": "Without prejudice to any other limitation (whether effective or not) of either Party's liability, neither Party shall be liable to the other Party (whether in contract, tort (including negligence) or for breach of statutory duty or otherwise) for any loss of profits, use, opportunity, goodwill, business or anticipated savings, for any indirect, incidental, special, indirect, punitive or consequential losses (in each case, irrespective of any negligence or other act, default or omission of a Party (or its employees or agents) and regardless of whether such loss or claim was foreseeable or not and whether the other Party has been informed of the possibility of such loss).",
      "page_number": 1,
      "words": [
        {
          "text": "1.4",
          "bbox": [
            379.0,
            281.0,
            442.0,
            327.0
          ],
          "confidence": 0.9997868537902832
        },
        {
          "text": "\"Batch' shall mean the defined quantity of the Product processed in a single process or series of processes in a manner designed to.",
          "bbox": [
            549.0,
            281.0,
            3011.0,
            329.0
          ],
          "confidence": 0.9841217398643494
        },
        {
          "text": "be homogeneous. The Batch size for the Product is **** tablets.",
          "bbox": [
            551.0,
            338.0,
            1756.0,
            382.0
          ],
          "confidence": 0.9994081258773804
        },
        {
          "text": "1.5",
          "bbox": [
            376.0,
            390.0,
            443.0,
            443.0
          ],
          "confidence": 0.9997324347496033
        },
        {
          "text": "\"cGMPs\" or \"Good Manufacturing Practice\"' shall mean the part of quality assurance which ensures that the Product is consistently.",
          "bbox": [
            549.0,
            395.0,
            3023.0,
            440.0
          ],
          "confidence": 0.985264241695404
        },
        {
          "text": "produced and controlled to the quality standards appropriate to their intended use, the principles and guidelines of which are",
          "bbox": [
            549.0,
            451.0,
            2884.0,
            499.0
          ],
          "confidence": 0.9912954568862915
        },
        {
          "text": "specified in European Commission Directive 2003/94/EC and the FDA's current Good Manufacturing Practices, particularly 21 CFR ",
          "bbox": [
            547.0,
            506.0,
            3003.0,
            557.0
          ],
          "confidence": 0.995246410369873
        },
        {
          "text": "210 et seq., and 21 CFR $$ 600-610, as both may be amended from time to time..",
          "bbox": [
            549.0,
            565.0,
            2006.0,
            607.0
          ],
          "confidence": 0.9747835993766785
        },
        {
          "text": "1.6",
          "bbox": [
            379.0,
            619.0,
            442.0,
            663.0
          ],
          "confidence": 0.9999213218688965
        },
        {
          "text": "\"Change of Control' shall mean (i) any change, sale, merger, reorganization, or any other event or action that results in a third party,",
          "bbox": [
            547.0,
            618.0,
            3005.0,
            669.0
          ],
          "confidence": 0.9930126070976257
        },
        {
          "text": "which is a material competitor to the other Party to this agreement, acquiring: (a) all or substantially all of the business or assets of a.",
          "bbox": [
            551.0,
            678.0,
            3002.0,
            722.0
          ],
          "confidence": 0.9852778911590576
        },
        {
          "text": "Party relating to this Agreement, (b) Control, directly or indirectly, of such Party (and/or any corporate entity that Controls, directly.",
          "bbox": [
            551.0,
            735.0,
            2985.0,
            778.0
          ],
          "confidence": 0.9932605624198914
        },
        {
          "text": "or indirectly, such Party), or (ii) any assignment or delegation of, sale or transfer of a Party's rights and obligations under this",
          "bbox": [
            549.0,
            789.0,
            2878.0,
            835.0
          ],
          "confidence": 0.9923490881919861
        },
        {
          "text": "Agreement (or any part hereof) to a third party.",
          "bbox": [
            555.0,
            848.0,
            1426.0,
            890.0
          ],
          "confidence": 0.9961597323417664
        },
        {
          "text": "Notwithstanding anything in the immediately preceding paragraph to the contrary, where the Party in question is Dexcel, any of the",
          "bbox": [
            549.0,
            903.0,
            2991.0,
            945.0
          ],
          "confidence": 0.9957303404808044
        },
        {
          "text": "foregoing events or actions shall not be considered a Change of Control where any one or more of the relevant third party or parties.",
          "bbox": [
            551.0,
            961.0,
            3007.0,
            1003.0
          ],
          "confidence": 0.9899225234985352
        },
        {
          "text": "referred to in clause (i) above is (A) a Family Member, or (B) any entity Controlled by Mr. **** and/or a Family Member.",
          "bbox": [
            544.0,
            1005.0,
            2788.0,
            1064.0
          ],
          "confidence": 0.9933032989501953
        },
        {
          "text": "1.7",
          "bbox": [
            379.0,
            1067.0,
            442.0,
            1113.0
          ],
          "confidence": 0.9998312592506409
        },
        {
          "text": "\"Claims' shall mean any demands, claims, actions, causes of action, assessments, losses, damages, injuries, liabilities, costs and.",
          "bbox": [
            549.0,
            1069.0,
            2953.0,
            1115.0
          ],
          "confidence": 0.9854910969734192
        },
        {
          "text": "expenses (including, without limitation, reasonable attorneys' fees and expenses) filed, raised, initiated or made by any governmental.",
          "bbox": [
            553.0,
            1129.0,
            3021.0,
            1171.0
          ],
          "confidence": 0.992518424987793
        },
        {
          "text": "authority and/or third party.",
          "bbox": [
            551.0,
            1184.0,
            1066.0,
            1226.0
          ],
          "confidence": 0.983346164226532
        },
        {
          "text": "1.8",
          "bbox": [
            379.0,
            1235.0,
            442.0,
            1281.0
          ],
          "confidence": 0.9999089241027832
        },
        {
          "text": "\"Confidential Information\"' shall have the meaning set forth in Section 7.1.",
          "bbox": [
            549.0,
            1235.0,
            1939.0,
            1281.0
          ],
          "confidence": 0.9719286561012268
        },
        {
          "text": "1.9",
          "bbox": [
            379.0,
            1292.0,
            440.0,
            1336.0
          ],
          "confidence": 0.9999080300331116
        },
        {
          "text": "\"Confirmed Order' shall have the meaning set forth in Section 3.3.2.",
          "bbox": [
            549.0,
            1292.0,
            1834.0,
            1338.0
          ],
          "confidence": 0.9867768883705139
        },
        {
          "text": "1.10",
          "bbox": [
            379.0,
            1347.0,
            462.0,
            1394.0
          ],
          "confidence": 0.9999012351036072
        },
        {
          "text": "\"Control' or \"Controlled' shall mean possession of more than fifty percent (50%) of the share capital of a corporation or other",
          "bbox": [
            547.0,
            1345.0,
            2915.0,
            1398.0
          ],
          "confidence": 0.981292724609375
        },
        {
          "text": "business entity, and/or the power to direct or cause the direction of the management and policies of a corporation or other entity",
          "bbox": [
            549.0,
            1405.0,
            2936.0,
            1451.0
          ],
          "confidence": 0.9941077828407288
        },
        {
          "text": "whether through the ownership of voting securities, by contract or otherwise..",
          "bbox": [
            553.0,
            1467.0,
            1996.0,
            1504.0
          ],
          "confidence": 0.9934757947921753
        },
        {
          "text": "1.11",
          "bbox": [
            379.0,
            1517.0,
            455.0,
            1561.0
          ],
          "confidence": 0.999779224395752
        },
        {
          "text": "\"Delivery' shall mean the time when the Product is placed at the disposal of Kitov at Dexcel's Facility based on an ****",
          "bbox": [
            546.0,
            1508.0,
            2799.0,
            1568.0
          ],
          "confidence": 0.992178738117218
        },
        {
          "text": "(Incoterms 2010).",
          "bbox": [
            555.0,
            1579.0,
            904.0,
            1617.0
          ],
          "confidence": 0.99842768907547
        },
        {
          "text": "1.12",
          "bbox": [
            377.0,
            1626.0,
            462.0,
            1674.0
          ],
          "confidence": 0.9999103546142578
        },
        {
          "text": "\"Distributors\" shall mean any Person under contract with Kitov or any of its Affiliates for the distribution of the Product in a certain",
          "bbox": [
            553.0,
            1634.0,
            3018.0,
            1670.0
          ],
          "confidence": 0.9918192625045776
        },
        {
          "text": "territory or territories..",
          "bbox": [
            551.0,
            1692.0,
            946.0,
            1729.0
          ],
          "confidence": 0.9840478301048279
        },
        {
          "text": "1.13",
          "bbox": [
            381.0,
            1741.0,
            459.0,
            1785.0
          ],
          "confidence": 0.8832098245620728
        },
        {
          "text": "\"Effective Date' shall mean the date of signature of the last Party to execute this Agreement..",
          "bbox": [
            549.0,
            1741.0,
            2267.0,
            1787.0
          ],
          "confidence": 0.9844200611114502
        },
        {
          "text": "1.14",
          "bbox": [
            379.0,
            1798.0,
            460.0,
            1840.0
          ],
          "confidence": 0.9994210004806519
        },
        {
          "text": "\"EMA\" means the European Medicines Agency or any successor entity.",
          "bbox": [
            549.0,
            1798.0,
            1898.0,
            1846.0
          ],
          "confidence": 0.9979910254478455
        },
        {
          "text": "1.15",
          "bbox": [
            379.0,
            1851.0,
            460.0,
            1900.0
          ],
          "confidence": 0.9995757341384888
        },
        {
          "text": "\"Family Member\" shall mean ****.",
          "bbox": [
            547.0,
            1847.0,
            1222.0,
            1902.0
          ],
          "confidence": 0.9885128736495972
        },
        {
          "text": "1.16",
          "bbox": [
            379.0,
            1908.0,
            462.0,
            1955.0
          ],
          "confidence": 0.9999197125434875
        },
        {
          "text": "\"FDA\" means the U.S. Food and Drug Administration or any successor entity..",
          "bbox": [
            549.0,
            1911.0,
            2005.0,
            1953.0
          ],
          "confidence": 0.986582338809967
        },
        {
          "text": "2",
          "bbox": [
            1638.0,
            2025.0,
            1669.0,
            2061.0
          ],
          "confidence": 0.999761164188385
        },
        {
          "text": "Source: KITOV PHARMA LTD., 20-F, 3/26/2019",
          "bbox": [
            332.0,
            4437.0,
            1256.0,
            4479.0
          ],
          "confidence": 0.989766538143158
        }
      ],
      "multi_page": true,
      "part_of": 2
    },
    {
      "id": "KitovPharmaLtd_20190326_20-F_EX-4.15_11584449_EX-4.15_Manufacturing Agreement__Warranty Duration_0_multi",
      "question": "Highlight the parts (if any) of this contract related to \"Warranty Duration\" that should be reviewed by a lawyer. Details: What is the duration of any  warranty against defects or errors in technology, products, or services  provided under the contract?",
      "answer_text": "Kitov shall provide Dexcel with written notification of any shortfalls in shipment quantity, and (a) any out-of-specification temperature excursions based on the downloaded data logger information following compliance with the provisions of the Quality Agreement, and/or (b) any failure of the Product to meet the Specifications which are apparent upon visual inspection and/or identification testing of the Product delivered to it by Dexcel (each of (a) and (b) being an \"Apparent Defect\"), such notification to be provided within thirty (30) Working Days of receipt of the Product at Kitov's warehouse, accompanied by samples of any such allegedly defective Product and any such Product shall not be removed from quarantine until their status is resolved.",
      "page_number": 0,
      "words": [
        {
          "text": "Exhibit 4.15",
          "bbox": [
            2798.0,
            283.0,
            3029.0,
            325.0
          ],
          "confidence": 0.9998080730438232
        },
        {
          "text": "THE SYMBOL <****\" DENOTES PLACES WHERE PORTIONS OF THIS DOCUMENT HAVE BEEN OMITTED PURSUANT TO A REQUEST",
          "bbox": [
            304.0,
            338.0,
            3009.0,
            380.0
          ],
          "confidence": 0.983539879322052
        },
        {
          "text": "FOR CONFIDENTIAL TREATMENT. SUCH MATERIAL WILL BE FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE",
          "bbox": [
            399.0,
            398.0,
            2907.0,
            435.0
          ],
          "confidence": 0.9926196932792664
        },
        {
          "text": "COMIMISSION.",
          "bbox": [
            1503.0,
            455.0,
            1805.0,
            492.0
          ],
          "confidence": 0.9562864303588867
        },
        {
          "text": "PRODUCT MANUFACTURING AGREEMENT",
          "bbox": [
            1216.0,
            510.0,
            2093.0,
            546.0
          ],
          "confidence": 0.994750440120697
        },
        {
          "text": "This Product Manufacturing Agreement (\"Agreement') is made as of the Effective Date by and between DEXCEL LTD., with its registered address.",
          "bbox": [
            275.0,
            563.0,
            3023.0,
            609.0
          ],
          "confidence": 0.989086925983429
        },
        {
          "text": "at ****, Israel (\"Dexcel'') and KITOV Pharma Ltd., with its registered office at 132 Menachem Begin Road, Azrieli Center, Tel Aviv, 6701101, Israel.",
          "bbox": [
            274.0,
            618.0,
            3000.0,
            665.0
          ],
          "confidence": 0.9887864589691162
        },
        {
          "text": "(\"Kitov'). Dexcel and Kitov are hereinafter jointly the \"Parties' and individually a \"Party.\".",
          "bbox": [
            279.0,
            678.0,
            1945.0,
            722.0
          ],
          "confidence": 0.98404461145401
        },
        {
          "text": "WHEREAS: Dexcel is a pharmaceutical company engaged in various activities including, but not limited to, the research, development,",
          "bbox": [
            275.0,
            729.0,
            2817.0,
            780.0
          ],
          "confidence": 0.9837751388549805
        },
        {
          "text": "manufacture, and marketing of various drugs and pharmaceutical specialties in various dosage forms;",
          "bbox": [
            549.0,
            795.0,
            2438.0,
            831.0
          ],
          "confidence": 0.9977880120277405
        },
        {
          "text": "WHEREAS:",
          "bbox": [
            281.0,
            848.0,
            515.0,
            884.0
          ],
          "confidence": 0.9993464946746826
        },
        {
          "text": "Kitov is a pharmaceutical company engaged in various activities including, but not limited to, the development of pharmaceutical",
          "bbox": [
            546.0,
            844.0,
            2951.0,
            890.0
          ],
          "confidence": 0.9910856485366821
        },
        {
          "text": "products;",
          "bbox": [
            551.0,
            906.0,
            732.0,
            945.0
          ],
          "confidence": 0.9994080066680908
        },
        {
          "text": "WHEREAS:",
          "bbox": [
            279.0,
            959.0,
            513.0,
            996.0
          ],
          "confidence": 0.9993117451667786
        },
        {
          "text": "Kitov and Dexcel entered into a Development Services Agreement on April 1, 2014 (\"Development Agreement'), pursuant to which",
          "bbox": [
            549.0,
            958.0,
            2991.0,
            1000.0
          ],
          "confidence": 0.9946937561035156
        },
        {
          "text": "Dexcel performed certain development services for Kitov with respect to the Product;",
          "bbox": [
            551.0,
            1016.0,
            2139.0,
            1058.0
          ],
          "confidence": 0.9957237243652344
        },
        {
          "text": "WHEREAS:",
          "bbox": [
            281.0,
            1071.0,
            515.0,
            1107.0
          ],
          "confidence": 0.9993150234222412
        },
        {
          "text": "Kitov desires that Dexcel manufacture and package the Product for Kitov in accordance with the terms of this Agreement, and Dexcel",
          "bbox": [
            546.0,
            1069.0,
            3029.0,
            1115.0
          ],
          "confidence": 0.9908015131950378
        },
        {
          "text": "is willing to manufacture and package the Product for Kitov in accordance with the terms of this Agreement..",
          "bbox": [
            547.0,
            1126.0,
            2561.0,
            1171.0
          ],
          "confidence": 0.9924741387367249
        },
        {
          "text": "NOw, THEREFORE, in consideration of the mutual covenants herein contained, the Parties, intending to be legally bound, hereby agree as",
          "bbox": [
            275.0,
            1180.0,
            2876.0,
            1228.0
          ],
          "confidence": 0.9950727820396423
        },
        {
          "text": "follows:",
          "bbox": [
            275.0,
            1237.0,
            426.0,
            1279.0
          ],
          "confidence": 0.9998461008071899
        },
        {
          "text": "1",
          "bbox": [
            277.0,
            1299.0,
            303.0,
            1330.0
          ],
          "confidence": 0.9999181032180786
        },
        {
          "text": "Definitions",
          "bbox": [
            368.0,
            1296.0,
            589.0,
            1334.0
          ],
          "confidence": 0.999856173992157
        },
        {
          "text": "For the purpose of this Agreement, the terms set forth in this clause, whether used in singular or plural form, shall mean, unless otherwise expressly.",
          "bbox": [
            277.0,
            1352.0,
            3012.0,
            1394.0
          ],
          "confidence": 0.9917291402816772
        },
        {
          "text": "provided for in this Agreement or the context otherwise requires, the following:.",
          "bbox": [
            277.0,
            1405.0,
            1749.0,
            1453.0
          ],
          "confidence": 0.9938557744026184
        },
        {
          "text": "1.1",
          "bbox": [
            379.0,
            1460.0,
            439.0,
            1506.0
          ],
          "confidence": 0.9998831748962402
        },
        {
          "text": "\"Affiliate\"' of a Party shall mean any corporation or other business entity directly or indirectly Controlled by, under common Control.",
          "bbox": [
            546.0,
            1458.0,
            3012.0,
            1509.0
          ],
          "confidence": 0.9893513917922974
        },
        {
          "text": "with, or in the Control of such Party..",
          "bbox": [
            551.0,
            1518.0,
            1222.0,
            1564.0
          ],
          "confidence": 0.9819372296333313
        },
        {
          "text": "1.2",
          "bbox": [
            377.0,
            1573.0,
            440.0,
            1619.0
          ],
          "confidence": 0.9997513890266418
        },
        {
          "text": "\"Anti-Corruption and Anti-Bribery Laws\" shall mean the United States Foreign Corrupt Practices Act of 1977, as amended, the",
          "bbox": [
            549.0,
            1577.0,
            2925.0,
            1619.0
          ],
          "confidence": 0.9937560558319092
        },
        {
          "text": "Bribery Act 2010 (2010 Chapter 23) of the Parliament of the United Kingdom, any rules or regulations under such acts, and any other",
          "bbox": [
            551.0,
            1634.0,
            3011.0,
            1676.0
          ],
          "confidence": 0.9908789992332458
        },
        {
          "text": "anti-corruption or anti-bribery statutes, laws or regulations applicable to a Party..",
          "bbox": [
            547.0,
            1687.0,
            2039.0,
            1732.0
          ],
          "confidence": 0.9931536316871643
        },
        {
          "text": "1.3",
          "bbox": [
            379.0,
            1741.0,
            440.0,
            1787.0
          ],
          "confidence": 0.9998380541801453
        },
        {
          "text": "\"API\"' shall mean the active pharmaceutical ingredients Celecoxib and Amlodipine Besylate..",
          "bbox": [
            549.0,
            1741.0,
            2277.0,
            1787.0
          ],
          "confidence": 0.9627962112426758
        },
        {
          "text": "Source: KITOV PHARMA LTD., 20-F, 3/26/2019",
          "bbox": [
            332.0,
            4437.0,
            1256.0,
            4479.0
          ],
          "confidence": 0.988348126411438
        }
      ],
      "multi_page": true,
      "part_of": 2,
      "nearby_headers": [
        {
          "text": "THE SYMBOL <****\" DENOTES PLACES WHERE PORTIONS OF THIS DOCUMENT HAVE BEEN OMITTED PURSUANT TO A REQUEST",
          "page": 0,
          "bbox": [
            304.0,
            338.0,
            3009.0,
            380.0
          ]
        },
        {
          "text": "FOR CONFIDENTIAL TREATMENT. SUCH MATERIAL WILL BE FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE",
          "page": 0,
          "bbox": [
            399.0,
            398.0,
            2907.0,
            435.0
          ]
        },
        {
          "text": "COMIMISSION.",
          "page": 0,
          "bbox": [
            1503.0,
            455.0,
            1805.0,
            492.0
          ]
        },
        {
          "text": "PRODUCT MANUFACTURING AGREEMENT",
          "page": 0,
          "bbox": [
            1216.0,
            510.0,
            2093.0,
            546.0
          ]
        },
        {
          "text": "WHEREAS:",
          "page": 0,
          "bbox": [
            281.0,
            848.0,
            515.0,
            884.0
          ]
        },
        {
          "text": "WHEREAS:",
          "page": 0,
          "bbox": [
            279.0,
            959.0,
            513.0,
            996.0
          ]
        },
        {
          "text": "WHEREAS:",
          "page": 0,
          "bbox": [
            281.0,
            1071.0,
            515.0,
            1107.0
          ]
        }
      ]
    },
    {
      "id": "KitovPharmaLtd_20190326_20-F_EX-4.15_11584449_EX-4.15_Manufacturing Agreement__Warranty Duration_1_multi",
      "question": "Highlight the parts (if any) of this contract related to \"Warranty Duration\" that should be reviewed by a lawyer. Details: What is the duration of any  warranty against defects or errors in technology, products, or services  provided under the contract?",
      "answer_text": "Kitov shall provide Dexcel with written notification of any shortfalls in shipment quantity, and (a) any out-of-specification temperature excursions based on the downloaded data logger information following compliance with the provisions of the Quality Agreement, and/or (b) any failure of the Product to meet the Specifications which are apparent upon visual inspection and/or identification testing of the Product delivered to it by Dexcel (each of (a) and (b) being an \"Apparent Defect\"), such notification to be provided within thirty (30) Working Days of receipt of the Product at Kitov's warehouse, accompanied by samples of any such allegedly defective Product and any such Product shall not be removed from quarantine until their status is resolved.",
      "page_number": 1,
      "words": [
        {
          "text": "1.4",
          "bbox": [
            379.0,
            281.0,
            442.0,
            327.0
          ],
          "confidence": 0.9997868537902832
        },
        {
          "text": "\"Batch' shall mean the defined quantity of the Product processed in a single process or series of processes in a manner designed to.",
          "bbox": [
            549.0,
            281.0,
            3011.0,
            329.0
          ],
          "confidence": 0.9841217398643494
        },
        {
          "text": "be homogeneous. The Batch size for the Product is **** tablets.",
          "bbox": [
            551.0,
            338.0,
            1756.0,
            382.0
          ],
          "confidence": 0.9994081258773804
        },
        {
          "text": "1.5",
          "bbox": [
            376.0,
            390.0,
            443.0,
            443.0
          ],
          "confidence": 0.9997324347496033
        },
        {
          "text": "\"cGMPs\" or \"Good Manufacturing Practice\"' shall mean the part of quality assurance which ensures that the Product is consistently.",
          "bbox": [
            549.0,
            395.0,
            3023.0,
            440.0
          ],
          "confidence": 0.985264241695404
        },
        {
          "text": "produced and controlled to the quality standards appropriate to their intended use, the principles and guidelines of which are",
          "bbox": [
            549.0,
            451.0,
            2884.0,
            499.0
          ],
          "confidence": 0.9912954568862915
        },
        {
          "text": "specified in European Commission Directive 2003/94/EC and the FDA's current Good Manufacturing Practices, particularly 21 CFR ",
          "bbox": [
            547.0,
            506.0,
            3003.0,
            557.0
          ],
          "confidence": 0.995246410369873
        },
        {
          "text": "210 et seq., and 21 CFR $$ 600-610, as both may be amended from time to time..",
          "bbox": [
            549.0,
            565.0,
            2006.0,
            607.0
          ],
          "confidence": 0.9747835993766785
        },
        {
          "text": "1.6",
          "bbox": [
            379.0,
            619.0,
            442.0,
            663.0
          ],
          "confidence": 0.9999213218688965
        },
        {
          "text": "\"Change of Control' shall mean (i) any change, sale, merger, reorganization, or any other event or action that results in a third party,",
          "bbox": [
            547.0,
            618.0,
            3005.0,
            669.0
          ],
          "confidence": 0.9930126070976257
        },
        {
          "text": "which is a material competitor to the other Party to this agreement, acquiring: (a) all or substantially all of the business or assets of a.",
          "bbox": [
            551.0,
            678.0,
            3002.0,
            722.0
          ],
          "confidence": 0.9852778911590576
        },
        {
          "text": "Party relating to this Agreement, (b) Control, directly or indirectly, of such Party (and/or any corporate entity that Controls, directly.",
          "bbox": [
            551.0,
            735.0,
            2985.0,
            778.0
          ],
          "confidence": 0.9932605624198914
        },
        {
          "text": "or indirectly, such Party), or (ii) any assignment or delegation of, sale or transfer of a Party's rights and obligations under this",
          "bbox": [
            549.0,
            789.0,
            2878.0,
            835.0
          ],
          "confidence": 0.9923490881919861
        },
        {
          "text": "Agreement (or any part hereof) to a third party.",
          "bbox": [
            555.0,
            848.0,
            1426.0,
            890.0
          ],
          "confidence": 0.9961597323417664
        },
        {
          "text": "Notwithstanding anything in the immediately preceding paragraph to the contrary, where the Party in question is Dexcel, any of the",
          "bbox": [
            549.0,
            903.0,
            2991.0,
            945.0
          ],
          "confidence": 0.9957303404808044
        },
        {
          "text": "foregoing events or actions shall not be considered a Change of Control where any one or more of the relevant third party or parties.",
          "bbox": [
            551.0,
            961.0,
            3007.0,
            1003.0
          ],
          "confidence": 0.9899225234985352
        },
        {
          "text": "referred to in clause (i) above is (A) a Family Member, or (B) any entity Controlled by Mr. **** and/or a Family Member.",
          "bbox": [
            544.0,
            1005.0,
            2788.0,
            1064.0
          ],
          "confidence": 0.9933032989501953
        },
        {
          "text": "1.7",
          "bbox": [
            379.0,
            1067.0,
            442.0,
            1113.0
          ],
          "confidence": 0.9998312592506409
        },
        {
          "text": "\"Claims' shall mean any demands, claims, actions, causes of action, assessments, losses, damages, injuries, liabilities, costs and.",
          "bbox": [
            549.0,
            1069.0,
            2953.0,
            1115.0
          ],
          "confidence": 0.9854910969734192
        },
        {
          "text": "expenses (including, without limitation, reasonable attorneys' fees and expenses) filed, raised, initiated or made by any governmental.",
          "bbox": [
            553.0,
            1129.0,
            3021.0,
            1171.0
          ],
          "confidence": 0.992518424987793
        },
        {
          "text": "authority and/or third party.",
          "bbox": [
            551.0,
            1184.0,
            1066.0,
            1226.0
          ],
          "confidence": 0.983346164226532
        },
        {
          "text": "1.8",
          "bbox": [
            379.0,
            1235.0,
            442.0,
            1281.0
          ],
          "confidence": 0.9999089241027832
        },
        {
          "text": "\"Confidential Information\"' shall have the meaning set forth in Section 7.1.",
          "bbox": [
            549.0,
            1235.0,
            1939.0,
            1281.0
          ],
          "confidence": 0.9719286561012268
        },
        {
          "text": "1.9",
          "bbox": [
            379.0,
            1292.0,
            440.0,
            1336.0
          ],
          "confidence": 0.9999080300331116
        },
        {
          "text": "\"Confirmed Order' shall have the meaning set forth in Section 3.3.2.",
          "bbox": [
            549.0,
            1292.0,
            1834.0,
            1338.0
          ],
          "confidence": 0.9867768883705139
        },
        {
          "text": "1.10",
          "bbox": [
            379.0,
            1347.0,
            462.0,
            1394.0
          ],
          "confidence": 0.9999012351036072
        },
        {
          "text": "\"Control' or \"Controlled' shall mean possession of more than fifty percent (50%) of the share capital of a corporation or other",
          "bbox": [
            547.0,
            1345.0,
            2915.0,
            1398.0
          ],
          "confidence": 0.981292724609375
        },
        {
          "text": "business entity, and/or the power to direct or cause the direction of the management and policies of a corporation or other entity",
          "bbox": [
            549.0,
            1405.0,
            2936.0,
            1451.0
          ],
          "confidence": 0.9941077828407288
        },
        {
          "text": "whether through the ownership of voting securities, by contract or otherwise..",
          "bbox": [
            553.0,
            1467.0,
            1996.0,
            1504.0
          ],
          "confidence": 0.9934757947921753
        },
        {
          "text": "1.11",
          "bbox": [
            379.0,
            1517.0,
            455.0,
            1561.0
          ],
          "confidence": 0.999779224395752
        },
        {
          "text": "\"Delivery' shall mean the time when the Product is placed at the disposal of Kitov at Dexcel's Facility based on an ****",
          "bbox": [
            546.0,
            1508.0,
            2799.0,
            1568.0
          ],
          "confidence": 0.992178738117218
        },
        {
          "text": "(Incoterms 2010).",
          "bbox": [
            555.0,
            1579.0,
            904.0,
            1617.0
          ],
          "confidence": 0.99842768907547
        },
        {
          "text": "1.12",
          "bbox": [
            377.0,
            1626.0,
            462.0,
            1674.0
          ],
          "confidence": 0.9999103546142578
        },
        {
          "text": "\"Distributors\" shall mean any Person under contract with Kitov or any of its Affiliates for the distribution of the Product in a certain",
          "bbox": [
            553.0,
            1634.0,
            3018.0,
            1670.0
          ],
          "confidence": 0.9918192625045776
        },
        {
          "text": "territory or territories..",
          "bbox": [
            551.0,
            1692.0,
            946.0,
            1729.0
          ],
          "confidence": 0.9840478301048279
        },
        {
          "text": "1.13",
          "bbox": [
            381.0,
            1741.0,
            459.0,
            1785.0
          ],
          "confidence": 0.8832098245620728
        },
        {
          "text": "\"Effective Date' shall mean the date of signature of the last Party to execute this Agreement..",
          "bbox": [
            549.0,
            1741.0,
            2267.0,
            1787.0
          ],
          "confidence": 0.9844200611114502
        },
        {
          "text": "1.14",
          "bbox": [
            379.0,
            1798.0,
            460.0,
            1840.0
          ],
          "confidence": 0.9994210004806519
        },
        {
          "text": "\"EMA\" means the European Medicines Agency or any successor entity.",
          "bbox": [
            549.0,
            1798.0,
            1898.0,
            1846.0
          ],
          "confidence": 0.9979910254478455
        },
        {
          "text": "1.15",
          "bbox": [
            379.0,
            1851.0,
            460.0,
            1900.0
          ],
          "confidence": 0.9995757341384888
        },
        {
          "text": "\"Family Member\" shall mean ****.",
          "bbox": [
            547.0,
            1847.0,
            1222.0,
            1902.0
          ],
          "confidence": 0.9885128736495972
        },
        {
          "text": "1.16",
          "bbox": [
            379.0,
            1908.0,
            462.0,
            1955.0
          ],
          "confidence": 0.9999197125434875
        },
        {
          "text": "\"FDA\" means the U.S. Food and Drug Administration or any successor entity..",
          "bbox": [
            549.0,
            1911.0,
            2005.0,
            1953.0
          ],
          "confidence": 0.986582338809967
        },
        {
          "text": "2",
          "bbox": [
            1638.0,
            2025.0,
            1669.0,
            2061.0
          ],
          "confidence": 0.999761164188385
        },
        {
          "text": "Source: KITOV PHARMA LTD., 20-F, 3/26/2019",
          "bbox": [
            332.0,
            4437.0,
            1256.0,
            4479.0
          ],
          "confidence": 0.989766538143158
        }
      ],
      "multi_page": true,
      "part_of": 2
    },
    {
      "id": "KitovPharmaLtd_20190326_20-F_EX-4.15_11584449_EX-4.15_Manufacturing Agreement__Warranty Duration_3_multi",
      "question": "Highlight the parts (if any) of this contract related to \"Warranty Duration\" that should be reviewed by a lawyer. Details: What is the duration of any  warranty against defects or errors in technology, products, or services  provided under the contract?",
      "answer_text": "In the event that a defect is not apparent upon visual inspection during the shelf life of the Product (\"Hidden Defect\"), Kitov shall use commercially reasonably best efforts to provide Dexcel with written notification within thirty (30) Working Days of discovering the same, to be accompanied by samples of any such allegedly defective Product, if such samples are available In the event of any failure by Kitov to provide Dexcel with written notification of any such shortfall, Apparent Defect or Hidden Defect within the respective aforementioned periods, it shall be deemed as Kitov having accepted the relevant consignment.",
      "page_number": 3,
      "words": [
        {
          "text": "1.30",
          "bbox": [
            379.0,
            283.0,
            460.0,
            325.0
          ],
          "confidence": 0.9997639656066895
        },
        {
          "text": "\"Person' means any individual, entity or corporation of any kind, domiciled in any jurisdiction.",
          "bbox": [
            549.0,
            281.0,
            2318.0,
            329.0
          ],
          "confidence": 0.9876704216003418
        },
        {
          "text": "1.31",
          "bbox": [
            377.0,
            336.0,
            460.0,
            384.0
          ],
          "confidence": 0.9999587535858154
        },
        {
          "text": "\"Product' shall mean tablets containing the APIs Celecoxib/Amlodipine in three dosage strengths (200/10mg, 200/5mg and",
          "bbox": [
            549.0,
            338.0,
            2837.0,
            384.0
          ],
          "confidence": 0.9909166693687439
        },
        {
          "text": "200/2.5mg), Labelled with the Livery and in Packs.",
          "bbox": [
            549.0,
            395.0,
            1472.0,
            439.0
          ],
          "confidence": 0.9967997074127197
        },
        {
          "text": "1.32",
          "bbox": [
            381.0,
            451.0,
            459.0,
            495.0
          ],
          "confidence": 0.9999807476997375
        },
        {
          "text": "Quality Agreement' shall mean the agreement to be entered into by the Parties pursuant to Section 4.1 below, which allocates the.",
          "bbox": [
            555.0,
            451.0,
            2989.0,
            497.0
          ],
          "confidence": 0.9831139445304871
        },
        {
          "text": "pharmaceutical responsibilities and obligations of the Parties with respect to Product quality.",
          "bbox": [
            553.0,
            510.0,
            2276.0,
            552.0
          ],
          "confidence": 0.999538004398346
        },
        {
          "text": "1.33",
          "bbox": [
            377.0,
            563.0,
            460.0,
            610.0
          ],
          "confidence": 0.9999569058418274
        },
        {
          "text": "\"Quarter\" shall mean the relevant three (3) month period ending on 31 March, 30 June, 30 September and 31 December in any.",
          "bbox": [
            551.0,
            565.0,
            2884.0,
            610.0
          ],
          "confidence": 0.9851745367050171
        },
        {
          "text": "calendar year, and any shorter period commencing on a day following the end of a Quarter and ending on the expiration or",
          "bbox": [
            551.0,
            623.0,
            2822.0,
            665.0
          ],
          "confidence": 0.9946756958961487
        },
        {
          "text": "termination of this Agreement.",
          "bbox": [
            553.0,
            682.0,
            1120.0,
            718.0
          ],
          "confidence": 0.999450147151947
        },
        {
          "text": "1.34",
          "bbox": [
            377.0,
            729.0,
            462.0,
            777.0
          ],
          "confidence": 0.9999774694442749
        },
        {
          "text": "\"Regulatory Authority\" shall mean, in a particular country or jurisdiction, any applicable governmental authority involved in",
          "bbox": [
            551.0,
            735.0,
            2873.0,
            777.0
          ],
          "confidence": 0.984786868095398
        },
        {
          "text": "granting a Marketing Authorization in such country or jurisdiction, including, inter alia, the FDA and EMA.",
          "bbox": [
            549.0,
            789.0,
            2567.0,
            835.0
          ],
          "confidence": 0.9920258522033691
        },
        {
          "text": "1.35",
          "bbox": [
            379.0,
            841.0,
            460.0,
            890.0
          ],
          "confidence": 0.9673759937286377
        },
        {
          "text": "\"Specifications' shall mean the pharmacochemical, manufacturing, stability and other specifications of a Product defined in such",
          "bbox": [
            555.0,
            846.0,
            2960.0,
            890.0
          ],
          "confidence": 0.9941126108169556
        },
        {
          "text": "Product's Marketing Authorization, subject to change from time to time as reasonably required to meet any requirements of the.",
          "bbox": [
            549.0,
            903.0,
            2911.0,
            945.0
          ],
          "confidence": 0.9940149188041687
        },
        {
          "text": "relevant Health Authorities.",
          "bbox": [
            551.0,
            961.0,
            1066.0,
            998.0
          ],
          "confidence": 0.9998623728752136
        },
        {
          "text": "1.36",
          "bbox": [
            379.0,
            1011.0,
            462.0,
            1058.0
          ],
          "confidence": 0.9999714493751526
        },
        {
          "text": "\"Supply Commencement Date\"' shall mean the date upon which Dexcel makes the first Delivery of the Product to Kitov pursuant to",
          "bbox": [
            553.0,
            1016.0,
            2987.0,
            1058.0
          ],
          "confidence": 0.9917580485343933
        },
        {
          "text": "an Confirmed Order",
          "bbox": [
            549.0,
            1071.0,
            917.0,
            1107.0
          ],
          "confidence": 0.9995799660682678
        },
        {
          "text": "1.37",
          "bbox": [
            377.0,
            1122.0,
            460.0,
            1170.0
          ],
          "confidence": 0.9999603033065796
        },
        {
          "text": "\"Supply Price\" shall have the meaning set forth in Section 3.4..",
          "bbox": [
            549.0,
            1124.0,
            1715.0,
            1170.0
          ],
          "confidence": 0.9860490560531616
        },
        {
          "text": "1.38",
          "bbox": [
            377.0,
            1179.0,
            460.0,
            1226.0
          ],
          "confidence": 0.9713299870491028
        },
        {
          "text": "\"Term\"' shall have the meaning set forth in Section 5.1..",
          "bbox": [
            549.0,
            1180.0,
            1571.0,
            1226.0
          ],
          "confidence": 0.9824877381324768
        },
        {
          "text": "1.39",
          "bbox": [
            377.0,
            1233.0,
            460.0,
            1281.0
          ],
          "confidence": 0.9999681711196899
        },
        {
          "text": "\"Trademark\" shall mean Kitov's trademark ConsensiTM..",
          "bbox": [
            551.0,
            1235.0,
            1593.0,
            1279.0
          ],
          "confidence": 0.9678188562393188
        },
        {
          "text": "1.40",
          "bbox": [
            381.0,
            1294.0,
            460.0,
            1336.0
          ],
          "confidence": 0.9995732307434082
        },
        {
          "text": "\"Working Day\" shall mean a day excluding Friday and Saturday and, for the avoidance of doubt, excluding statutory holidays in the",
          "bbox": [
            547.0,
            1288.0,
            3020.0,
            1343.0
          ],
          "confidence": 0.9940633773803711
        },
        {
          "text": "State of Israel..",
          "bbox": [
            551.0,
            1352.0,
            817.0,
            1391.0
          ],
          "confidence": 0.9796075224876404
        },
        {
          "text": "1.41",
          "bbox": [
            379.0,
            1405.0,
            457.0,
            1447.0
          ],
          "confidence": 0.9997221827507019
        },
        {
          "text": "\"Year\"' shall mean the twelve (12) months following the Supply Commencement Date and each successive twelve (12) month period",
          "bbox": [
            547.0,
            1402.0,
            2994.0,
            1453.0
          ],
          "confidence": 0.9935591220855713
        },
        {
          "text": "commencing on the anniversary of the Supply Commencement Date..",
          "bbox": [
            549.0,
            1466.0,
            1822.0,
            1508.0
          ],
          "confidence": 0.9896640181541443
        },
        {
          "text": "2",
          "bbox": [
            272.0,
            1519.0,
            304.0,
            1559.0
          ],
          "confidence": 0.9996459484100342
        },
        {
          "text": "Basics of the Agreement",
          "bbox": [
            375.0,
            1520.0,
            850.0,
            1562.0
          ],
          "confidence": 0.9983623623847961
        },
        {
          "text": "2.1",
          "bbox": [
            376.0,
            1569.0,
            441.0,
            1621.0
          ],
          "confidence": 0.9998138546943665
        },
        {
          "text": "Grant of Rights; Exclusivity",
          "bbox": [
            551.0,
            1577.0,
            1060.0,
            1619.0
          ],
          "confidence": 0.9986028671264648
        },
        {
          "text": "2.1.1",
          "bbox": [
            547.0,
            1630.0,
            638.0,
            1672.0
          ],
          "confidence": 0.9993549585342407
        },
        {
          "text": "Kitov hereby grants to Dexcel a fully paid, limited license right to use all of its Confidential Information and Intellectual",
          "bbox": [
            718.0,
            1632.0,
            2927.0,
            1676.0
          ],
          "confidence": 0.9968106150627136
        },
        {
          "text": "Property Rights (including, inter alia, the Kitov Foreground IP, Kitov Data, Kitov's share of the Joint IP, and the Trademark.",
          "bbox": [
            716.0,
            1687.0,
            3007.0,
            1732.0
          ],
          "confidence": 0.9934660792350769
        },
        {
          "text": "(\"Kitov Product IP')) necessary in order for Dexcel to manufacture, Label, package with the Livery, test and release the.",
          "bbox": [
            720.0,
            1743.0,
            2925.0,
            1787.0
          ],
          "confidence": 0.9945591688156128
        },
        {
          "text": "Product for shipment, exclusively for Kitov, for and during the Term..",
          "bbox": [
            720.0,
            1802.0,
            1981.0,
            1844.0
          ],
          "confidence": 0.990795910358429
        },
        {
          "text": "4",
          "bbox": [
            1638.0,
            1915.0,
            1669.0,
            1952.0
          ],
          "confidence": 0.9998841285705566
        },
        {
          "text": "Source: KITOV PHARMA LTD., 20-F, 3/26/2019",
          "bbox": [
            332.0,
            4437.0,
            1256.0,
            4479.0
          ],
          "confidence": 0.9937085509300232
        }
      ],
      "multi_page": true,
      "part_of": 2
    },
    {
      "id": "KitovPharmaLtd_20190326_20-F_EX-4.15_11584449_EX-4.15_Manufacturing Agreement__Warranty Duration_4_multi",
      "question": "Highlight the parts (if any) of this contract related to \"Warranty Duration\" that should be reviewed by a lawyer. Details: What is the duration of any  warranty against defects or errors in technology, products, or services  provided under the contract?",
      "answer_text": "In the event that a defect is not apparent upon visual inspection during the shelf life of the Product (\"Hidden Defect\"), Kitov shall use commercially reasonably best efforts to provide Dexcel with written notification within thirty (30) Working Days of discovering the same, to be accompanied by samples of any such allegedly defective Product, if such samples are available In the event of any failure by Kitov to provide Dexcel with written notification of any such shortfall, Apparent Defect or Hidden Defect within the respective aforementioned periods, it shall be deemed as Kitov having accepted the relevant consignment.",
      "page_number": 4,
      "words": [
        {
          "text": "2.2",
          "bbox": [
            379.0,
            281.0,
            440.0,
            327.0
          ],
          "confidence": 0.9997054934501648
        },
        {
          "text": "Kitov shall be responsible (itself or through its Affiliates and Distributors) for all costs related to the maintenance of or changes to",
          "bbox": [
            549.0,
            283.0,
            2978.0,
            329.0
          ],
          "confidence": 0.9878988862037659
        },
        {
          "text": "the Specifications, materials, suppliers of the API and/or other materials used for the manufacture or Packaging of the Product,",
          "bbox": [
            549.0,
            340.0,
            2900.0,
            386.0
          ],
          "confidence": 0.9962407350540161
        },
        {
          "text": "regulatory dossiers, and/or the Marketing Authorizations for the Product. Dexcel shall provide any and all reasonable assistance to",
          "bbox": [
            551.0,
            398.0,
            2991.0,
            439.0
          ],
          "confidence": 0.9964492321014404
        },
        {
          "text": "Kitov in this respect during the Term.",
          "bbox": [
            549.0,
            451.0,
            1245.0,
            497.0
          ],
          "confidence": 0.9853467345237732
        },
        {
          "text": "3",
          "bbox": [
            272.0,
            508.0,
            304.0,
            548.0
          ],
          "confidence": 0.9999020099639893
        },
        {
          "text": "Purchase and Supply of Product",
          "bbox": [
            373.0,
            508.0,
            986.0,
            554.0
          ],
          "confidence": 0.9964756369590759
        },
        {
          "text": "3.1",
          "bbox": [
            379.0,
            563.0,
            439.0,
            609.0
          ],
          "confidence": 0.9998199939727783
        },
        {
          "text": "Packaging",
          "bbox": [
            545.0,
            560.0,
            747.0,
            615.0
          ],
          "confidence": 0.9999397993087769
        },
        {
          "text": "3.1.1",
          "bbox": [
            546.0,
            618.0,
            640.0,
            665.0
          ],
          "confidence": 0.9999324679374695
        },
        {
          "text": "Kitov shall provide Dexcel with reasonable Packaging and Labelling instructions for the Livery (by SKU), including, but not",
          "bbox": [
            718.0,
            623.0,
            3020.0,
            665.0
          ],
          "confidence": 0.9956997632980347
        },
        {
          "text": "limited to, artwork for Labels and patient leaflets, as soon as practicable following the Effective Date; provided, however,",
          "bbox": [
            718.0,
            676.0,
            2963.0,
            722.0
          ],
          "confidence": 0.9931086301803589
        },
        {
          "text": "that Kitov shall provide such instructions at least one hundred and twenty (120) days prior to the anticipated Supply",
          "bbox": [
            718.0,
            731.0,
            2893.0,
            778.0
          ],
          "confidence": 0.9995433688163757
        },
        {
          "text": "Commencement Date. Kitov shall provide Dexcel with its Product Packaging and Labeling instructions, including, but not",
          "bbox": [
            718.0,
            789.0,
            2978.0,
            833.0
          ],
          "confidence": 0.9988670945167542
        },
        {
          "text": "limited to, approved artwork, with respect to any new SKU (for a new Product Distributor or new country), as well as.",
          "bbox": [
            716.0,
            844.0,
            2886.0,
            890.0
          ],
          "confidence": 0.9907992482185364
        },
        {
          "text": "changes to or destruction of existing materials at least one hundred and fifty (150) days prior to the anticipated first supply.",
          "bbox": [
            718.0,
            901.0,
            2998.0,
            947.0
          ],
          "confidence": 0.9935840964317322
        },
        {
          "text": "of each such SKU.",
          "bbox": [
            719.0,
            957.0,
            1066.0,
            998.0
          ],
          "confidence": 0.9851180911064148
        },
        {
          "text": "3.1.2",
          "bbox": [
            547.0,
            1012.0,
            640.0,
            1054.0
          ],
          "confidence": 0.9999217987060547
        },
        {
          "text": "Kitov shall ensure that the Packaging and Labelling instructions and the Livery shall comply in all respects with the",
          "bbox": [
            718.0,
            1012.0,
            2867.0,
            1058.0
          ],
          "confidence": 0.9940991997718811
        },
        {
          "text": "relevant Marketing Authorizations.",
          "bbox": [
            720.0,
            1071.0,
            1376.0,
            1111.0
          ],
          "confidence": 0.9994242191314697
        },
        {
          "text": "3.1.3",
          "bbox": [
            546.0,
            1122.0,
            640.0,
            1170.0
          ],
          "confidence": 0.9998054504394531
        },
        {
          "text": "In the event that Kitov has Packaging requirements that are not standard for Dexcel, the Parties shall discuss the",
          "bbox": [
            718.0,
            1127.0,
            2813.0,
            1171.0
          ],
          "confidence": 0.9986227750778198
        },
        {
          "text": "implementation and costs of the same in good faith. Any additional costs and expenses incurred by Dexcel as a result of",
          "bbox": [
            720.0,
            1180.0,
            2958.0,
            1226.0
          ],
          "confidence": 0.9859452247619629
        },
        {
          "text": "such additional requirements shall be borne solely by Kitov.",
          "bbox": [
            721.0,
            1243.0,
            1834.0,
            1279.0
          ],
          "confidence": 0.9950716495513916
        },
        {
          "text": "3.1.4",
          "bbox": [
            547.0,
            1294.0,
            640.0,
            1336.0
          ],
          "confidence": 0.9999433755874634
        },
        {
          "text": "Dexcel shall order the Packaging materials required for the Product Packaging (including, but not limited to, all Labeling);.",
          "bbox": [
            718.0,
            1296.0,
            2960.0,
            1339.0
          ],
          "confidence": 0.9929775595664978
        },
        {
          "text": "provided that such orders shall not exceed the forecasted demand of such materials for the next following twelve (12).",
          "bbox": [
            720.0,
            1350.0,
            2895.0,
            1396.0
          ],
          "confidence": 0.9969637989997864
        },
        {
          "text": "months. In the event that any Product artwork needs to be changed and/or discarded further to Kitov's written instructions",
          "bbox": [
            721.0,
            1411.0,
            3011.0,
            1447.0
          ],
          "confidence": 0.9932217597961426
        },
        {
          "text": "or due to requirements of a relevant Regulatory Authority, Kitov shall fully bear any costs arising from any such changes,",
          "bbox": [
            718.0,
            1462.0,
            2985.0,
            1508.0
          ],
          "confidence": 0.9954801797866821
        },
        {
          "text": "including the costs of any discarded Packaging materials and/or any destruction costs. However, if such changes are.",
          "bbox": [
            718.0,
            1520.0,
            2898.0,
            1562.0
          ],
          "confidence": 0.9972043633460999
        },
        {
          "text": "required to be carried out at Dexcel's request, the cost for such changes shall be assumed by Dexcel.",
          "bbox": [
            720.0,
            1577.0,
            2590.0,
            1619.0
          ],
          "confidence": 0.9969484210014343
        },
        {
          "text": "3.2",
          "bbox": [
            379.0,
            1628.0,
            440.0,
            1674.0
          ],
          "confidence": 0.9996663928031921
        },
        {
          "text": "Kitov shall provide Dexcel with a twelve (12) month rolling forecast of its Product requirements (by SKU), no later than the fifteenth",
          "bbox": [
            553.0,
            1635.0,
            2992.0,
            1672.0
          ],
          "confidence": 0.9927588105201721
        },
        {
          "text": "(15th) Working Day of each Quarter (\"Forecast'). The first Forecast will be provided by Kitov to Dexcel at least six (6) months less",
          "bbox": [
            553.0,
            1688.0,
            2978.0,
            1730.0
          ],
          "confidence": 0.9924358129501343
        },
        {
          "text": "one week prior to the anticipated Supply Commencement Date and shall represent Kitov's best estimates of the quantity of each",
          "bbox": [
            549.0,
            1745.0,
            2933.0,
            1787.0
          ],
          "confidence": 0.9965736269950867
        },
        {
          "text": "Product SKU to be ordered during the twelve (12) months period covered by the Forecast;.",
          "bbox": [
            549.0,
            1798.0,
            2240.0,
            1846.0
          ],
          "confidence": 0.9975662231445312
        },
        {
          "text": "3.3",
          "bbox": [
            379.0,
            1853.0,
            439.0,
            1899.0
          ],
          "confidence": 0.9998868107795715
        },
        {
          "text": "Purchase Orders",
          "bbox": [
            551.0,
            1858.0,
            861.0,
            1895.0
          ],
          "confidence": 0.999793291091919
        },
        {
          "text": "3.3.1",
          "bbox": [
            547.0,
            1911.0,
            638.0,
            1953.0
          ],
          "confidence": 0.9999564290046692
        },
        {
          "text": "Kitov shall provide Dexcel with written purchase orders meeting the Minimum Order Requirements and in a form reasonably",
          "bbox": [
            718.0,
            1913.0,
            3016.0,
            1955.0
          ],
          "confidence": 0.9970398545265198
        },
        {
          "text": "acceptable to Dexcel, and which shall specify at least the following: a description of the Product ordered, the quantity.",
          "bbox": [
            720.0,
            1970.0,
            2902.0,
            2012.0
          ],
          "confidence": 0.9917050004005432
        },
        {
          "text": "ordered, the current Supply Price, and the required delivery date thereof, such required delivery date to be not less than one",
          "bbox": [
            721.0,
            2027.0,
            3023.0,
            2069.0
          ],
          "confidence": 0.9979385733604431
        },
        {
          "text": "hundred and twenty (120) days from the purchase order placement date (one hundred and eighty (180) days before the.",
          "bbox": [
            716.0,
            2080.0,
            2925.0,
            2125.0
          ],
          "confidence": 0.9912009835243225
        },
        {
          "text": "anticipated Supply Commencement Date and/or the launch of a new SKU).",
          "bbox": [
            718.0,
            2136.0,
            2103.0,
            2182.0
          ],
          "confidence": 0.9927791357040405
        },
        {
          "text": "5",
          "bbox": [
            1638.0,
            2248.0,
            1669.0,
            2288.0
          ],
          "confidence": 0.9999232292175293
        },
        {
          "text": "Source: KITOV PHARMA LTD., 20-F, 3/26/2019",
          "bbox": [
            332.0,
            4437.0,
            1256.0,
            4479.0
          ],
          "confidence": 0.9937085509300232
        }
      ],
      "multi_page": true,
      "part_of": 2
    },
    {
      "id": "KitovPharmaLtd_20190326_20-F_EX-4.15_11584449_EX-4.15_Manufacturing Agreement__Insurance_0_multi",
      "question": "Highlight the parts (if any) of this contract related to \"Insurance\" that should be reviewed by a lawyer. Details: Is there a requirement for insurance that must be maintained by one party for the benefit of the counterparty?",
      "answer_text": "At the time of entering this Agreement, each Party shall be fully insured and shall duly maintain such insurance during the term of this Agreement and thereafter for so long as it customarily maintains insurance for itself for similar products and activities.",
      "page_number": 0,
      "words": [
        {
          "text": "Exhibit 4.15",
          "bbox": [
            2798.0,
            283.0,
            3029.0,
            325.0
          ],
          "confidence": 0.9998080730438232
        },
        {
          "text": "THE SYMBOL <****\" DENOTES PLACES WHERE PORTIONS OF THIS DOCUMENT HAVE BEEN OMITTED PURSUANT TO A REQUEST",
          "bbox": [
            304.0,
            338.0,
            3009.0,
            380.0
          ],
          "confidence": 0.983539879322052
        },
        {
          "text": "FOR CONFIDENTIAL TREATMENT. SUCH MATERIAL WILL BE FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE",
          "bbox": [
            399.0,
            398.0,
            2907.0,
            435.0
          ],
          "confidence": 0.9926196932792664
        },
        {
          "text": "COMIMISSION.",
          "bbox": [
            1503.0,
            455.0,
            1805.0,
            492.0
          ],
          "confidence": 0.9562864303588867
        },
        {
          "text": "PRODUCT MANUFACTURING AGREEMENT",
          "bbox": [
            1216.0,
            510.0,
            2093.0,
            546.0
          ],
          "confidence": 0.994750440120697
        },
        {
          "text": "This Product Manufacturing Agreement (\"Agreement') is made as of the Effective Date by and between DEXCEL LTD., with its registered address.",
          "bbox": [
            275.0,
            563.0,
            3023.0,
            609.0
          ],
          "confidence": 0.989086925983429
        },
        {
          "text": "at ****, Israel (\"Dexcel'') and KITOV Pharma Ltd., with its registered office at 132 Menachem Begin Road, Azrieli Center, Tel Aviv, 6701101, Israel.",
          "bbox": [
            274.0,
            618.0,
            3000.0,
            665.0
          ],
          "confidence": 0.9887864589691162
        },
        {
          "text": "(\"Kitov'). Dexcel and Kitov are hereinafter jointly the \"Parties' and individually a \"Party.\".",
          "bbox": [
            279.0,
            678.0,
            1945.0,
            722.0
          ],
          "confidence": 0.98404461145401
        },
        {
          "text": "WHEREAS: Dexcel is a pharmaceutical company engaged in various activities including, but not limited to, the research, development,",
          "bbox": [
            275.0,
            729.0,
            2817.0,
            780.0
          ],
          "confidence": 0.9837751388549805
        },
        {
          "text": "manufacture, and marketing of various drugs and pharmaceutical specialties in various dosage forms;",
          "bbox": [
            549.0,
            795.0,
            2438.0,
            831.0
          ],
          "confidence": 0.9977880120277405
        },
        {
          "text": "WHEREAS:",
          "bbox": [
            281.0,
            848.0,
            515.0,
            884.0
          ],
          "confidence": 0.9993464946746826
        },
        {
          "text": "Kitov is a pharmaceutical company engaged in various activities including, but not limited to, the development of pharmaceutical",
          "bbox": [
            546.0,
            844.0,
            2951.0,
            890.0
          ],
          "confidence": 0.9910856485366821
        },
        {
          "text": "products;",
          "bbox": [
            551.0,
            906.0,
            732.0,
            945.0
          ],
          "confidence": 0.9994080066680908
        },
        {
          "text": "WHEREAS:",
          "bbox": [
            279.0,
            959.0,
            513.0,
            996.0
          ],
          "confidence": 0.9993117451667786
        },
        {
          "text": "Kitov and Dexcel entered into a Development Services Agreement on April 1, 2014 (\"Development Agreement'), pursuant to which",
          "bbox": [
            549.0,
            958.0,
            2991.0,
            1000.0
          ],
          "confidence": 0.9946937561035156
        },
        {
          "text": "Dexcel performed certain development services for Kitov with respect to the Product;",
          "bbox": [
            551.0,
            1016.0,
            2139.0,
            1058.0
          ],
          "confidence": 0.9957237243652344
        },
        {
          "text": "WHEREAS:",
          "bbox": [
            281.0,
            1071.0,
            515.0,
            1107.0
          ],
          "confidence": 0.9993150234222412
        },
        {
          "text": "Kitov desires that Dexcel manufacture and package the Product for Kitov in accordance with the terms of this Agreement, and Dexcel",
          "bbox": [
            546.0,
            1069.0,
            3029.0,
            1115.0
          ],
          "confidence": 0.9908015131950378
        },
        {
          "text": "is willing to manufacture and package the Product for Kitov in accordance with the terms of this Agreement..",
          "bbox": [
            547.0,
            1126.0,
            2561.0,
            1171.0
          ],
          "confidence": 0.9924741387367249
        },
        {
          "text": "NOw, THEREFORE, in consideration of the mutual covenants herein contained, the Parties, intending to be legally bound, hereby agree as",
          "bbox": [
            275.0,
            1180.0,
            2876.0,
            1228.0
          ],
          "confidence": 0.9950727820396423
        },
        {
          "text": "follows:",
          "bbox": [
            275.0,
            1237.0,
            426.0,
            1279.0
          ],
          "confidence": 0.9998461008071899
        },
        {
          "text": "1",
          "bbox": [
            277.0,
            1299.0,
            303.0,
            1330.0
          ],
          "confidence": 0.9999181032180786
        },
        {
          "text": "Definitions",
          "bbox": [
            368.0,
            1296.0,
            589.0,
            1334.0
          ],
          "confidence": 0.999856173992157
        },
        {
          "text": "For the purpose of this Agreement, the terms set forth in this clause, whether used in singular or plural form, shall mean, unless otherwise expressly.",
          "bbox": [
            277.0,
            1352.0,
            3012.0,
            1394.0
          ],
          "confidence": 0.9917291402816772
        },
        {
          "text": "provided for in this Agreement or the context otherwise requires, the following:.",
          "bbox": [
            277.0,
            1405.0,
            1749.0,
            1453.0
          ],
          "confidence": 0.9938557744026184
        },
        {
          "text": "1.1",
          "bbox": [
            379.0,
            1460.0,
            439.0,
            1506.0
          ],
          "confidence": 0.9998831748962402
        },
        {
          "text": "\"Affiliate\"' of a Party shall mean any corporation or other business entity directly or indirectly Controlled by, under common Control.",
          "bbox": [
            546.0,
            1458.0,
            3012.0,
            1509.0
          ],
          "confidence": 0.9893513917922974
        },
        {
          "text": "with, or in the Control of such Party..",
          "bbox": [
            551.0,
            1518.0,
            1222.0,
            1564.0
          ],
          "confidence": 0.9819372296333313
        },
        {
          "text": "1.2",
          "bbox": [
            377.0,
            1573.0,
            440.0,
            1619.0
          ],
          "confidence": 0.9997513890266418
        },
        {
          "text": "\"Anti-Corruption and Anti-Bribery Laws\" shall mean the United States Foreign Corrupt Practices Act of 1977, as amended, the",
          "bbox": [
            549.0,
            1577.0,
            2925.0,
            1619.0
          ],
          "confidence": 0.9937560558319092
        },
        {
          "text": "Bribery Act 2010 (2010 Chapter 23) of the Parliament of the United Kingdom, any rules or regulations under such acts, and any other",
          "bbox": [
            551.0,
            1634.0,
            3011.0,
            1676.0
          ],
          "confidence": 0.9908789992332458
        },
        {
          "text": "anti-corruption or anti-bribery statutes, laws or regulations applicable to a Party..",
          "bbox": [
            547.0,
            1687.0,
            2039.0,
            1732.0
          ],
          "confidence": 0.9931536316871643
        },
        {
          "text": "1.3",
          "bbox": [
            379.0,
            1741.0,
            440.0,
            1787.0
          ],
          "confidence": 0.9998380541801453
        },
        {
          "text": "\"API\"' shall mean the active pharmaceutical ingredients Celecoxib and Amlodipine Besylate..",
          "bbox": [
            549.0,
            1741.0,
            2277.0,
            1787.0
          ],
          "confidence": 0.9627962112426758
        },
        {
          "text": "Source: KITOV PHARMA LTD., 20-F, 3/26/2019",
          "bbox": [
            332.0,
            4437.0,
            1256.0,
            4479.0
          ],
          "confidence": 0.988348126411438
        }
      ],
      "multi_page": true,
      "part_of": 2,
      "nearby_headers": [
        {
          "text": "THE SYMBOL <****\" DENOTES PLACES WHERE PORTIONS OF THIS DOCUMENT HAVE BEEN OMITTED PURSUANT TO A REQUEST",
          "page": 0,
          "bbox": [
            304.0,
            338.0,
            3009.0,
            380.0
          ]
        },
        {
          "text": "FOR CONFIDENTIAL TREATMENT. SUCH MATERIAL WILL BE FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE",
          "page": 0,
          "bbox": [
            399.0,
            398.0,
            2907.0,
            435.0
          ]
        },
        {
          "text": "COMIMISSION.",
          "page": 0,
          "bbox": [
            1503.0,
            455.0,
            1805.0,
            492.0
          ]
        },
        {
          "text": "PRODUCT MANUFACTURING AGREEMENT",
          "page": 0,
          "bbox": [
            1216.0,
            510.0,
            2093.0,
            546.0
          ]
        },
        {
          "text": "WHEREAS:",
          "page": 0,
          "bbox": [
            281.0,
            848.0,
            515.0,
            884.0
          ]
        },
        {
          "text": "WHEREAS:",
          "page": 0,
          "bbox": [
            279.0,
            959.0,
            513.0,
            996.0
          ]
        },
        {
          "text": "WHEREAS:",
          "page": 0,
          "bbox": [
            281.0,
            1071.0,
            515.0,
            1107.0
          ]
        }
      ]
    },
    {
      "id": "KitovPharmaLtd_20190326_20-F_EX-4.15_11584449_EX-4.15_Manufacturing Agreement__Insurance_1_multi",
      "question": "Highlight the parts (if any) of this contract related to \"Insurance\" that should be reviewed by a lawyer. Details: Is there a requirement for insurance that must be maintained by one party for the benefit of the counterparty?",
      "answer_text": "At the time of entering this Agreement, each Party shall be fully insured and shall duly maintain such insurance during the term of this Agreement and thereafter for so long as it customarily maintains insurance for itself for similar products and activities.",
      "page_number": 1,
      "words": [
        {
          "text": "1.4",
          "bbox": [
            379.0,
            281.0,
            442.0,
            327.0
          ],
          "confidence": 0.9997868537902832
        },
        {
          "text": "\"Batch' shall mean the defined quantity of the Product processed in a single process or series of processes in a manner designed to.",
          "bbox": [
            549.0,
            281.0,
            3011.0,
            329.0
          ],
          "confidence": 0.9841217398643494
        },
        {
          "text": "be homogeneous. The Batch size for the Product is **** tablets.",
          "bbox": [
            551.0,
            338.0,
            1756.0,
            382.0
          ],
          "confidence": 0.9994081258773804
        },
        {
          "text": "1.5",
          "bbox": [
            376.0,
            390.0,
            443.0,
            443.0
          ],
          "confidence": 0.9997324347496033
        },
        {
          "text": "\"cGMPs\" or \"Good Manufacturing Practice\"' shall mean the part of quality assurance which ensures that the Product is consistently.",
          "bbox": [
            549.0,
            395.0,
            3023.0,
            440.0
          ],
          "confidence": 0.985264241695404
        },
        {
          "text": "produced and controlled to the quality standards appropriate to their intended use, the principles and guidelines of which are",
          "bbox": [
            549.0,
            451.0,
            2884.0,
            499.0
          ],
          "confidence": 0.9912954568862915
        },
        {
          "text": "specified in European Commission Directive 2003/94/EC and the FDA's current Good Manufacturing Practices, particularly 21 CFR ",
          "bbox": [
            547.0,
            506.0,
            3003.0,
            557.0
          ],
          "confidence": 0.995246410369873
        },
        {
          "text": "210 et seq., and 21 CFR $$ 600-610, as both may be amended from time to time..",
          "bbox": [
            549.0,
            565.0,
            2006.0,
            607.0
          ],
          "confidence": 0.9747835993766785
        },
        {
          "text": "1.6",
          "bbox": [
            379.0,
            619.0,
            442.0,
            663.0
          ],
          "confidence": 0.9999213218688965
        },
        {
          "text": "\"Change of Control' shall mean (i) any change, sale, merger, reorganization, or any other event or action that results in a third party,",
          "bbox": [
            547.0,
            618.0,
            3005.0,
            669.0
          ],
          "confidence": 0.9930126070976257
        },
        {
          "text": "which is a material competitor to the other Party to this agreement, acquiring: (a) all or substantially all of the business or assets of a.",
          "bbox": [
            551.0,
            678.0,
            3002.0,
            722.0
          ],
          "confidence": 0.9852778911590576
        },
        {
          "text": "Party relating to this Agreement, (b) Control, directly or indirectly, of such Party (and/or any corporate entity that Controls, directly.",
          "bbox": [
            551.0,
            735.0,
            2985.0,
            778.0
          ],
          "confidence": 0.9932605624198914
        },
        {
          "text": "or indirectly, such Party), or (ii) any assignment or delegation of, sale or transfer of a Party's rights and obligations under this",
          "bbox": [
            549.0,
            789.0,
            2878.0,
            835.0
          ],
          "confidence": 0.9923490881919861
        },
        {
          "text": "Agreement (or any part hereof) to a third party.",
          "bbox": [
            555.0,
            848.0,
            1426.0,
            890.0
          ],
          "confidence": 0.9961597323417664
        },
        {
          "text": "Notwithstanding anything in the immediately preceding paragraph to the contrary, where the Party in question is Dexcel, any of the",
          "bbox": [
            549.0,
            903.0,
            2991.0,
            945.0
          ],
          "confidence": 0.9957303404808044
        },
        {
          "text": "foregoing events or actions shall not be considered a Change of Control where any one or more of the relevant third party or parties.",
          "bbox": [
            551.0,
            961.0,
            3007.0,
            1003.0
          ],
          "confidence": 0.9899225234985352
        },
        {
          "text": "referred to in clause (i) above is (A) a Family Member, or (B) any entity Controlled by Mr. **** and/or a Family Member.",
          "bbox": [
            544.0,
            1005.0,
            2788.0,
            1064.0
          ],
          "confidence": 0.9933032989501953
        },
        {
          "text": "1.7",
          "bbox": [
            379.0,
            1067.0,
            442.0,
            1113.0
          ],
          "confidence": 0.9998312592506409
        },
        {
          "text": "\"Claims' shall mean any demands, claims, actions, causes of action, assessments, losses, damages, injuries, liabilities, costs and.",
          "bbox": [
            549.0,
            1069.0,
            2953.0,
            1115.0
          ],
          "confidence": 0.9854910969734192
        },
        {
          "text": "expenses (including, without limitation, reasonable attorneys' fees and expenses) filed, raised, initiated or made by any governmental.",
          "bbox": [
            553.0,
            1129.0,
            3021.0,
            1171.0
          ],
          "confidence": 0.992518424987793
        },
        {
          "text": "authority and/or third party.",
          "bbox": [
            551.0,
            1184.0,
            1066.0,
            1226.0
          ],
          "confidence": 0.983346164226532
        },
        {
          "text": "1.8",
          "bbox": [
            379.0,
            1235.0,
            442.0,
            1281.0
          ],
          "confidence": 0.9999089241027832
        },
        {
          "text": "\"Confidential Information\"' shall have the meaning set forth in Section 7.1.",
          "bbox": [
            549.0,
            1235.0,
            1939.0,
            1281.0
          ],
          "confidence": 0.9719286561012268
        },
        {
          "text": "1.9",
          "bbox": [
            379.0,
            1292.0,
            440.0,
            1336.0
          ],
          "confidence": 0.9999080300331116
        },
        {
          "text": "\"Confirmed Order' shall have the meaning set forth in Section 3.3.2.",
          "bbox": [
            549.0,
            1292.0,
            1834.0,
            1338.0
          ],
          "confidence": 0.9867768883705139
        },
        {
          "text": "1.10",
          "bbox": [
            379.0,
            1347.0,
            462.0,
            1394.0
          ],
          "confidence": 0.9999012351036072
        },
        {
          "text": "\"Control' or \"Controlled' shall mean possession of more than fifty percent (50%) of the share capital of a corporation or other",
          "bbox": [
            547.0,
            1345.0,
            2915.0,
            1398.0
          ],
          "confidence": 0.981292724609375
        },
        {
          "text": "business entity, and/or the power to direct or cause the direction of the management and policies of a corporation or other entity",
          "bbox": [
            549.0,
            1405.0,
            2936.0,
            1451.0
          ],
          "confidence": 0.9941077828407288
        },
        {
          "text": "whether through the ownership of voting securities, by contract or otherwise..",
          "bbox": [
            553.0,
            1467.0,
            1996.0,
            1504.0
          ],
          "confidence": 0.9934757947921753
        },
        {
          "text": "1.11",
          "bbox": [
            379.0,
            1517.0,
            455.0,
            1561.0
          ],
          "confidence": 0.999779224395752
        },
        {
          "text": "\"Delivery' shall mean the time when the Product is placed at the disposal of Kitov at Dexcel's Facility based on an ****",
          "bbox": [
            546.0,
            1508.0,
            2799.0,
            1568.0
          ],
          "confidence": 0.992178738117218
        },
        {
          "text": "(Incoterms 2010).",
          "bbox": [
            555.0,
            1579.0,
            904.0,
            1617.0
          ],
          "confidence": 0.99842768907547
        },
        {
          "text": "1.12",
          "bbox": [
            377.0,
            1626.0,
            462.0,
            1674.0
          ],
          "confidence": 0.9999103546142578
        },
        {
          "text": "\"Distributors\" shall mean any Person under contract with Kitov or any of its Affiliates for the distribution of the Product in a certain",
          "bbox": [
            553.0,
            1634.0,
            3018.0,
            1670.0
          ],
          "confidence": 0.9918192625045776
        },
        {
          "text": "territory or territories..",
          "bbox": [
            551.0,
            1692.0,
            946.0,
            1729.0
          ],
          "confidence": 0.9840478301048279
        },
        {
          "text": "1.13",
          "bbox": [
            381.0,
            1741.0,
            459.0,
            1785.0
          ],
          "confidence": 0.8832098245620728
        },
        {
          "text": "\"Effective Date' shall mean the date of signature of the last Party to execute this Agreement..",
          "bbox": [
            549.0,
            1741.0,
            2267.0,
            1787.0
          ],
          "confidence": 0.9844200611114502
        },
        {
          "text": "1.14",
          "bbox": [
            379.0,
            1798.0,
            460.0,
            1840.0
          ],
          "confidence": 0.9994210004806519
        },
        {
          "text": "\"EMA\" means the European Medicines Agency or any successor entity.",
          "bbox": [
            549.0,
            1798.0,
            1898.0,
            1846.0
          ],
          "confidence": 0.9979910254478455
        },
        {
          "text": "1.15",
          "bbox": [
            379.0,
            1851.0,
            460.0,
            1900.0
          ],
          "confidence": 0.9995757341384888
        },
        {
          "text": "\"Family Member\" shall mean ****.",
          "bbox": [
            547.0,
            1847.0,
            1222.0,
            1902.0
          ],
          "confidence": 0.9885128736495972
        },
        {
          "text": "1.16",
          "bbox": [
            379.0,
            1908.0,
            462.0,
            1955.0
          ],
          "confidence": 0.9999197125434875
        },
        {
          "text": "\"FDA\" means the U.S. Food and Drug Administration or any successor entity..",
          "bbox": [
            549.0,
            1911.0,
            2005.0,
            1953.0
          ],
          "confidence": 0.986582338809967
        },
        {
          "text": "2",
          "bbox": [
            1638.0,
            2025.0,
            1669.0,
            2061.0
          ],
          "confidence": 0.999761164188385
        },
        {
          "text": "Source: KITOV PHARMA LTD., 20-F, 3/26/2019",
          "bbox": [
            332.0,
            4437.0,
            1256.0,
            4479.0
          ],
          "confidence": 0.989766538143158
        }
      ],
      "multi_page": true,
      "part_of": 2
    },
    {
      "id": "KitovPharmaLtd_20190326_20-F_EX-4.15_11584449_EX-4.15_Manufacturing Agreement__Insurance_1",
      "question": "Highlight the parts (if any) of this contract related to \"Insurance\" that should be reviewed by a lawyer. Details: Is there a requirement for insurance that must be maintained by one party for the benefit of the counterparty?",
      "answer_text": "Each Party shall cause such insurance policies to provide that the other Party shall be given at least thirty (30) days' notice of any cancellation, termination or change in such insurance.",
      "page_number": 1,
      "words": [
        {
          "text": "1.4",
          "bbox": [
            379.0,
            281.0,
            442.0,
            327.0
          ],
          "confidence": 0.9997868537902832
        },
        {
          "text": "\"Batch' shall mean the defined quantity of the Product processed in a single process or series of processes in a manner designed to.",
          "bbox": [
            549.0,
            281.0,
            3011.0,
            329.0
          ],
          "confidence": 0.9841217398643494
        },
        {
          "text": "be homogeneous. The Batch size for the Product is **** tablets.",
          "bbox": [
            551.0,
            338.0,
            1756.0,
            382.0
          ],
          "confidence": 0.9994081258773804
        },
        {
          "text": "1.5",
          "bbox": [
            376.0,
            390.0,
            443.0,
            443.0
          ],
          "confidence": 0.9997324347496033
        },
        {
          "text": "\"cGMPs\" or \"Good Manufacturing Practice\"' shall mean the part of quality assurance which ensures that the Product is consistently.",
          "bbox": [
            549.0,
            395.0,
            3023.0,
            440.0
          ],
          "confidence": 0.985264241695404
        },
        {
          "text": "produced and controlled to the quality standards appropriate to their intended use, the principles and guidelines of which are",
          "bbox": [
            549.0,
            451.0,
            2884.0,
            499.0
          ],
          "confidence": 0.9912954568862915
        },
        {
          "text": "specified in European Commission Directive 2003/94/EC and the FDA's current Good Manufacturing Practices, particularly 21 CFR ",
          "bbox": [
            547.0,
            506.0,
            3003.0,
            557.0
          ],
          "confidence": 0.995246410369873
        },
        {
          "text": "210 et seq., and 21 CFR $$ 600-610, as both may be amended from time to time..",
          "bbox": [
            549.0,
            565.0,
            2006.0,
            607.0
          ],
          "confidence": 0.9747835993766785
        },
        {
          "text": "1.6",
          "bbox": [
            379.0,
            619.0,
            442.0,
            663.0
          ],
          "confidence": 0.9999213218688965
        },
        {
          "text": "\"Change of Control' shall mean (i) any change, sale, merger, reorganization, or any other event or action that results in a third party,",
          "bbox": [
            547.0,
            618.0,
            3005.0,
            669.0
          ],
          "confidence": 0.9930126070976257
        },
        {
          "text": "which is a material competitor to the other Party to this agreement, acquiring: (a) all or substantially all of the business or assets of a.",
          "bbox": [
            551.0,
            678.0,
            3002.0,
            722.0
          ],
          "confidence": 0.9852778911590576
        },
        {
          "text": "Party relating to this Agreement, (b) Control, directly or indirectly, of such Party (and/or any corporate entity that Controls, directly.",
          "bbox": [
            551.0,
            735.0,
            2985.0,
            778.0
          ],
          "confidence": 0.9932605624198914
        },
        {
          "text": "or indirectly, such Party), or (ii) any assignment or delegation of, sale or transfer of a Party's rights and obligations under this",
          "bbox": [
            549.0,
            789.0,
            2878.0,
            835.0
          ],
          "confidence": 0.9923490881919861
        },
        {
          "text": "Agreement (or any part hereof) to a third party.",
          "bbox": [
            555.0,
            848.0,
            1426.0,
            890.0
          ],
          "confidence": 0.9961597323417664
        },
        {
          "text": "Notwithstanding anything in the immediately preceding paragraph to the contrary, where the Party in question is Dexcel, any of the",
          "bbox": [
            549.0,
            903.0,
            2991.0,
            945.0
          ],
          "confidence": 0.9957303404808044
        },
        {
          "text": "foregoing events or actions shall not be considered a Change of Control where any one or more of the relevant third party or parties.",
          "bbox": [
            551.0,
            961.0,
            3007.0,
            1003.0
          ],
          "confidence": 0.9899225234985352
        },
        {
          "text": "referred to in clause (i) above is (A) a Family Member, or (B) any entity Controlled by Mr. **** and/or a Family Member.",
          "bbox": [
            544.0,
            1005.0,
            2788.0,
            1064.0
          ],
          "confidence": 0.9933032989501953
        },
        {
          "text": "1.7",
          "bbox": [
            379.0,
            1067.0,
            442.0,
            1113.0
          ],
          "confidence": 0.9998312592506409
        },
        {
          "text": "\"Claims' shall mean any demands, claims, actions, causes of action, assessments, losses, damages, injuries, liabilities, costs and.",
          "bbox": [
            549.0,
            1069.0,
            2953.0,
            1115.0
          ],
          "confidence": 0.9854910969734192
        },
        {
          "text": "expenses (including, without limitation, reasonable attorneys' fees and expenses) filed, raised, initiated or made by any governmental.",
          "bbox": [
            553.0,
            1129.0,
            3021.0,
            1171.0
          ],
          "confidence": 0.992518424987793
        },
        {
          "text": "authority and/or third party.",
          "bbox": [
            551.0,
            1184.0,
            1066.0,
            1226.0
          ],
          "confidence": 0.983346164226532
        },
        {
          "text": "1.8",
          "bbox": [
            379.0,
            1235.0,
            442.0,
            1281.0
          ],
          "confidence": 0.9999089241027832
        },
        {
          "text": "\"Confidential Information\"' shall have the meaning set forth in Section 7.1.",
          "bbox": [
            549.0,
            1235.0,
            1939.0,
            1281.0
          ],
          "confidence": 0.9719286561012268
        },
        {
          "text": "1.9",
          "bbox": [
            379.0,
            1292.0,
            440.0,
            1336.0
          ],
          "confidence": 0.9999080300331116
        },
        {
          "text": "\"Confirmed Order' shall have the meaning set forth in Section 3.3.2.",
          "bbox": [
            549.0,
            1292.0,
            1834.0,
            1338.0
          ],
          "confidence": 0.9867768883705139
        },
        {
          "text": "1.10",
          "bbox": [
            379.0,
            1347.0,
            462.0,
            1394.0
          ],
          "confidence": 0.9999012351036072
        },
        {
          "text": "\"Control' or \"Controlled' shall mean possession of more than fifty percent (50%) of the share capital of a corporation or other",
          "bbox": [
            547.0,
            1345.0,
            2915.0,
            1398.0
          ],
          "confidence": 0.981292724609375
        },
        {
          "text": "business entity, and/or the power to direct or cause the direction of the management and policies of a corporation or other entity",
          "bbox": [
            549.0,
            1405.0,
            2936.0,
            1451.0
          ],
          "confidence": 0.9941077828407288
        },
        {
          "text": "whether through the ownership of voting securities, by contract or otherwise..",
          "bbox": [
            553.0,
            1467.0,
            1996.0,
            1504.0
          ],
          "confidence": 0.9934757947921753
        },
        {
          "text": "1.11",
          "bbox": [
            379.0,
            1517.0,
            455.0,
            1561.0
          ],
          "confidence": 0.999779224395752
        },
        {
          "text": "\"Delivery' shall mean the time when the Product is placed at the disposal of Kitov at Dexcel's Facility based on an ****",
          "bbox": [
            546.0,
            1508.0,
            2799.0,
            1568.0
          ],
          "confidence": 0.992178738117218
        },
        {
          "text": "(Incoterms 2010).",
          "bbox": [
            555.0,
            1579.0,
            904.0,
            1617.0
          ],
          "confidence": 0.99842768907547
        },
        {
          "text": "1.12",
          "bbox": [
            377.0,
            1626.0,
            462.0,
            1674.0
          ],
          "confidence": 0.9999103546142578
        },
        {
          "text": "\"Distributors\" shall mean any Person under contract with Kitov or any of its Affiliates for the distribution of the Product in a certain",
          "bbox": [
            553.0,
            1634.0,
            3018.0,
            1670.0
          ],
          "confidence": 0.9918192625045776
        },
        {
          "text": "territory or territories..",
          "bbox": [
            551.0,
            1692.0,
            946.0,
            1729.0
          ],
          "confidence": 0.9840478301048279
        },
        {
          "text": "1.13",
          "bbox": [
            381.0,
            1741.0,
            459.0,
            1785.0
          ],
          "confidence": 0.8832098245620728
        },
        {
          "text": "\"Effective Date' shall mean the date of signature of the last Party to execute this Agreement..",
          "bbox": [
            549.0,
            1741.0,
            2267.0,
            1787.0
          ],
          "confidence": 0.9844200611114502
        },
        {
          "text": "1.14",
          "bbox": [
            379.0,
            1798.0,
            460.0,
            1840.0
          ],
          "confidence": 0.9994210004806519
        },
        {
          "text": "\"EMA\" means the European Medicines Agency or any successor entity.",
          "bbox": [
            549.0,
            1798.0,
            1898.0,
            1846.0
          ],
          "confidence": 0.9979910254478455
        },
        {
          "text": "1.15",
          "bbox": [
            379.0,
            1851.0,
            460.0,
            1900.0
          ],
          "confidence": 0.9995757341384888
        },
        {
          "text": "\"Family Member\" shall mean ****.",
          "bbox": [
            547.0,
            1847.0,
            1222.0,
            1902.0
          ],
          "confidence": 0.9885128736495972
        },
        {
          "text": "1.16",
          "bbox": [
            379.0,
            1908.0,
            462.0,
            1955.0
          ],
          "confidence": 0.9999197125434875
        },
        {
          "text": "\"FDA\" means the U.S. Food and Drug Administration or any successor entity..",
          "bbox": [
            549.0,
            1911.0,
            2005.0,
            1953.0
          ],
          "confidence": 0.986582338809967
        },
        {
          "text": "2",
          "bbox": [
            1638.0,
            2025.0,
            1669.0,
            2061.0
          ],
          "confidence": 0.999761164188385
        },
        {
          "text": "Source: KITOV PHARMA LTD., 20-F, 3/26/2019",
          "bbox": [
            332.0,
            4437.0,
            1256.0,
            4479.0
          ],
          "confidence": 0.989766538143158
        }
      ]
    },
    {
      "id": "KitovPharmaLtd_20190326_20-F_EX-4.15_11584449_EX-4.15_Manufacturing Agreement__Insurance_0_multi",
      "question": "Highlight the parts (if any) of this contract related to \"Insurance\" that should be reviewed by a lawyer. Details: Is there a requirement for insurance that must be maintained by one party for the benefit of the counterparty?",
      "answer_text": "Each Party shall maintain (a) comprehensive general liability insurance (including without limitation, coverage for bodily injury, personal injury, property damage, casualty loss and contractual and trademark liability); and (b) product liability insurance, providing full indemnification and defense against claims, liabilities, damages, demands and causes of action, alleged or actual, arising out of any defects in or use of the Product under this Agreement (including manufacturing, design, warning, or instruction claims), in such amounts as it customarily maintains for similar products and activities, but in no event less than $5,000,000 per individual claim and $10,000,000 in the aggregate",
      "page_number": 0,
      "words": [
        {
          "text": "Exhibit 4.15",
          "bbox": [
            2798.0,
            283.0,
            3029.0,
            325.0
          ],
          "confidence": 0.9998080730438232
        },
        {
          "text": "THE SYMBOL <****\" DENOTES PLACES WHERE PORTIONS OF THIS DOCUMENT HAVE BEEN OMITTED PURSUANT TO A REQUEST",
          "bbox": [
            304.0,
            338.0,
            3009.0,
            380.0
          ],
          "confidence": 0.983539879322052
        },
        {
          "text": "FOR CONFIDENTIAL TREATMENT. SUCH MATERIAL WILL BE FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE",
          "bbox": [
            399.0,
            398.0,
            2907.0,
            435.0
          ],
          "confidence": 0.9926196932792664
        },
        {
          "text": "COMIMISSION.",
          "bbox": [
            1503.0,
            455.0,
            1805.0,
            492.0
          ],
          "confidence": 0.9562864303588867
        },
        {
          "text": "PRODUCT MANUFACTURING AGREEMENT",
          "bbox": [
            1216.0,
            510.0,
            2093.0,
            546.0
          ],
          "confidence": 0.994750440120697
        },
        {
          "text": "This Product Manufacturing Agreement (\"Agreement') is made as of the Effective Date by and between DEXCEL LTD., with its registered address.",
          "bbox": [
            275.0,
            563.0,
            3023.0,
            609.0
          ],
          "confidence": 0.989086925983429
        },
        {
          "text": "at ****, Israel (\"Dexcel'') and KITOV Pharma Ltd., with its registered office at 132 Menachem Begin Road, Azrieli Center, Tel Aviv, 6701101, Israel.",
          "bbox": [
            274.0,
            618.0,
            3000.0,
            665.0
          ],
          "confidence": 0.9887864589691162
        },
        {
          "text": "(\"Kitov'). Dexcel and Kitov are hereinafter jointly the \"Parties' and individually a \"Party.\".",
          "bbox": [
            279.0,
            678.0,
            1945.0,
            722.0
          ],
          "confidence": 0.98404461145401
        },
        {
          "text": "WHEREAS: Dexcel is a pharmaceutical company engaged in various activities including, but not limited to, the research, development,",
          "bbox": [
            275.0,
            729.0,
            2817.0,
            780.0
          ],
          "confidence": 0.9837751388549805
        },
        {
          "text": "manufacture, and marketing of various drugs and pharmaceutical specialties in various dosage forms;",
          "bbox": [
            549.0,
            795.0,
            2438.0,
            831.0
          ],
          "confidence": 0.9977880120277405
        },
        {
          "text": "WHEREAS:",
          "bbox": [
            281.0,
            848.0,
            515.0,
            884.0
          ],
          "confidence": 0.9993464946746826
        },
        {
          "text": "Kitov is a pharmaceutical company engaged in various activities including, but not limited to, the development of pharmaceutical",
          "bbox": [
            546.0,
            844.0,
            2951.0,
            890.0
          ],
          "confidence": 0.9910856485366821
        },
        {
          "text": "products;",
          "bbox": [
            551.0,
            906.0,
            732.0,
            945.0
          ],
          "confidence": 0.9994080066680908
        },
        {
          "text": "WHEREAS:",
          "bbox": [
            279.0,
            959.0,
            513.0,
            996.0
          ],
          "confidence": 0.9993117451667786
        },
        {
          "text": "Kitov and Dexcel entered into a Development Services Agreement on April 1, 2014 (\"Development Agreement'), pursuant to which",
          "bbox": [
            549.0,
            958.0,
            2991.0,
            1000.0
          ],
          "confidence": 0.9946937561035156
        },
        {
          "text": "Dexcel performed certain development services for Kitov with respect to the Product;",
          "bbox": [
            551.0,
            1016.0,
            2139.0,
            1058.0
          ],
          "confidence": 0.9957237243652344
        },
        {
          "text": "WHEREAS:",
          "bbox": [
            281.0,
            1071.0,
            515.0,
            1107.0
          ],
          "confidence": 0.9993150234222412
        },
        {
          "text": "Kitov desires that Dexcel manufacture and package the Product for Kitov in accordance with the terms of this Agreement, and Dexcel",
          "bbox": [
            546.0,
            1069.0,
            3029.0,
            1115.0
          ],
          "confidence": 0.9908015131950378
        },
        {
          "text": "is willing to manufacture and package the Product for Kitov in accordance with the terms of this Agreement..",
          "bbox": [
            547.0,
            1126.0,
            2561.0,
            1171.0
          ],
          "confidence": 0.9924741387367249
        },
        {
          "text": "NOw, THEREFORE, in consideration of the mutual covenants herein contained, the Parties, intending to be legally bound, hereby agree as",
          "bbox": [
            275.0,
            1180.0,
            2876.0,
            1228.0
          ],
          "confidence": 0.9950727820396423
        },
        {
          "text": "follows:",
          "bbox": [
            275.0,
            1237.0,
            426.0,
            1279.0
          ],
          "confidence": 0.9998461008071899
        },
        {
          "text": "1",
          "bbox": [
            277.0,
            1299.0,
            303.0,
            1330.0
          ],
          "confidence": 0.9999181032180786
        },
        {
          "text": "Definitions",
          "bbox": [
            368.0,
            1296.0,
            589.0,
            1334.0
          ],
          "confidence": 0.999856173992157
        },
        {
          "text": "For the purpose of this Agreement, the terms set forth in this clause, whether used in singular or plural form, shall mean, unless otherwise expressly.",
          "bbox": [
            277.0,
            1352.0,
            3012.0,
            1394.0
          ],
          "confidence": 0.9917291402816772
        },
        {
          "text": "provided for in this Agreement or the context otherwise requires, the following:.",
          "bbox": [
            277.0,
            1405.0,
            1749.0,
            1453.0
          ],
          "confidence": 0.9938557744026184
        },
        {
          "text": "1.1",
          "bbox": [
            379.0,
            1460.0,
            439.0,
            1506.0
          ],
          "confidence": 0.9998831748962402
        },
        {
          "text": "\"Affiliate\"' of a Party shall mean any corporation or other business entity directly or indirectly Controlled by, under common Control.",
          "bbox": [
            546.0,
            1458.0,
            3012.0,
            1509.0
          ],
          "confidence": 0.9893513917922974
        },
        {
          "text": "with, or in the Control of such Party..",
          "bbox": [
            551.0,
            1518.0,
            1222.0,
            1564.0
          ],
          "confidence": 0.9819372296333313
        },
        {
          "text": "1.2",
          "bbox": [
            377.0,
            1573.0,
            440.0,
            1619.0
          ],
          "confidence": 0.9997513890266418
        },
        {
          "text": "\"Anti-Corruption and Anti-Bribery Laws\" shall mean the United States Foreign Corrupt Practices Act of 1977, as amended, the",
          "bbox": [
            549.0,
            1577.0,
            2925.0,
            1619.0
          ],
          "confidence": 0.9937560558319092
        },
        {
          "text": "Bribery Act 2010 (2010 Chapter 23) of the Parliament of the United Kingdom, any rules or regulations under such acts, and any other",
          "bbox": [
            551.0,
            1634.0,
            3011.0,
            1676.0
          ],
          "confidence": 0.9908789992332458
        },
        {
          "text": "anti-corruption or anti-bribery statutes, laws or regulations applicable to a Party..",
          "bbox": [
            547.0,
            1687.0,
            2039.0,
            1732.0
          ],
          "confidence": 0.9931536316871643
        },
        {
          "text": "1.3",
          "bbox": [
            379.0,
            1741.0,
            440.0,
            1787.0
          ],
          "confidence": 0.9998380541801453
        },
        {
          "text": "\"API\"' shall mean the active pharmaceutical ingredients Celecoxib and Amlodipine Besylate..",
          "bbox": [
            549.0,
            1741.0,
            2277.0,
            1787.0
          ],
          "confidence": 0.9627962112426758
        },
        {
          "text": "Source: KITOV PHARMA LTD., 20-F, 3/26/2019",
          "bbox": [
            332.0,
            4437.0,
            1256.0,
            4479.0
          ],
          "confidence": 0.988348126411438
        }
      ],
      "multi_page": true,
      "part_of": 2,
      "nearby_headers": [
        {
          "text": "THE SYMBOL <****\" DENOTES PLACES WHERE PORTIONS OF THIS DOCUMENT HAVE BEEN OMITTED PURSUANT TO A REQUEST",
          "page": 0,
          "bbox": [
            304.0,
            338.0,
            3009.0,
            380.0
          ]
        },
        {
          "text": "FOR CONFIDENTIAL TREATMENT. SUCH MATERIAL WILL BE FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE",
          "page": 0,
          "bbox": [
            399.0,
            398.0,
            2907.0,
            435.0
          ]
        },
        {
          "text": "COMIMISSION.",
          "page": 0,
          "bbox": [
            1503.0,
            455.0,
            1805.0,
            492.0
          ]
        },
        {
          "text": "PRODUCT MANUFACTURING AGREEMENT",
          "page": 0,
          "bbox": [
            1216.0,
            510.0,
            2093.0,
            546.0
          ]
        },
        {
          "text": "WHEREAS:",
          "page": 0,
          "bbox": [
            281.0,
            848.0,
            515.0,
            884.0
          ]
        },
        {
          "text": "WHEREAS:",
          "page": 0,
          "bbox": [
            279.0,
            959.0,
            513.0,
            996.0
          ]
        },
        {
          "text": "WHEREAS:",
          "page": 0,
          "bbox": [
            281.0,
            1071.0,
            515.0,
            1107.0
          ]
        }
      ]
    },
    {
      "id": "KitovPharmaLtd_20190326_20-F_EX-4.15_11584449_EX-4.15_Manufacturing Agreement__Insurance_1_multi",
      "question": "Highlight the parts (if any) of this contract related to \"Insurance\" that should be reviewed by a lawyer. Details: Is there a requirement for insurance that must be maintained by one party for the benefit of the counterparty?",
      "answer_text": "Each Party shall maintain (a) comprehensive general liability insurance (including without limitation, coverage for bodily injury, personal injury, property damage, casualty loss and contractual and trademark liability); and (b) product liability insurance, providing full indemnification and defense against claims, liabilities, damages, demands and causes of action, alleged or actual, arising out of any defects in or use of the Product under this Agreement (including manufacturing, design, warning, or instruction claims), in such amounts as it customarily maintains for similar products and activities, but in no event less than $5,000,000 per individual claim and $10,000,000 in the aggregate",
      "page_number": 1,
      "words": [
        {
          "text": "1.4",
          "bbox": [
            379.0,
            281.0,
            442.0,
            327.0
          ],
          "confidence": 0.9997868537902832
        },
        {
          "text": "\"Batch' shall mean the defined quantity of the Product processed in a single process or series of processes in a manner designed to.",
          "bbox": [
            549.0,
            281.0,
            3011.0,
            329.0
          ],
          "confidence": 0.9841217398643494
        },
        {
          "text": "be homogeneous. The Batch size for the Product is **** tablets.",
          "bbox": [
            551.0,
            338.0,
            1756.0,
            382.0
          ],
          "confidence": 0.9994081258773804
        },
        {
          "text": "1.5",
          "bbox": [
            376.0,
            390.0,
            443.0,
            443.0
          ],
          "confidence": 0.9997324347496033
        },
        {
          "text": "\"cGMPs\" or \"Good Manufacturing Practice\"' shall mean the part of quality assurance which ensures that the Product is consistently.",
          "bbox": [
            549.0,
            395.0,
            3023.0,
            440.0
          ],
          "confidence": 0.985264241695404
        },
        {
          "text": "produced and controlled to the quality standards appropriate to their intended use, the principles and guidelines of which are",
          "bbox": [
            549.0,
            451.0,
            2884.0,
            499.0
          ],
          "confidence": 0.9912954568862915
        },
        {
          "text": "specified in European Commission Directive 2003/94/EC and the FDA's current Good Manufacturing Practices, particularly 21 CFR ",
          "bbox": [
            547.0,
            506.0,
            3003.0,
            557.0
          ],
          "confidence": 0.995246410369873
        },
        {
          "text": "210 et seq., and 21 CFR $$ 600-610, as both may be amended from time to time..",
          "bbox": [
            549.0,
            565.0,
            2006.0,
            607.0
          ],
          "confidence": 0.9747835993766785
        },
        {
          "text": "1.6",
          "bbox": [
            379.0,
            619.0,
            442.0,
            663.0
          ],
          "confidence": 0.9999213218688965
        },
        {
          "text": "\"Change of Control' shall mean (i) any change, sale, merger, reorganization, or any other event or action that results in a third party,",
          "bbox": [
            547.0,
            618.0,
            3005.0,
            669.0
          ],
          "confidence": 0.9930126070976257
        },
        {
          "text": "which is a material competitor to the other Party to this agreement, acquiring: (a) all or substantially all of the business or assets of a.",
          "bbox": [
            551.0,
            678.0,
            3002.0,
            722.0
          ],
          "confidence": 0.9852778911590576
        },
        {
          "text": "Party relating to this Agreement, (b) Control, directly or indirectly, of such Party (and/or any corporate entity that Controls, directly.",
          "bbox": [
            551.0,
            735.0,
            2985.0,
            778.0
          ],
          "confidence": 0.9932605624198914
        },
        {
          "text": "or indirectly, such Party), or (ii) any assignment or delegation of, sale or transfer of a Party's rights and obligations under this",
          "bbox": [
            549.0,
            789.0,
            2878.0,
            835.0
          ],
          "confidence": 0.9923490881919861
        },
        {
          "text": "Agreement (or any part hereof) to a third party.",
          "bbox": [
            555.0,
            848.0,
            1426.0,
            890.0
          ],
          "confidence": 0.9961597323417664
        },
        {
          "text": "Notwithstanding anything in the immediately preceding paragraph to the contrary, where the Party in question is Dexcel, any of the",
          "bbox": [
            549.0,
            903.0,
            2991.0,
            945.0
          ],
          "confidence": 0.9957303404808044
        },
        {
          "text": "foregoing events or actions shall not be considered a Change of Control where any one or more of the relevant third party or parties.",
          "bbox": [
            551.0,
            961.0,
            3007.0,
            1003.0
          ],
          "confidence": 0.9899225234985352
        },
        {
          "text": "referred to in clause (i) above is (A) a Family Member, or (B) any entity Controlled by Mr. **** and/or a Family Member.",
          "bbox": [
            544.0,
            1005.0,
            2788.0,
            1064.0
          ],
          "confidence": 0.9933032989501953
        },
        {
          "text": "1.7",
          "bbox": [
            379.0,
            1067.0,
            442.0,
            1113.0
          ],
          "confidence": 0.9998312592506409
        },
        {
          "text": "\"Claims' shall mean any demands, claims, actions, causes of action, assessments, losses, damages, injuries, liabilities, costs and.",
          "bbox": [
            549.0,
            1069.0,
            2953.0,
            1115.0
          ],
          "confidence": 0.9854910969734192
        },
        {
          "text": "expenses (including, without limitation, reasonable attorneys' fees and expenses) filed, raised, initiated or made by any governmental.",
          "bbox": [
            553.0,
            1129.0,
            3021.0,
            1171.0
          ],
          "confidence": 0.992518424987793
        },
        {
          "text": "authority and/or third party.",
          "bbox": [
            551.0,
            1184.0,
            1066.0,
            1226.0
          ],
          "confidence": 0.983346164226532
        },
        {
          "text": "1.8",
          "bbox": [
            379.0,
            1235.0,
            442.0,
            1281.0
          ],
          "confidence": 0.9999089241027832
        },
        {
          "text": "\"Confidential Information\"' shall have the meaning set forth in Section 7.1.",
          "bbox": [
            549.0,
            1235.0,
            1939.0,
            1281.0
          ],
          "confidence": 0.9719286561012268
        },
        {
          "text": "1.9",
          "bbox": [
            379.0,
            1292.0,
            440.0,
            1336.0
          ],
          "confidence": 0.9999080300331116
        },
        {
          "text": "\"Confirmed Order' shall have the meaning set forth in Section 3.3.2.",
          "bbox": [
            549.0,
            1292.0,
            1834.0,
            1338.0
          ],
          "confidence": 0.9867768883705139
        },
        {
          "text": "1.10",
          "bbox": [
            379.0,
            1347.0,
            462.0,
            1394.0
          ],
          "confidence": 0.9999012351036072
        },
        {
          "text": "\"Control' or \"Controlled' shall mean possession of more than fifty percent (50%) of the share capital of a corporation or other",
          "bbox": [
            547.0,
            1345.0,
            2915.0,
            1398.0
          ],
          "confidence": 0.981292724609375
        },
        {
          "text": "business entity, and/or the power to direct or cause the direction of the management and policies of a corporation or other entity",
          "bbox": [
            549.0,
            1405.0,
            2936.0,
            1451.0
          ],
          "confidence": 0.9941077828407288
        },
        {
          "text": "whether through the ownership of voting securities, by contract or otherwise..",
          "bbox": [
            553.0,
            1467.0,
            1996.0,
            1504.0
          ],
          "confidence": 0.9934757947921753
        },
        {
          "text": "1.11",
          "bbox": [
            379.0,
            1517.0,
            455.0,
            1561.0
          ],
          "confidence": 0.999779224395752
        },
        {
          "text": "\"Delivery' shall mean the time when the Product is placed at the disposal of Kitov at Dexcel's Facility based on an ****",
          "bbox": [
            546.0,
            1508.0,
            2799.0,
            1568.0
          ],
          "confidence": 0.992178738117218
        },
        {
          "text": "(Incoterms 2010).",
          "bbox": [
            555.0,
            1579.0,
            904.0,
            1617.0
          ],
          "confidence": 0.99842768907547
        },
        {
          "text": "1.12",
          "bbox": [
            377.0,
            1626.0,
            462.0,
            1674.0
          ],
          "confidence": 0.9999103546142578
        },
        {
          "text": "\"Distributors\" shall mean any Person under contract with Kitov or any of its Affiliates for the distribution of the Product in a certain",
          "bbox": [
            553.0,
            1634.0,
            3018.0,
            1670.0
          ],
          "confidence": 0.9918192625045776
        },
        {
          "text": "territory or territories..",
          "bbox": [
            551.0,
            1692.0,
            946.0,
            1729.0
          ],
          "confidence": 0.9840478301048279
        },
        {
          "text": "1.13",
          "bbox": [
            381.0,
            1741.0,
            459.0,
            1785.0
          ],
          "confidence": 0.8832098245620728
        },
        {
          "text": "\"Effective Date' shall mean the date of signature of the last Party to execute this Agreement..",
          "bbox": [
            549.0,
            1741.0,
            2267.0,
            1787.0
          ],
          "confidence": 0.9844200611114502
        },
        {
          "text": "1.14",
          "bbox": [
            379.0,
            1798.0,
            460.0,
            1840.0
          ],
          "confidence": 0.9994210004806519
        },
        {
          "text": "\"EMA\" means the European Medicines Agency or any successor entity.",
          "bbox": [
            549.0,
            1798.0,
            1898.0,
            1846.0
          ],
          "confidence": 0.9979910254478455
        },
        {
          "text": "1.15",
          "bbox": [
            379.0,
            1851.0,
            460.0,
            1900.0
          ],
          "confidence": 0.9995757341384888
        },
        {
          "text": "\"Family Member\" shall mean ****.",
          "bbox": [
            547.0,
            1847.0,
            1222.0,
            1902.0
          ],
          "confidence": 0.9885128736495972
        },
        {
          "text": "1.16",
          "bbox": [
            379.0,
            1908.0,
            462.0,
            1955.0
          ],
          "confidence": 0.9999197125434875
        },
        {
          "text": "\"FDA\" means the U.S. Food and Drug Administration or any successor entity..",
          "bbox": [
            549.0,
            1911.0,
            2005.0,
            1953.0
          ],
          "confidence": 0.986582338809967
        },
        {
          "text": "2",
          "bbox": [
            1638.0,
            2025.0,
            1669.0,
            2061.0
          ],
          "confidence": 0.999761164188385
        },
        {
          "text": "Source: KITOV PHARMA LTD., 20-F, 3/26/2019",
          "bbox": [
            332.0,
            4437.0,
            1256.0,
            4479.0
          ],
          "confidence": 0.989766538143158
        }
      ],
      "multi_page": true,
      "part_of": 2
    }
  ]
}